ID	Gene Name	Species	GAD_DISEASE	GAD_DISEASE_CLASS	GOTERM_BP_FAT	GOTERM_CC_FAT	GOTERM_MF_FAT	KEGG_PATHWAY	OMIM_DISEASE
37166_at	3-hydroxyanthranilate 3,4-dioxygenase(HAAO)	Homo sapiens	Alcoholism,Amyotrophic Lateral Sclerosis,Celiac Disease|,Heart Rate,Hemoglobin A, Glycosylated,Multiple Sclerosis,	CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,IMMUNE,NEUROLOGICAL,	GO:0006082~organic acid metabolic process,GO:0006568~tryptophan metabolic process,GO:0006569~tryptophan catabolic process,GO:0006576~cellular biogenic amine metabolic process,GO:0006586~indolalkylamine metabolic process,GO:0006732~coenzyme metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006753~nucleoside phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0009072~aromatic amino acid family metabolic process,GO:0009074~aromatic amino acid family catabolic process,GO:0009108~coenzyme biosynthetic process,GO:0009117~nucleotide metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009308~amine metabolic process,GO:0009310~amine catabolic process,GO:0009435~NAD biosynthetic process,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010043~response to zinc ion,GO:0016053~organic acid biosynthetic process,GO:0016054~organic acid catabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019359~nicotinamide nucleotide biosynthetic process,GO:0019362~pyridine nucleotide metabolic process,GO:0019363~pyridine nucleotide biosynthetic process,GO:0019438~aromatic compound biosynthetic process,GO:0019439~aromatic compound catabolic process,GO:0019637~organophosphate metabolic process,GO:0019674~NAD metabolic process,GO:0019725~cellular homeostasis,GO:0019752~carboxylic acid metabolic process,GO:0019805~quinolinate biosynthetic process,GO:0032787~monocarboxylic acid metabolic process,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0034627~'de novo' NAD biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0042402~cellular biogenic amine catabolic process,GO:0042430~indole-containing compound metabolic process,GO:0042436~indole-containing compound catabolic process,GO:0042592~homeostatic process,GO:0043420~anthranilate metabolic process,GO:0043436~oxoacid metabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0043650~dicarboxylic acid biosynthetic process,GO:0044106~cellular amine metabolic process,GO:0044248~cellular catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0044282~small molecule catabolic process,GO:0044283~small molecule biosynthetic process,GO:0044712~single-organism catabolic process,GO:0046218~indolalkylamine catabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046496~nicotinamide nucleotide metabolic process,GO:0046686~response to cadmium ion,GO:0046700~heterocycle catabolic process,GO:0046874~quinolinate metabolic process,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,GO:0055086~nucleobase-containing small molecule metabolic process,GO:0055114~oxidation-reduction process,GO:0060249~anatomical structure homeostasis,GO:0070050~neuron cellular homeostasis,GO:0072524~pyridine-containing compound metabolic process,GO:0072525~pyridine-containing compound biosynthetic process,GO:0090407~organophosphate biosynthetic process,GO:1901293~nucleoside phosphate biosynthetic process,GO:1901361~organic cyclic compound catabolic process,GO:1901565~organonitrogen compound catabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:1901605~alpha-amino acid metabolic process,GO:1901606~alpha-amino acid catabolic process,GO:1990267~response to transition metal nanoparticle,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0000334~3-hydroxyanthranilate 3,4-dioxygenase activity,GO:0005506~iron ion binding,GO:0008198~ferrous iron binding,GO:0009055~electron carrier activity,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051213~dioxygenase activity,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,	
34467_g_at	5-hydroxytryptamine receptor 4(HTR4)	Homo sapiens	ADHD | attention-deficit hyperactivity disorder,attention deficit hyperactivity disorder,attention deficit hyperactivity disorder behavior disorder,Bipolar Disorder,Body Weight,C-Reactive Protein,Cholesterol, LDL,Fatigue Syndrome, Chronic,Fatigue|Fatigue Syndrome, Chronic,Hip,Lung Diseases,migraine ,normal variation,null,Pulmonary Disease, Chronic Obstructive,pulmonary function,Respiratory Function Tests,Schizophrenia,several psychiatric disorders,Tissue Plasminogen Activator,Urinalysis,Weight Gain,	CARDIOVASCULAR,METABOLIC,NEUROLOGICAL,PSYCH,RENAL,UNKNOWN,	GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007210~serotonin receptor signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0009605~response to external stimulus,GO:0009991~response to extracellular stimulus,GO:0031667~response to nutrient levels,GO:0032098~regulation of appetite,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,	GO:0005768~endosome,GO:0005773~vacuole,GO:0005887~integral component of plasma membrane,GO:0031226~intrinsic component of plasma membrane,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0008227~G-protein coupled amine receptor activity,GO:0038023~signaling receptor activity,GO:0060089~molecular transducer activity,GO:0099589~serotonin receptor activity,GO:0099600~transmembrane receptor activity,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,	
40350_at	ADAM metallopeptidase domain 23(ADAM23)	Homo sapiens	Albuminuria,Asthma|Hypersensitivity, Immediate,Cholesterol,Chronic renal failure|Kidney Failure, Chronic,Dehydroepiandrosterone,Tobacco Use Disorder,	CHEMDEPENDENCY,IMMUNE,METABOLIC,RENAL,	GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0022610~biological adhesion,	GO:0005576~extracellular region,GO:0005887~integral component of plasma membrane,GO:0031226~intrinsic component of plasma membrane,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005102~receptor binding,GO:0005178~integrin binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0032403~protein complex binding,GO:0044877~macromolecular complex binding,GO:0050839~cell adhesion molecule binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,		
1575_at	ATP binding cassette subfamily B member 1(ABCB1)	Homo sapiens	9-aminocamptothecin pharmacokinetics 9-nitrocamptothecin pharmacokinetics,9-Hydroxyrisperidone and Risperidone,9-hydroxyrisperidone; risperidone,ABT-773 plasma levels,Acquired Immunodeficiency Syndrome|,Acquired Immunodeficiency Syndrome|HIV Infections,Acute Coronary Syndrome,Acute Coronary Syndrome|Cardiovascular Diseases,acute rejection after kidney transplantation,Addison Disease,Adenocarcinoma|Cell Transformation, Neoplastic|Colorectal Neoplasms,Adenocarcinoma|Pancreatic Neoplasms,Adenocarcinoma|Stomach Neoplasms,aging,Alcoholism|Head and Neck Neoplasms,aldosterone blood pressure, arterial kidney function left ventricular function,aldosterone blood pressure, arterial renin activity,allogenic stem cell transplantation,altered efflux of the P-glycoprotein substrate rhodamine,Alzheimer Disease|Alzheimer's Disease|Amnesia,Alzheimer's Disease,Alzheimer's disease   ,amlodipine pharmacokinetics,anticoagulant complications,antiemetic response,Apoplexy|Cardiovascular Diseases|Coronary Restenosis|Myocardial Infarction|Recurrence|Stroke,arthritis Crohn's disease ulcerative colitis,Arthritis, Rheumatoid,Arthritis, Rheumatoid|,Arthritis, Rheumatoid|Rheumatoid Arthritis,Asthma|,atazanavir pharmacokinetics lopinavir pharmacokinetics,atazanavir pharmacokinetics; hyperbilirubinemia,atrasentan phamacokinetics,autism,bilirubin indinavir oral clearance lamivudine-triphosphate concentration zidovudine-triphosphate concentration,Birth Weight|Respiratory Distress Syndrome, Newborn,Bladder Cancer,blood tacrolimus concentrations ,BMI- Edema rosiglitazone or pioglitazone,Body Weight,Body Weight|Gastrointestinal Stromal Tumors,Bone necrosis|Lupus Erythematosus, Systemic|Osteonecrosis|Systemic lupus erythematosus,brain cancer,Brain Neoplasms|Glioblastoma,Breast Cancer,breast cancer   ,C-reactive protein gingival overgrowth,Cancer,Carcinoma, Renal Cell|Gilbert Disease|Hyperbilirubinemia|Kidney Neoplasms|Renal Cell Carcinoma,Carcinoma, Renal Cell|Kidney Neoplasms|Renal Cell Carcinoma,Carcinoma, Squamous Cell|Head and Neck Neoplasms,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Squamous cell carcinoma,cardiotoxicity,cardiovascular disease,carvedilol pharmacokinetics,central nervous system relapse,Cholangitis, Sclerosing,Cholesterol, HDL,cholesterol, HDL cholesterol, LDL heart transplant,cholesterol, HDL; cholesterol, LDL; leukemia; 9-hydroxyrisperidone; risperidone,cholesterol; cholesterol, HDL; triglycerides; cholesterol, LDL,cholesterol; cholesterol, HDL; triglycerides; diabetes, type 2; ulcerative colitis; cholesterol, LDL; liver disease;,cholesterol; cholesterol, LDL,chronic obstructive pulmonary disease,Chronic renal failure|Kidney Failure, Chronic,Chronic ulcerative colitis|Colitis, Ulcerative|Crohn Disease|Crohn's disease,ciclosporin pharmacokinetics,cirrhosis, biliary primary,citalopram,Cleft Lip|Cleft Palate,clopidogrel,Clozapine,clozapine plasma levels,colchicine response,Colitis, Ulcerative|,colorectal adenomas,Colorectal Cancer,colorectal cancer Crohn's disease ulcerative colitis,colorectal cancer esophageal cancer,Colorectal Neoplasms|Neutropenia,Coronary Artery Disease|Myocardial Infarction,creatinine kidney failure, chronic,Crohn Disease,Crohn Disease|,Crohn's disease,Crohn's disease inflammatory bowel disease,Crohn's disease ulcerative colitis,Crohn's disease; ulcerative colitis,cyclosporine,cyclosporine A,cyclosporine absorption,cyclosporine levels,cyclosporine nephrotoxicity,cyclosporine pahrmacokinetics,cyclosporine pharmacokinetics,cyclosporine resistance,CYP2D6 activity CYP3A4 activity,Cystic Fibrosis,cytokine release,Delayed Graft Function,Delayed Graft Function|Diabetes mellitus,dementia longevity,Depression,dexamethasone pharmacokinetics,Diabetes Mellitus|Postoperative Complications,dicloxacillin pharmacokinetics,digoxin pharmacokinetics,digoxin serum concentration,digoxin, bioavailability,digoxin, serum concentration,docetaxel elimination,docetaxel pharmacokinetics,docetaxel pharmacokinetics docetaxel toxicity,dose of nevirapine or efavirenz,Drug Hypersensitivity,Drug-Induced Liver Injury|Graft vs Host Disease|Inflammation|Leukemia|Liver Diseases,drug-related genes ,Dyskinesia, Drug-Induced,Dyslipidemias|HIV Infections|[X]Human immunodeficiency virus disease,ebastine metabolism,Efavirenz ,efavirenz pharmacokinetics,Encephalomyelitis, Autoimmune, Experimental|Multiple Sclerosis,endometrial cancer,Epilepsies, Partial,epilepsy,epilepsy phentoin levels,Epilepsy, Generalized,epilepsy, multidrug-resistant,epilepsy, refractory,epilepsy, temporal lobe,epilepsy; anticoagulant complications,Epilepsy|,epilpsy,esophageal adenocarcinoma,Esophageal Cancer,Familial Mediterranean Fever,Femur Head Necrosis,Femur Head Necrosis|,fentanyl effects,fexofenadine pharmacokinetics,fluvoxamine pharmacokinetics,gabapentin pharmacokinetics,gastric cancer,Gastritis|Helicobacter Infections,Gastritis|Helicobacter Infections|Peptic Ulcer,Gastroparesis,gefitinib pharmacokinetics,gefitinib toxicity,Genitourinary Neoplasms|Urogenital Neoplasms,Gingival Overgrowth,graft-versus-host disease,Graves Disease|Hashimoto Disease|Hyperthyroidism|Hypothyroidism,H. pylori infection,head and neck cancer,Heart Failure,heart transplant,Helicobacter Infections,Helicobacter Infections|Peptic Ulcer,Helicobacter Infections|Peptic Ulcer|Stomach Neoplasms,hepatic CYP3A4 expression,Hepatitis B, Chronic,Heroin Dependence,HIV,HIV infection,HIV Infections,HIV Infections|[X]Human immunodeficiency virus disease,HIV Infections|Hyperbilirubinemia|[X]Human immunodeficiency virus disease,HIV Infections|Kidney Failure,HIV-1,HIV; CYP3A activity,HIV; CYP3A activity; prostate cancer,Hypercholesterolemia,hypercholesterolemia; drug hypersensitivity,hypercholesterolemia; H. pylori infection; coagulation disorder,Hypercholesterolemia|LDLC levels,Hyperlipidemias,hypertension,Hypotension,imatinib toxicity,immunosuppression, chemotherapy induced,indinavir pharmacokinetics,Infection|Precursor Cell Lymphoblastic Leukemia-Lymphoma,inflammatory bowel disease,inflammatory bowel disease ,inflammatory bowel disease breast cancer   ,irinotecan pharmacokinetics,irinotecan pharmacokinetics irinotecan toxicity lung cancer,irinotecan toxicity,irinotecan, renal clearance of,Kidney Diseases,kidney dysfunction,kidney failure, chronic,kidney transplant,kidney transplant complications,kidney transplant; cyclospoine pharmacokinetics; heart transplant,kidney transplant; tacrolium pharmacokinetic,lansoprazole pharmacokinetics,leukemia,leukemia, acute lymphoblastic,leukemia, acute myeloblastic,leukemia, acute myeloid,leukemia, childhood acute; hypertension,Leukemia, Erythroblastic, Acute|Leukemia, Megakaryoblastic, Acute|Leukemia, Monocytic, Acute|Leukemia, Myeloid|Leukemia, Myeloid, Acute|Leukemia, Myelomonocytic, Acute|Leukemia, Promyelocytic, Acute,Leukemia, Lymphocytic, Chronic, B-Cell,Leukemia, Lymphoid,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Leukemia, Myelogenous, Chronic, BCR-ABL Positive|Neovascularization, Pathologic,Leukemia, Myeloid,Leukemia, Myeloid, Acute,Leukemia, Myeloid, Chronic-Phase,Leukopenia|Neutropenia,liver cancer,liver transplant,liver transplant; prostate cancer; premature ovarian failure; lupus nephritis,loperamide concentration,loperamide disposition and central nervous system effects.,lopinavir accumulation,Lung Cancer,lung cancer ,lung transplant,lung transplant complications,Lupus Nephritis|Nephritis SLE|Vasculitis,Lymphoma, T-Cell, Cutaneous|Lymphoma, T-Cell, Peripheral|Skin Neoplasms,lymphoproliferative disorders,maculopathy,major depression,Malaria,male infertility,manic depression,Marijuana Abuse,mefloquine adverse effects,Menopause,metabolite of mycophenolic acid,methadone dose requirement,methadone levels,methotrexate toxicity,mood disorder schizophrenia,morphine response,morphine-induced adverse drug reactions,multiple myeloma,Multiple Myeloma|Recurrence,myasthenia gravis,mycophenolic acid pharmacokinetics,Myocardial Infarction,Myocardial Infarction|Stroke,nasopharyngeal cancer,Nasopharyngeal Neoplasms,nelfinavir pharmacokinetics,Neoplasms,Neoplasms|Pain,Nephrotic Syndrome,Neurotoxicity Syndromes|Precursor Cell Lymphoblastic Leukemia-Lymphoma,neutropenia,nevaprine pharmacokinetics,Nevirapine,nevirapine hepatotoxicity,normal menstrual cycles,normal variation,null,Obesity,Obesity|Weight Gain,osteonecrosis, steroid induced,Osteonecrosis|Precursor Cell Lymphoblastic Leukemia-Lymphoma,ovarian cancer,ovarian cancer  ,P-glycoprotein,P-glycoprotein expression, placental,P-glycoprotein substrate loperamide,paclitaxel pharmacokinetics,paclitaxel toxicity,paediatric renal allograft,Pain,Pain, Postoperative|Postoperative Nausea and Vomiting|Pruritus|Pruritus NOS|Respiratory Insufficiency,Pancreatitis, Alcoholic,Parkinson's Disease,Parkinson's disease    ,Parkinson's disease; HIV,pharmacogenetic diversity ,pharmacogenetic studies,pharmacogenetic variation,pharmacogenetics of cyclosporine,phenytoin,phenytoin levels,Phospholipids,plasma cell myeloma,plasma HDL-C levels,Postoperative Nausea and Vomiting,pravastatin kinetics,Precursor Cell Lymphoblastic Leukemia-Lymphoma,prolactin,prostate cancer,renal cancer,renal cancer; morphine response,renal function,Renal Insufficiency,renal transplant,repaglinide pharmacokinetics,rheumatoid arthritis,rifampicin pharmacokinetics,Risperidone,saquinavir pharmacokinetics,Schizophrenia,seizures,several psychiatric disorders,simvastatin,simvastatin pharmacokinetics talinol pharmacokinetics,solid tumors,steroid weaning,stomach cancer,Stomach Neoplasms,tacrolimus,tacrolimus and cyclosporine,tacrolimus dose requirements,tacrolimus nephrotoxicity,tacrolimus phamacokinetics,tacrolimus pharmacokinetics,tacrolimus pharmacokinetics; sirolimus pharmacokinetics,tacrolimus pharmcokinetics,talinolol pharmacokinetics,telmisartan,thrombosis,Tobacco Use Disorder,treatment response in psychotic patients,Tuberculosis,Tuberculosis, Pulmonary,Type 2 Diabetes| edema | rosiglitazone,ulcerative colitis,Urologic Neoplasms,vincristine pharmacokinetics,voriconazole,	AGING,CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0002428~antigen processing and presentation of peptide antigen via MHC class Ib,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002475~antigen processing and presentation via MHC class Ib,GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib,GO:0002477~antigen processing and presentation of exogenous peptide antigen via MHC class Ib,GO:0002478~antigen processing and presentation of exogenous peptide antigen,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002483~antigen processing and presentation of endogenous peptide antigen,GO:0002484~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002488~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002577~regulation of antigen processing and presentation,GO:0002579~positive regulation of antigen processing and presentation,GO:0002583~regulation of antigen processing and presentation of peptide antigen,GO:0002585~positive regulation of antigen processing and presentation of peptide antigen,GO:0002589~regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0006855~drug transmembrane transport,GO:0006869~lipid transport,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0010876~lipid localization,GO:0015748~organophosphate ester transport,GO:0015893~drug transport,GO:0015914~phospholipid transport,GO:0019882~antigen processing and presentation,GO:0019883~antigen processing and presentation of endogenous antigen,GO:0019884~antigen processing and presentation of exogenous antigen,GO:0019885~antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0022402~cell cycle process,GO:0033036~macromolecule localization,GO:0034204~lipid translocation,GO:0042493~response to drug,GO:0042908~xenobiotic transport,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044802~single-organism membrane organization,GO:0044839~cell cycle G2/M phase transition,GO:0045332~phospholipid translocation,GO:0048002~antigen processing and presentation of peptide antigen,GO:0055085~transmembrane transport,GO:0061024~membrane organization,GO:0072089~stem cell proliferation,GO:0097035~regulation of membrane lipid distribution,GO:1903047~mitotic cell cycle process,	GO:0005576~extracellular region,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,GO:0098590~plasma membrane region,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0008525~phosphatidylcholine transporter activity,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015238~drug transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0022804~active transmembrane transporter activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042910~xenobiotic transporter activity,GO:0043492~ATPase activity, coupled to movement of substances,GO:0090484~drug transporter activity,GO:0090554~phosphatidylcholine-translocating ATPase activity,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa02010:ABC transporters,hsa04976:Bile secretion,hsa05206:MicroRNAs in cancer,	120080~Colchicine resistance,612244~Inflammatory bowel disease 13,
40294_at	ATP binding cassette subfamily B member 9(ABCB9)	Homo sapiens	drug-related genes ,Neutrophils,	IMMUNE,PHARMACOGENOMIC,	GO:0002428~antigen processing and presentation of peptide antigen via MHC class Ib,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002475~antigen processing and presentation via MHC class Ib,GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib,GO:0002477~antigen processing and presentation of exogenous peptide antigen via MHC class Ib,GO:0002478~antigen processing and presentation of exogenous peptide antigen,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002483~antigen processing and presentation of endogenous peptide antigen,GO:0002484~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002488~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002577~regulation of antigen processing and presentation,GO:0002579~positive regulation of antigen processing and presentation,GO:0002583~regulation of antigen processing and presentation of peptide antigen,GO:0002585~positive regulation of antigen processing and presentation of peptide antigen,GO:0002589~regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0006857~oligopeptide transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0015833~peptide transport,GO:0019882~antigen processing and presentation,GO:0019883~antigen processing and presentation of endogenous antigen,GO:0019884~antigen processing and presentation of exogenous antigen,GO:0019885~antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0033036~macromolecule localization,GO:0035672~oligopeptide transmembrane transport,GO:0042886~amide transport,GO:0045184~establishment of protein localization,GO:0048002~antigen processing and presentation of peptide antigen,GO:0055085~transmembrane transport,GO:0071705~nitrogen compound transport,	GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0031227~intrinsic component of endoplasmic reticulum membrane,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0044432~endoplasmic reticulum part,GO:0044437~vacuolar part,GO:0098852~lytic vacuole membrane,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0015197~peptide transporter activity,GO:0015198~oligopeptide transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015421~oligopeptide-transporting ATPase activity,GO:0015440~peptide-transporting ATPase activity,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0022804~active transmembrane transporter activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0035673~oligopeptide transmembrane transporter activity,GO:0036094~small molecule binding,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0042887~amide transmembrane transporter activity,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046983~protein dimerization activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,GO:1904680~peptide transmembrane transporter activity,	hsa02010:ABC transporters,hsa04142:Lysosome,	
32439_at	ATPase H+/K+ transporting beta subunit(ATP4B)	Homo sapiens	Bipolar Disorder,Cardiovascular Diseases,monocyte chemoattractant protein 1 (66-77),	CARDIOVASCULAR,IMMUNE,PSYCH,	GO:0002237~response to molecule of bacterial origin,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006818~hydrogen transport,GO:0007155~cell adhesion,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0015672~monovalent inorganic cation transport,GO:0015992~proton transport,GO:0022610~biological adhesion,GO:0030001~metal ion transport,GO:0032496~response to lipopolysaccharide,GO:0033993~response to lipid,GO:0034220~ion transmembrane transport,GO:0043207~response to external biotic stimulus,GO:0051707~response to other organism,GO:0055085~transmembrane transport,GO:0098655~cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098662~inorganic cation transmembrane transport,GO:1901698~response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1902600~hydrogen ion transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0031226~intrinsic component of plasma membrane,GO:0090533~cation-transporting ATPase complex,GO:0098533~ATPase dependent transmembrane transport complex,GO:1902495~transmembrane transporter complex,GO:1904949~ATPase complex,GO:1990351~transporter complex,	GO:0008324~cation transmembrane transporter activity,GO:0008556~potassium-transporting ATPase activity,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015079~potassium ion transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0019829~cation-transporting ATPase activity,GO:0022804~active transmembrane transporter activity,GO:0022853~active ion transmembrane transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase coupled ion transmembrane transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046873~metal ion transmembrane transporter activity,	hsa00190:Oxidative phosphorylation,hsa04966:Collecting duct acid secretion,hsa04971:Gastric acid secretion,	
39469_s_at	ATPase phospholipid transporting 8A2(ATP8A2)	Homo sapiens	Body Weight,Subcutaneous Fat,Tobacco Use Disorder,	CHEMDEPENDENCY,METABOLIC,	GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001654~eye development,GO:0003008~system process,GO:0003009~skeletal muscle contraction,GO:0003011~involuntary skeletal muscle contraction,GO:0003012~muscle system process,GO:0003407~neural retina development,GO:0006869~lipid transport,GO:0006900~membrane budding,GO:0006936~muscle contraction,GO:0006941~striated muscle contraction,GO:0007010~cytoskeleton organization,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007423~sensory organ development,GO:0007568~aging,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009581~detection of external stimulus,GO:0009582~detection of abiotic stimulus,GO:0009583~detection of light stimulus,GO:0009584~detection of visible light,GO:0009605~response to external stimulus,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009790~embryo development,GO:0009887~organ morphogenesis,GO:0010720~positive regulation of cell development,GO:0010842~retina layer formation,GO:0010876~lipid localization,GO:0010975~regulation of neuron projection development,GO:0010976~positive regulation of neuron projection development,GO:0010996~response to auditory stimulus,GO:0015748~organophosphate ester transport,GO:0015914~phospholipid transport,GO:0016050~vesicle organization,GO:0016192~vesicle-mediated transport,GO:0022008~neurogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0032368~regulation of lipid transport,GO:0032370~positive regulation of lipid transport,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033036~macromolecule localization,GO:0034204~lipid translocation,GO:0035264~multicellular organism growth,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040014~regulation of multicellular organism growth,GO:0040018~positive regulation of multicellular organism growth,GO:0042127~regulation of cell proliferation,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0042755~eating behavior,GO:0043010~camera-type eye development,GO:0043583~ear development,GO:0043588~skin development,GO:0044802~single-organism membrane organization,GO:0045103~intermediate filament-based process,GO:0045104~intermediate filament cytoskeleton organization,GO:0045332~phospholipid translocation,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045927~positive regulation of growth,GO:0048193~Golgi vesicle transport,GO:0048194~Golgi vesicle budding,GO:0048468~cell development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048589~developmental growth,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048812~neuron projection morphogenesis,GO:0048839~inner ear development,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050877~neurological system process,GO:0050879~multicellular organismal movement,GO:0050881~musculoskeletal movement,GO:0050884~neuromuscular process controlling posture,GO:0050905~neuromuscular process,GO:0050906~detection of stimulus involved in sensory perception,GO:0050908~detection of light stimulus involved in visual perception,GO:0050953~sensory perception of light stimulus,GO:0050962~detection of light stimulus involved in sensory perception,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051606~detection of stimulus,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0060041~retina development in camera-type eye,GO:0060042~retina morphogenesis in camera-type eye,GO:0060052~neurofilament cytoskeleton organization,GO:0060284~regulation of cell development,GO:0061024~membrane organization,GO:0061091~regulation of phospholipid translocation,GO:0061092~positive regulation of phospholipid translocation,GO:0061564~axon development,GO:0090596~sensory organ morphogenesis,GO:0097035~regulation of membrane lipid distribution,GO:1902589~single-organism organelle organization,GO:2000026~regulation of multicellular organismal development,GO:2001138~regulation of phospholipid transport,GO:2001140~positive regulation of phospholipid transport,	GO:0000139~Golgi membrane,GO:0001750~photoreceptor outer segment,GO:0005768~endosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005929~cilium,GO:0031513~nonmotile primary cilium,GO:0031984~organelle subcompartment,GO:0044431~Golgi apparatus part,GO:0072372~primary cilium,GO:0097458~neuron part,GO:0098791~Golgi subcompartment,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0042623~ATPase activity, coupled,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		615268~Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4,
33685_at	ATPase phospholipid transporting 8B3(ATP8B3)	Homo sapiens	Bipolar Disorder,	PSYCH,	GO:0000003~reproduction,GO:0006869~lipid transport,GO:0007030~Golgi organization,GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0008037~cell recognition,GO:0009566~fertilization,GO:0009988~cell-cell recognition,GO:0010256~endomembrane system organization,GO:0010876~lipid localization,GO:0015748~organophosphate ester transport,GO:0015914~phospholipid transport,GO:0019953~sexual reproduction,GO:0022414~reproductive process,GO:0033036~macromolecule localization,GO:0034204~lipid translocation,GO:0035036~sperm-egg recognition,GO:0044702~single organism reproductive process,GO:0044703~multi-organism reproductive process,GO:0044802~single-organism membrane organization,GO:0045332~phospholipid translocation,GO:0061024~membrane organization,GO:0097035~regulation of membrane lipid distribution,	GO:0001669~acrosomal vesicle,GO:0002080~acrosomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0030659~cytoplasmic vesicle membrane,GO:0030667~secretory granule membrane,GO:0031988~membrane-bounded vesicle,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0044432~endoplasmic reticulum part,GO:0044433~cytoplasmic vesicle part,GO:0097223~sperm part,GO:0099503~secretory vesicle,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0042623~ATPase activity, coupled,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		
33027_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4(AGAP4)	Homo sapiens			GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0050790~regulation of catalytic activity,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0065009~regulation of molecular function,		GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030234~enzyme regulator activity,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0098772~molecular function regulator,		
1910_s_at	BCL2, apoptosis regulator(BCL2)	Homo sapiens	Acquired Immunodeficiency Syndrome|Disease Progression,Alzheimer Disease|Alzheimer's Disease|Amnesia,autism,Azoospermia,benzene haematotoxicity,Bone Mineral Density,Brain Injuries,breast and carcinoma,Breast Cancer,breast cancer   ,Carcinoma, Medullary|Medullary carcinoma|thyroid neoplasm|Thyroid Neoplasms,Carcinoma, Non-Small-Cell Lung,Carcinoma, Renal Cell|Kidney Neoplasms,Carcinoma, Squamous Cell|Esophageal Neoplasms,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Squamous cell carcinoma,Carcinoma, Squamous Cell|Neoplasm Recurrence, Local|Oropharyngeal Neoplasms,chronic obstructive pulmonary disease/COPD lung function,Chronic renal failure|Kidney Failure, Chronic,Clubfoot,diabetes, type 1,Echocardiography,esophageal adenocarcinoma,Esophageal Cancer,follicular lymphoma,follicular lymphoma to diffuse large-cell lymphoma,Glucose,hematology indices,Hodgkin Disease|Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoproliferative Disorders|Waldenstrom Macroglobulinemia,Hodgkin's disease,laryngeal cancer,leukemia,Leukemia, Lymphocytic, Chronic, B-Cell,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Leukemia, Myelogenous, Chronic, BCR-ABL Positive|Neovascularization, Pathologic,leukemia/lymphoma, T-Cell,lung cancer ,Lupus,Lupus Erythematosus, Systemic|Systemic lupus erythematosus,Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse,Lymphoma, Large B-Cell, Diffuse,Lymphoma, Non-Hodgkin,Lymphoma, Non-Hodgkin|Lymphoma, Non-Hodgkin's,Lymphoma, Non-Hodgkin|Lymphoma, Non-Hodgkin's|Translocation, Genetic,Multiple Sclerosis,myeloid leukemia,Neoplasm Recurrence, Local|Prostatic Neoplasms,non-Hodgkin's lymphoma,null,ovarian cancer,pharmacogenetic studies,Postoperative Complications|Prosthesis Failure,prostate cancer,systemic lupus erythematosus,Tunica Media,Type 2 Diabetes| edema | rosiglitazone,	CANCER,CARDIOVASCULAR,DEVELOPMENTAL,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,	GO:0000003~reproduction,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0000278~mitotic cell cycle,GO:0000302~response to reactive oxygen species,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001503~ossification,GO:0001541~ovarian follicle development,GO:0001558~regulation of cell growth,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001662~behavioral fear response,GO:0001666~response to hypoxia,GO:0001763~morphogenesis of a branching structure,GO:0001775~cell activation,GO:0001776~leukocyte homeostasis,GO:0001782~B cell homeostasis,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0001836~release of cytochrome c from mitochondria,GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:0001894~tissue homeostasis,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001942~hair follicle development,GO:0001952~regulation of cell-matrix adhesion,GO:0002009~morphogenesis of an epithelium,GO:0002209~behavioral defense response,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002260~lymphocyte homeostasis,GO:0002320~lymphoid progenitor cell differentiation,GO:0002326~B cell lineage commitment,GO:0002360~T cell lineage commitment,GO:0002363~alpha-beta T cell lineage commitment,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signaling pathway,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002931~response to ischemia,GO:0003006~developmental process involved in reproduction,GO:0003008~system process,GO:0003014~renal system process,GO:0003254~regulation of membrane depolarization,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006470~protein dephosphorylation,GO:0006582~melanin metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006808~regulation of nitrogen utilization,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006839~mitochondrial transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006885~regulation of pH,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007044~cell-substrate junction assembly,GO:0007045~cell-substrate adherens junction assembly,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007292~female gamete generation,GO:0007346~regulation of mitotic cell cycle,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007423~sensory organ development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007548~sex differentiation,GO:0007565~female pregnancy,GO:0007568~aging,GO:0007569~cell aging,GO:0007610~behavior,GO:0008104~protein localization,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008406~gonad development,GO:0008544~epidermis development,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008637~apoptotic mitochondrial changes,GO:0009100~glycoprotein metabolic process,GO:0009267~cellular response to starvation,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009611~response to wounding,GO:0009615~response to virus,GO:0009628~response to abiotic stimulus,GO:0009636~response to toxic substance,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone,GO:0009791~post-embryonic development,GO:0009887~organ morphogenesis,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0009991~response to extracellular stimulus,GO:0009994~oocyte differentiation,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010039~response to iron ion,GO:0010212~response to ionizing radiation,GO:0010224~response to UV-B,GO:0010243~response to organonitrogen compound,GO:0010332~response to gamma radiation,GO:0010468~regulation of gene expression,GO:0010506~regulation of autophagy,GO:0010507~negative regulation of autophagy,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010523~negative regulation of calcium ion transport into cytosol,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010623~programmed cell death involved in cell development,GO:0010638~positive regulation of organelle organization,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010720~positive regulation of cell development,GO:0010721~negative regulation of cell development,GO:0010810~regulation of cell-substrate adhesion,GO:0010821~regulation of mitochondrion organization,GO:0010822~positive regulation of mitochondrion organization,GO:0010830~regulation of myotube differentiation,GO:0010831~positive regulation of myotube differentiation,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010948~negative regulation of cell cycle process,GO:0010959~regulation of metal ion transport,GO:0012501~programmed cell death,GO:0014031~mesenchymal cell development,GO:0014041~regulation of neuron maturation,GO:0014042~positive regulation of neuron maturation,GO:0014070~response to organic cyclic compound,GO:0014706~striated muscle tissue development,GO:0014812~muscle cell migration,GO:0014902~myotube differentiation,GO:0014904~myotube cell development,GO:0014909~smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016032~viral process,GO:0016049~cell growth,GO:0016050~vesicle organization,GO:0016202~regulation of striated muscle tissue development,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018193~peptidyl-amino acid modification,GO:0018209~peptidyl-serine modification,GO:0018210~peptidyl-threonine modification,GO:0018958~phenol-containing compound metabolic process,GO:0019058~viral life cycle,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0019748~secondary metabolic process,GO:0019953~sexual reproduction,GO:0021548~pons development,GO:0021700~developmental maturation,GO:0021747~cochlear nucleus development,GO:0022008~neurogenesis,GO:0022037~metencephalon development,GO:0022402~cell cycle process,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0022412~cellular process involved in reproduction in multicellular organism,GO:0022414~reproductive process,GO:0022602~ovulation cycle process,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022607~cellular component assembly,GO:0022610~biological adhesion,GO:0022612~gland morphogenesis,GO:0022898~regulation of transmembrane transporter activity,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023057~negative regulation of signaling,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030278~regulation of ossification,GO:0030279~negative regulation of ossification,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0030318~melanocyte differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030641~regulation of cellular pH,GO:0030888~regulation of B cell proliferation,GO:0030890~positive regulation of B cell proliferation,GO:0030902~hindbrain development,GO:0031069~hair follicle morphogenesis,GO:0031099~regeneration,GO:0031102~neuron projection regeneration,GO:0031103~axon regeneration,GO:0031175~neuron projection development,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031589~cell-substrate adhesion,GO:0031647~regulation of protein stability,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0031960~response to corticosteroid,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032409~regulation of transporter activity,GO:0032446~protein modification by small protein conjugation,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032504~multicellular organism reproduction,GO:0032835~glomerulus development,GO:0032844~regulation of homeostatic process,GO:0032845~negative regulation of homeostatic process,GO:0032847~regulation of cellular pH reduction,GO:0032848~negative regulation of cellular pH reduction,GO:0032880~regulation of protein localization,GO:0032943~mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033028~myeloid cell apoptotic process,GO:0033032~regulation of myeloid cell apoptotic process,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033036~macromolecule localization,GO:0033043~regulation of organelle organization,GO:0033059~cellular pigmentation,GO:0033077~T cell differentiation in thymus,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033365~protein localization to organelle,GO:0033554~cellular response to stress,GO:0033555~multicellular organismal response to stress,GO:0033687~osteoblast proliferation,GO:0033688~regulation of osteoblast proliferation,GO:0033689~negative regulation of osteoblast proliferation,GO:0033993~response to lipid,GO:0034097~response to cytokine,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0034332~adherens junction organization,GO:0034333~adherens junction assembly,GO:0034599~cellular response to oxidative stress,GO:0034613~cellular protein localization,GO:0034645~cellular macromolecule biosynthetic process,GO:0034762~regulation of transmembrane transport,GO:0034976~response to endoplasmic reticulum stress,GO:0035094~response to nicotine,GO:0035239~tube morphogenesis,GO:0035264~multicellular organism growth,GO:0035265~organ growth,GO:0035295~tube development,GO:0035556~intracellular signal transduction,GO:0035794~positive regulation of mitochondrial membrane permeability,GO:0036037~CD8-positive, alpha-beta T cell activation,GO:0036211~protein modification process,GO:0036293~response to decreased oxygen levels,GO:0036294~cellular response to decreased oxygen levels,GO:0036473~cell death in response to oxidative stress,GO:0038034~signal transduction in absence of ligand,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0040014~regulation of multicellular organism growth,GO:0040017~positive regulation of locomotion,GO:0040018~positive regulation of multicellular organism growth,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042303~molting cycle,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042440~pigment metabolic process,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042551~neuron maturation,GO:0042592~homeostatic process,GO:0042594~response to starvation,GO:0042596~fear response,GO:0042633~hair cycle,GO:0042692~muscle cell differentiation,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptotic process,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043207~response to external biotic stimulus,GO:0043269~regulation of ion transport,GO:0043271~negative regulation of ion transport,GO:0043276~anoikis,GO:0043279~response to alkaloid,GO:0043368~positive T cell selection,GO:0043369~CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0043375~CD8-positive, alpha-beta T cell lineage commitment,GO:0043393~regulation of protein binding,GO:0043473~pigmentation,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0043583~ear development,GO:0043588~skin development,GO:0043900~regulation of multi-organism process,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0044085~cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044702~single organism reproductive process,GO:0044703~multi-organism reproductive process,GO:0044706~multi-multicellular organism process,GO:0044708~single-organism behavior,GO:0044764~multi-organism cellular process,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044802~single-organism membrane organization,GO:0044843~cell cycle G1/S phase transition,GO:0045058~T cell selection,GO:0045069~regulation of viral genome replication,GO:0045137~development of primary sexual characteristics,GO:0045165~cell fate commitment,GO:0045184~establishment of protein localization,GO:0045216~cell-cell junction organization,GO:0045321~leukocyte activation,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045634~regulation of melanocyte differentiation,GO:0045636~positive regulation of melanocyte differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045786~negative regulation of cell cycle,GO:0045844~positive regulation of striated muscle tissue development,GO:0045851~pH reduction,GO:0045852~pH elevation,GO:0045926~negative regulation of growth,GO:0045927~positive regulation of growth,GO:0045930~negative regulation of mitotic cell cycle,GO:0045937~positive regulation of phosphate metabolic process,GO:0046545~development of primary female sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046631~alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046660~female sex differentiation,GO:0046661~male sex differentiation,GO:0046666~retinal cell programmed cell death,GO:0046668~regulation of retinal cell programmed cell death,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048041~focal adhesion assembly,GO:0048066~developmental pigmentation,GO:0048070~regulation of developmental pigmentation,GO:0048087~positive regulation of developmental pigmentation,GO:0048468~cell development,GO:0048469~cell maturation,GO:0048477~oogenesis,GO:0048511~rhythmic process,GO:0048534~hematopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048545~response to steroid hormone,GO:0048546~digestive tract morphogenesis,GO:0048565~digestive tract development,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048589~developmental growth,GO:0048592~eye morphogenesis,GO:0048599~oocyte development,GO:0048608~reproductive structure development,GO:0048609~multicellular organismal reproductive process,GO:0048634~regulation of muscle organ development,GO:0048636~positive regulation of muscle organ development,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048641~regulation of skeletal muscle tissue development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048678~response to axon injury,GO:0048699~generation of neurons,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0048732~gland development,GO:0048741~skeletal muscle fiber development,GO:0048742~regulation of skeletal muscle fiber development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0048747~muscle fiber development,GO:0048753~pigment granule organization,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048762~mesenchymal cell differentiation,GO:0048812~neuron projection morphogenesis,GO:0048857~neural nucleus development,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0048871~multicellular organismal homeostasis,GO:0048872~homeostasis of number of cells,GO:0048873~homeostasis of number of cells within a tissue,GO:0048878~chemical homeostasis,GO:0050670~regulation of lymphocyte proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050790~regulation of catalytic activity,GO:0050792~regulation of viral process,GO:0050801~ion homeostasis,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050871~positive regulation of B cell activation,GO:0050931~pigment cell differentiation,GO:0050932~regulation of pigment cell differentiation,GO:0050942~positive regulation of pigment cell differentiation,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051051~negative regulation of transport,GO:0051093~negative regulation of developmental process,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051146~striated muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051204~protein insertion into mitochondrial membrane,GO:0051205~protein insertion into membrane,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051270~regulation of cellular component movement,GO:0051271~negative regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0051384~response to glucocorticoid,GO:0051402~neuron apoptotic process,GO:0051452~intracellular pH reduction,GO:0051453~regulation of intracellular pH,GO:0051454~intracellular pH elevation,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051607~defense response to virus,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0051674~localization of cell,GO:0051707~response to other organism,GO:0051726~regulation of cell cycle,GO:0051881~regulation of mitochondrial membrane potential,GO:0051882~mitochondrial depolarization,GO:0051899~membrane depolarization,GO:0051900~regulation of mitochondrial depolarization,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051924~regulation of calcium ion transport,GO:0051926~negative regulation of calcium ion transport,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055065~metal ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0055123~digestive system development,GO:0060249~anatomical structure homeostasis,GO:0060284~regulation of cell development,GO:0060322~head development,GO:0060341~regulation of cellular localization,GO:0060401~cytosolic calcium ion transport,GO:0060402~calcium ion transport into cytosol,GO:0060429~epithelium development,GO:0060485~mesenchyme development,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060548~negative regulation of cell death,GO:0060562~epithelial tube morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0060993~kidney morphogenesis,GO:0061024~membrane organization,GO:0061061~muscle structure development,GO:0061138~morphogenesis of a branching epithelium,GO:0061326~renal tubule development,GO:0061333~renal tubule morphogenesis,GO:0061458~reproductive system development,GO:0061564~axon development,GO:0065009~regulation of molecular function,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070201~regulation of establishment of protein localization,GO:0070482~response to oxygen levels,GO:0070486~leukocyte aggregation,GO:0070489~T cell aggregation,GO:0070585~protein localization to mitochondrion,GO:0070647~protein modification by small protein conjugation or removal,GO:0070661~leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070665~positive regulation of leukocyte proliferation,GO:0070727~cellular macromolecule localization,GO:0070838~divalent metal ion transport,GO:0070887~cellular response to chemical stimulus,GO:0070997~neuron death,GO:0071310~cellular response to organic substance,GO:0071453~cellular response to oxygen levels,GO:0071456~cellular response to hypoxia,GO:0071496~cellular response to external stimulus,GO:0071593~lymphocyte aggregation,GO:0071594~thymocyte aggregation,GO:0072001~renal system development,GO:0072006~nephron development,GO:0072009~nephron epithelium development,GO:0072028~nephron morphogenesis,GO:0072073~kidney epithelium development,GO:0072078~nephron tubule morphogenesis,GO:0072080~nephron tubule development,GO:0072088~nephron epithelium morphogenesis,GO:0072163~mesonephric epithelium development,GO:0072164~mesonephric tubule development,GO:0072171~mesonephric tubule morphogenesis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072507~divalent inorganic cation homeostasis,GO:0072511~divalent inorganic cation transport,GO:0072593~reactive oxygen species metabolic process,GO:0072594~establishment of protein localization to organelle,GO:0072655~establishment of protein localization to mitochondrion,GO:0072657~protein localization to membrane,GO:0090150~establishment of protein localization to membrane,GO:0090559~regulation of membrane permeability,GO:0090596~sensory organ morphogenesis,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097345~mitochondrial outer membrane permeabilization,GO:0098542~defense response to other organism,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:0098771~inorganic ion homeostasis,GO:0098773~skin epidermis development,GO:1900739~regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901028~regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901099~negative regulation of signal transduction in absence of ligand,GO:1901135~carbohydrate derivative metabolic process,GO:1901214~regulation of neuron death,GO:1901215~negative regulation of neuron death,GO:1901615~organic hydroxy compound metabolic process,GO:1901698~response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901861~regulation of muscle tissue development,GO:1901863~positive regulation of muscle tissue development,GO:1901987~regulation of cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1902108~regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902110~positive regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902531~regulation of intracellular signal transduction,GO:1902532~negative regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902580~single-organism cellular localization,GO:1902589~single-organism organelle organization,GO:1902686~mitochondrial outer membrane permeabilization involved in programmed cell death,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1903018~regulation of glycoprotein metabolic process,GO:1903047~mitotic cell cycle process,GO:1903429~regulation of cell maturation,GO:1903431~positive regulation of cell maturation,GO:1903747~regulation of establishment of protein localization to mitochondrion,GO:1903749~positive regulation of establishment of protein localization to mitochondrion,GO:1903827~regulation of cellular protein localization,GO:1903829~positive regulation of cellular protein localization,GO:1903900~regulation of viral life cycle,GO:1904180~negative regulation of membrane depolarization,GO:1904951~positive regulation of establishment of protein localization,GO:1990267~response to transition metal nanoparticle,GO:2000021~regulation of ion homeostasis,GO:2000026~regulation of multicellular organismal development,GO:2000027~regulation of organ morphogenesis,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000145~regulation of cell motility,GO:2000146~negative regulation of cell motility,GO:2000147~positive regulation of cell motility,GO:2000209~regulation of anoikis,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000811~negative regulation of anoikis,GO:2001233~regulation of apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001236~regulation of extrinsic apoptotic signaling pathway,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001239~regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001242~regulation of intrinsic apoptotic signaling pathway,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005635~nuclear envelope,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0019867~outer membrane,GO:0031965~nuclear membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0043209~myelin sheath,GO:0044429~mitochondrial part,GO:0044432~endoplasmic reticulum part,GO:0046930~pore complex,	GO:0002020~protease binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0008134~transcription factor binding,GO:0015267~channel activity,GO:0016247~channel regulator activity,GO:0016248~channel inhibitor activity,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0022803~passive transmembrane transporter activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051400~BH domain binding,GO:0051434~BH3 domain binding,GO:0051721~protein phosphatase 2A binding,GO:0070513~death domain binding,GO:0097159~organic cyclic compound binding,GO:0098772~molecular function regulator,GO:1901363~heterocyclic compound binding,	hsa04064:NF-kappa B signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04510:Focal adhesion,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,	Leukemia/lymphoma, B-cell, 2~Leukemia/lymphoma, B-cell, 2,
37454_at	C-C motif chemokine ligand 13(CCL13)	Homo sapiens	Asthma|Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma,Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,HIV,Meningeal Neoplasms|meningioma,Multiple Sclerosis,ovarian cancer,respiratory syncytial virus bronchiolitis,	CANCER,IMMUNE,INFECTION,	GO:0000165~MAPK cascade,GO:0000902~cell morphogenesis,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002548~monocyte chemotaxis,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0009605~response to external stimulus,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0019221~cytokine-mediated signaling pathway,GO:0019725~cellular homeostasis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022604~regulation of cell morphogenesis,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030003~cellular cation homeostasis,GO:0030593~neutrophil chemotaxis,GO:0030595~leukocyte chemotaxis,GO:0031325~positive regulation of cellular metabolic process,GO:0031347~regulation of defense response,GO:0031349~positive regulation of defense response,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032989~cellular component morphogenesis,GO:0034097~response to cytokine,GO:0034341~response to interferon-gamma,GO:0034612~response to tumor necrosis factor,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0040011~locomotion,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042330~taxis,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0045087~innate immune response,GO:0045937~positive regulation of phosphate metabolic process,GO:0048245~eosinophil chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050790~regulation of catalytic activity,GO:0050801~ion homeostasis,GO:0050900~leukocyte migration,GO:0051128~regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051674~localization of cell,GO:0055065~metal ion homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060326~cell chemotaxis,GO:0065009~regulation of molecular function,GO:0070098~chemokine-mediated signaling pathway,GO:0070371~ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070555~response to interleukin-1,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071345~cellular response to cytokine stimulus,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071621~granulocyte chemotaxis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072507~divalent inorganic cation homeostasis,GO:0072676~lymphocyte migration,GO:0072677~eosinophil migration,GO:0080134~regulation of response to stress,GO:0097529~myeloid leukocyte migration,GO:0097530~granulocyte migration,GO:0098771~inorganic ion homeostasis,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1990266~neutrophil migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0008009~chemokine activity,GO:0042379~chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,	
36703_at	C-C motif chemokine ligand 25(CCL25)	Homo sapiens	Asthma|Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Hyperparathyroidism, Secondary,respiratory syncytial virus bronchiolitis,	INFECTION,METABOLIC,	GO:0000165~MAPK cascade,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001952~regulation of cell-matrix adhesion,GO:0001954~positive regulation of cell-matrix adhesion,GO:0002548~monocyte chemotaxis,GO:0002682~regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002685~regulation of leukocyte migration,GO:0002686~negative regulation of leukocyte migration,GO:0002691~regulation of cellular extravasation,GO:0002692~negative regulation of cellular extravasation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0009605~response to external stimulus,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010810~regulation of cell-substrate adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0016310~phosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0019221~cytokine-mediated signaling pathway,GO:0022407~regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0022610~biological adhesion,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0030595~leukocyte chemotaxis,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031589~cell-substrate adhesion,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0034097~response to cytokine,GO:0034341~response to interferon-gamma,GO:0034612~response to tumor necrosis factor,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042330~taxis,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0045087~innate immune response,GO:0045123~cellular extravasation,GO:0045785~positive regulation of cell adhesion,GO:0045937~positive regulation of phosphate metabolic process,GO:0048247~lymphocyte chemotaxis,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0050790~regulation of catalytic activity,GO:0050900~leukocyte migration,GO:0050901~leukocyte tethering or rolling,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051270~regulation of cellular component movement,GO:0051271~negative regulation of cellular component movement,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051674~localization of cell,GO:0060326~cell chemotaxis,GO:0061756~leukocyte adhesion to vascular endothelial cell,GO:0065009~regulation of molecular function,GO:0070098~chemokine-mediated signaling pathway,GO:0070371~ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070555~response to interleukin-1,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071345~cellular response to cytokine stimulus,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071621~granulocyte chemotaxis,GO:0072676~lymphocyte migration,GO:0097529~myeloid leukocyte migration,GO:0097530~granulocyte migration,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903236~regulation of leukocyte tethering or rolling,GO:1903237~negative regulation of leukocyte tethering or rolling,GO:1904994~regulation of leukocyte adhesion to vascular endothelial cell,GO:1904995~negative regulation of leukocyte adhesion to vascular endothelial cell,GO:1990266~neutrophil migration,GO:2000145~regulation of cell motility,GO:2000146~negative regulation of cell motility,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0005179~hormone activity,GO:0008009~chemokine activity,GO:0031735~CCR10 chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,	
1403_s_at	C-C motif chemokine ligand 5(CCL5)	Homo sapiens	Albuminuria,Albuminuria|Inflammation|Kidney Diseases,allergic rhinitis,Alzheimer's disease; Parkinson's disease,Anemia, Sickle Cell|Bacteremia|,Arthritis, Juvenile Rheumatoid|Recurrence,Asthma,asthma Chlamydophila pneumoniae infection,Asthma. atopy,Asthma. atopy. atopic dermatitis,asthma; atopy,Asthma|,Asthma|Bronchial Hyperreactivity|Hypersensitivity, Immediate,Asthma|Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Asthma|Pulmonary Disease, Chronic Obstructive|Pulmonary Emphysema,atherosclerosis, carotid myocardial infarct,atherosclerosis, coronary,Atherosclerosis|Carotid Stenosis,Atherosclerosis|Inflammation|Retinal Vein Occlusion,atopic dermatitis,atopic eczema/dermatitis syndrome,Behcet's disease; retinal vasculitis; uveitis,Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma,Bladder Cancer,Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Bronchiolitis|Disease Susceptibility|Respiratory Syncytial Virus Infections,Carcinoma, Renal Cell|Inflammation|Kidney Neoplasms|Neoplasm Metastasis,cardiovascular disease; kidney failure, chronic,Celiac disease,Central Nervous System Neoplasms|Central Nervous System Tumors|HIV Infections|Lymphoma, AIDS-Related|[X]Human immunodeficiency virus disease,cerebral infarct, atherothrombotic,Cerebral Infarction|,chronic obstructive pulmonary disease,chronic obstructive pulmonary disease/COPD,Chronic renal failure|Diabetes mellitus type II|Diabetes Mellitus, Type 2|Kidney Failure, Chronic,Chronic renal failure|Kidney Failure, Chronic,Coronary Artery Disease,Coronary Disease|Inflammation,dermatitis and eczema,dermatitis syndrome; eczema,Diabetes Mellitus,diabetes, type 2,Diabetic Nephropathies|Diabetic Nephropathy,Endometriosis,Erythema Nodosum|Sarcoidosis,esophageal adenocarcinoma,Eye Diseases|Hypersensitivity|Respiratory Tract Diseases,Gastritis|Helicobacter Infections|Stomach Neoplasms,giant cell arteritis,Glomerulonephritis, IGA,Graft vs Host Disease,heart transplant complications,Helicobacter Infections|Intestinal Diseases|Metaplasia,hepatitis B,Hepatitis B, Chronic,hepatitis C,hepatitis C HIV,hepatitis C, chronic,Hepatitis C|Remission, Spontaneous,HIV,HIV infection,HIV Infections,HIV Infections|Pregnancy Complications, Infectious|Viremia|[X]Human immunodeficiency virus disease,HIV leukoencephalopathy,HIV/SIV infection,Hypertension, Pulmonary|Pulmonary Disease, Chronic Obstructive,Inflammation,kidney failure, chronic,kidney transplant,liver cancer liver disease,liver transplant,Lung Cancer,lung cancer ,lupus erythematosus,Lupus Erythematosus, Systemic|Systemic lupus erythematosus,lupus erythematosus; kidney disease,Lymphocytosis|Lymphoproliferative Disorders,lymphoma,Lymphoma, Non-Hodgkin,Meningeal Neoplasms|meningioma,Multiple Sclerosis,Myocardial Infarction,nasal polyps,nephropathy in other diseases,nephropathy, diabetic,normal variation,null,Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious|Thrombophilia|Tobacco Use Disorder,pancreatic cancer,Pancreatitis,periodontitis,prostate cancer,respiratory syncytial virus bronchiolitis,rheumatoid arthritis,Sarcoidosis,sclerosis, systemic,Severe Acute Respiratory Syndrome,Stomach Neoplasms,thyroid cancer,Tuberculosis,Tuberculosis, Pulmonary,Type 2 Diabetes| edema | rosiglitazone,uveitis,Uveitis, Anterior,Wegener's granulomatosis,	CANCER,CARDIOVASCULAR,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0000165~MAPK cascade,GO:0001775~cell activation,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001959~regulation of cytokine-mediated signaling pathway,GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0002237~response to molecule of bacterial origin,GO:0002274~myeloid leukocyte activation,GO:0002407~dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002676~regulation of chronic inflammatory response,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002685~regulation of leukocyte migration,GO:0002687~positive regulation of leukocyte migration,GO:0002688~regulation of leukocyte chemotaxis,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002790~peptide secretion,GO:0002791~regulation of peptide secretion,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0006461~protein complex assembly,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006518~peptide metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006887~exocytosis,GO:0006915~apoptotic process,GO:0006925~inflammatory cell apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007259~JAK-STAT cascade,GO:0007260~tyrosine phosphorylation of STAT protein,GO:0007267~cell-cell signaling,GO:0008104~protein localization,GO:0008219~cell death,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009306~protein secretion,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009636~response to toxic substance,GO:0009719~response to endogenous stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009914~hormone transport,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010533~regulation of activation of Janus kinase activity,GO:0010534~regulation of activation of JAK2 kinase activity,GO:0010535~positive regulation of activation of JAK2 kinase activity,GO:0010536~positive regulation of activation of Janus kinase activity,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010758~regulation of macrophage chemotaxis,GO:0010759~positive regulation of macrophage chemotaxis,GO:0010817~regulation of hormone levels,GO:0010818~T cell chemotaxis,GO:0010819~regulation of T cell chemotaxis,GO:0010820~positive regulation of T cell chemotaxis,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010959~regulation of metal ion transport,GO:0012501~programmed cell death,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014070~response to organic cyclic compound,GO:0014812~muscle cell migration,GO:0014909~smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0014911~positive regulation of smooth muscle cell migration,GO:0015031~protein transport,GO:0015833~peptide transport,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018212~peptidyl-tyrosine modification,GO:0019058~viral life cycle,GO:0019079~viral genome replication,GO:0019080~viral gene expression,GO:0019083~viral transcription,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019221~cytokine-mediated signaling pathway,GO:0019438~aromatic compound biosynthetic process,GO:0019725~cellular homeostasis,GO:0022407~regulation of cell-cell adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022607~cellular component assembly,GO:0022610~biological adhesion,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023057~negative regulation of signaling,GO:0023061~signal release,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030072~peptide hormone secretion,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0030595~leukocyte chemotaxis,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031347~regulation of defense response,GO:0031349~positive regulation of defense response,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031584~activation of phospholipase D activity,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032147~activation of protein kinase activity,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032496~response to lipopolysaccharide,GO:0032774~RNA biosynthetic process,GO:0032880~regulation of protein localization,GO:0032897~negative regulation of viral transcription,GO:0032940~secretion by cell,GO:0032943~mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0033002~muscle cell proliferation,GO:0033028~myeloid cell apoptotic process,GO:0033032~regulation of myeloid cell apoptotic process,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033036~macromolecule localization,GO:0033627~cell adhesion mediated by integrin,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0033631~cell-cell adhesion mediated by integrin,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0033634~positive regulation of cell-cell adhesion mediated by integrin,GO:0033674~positive regulation of kinase activity,GO:0033993~response to lipid,GO:0034097~response to cytokine,GO:0034109~homotypic cell-cell adhesion,GO:0034110~regulation of homotypic cell-cell adhesion,GO:0034112~positive regulation of homotypic cell-cell adhesion,GO:0034248~regulation of cellular amide metabolic process,GO:0034250~positive regulation of cellular amide metabolic process,GO:0034341~response to interferon-gamma,GO:0034612~response to tumor necrosis factor,GO:0034622~cellular macromolecular complex assembly,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035556~intracellular signal transduction,GO:0035747~natural killer cell chemotaxis,GO:0035821~modification of morphology or physiology of other organism,GO:0036211~protein modification process,GO:0036230~granulocyte activation,GO:0036336~dendritic cell migration,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042098~T cell proliferation,GO:0042102~positive regulation of T cell proliferation,GO:0042110~T cell activation,GO:0042119~neutrophil activation,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042330~taxis,GO:0042509~regulation of tyrosine phosphorylation of STAT protein,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0042592~homeostatic process,GO:0042886~amide transport,GO:0042976~activation of Janus kinase activity,GO:0042977~activation of JAK2 kinase activity,GO:0042981~regulation of apoptotic process,GO:0043043~peptide biosynthetic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043207~response to external biotic stimulus,GO:0043269~regulation of ion transport,GO:0043270~positive regulation of ion transport,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0043549~regulation of kinase activity,GO:0043603~cellular amide metabolic process,GO:0043604~amide biosynthetic process,GO:0043623~cellular protein complex assembly,GO:0043900~regulation of multi-organism process,GO:0043901~negative regulation of multi-organism process,GO:0043902~positive regulation of multi-organism process,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0043921~modulation by host of viral transcription,GO:0043922~negative regulation by host of viral transcription,GO:0043933~macromolecular complex subunit organization,GO:0044033~multi-organism metabolic process,GO:0044085~cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0045069~regulation of viral genome replication,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045184~establishment of protein localization,GO:0045321~leukocyte activation,GO:0045727~positive regulation of translation,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045785~positive regulation of cell adhesion,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045948~positive regulation of translational initiation,GO:0046425~regulation of JAK-STAT cascade,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046782~regulation of viral transcription,GO:0046879~hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046903~secretion,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048017~inositol lipid-mediated signaling,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0048524~positive regulation of viral process,GO:0048525~negative regulation of viral process,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048659~smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050670~regulation of lymphocyte proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050673~epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050708~regulation of protein secretion,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050790~regulation of catalytic activity,GO:0050792~regulation of viral process,GO:0050796~regulation of insulin secretion,GO:0050801~ion homeostasis,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050870~positive regulation of T cell activation,GO:0050900~leukocyte migration,GO:0050918~positive chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050921~positive regulation of chemotaxis,GO:0051046~regulation of secretion,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051223~regulation of protein transport,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051262~protein tetramerization,GO:0051270~regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051347~positive regulation of transferase activity,GO:0051674~localization of cell,GO:0051702~interaction with symbiont,GO:0051707~response to other organism,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051924~regulation of calcium ion transport,GO:0051928~positive regulation of calcium ion transport,GO:0052312~modulation of transcription in other organism involved in symbiotic interaction,GO:0052472~modulation by host of symbiont transcription,GO:0055065~metal ion homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0060326~cell chemotaxis,GO:0060548~negative regulation of cell death,GO:0060759~regulation of response to cytokine stimulus,GO:0060761~negative regulation of response to cytokine stimulus,GO:0061097~regulation of protein tyrosine kinase activity,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0065003~macromolecular complex assembly,GO:0065009~regulation of molecular function,GO:0070098~chemokine-mediated signaling pathway,GO:0070099~regulation of chemokine-mediated signaling pathway,GO:0070100~negative regulation of chemokine-mediated signaling pathway,GO:0070201~regulation of establishment of protein localization,GO:0070227~lymphocyte apoptotic process,GO:0070228~regulation of lymphocyte apoptotic process,GO:0070229~negative regulation of lymphocyte apoptotic process,GO:0070230~positive regulation of lymphocyte apoptotic process,GO:0070231~T cell apoptotic process,GO:0070232~regulation of T cell apoptotic process,GO:0070233~negative regulation of T cell apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,GO:0070271~protein complex biogenesis,GO:0070371~ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070486~leukocyte aggregation,GO:0070489~T cell aggregation,GO:0070555~response to interleukin-1,GO:0070661~leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070665~positive regulation of leukocyte proliferation,GO:0070838~divalent metal ion transport,GO:0070848~response to growth factor,GO:0070887~cellular response to chemical stimulus,GO:0071216~cellular response to biotic stimulus,GO:0071219~cellular response to molecule of bacterial origin,GO:0071222~cellular response to lipopolysaccharide,GO:0071310~cellular response to organic substance,GO:0071345~cellular response to cytokine stimulus,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071363~cellular response to growth factor stimulus,GO:0071396~cellular response to lipid,GO:0071407~cellular response to organic cyclic compound,GO:0071495~cellular response to endogenous stimulus,GO:0071593~lymphocyte aggregation,GO:0071621~granulocyte chemotaxis,GO:0071622~regulation of granulocyte chemotaxis,GO:0071674~mononuclear cell migration,GO:0071675~regulation of mononuclear cell migration,GO:0071705~nitrogen compound transport,GO:0071774~response to fibroblast growth factor,GO:0071822~protein complex subunit organization,GO:0071887~leukocyte apoptotic process,GO:0071888~macrophage apoptotic process,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072507~divalent inorganic cation homeostasis,GO:0072511~divalent inorganic cation transport,GO:0072676~lymphocyte migration,GO:0072677~eosinophil migration,GO:0072678~T cell migration,GO:0080134~regulation of response to stress,GO:0090025~regulation of monocyte chemotaxis,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090087~regulation of peptide transport,GO:0090276~regulation of peptide hormone secretion,GO:0097529~myeloid leukocyte migration,GO:0097530~granulocyte migration,GO:0097696~STAT cascade,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:0098771~inorganic ion homeostasis,GO:1901214~regulation of neuron death,GO:1901566~organonitrogen compound biosynthetic process,GO:1901623~regulation of lymphocyte chemotaxis,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903530~regulation of secretion by cell,GO:1903900~regulation of viral life cycle,GO:1903901~negative regulation of viral life cycle,GO:1903902~positive regulation of viral life cycle,GO:1904892~regulation of STAT cascade,GO:1904894~positive regulation of STAT cascade,GO:1990266~neutrophil migration,GO:2000106~regulation of leukocyte apoptotic process,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000108~positive regulation of leukocyte apoptotic process,GO:2000109~regulation of macrophage apoptotic process,GO:2000110~negative regulation of macrophage apoptotic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000145~regulation of cell motility,GO:2000147~positive regulation of cell motility,GO:2000401~regulation of lymphocyte migration,GO:2000403~positive regulation of lymphocyte migration,GO:2000404~regulation of T cell migration,GO:2000406~positive regulation of T cell migration,GO:2000501~regulation of natural killer cell chemotaxis,GO:2000503~positive regulation of natural killer cell chemotaxis,GO:2001141~regulation of RNA biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0001664~G-protein coupled receptor binding,GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004620~phospholipase activity,GO:0004629~phospholipase C activity,GO:0004672~protein kinase activity,GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0008009~chemokine activity,GO:0008047~enzyme activator activity,GO:0008081~phosphoric diester hydrolase activity,GO:0016004~phospholipase activator activity,GO:0016298~lipase activity,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0019887~protein kinase regulator activity,GO:0030234~enzyme regulator activity,GO:0030295~protein kinase activator activity,GO:0030296~protein tyrosine kinase activator activity,GO:0030298~receptor signaling protein tyrosine kinase activator activity,GO:0030545~receptor regulator activity,GO:0030547~receptor inhibitor activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031729~CCR4 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0042379~chemokine receptor binding,GO:0042578~phosphoric ester hydrolase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,GO:0046817~chemokine receptor antagonist activity,GO:0046983~protein dimerization activity,GO:0048019~receptor antagonist activity,GO:0048020~CCR chemokine receptor binding,GO:0060229~lipase activator activity,GO:0098772~molecular function regulator,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04668:TNF signaling pathway,hsa05020:Prion diseases,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05323:Rheumatoid arthritis,	HIV-1 disease, delayed progression of~HIV-1 disease, delayed progression of,HIV-1 disease, rapid progression of~HIV-1 disease, rapid progression of,
822_s_at	CASP2 and RIPK1 domain containing adaptor with death domain(CRADD)	Homo sapiens	Blood Vessels,Body Height,Body Mass Index,height,Hip,Mental Competency,Myocardial Infarction,Narcolepsy,	AGING,CARDIOVASCULAR,DEVELOPMENTAL,METABOLIC,NEUROLOGICAL,	GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007166~cell surface receptor signaling pathway,GO:0007346~regulation of mitotic cell cycle,GO:0008219~cell death,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009605~response to external stimulus,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010948~negative regulation of cell cycle process,GO:0010950~positive regulation of endopeptidase activity,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0022402~cell cycle process,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030162~regulation of proteolysis,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031325~positive regulation of cellular metabolic process,GO:0031570~DNA integrity checkpoint,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0035556~intracellular signal transduction,GO:0042770~signal transduction in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0044093~positive regulation of molecular function,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044773~mitotic DNA damage checkpoint,GO:0044774~mitotic DNA integrity checkpoint,GO:0044783~G1 DNA damage checkpoint,GO:0044819~mitotic G1/S transition checkpoint,GO:0044843~cell cycle G1/S phase transition,GO:0045786~negative regulation of cell cycle,GO:0045787~positive regulation of cell cycle,GO:0045862~positive regulation of proteolysis,GO:0045930~negative regulation of mitotic cell cycle,GO:0048584~positive regulation of response to stimulus,GO:0050790~regulation of catalytic activity,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051726~regulation of cell cycle,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0065009~regulation of molecular function,GO:0071156~regulation of cell cycle arrest,GO:0071158~positive regulation of cell cycle arrest,GO:0071214~cellular response to abiotic stimulus,GO:0071260~cellular response to mechanical stimulus,GO:0071496~cellular response to external stimulus,GO:0072331~signal transduction by p53 class mediator,GO:0072395~signal transduction involved in cell cycle checkpoint,GO:0072401~signal transduction involved in DNA integrity checkpoint,GO:0072413~signal transduction involved in mitotic cell cycle checkpoint,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:0072431~signal transduction involved in mitotic G1 DNA damage checkpoint,GO:0090068~positive regulation of cell cycle process,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:1901987~regulation of cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1902400~intracellular signal transduction involved in G1 DNA damage checkpoint,GO:1902402~signal transduction involved in mitotic DNA damage checkpoint,GO:1902403~signal transduction involved in mitotic DNA integrity checkpoint,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1903047~mitotic cell cycle process,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2000116~regulation of cysteine-type endopeptidase activity,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2001056~positive regulation of cysteine-type endopeptidase activity,GO:2001233~regulation of apoptotic signaling pathway,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005829~cytosol,	GO:0002020~protease binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0030674~protein binding, bridging,GO:0060090~binding, bridging,GO:0070513~death domain binding,		614499~Mental retardation, autosomal recessive 34,
35595_at	CGRP receptor component(CRCP)	Homo sapiens	Aorta,Tobacco Use Disorder,	CARDIOVASCULAR,CHEMDEPENDENCY,	GO:0001816~cytokine production,GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0002252~immune effector process,GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006383~transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0006952~defense response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009615~response to virus,GO:0010467~gene expression,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019438~aromatic compound biosynthetic process,GO:0032479~regulation of type I interferon production,GO:0032481~positive regulation of type I interferon production,GO:0032606~type I interferon production,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0043207~response to external biotic stimulus,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0045087~innate immune response,GO:0051240~positive regulation of multicellular organismal process,GO:0051607~defense response to virus,GO:0051707~response to other organism,GO:0097659~nucleic acid-templated transcription,GO:0098542~defense response to other organism,	GO:0000428~DNA-directed RNA polymerase complex,GO:0001669~acrosomal vesicle,GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005829~cytosol,GO:0009360~DNA polymerase III complex,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0030880~RNA polymerase complex,GO:0031988~membrane-bounded vesicle,GO:0042575~DNA polymerase complex,GO:0044451~nucleoplasm part,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0097223~sperm part,GO:0099503~secretory vesicle,	GO:0000166~nucleotide binding,GO:0001056~RNA polymerase III activity,GO:0001635~calcitonin gene-related peptide receptor activity,GO:0001653~peptide receptor activity,GO:0003899~DNA-directed RNA polymerase activity,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0016779~nucleotidyltransferase activity,GO:0034062~RNA polymerase activity,GO:0036094~small molecule binding,GO:0038023~signaling receptor activity,GO:0060089~molecular transducer activity,GO:0097159~organic cyclic compound binding,GO:0097642~calcitonin family receptor activity,GO:0099600~transmembrane receptor activity,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		
37814_g_at	DEAD-box helicase 51(DDX51)	Homo sapiens			GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0010467~gene expression,GO:0010501~RNA secondary structure unwinding,GO:0016070~RNA metabolic process,GO:0016072~rRNA metabolic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0042254~ribosome biogenesis,GO:0044085~cellular component biogenesis,	GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008186~RNA-dependent ATPase activity,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0042623~ATPase activity, coupled,GO:0044822~poly(A) RNA binding,GO:0070035~purine NTP-dependent helicase activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		
32148_at	FERM, ARH/RhoGEF and pleckstrin domain protein 1(FARP1)	Homo sapiens	Alzheimer Disease,Body Fat Distribution,Brain,Brain structure ,Iron,Nonalcoholic Fatty Liver Disease,Parkinson's disease    ,Tobacco Use Disorder,Waist Circumference,	CHEMDEPENDENCY,METABOLIC,NEUROLOGICAL,	GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007399~nervous system development,GO:0007416~synapse assembly,GO:0009892~negative regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010646~regulation of cell communication,GO:0010921~regulation of phosphatase activity,GO:0010923~negative regulation of phosphatase activity,GO:0016311~dephosphorylation,GO:0016358~dendrite development,GO:0019220~regulation of phosphate metabolic process,GO:0022008~neurogenesis,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031324~negative regulation of cellular metabolic process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035023~regulation of Rho protein signal transduction,GO:0035303~regulation of dephosphorylation,GO:0035305~negative regulation of dephosphorylation,GO:0035556~intracellular signal transduction,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044085~cellular component biogenesis,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045936~negative regulation of phosphate metabolic process,GO:0046578~regulation of Ras protein signal transduction,GO:0048468~cell development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048812~neuron projection morphogenesis,GO:0048813~dendrite morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050790~regulation of catalytic activity,GO:0050808~synapse organization,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051174~regulation of phosphorus metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051346~negative regulation of hydrolase activity,GO:0065009~regulation of molecular function,GO:1902531~regulation of intracellular signal transduction,	GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0019897~extrinsic component of plasma membrane,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030425~dendrite,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0036477~somatodendritic compartment,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0044309~neuron spine,GO:0044456~synapse part,GO:0045202~synapse,GO:0097458~neuron part,GO:0098552~side of membrane,GO:0098562~cytoplasmic side of membrane,GO:0098794~postsynapse,GO:0098858~actin-based cell projection,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0098772~molecular function regulator,		
33293_at	Fas apoptotic inhibitory molecule 2(FAIM2)	Homo sapiens	Body Mass Index,Body Weight|Obesity,Hip,Leukocyte Count,Obesity,obesity|Type 2 diabetes,Waist Circumference,weight ,	HEMATOLOGICAL,METABOLIC,	GO:0002931~response to ischemia,GO:0006915~apoptotic process,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0008219~cell death,GO:0009966~regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010646~regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0021533~cell differentiation in hindbrain,GO:0021549~cerebellum development,GO:0021575~hindbrain morphogenesis,GO:0021587~cerebellum morphogenesis,GO:0021680~cerebellar Purkinje cell layer development,GO:0021681~cerebellar granular layer development,GO:0021692~cerebellar Purkinje cell layer morphogenesis,GO:0021694~cerebellar Purkinje cell layer formation,GO:0021695~cerebellar cortex development,GO:0021696~cerebellar cortex morphogenesis,GO:0021697~cerebellar cortex formation,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021953~central nervous system neuron differentiation,GO:0022008~neurogenesis,GO:0022037~metencephalon development,GO:0023051~regulation of signaling,GO:0023057~negative regulation of signaling,GO:0030182~neuron differentiation,GO:0030902~hindbrain development,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0048585~negative regulation of response to stimulus,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048699~generation of neurons,GO:0051402~neuron apoptotic process,GO:0060322~head development,GO:0060548~negative regulation of cell death,GO:0070997~neuron death,GO:0097190~apoptotic signaling pathway,GO:1901214~regulation of neuron death,GO:1901215~negative regulation of neuron death,GO:2001233~regulation of apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0030054~cell junction,GO:0044456~synapse part,GO:0045121~membrane raft,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0097060~synaptic membrane,GO:0098589~membrane region,GO:0098590~plasma membrane region,GO:0098794~postsynapse,GO:0098857~membrane microdomain,			
37905_r_at	G protein nucleolar 1 (putative)(GNL1)	Homo sapiens	ankylosing spondylitis,Lupus Erythematosus, Systemic,	IMMUNE,	GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002456~T cell mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0006955~immune response,GO:0006974~cellular response to DNA damage stimulus,GO:0022613~ribonucleoprotein complex biogenesis,GO:0033554~cellular response to stress,GO:0042254~ribosome biogenesis,GO:0044085~cellular component biogenesis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003924~GTPase activity,GO:0005198~structural molecule activity,GO:0005525~GTP binding,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0019001~guanyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		
919_at	G protein subunit alpha 12(GNA12)	Homo sapiens	Aorta,Body Height,Cholesterol,Cholesterol, HDL,Colitis, Ulcerative,Depressive Disorder, Major,height,skeletal frame size,Tobacco Use Disorder,	CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,IMMUNE,METABOLIC,NORMALVARIATION,PSYCH,	GO:0000902~cell morphogenesis,GO:0001701~in utero embryonic development,GO:0001775~cell activation,GO:0006508~proteolysis,GO:0006928~movement of cell or subcellular component,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008360~regulation of cell shape,GO:0009057~macromolecule catabolic process,GO:0009611~response to wounding,GO:0009790~embryo development,GO:0009792~embryo development ending in birth or egg hatching,GO:0009894~regulation of catabolic process,GO:0009966~regulation of signal transduction,GO:0010498~proteasomal protein catabolic process,GO:0010646~regulation of cell communication,GO:0010762~regulation of fibroblast migration,GO:0016477~cell migration,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022604~regulation of cell morphogenesis,GO:0023051~regulation of signaling,GO:0030162~regulation of proteolysis,GO:0030163~protein catabolic process,GO:0030168~platelet activation,GO:0030326~embryonic limb morphogenesis,GO:0030334~regulation of cell migration,GO:0031329~regulation of cellular catabolic process,GO:0032006~regulation of TOR signaling,GO:0032268~regulation of cellular protein metabolic process,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032989~cellular component morphogenesis,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035556~intracellular signal transduction,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0042060~wound healing,GO:0042176~regulation of protein catabolic process,GO:0042493~response to drug,GO:0042733~embryonic digit morphogenesis,GO:0043009~chordate embryonic development,GO:0044248~cellular catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0048870~cell motility,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051128~regulation of cellular component organization,GO:0051246~regulation of protein metabolic process,GO:0051270~regulation of cellular component movement,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051674~localization of cell,GO:0060173~limb development,GO:0061136~regulation of proteasomal protein catabolic process,GO:1902531~regulation of intracellular signal transduction,GO:1903050~regulation of proteolysis involved in cellular protein catabolic process,GO:1903362~regulation of cellular protein catabolic process,GO:2000145~regulation of cell motility,	GO:0005834~heterotrimeric G-protein complex,GO:0005903~brush border,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0009898~cytoplasmic side of plasma membrane,GO:0019897~extrinsic component of plasma membrane,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0070161~anchoring junction,GO:0098552~side of membrane,GO:0098562~cytoplasmic side of membrane,GO:0098590~plasma membrane region,GO:0098862~cluster of actin-based cell projections,	GO:0000166~nucleotide binding,GO:0001664~G-protein coupled receptor binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005102~receptor binding,GO:0005525~GTP binding,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031752~D5 dopamine receptor binding,GO:0032403~protein complex binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0050780~dopamine receptor binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,	
38103_at	GRB10 interacting GYF protein 2(GIGYF2)	Homo sapiens	Parkinson's Disease,Parkinson's disease    ,Tobacco Use Disorder,	CHEMDEPENDENCY,NEUROLOGICAL,	GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001894~tissue homeostasis,GO:0003008~system process,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006518~peptide metabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007093~mitotic cell cycle checkpoint,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007346~regulation of mitotic cell cycle,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0007631~feeding behavior,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010948~negative regulation of cell cycle process,GO:0017148~negative regulation of translation,GO:0021510~spinal cord development,GO:0021515~cell differentiation in spinal cord,GO:0021517~ventral spinal cord development,GO:0021522~spinal cord motor neuron differentiation,GO:0021953~central nervous system neuron differentiation,GO:0022008~neurogenesis,GO:0022402~cell cycle process,GO:0022610~biological adhesion,GO:0030182~neuron differentiation,GO:0030534~adult behavior,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031570~DNA integrity checkpoint,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0034248~regulation of cellular amide metabolic process,GO:0034249~negative regulation of cellular amide metabolic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0035264~multicellular organism growth,GO:0040007~growth,GO:0042592~homeostatic process,GO:0043043~peptide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043604~amide biosynthetic process,GO:0044708~single-organism behavior,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044773~mitotic DNA damage checkpoint,GO:0044774~mitotic DNA integrity checkpoint,GO:0044783~G1 DNA damage checkpoint,GO:0044819~mitotic G1/S transition checkpoint,GO:0044843~cell cycle G1/S phase transition,GO:0045786~negative regulation of cell cycle,GO:0045930~negative regulation of mitotic cell cycle,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048589~developmental growth,GO:0048699~generation of neurons,GO:0048871~multicellular organismal homeostasis,GO:0048872~homeostasis of number of cells,GO:0048873~homeostasis of number of cells within a tissue,GO:0050877~neurological system process,GO:0050879~multicellular organismal movement,GO:0050881~musculoskeletal movement,GO:0050885~neuromuscular process controlling balance,GO:0050905~neuromuscular process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051726~regulation of cell cycle,GO:0060249~anatomical structure homeostasis,GO:0098609~cell-cell adhesion,GO:1901566~organonitrogen compound biosynthetic process,GO:1901987~regulation of cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1903047~mitotic cell cycle process,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0030054~cell junction,GO:0070161~anchoring junction,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,GO:0097159~organic cyclic compound binding,GO:0098631~protein binding involved in cell adhesion,GO:0098632~protein binding involved in cell-cell adhesion,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1901363~heterocyclic compound binding,		607688~Parkinson disease 11,
34703_f_at	HERV-H LTR-associating 1(HHLA1)	Homo sapiens	Taste,	OTHER,		GO:0005576~extracellular region,			
39698_at	HOP homeobox(HOPX)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0003008~system process,GO:0003013~circulatory system process,GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0006476~protein deacetylation,GO:0007507~heart development,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0009605~response to external stimulus,GO:0009611~response to wounding,GO:0009790~embryo development,GO:0009792~embryo development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016070~RNA metabolic process,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016575~histone deacetylation,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0031099~regeneration,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032101~regulation of response to external stimulus,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035295~tube development,GO:0035601~protein deacylation,GO:0036211~protein modification process,GO:0040007~growth,GO:0040008~regulation of growth,GO:0042060~wound healing,GO:0042246~tissue regeneration,GO:0042692~muscle cell differentiation,GO:0043009~chordate embryonic development,GO:0043393~regulation of protein binding,GO:0043403~skeletal muscle tissue regeneration,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0043416~regulation of skeletal muscle tissue regeneration,GO:0043933~macromolecular complex subunit organization,GO:0044057~regulation of system process,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045927~positive regulation of growth,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0048286~lung alveolus development,GO:0048584~positive regulation of response to stimulus,GO:0048589~developmental growth,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051146~striated muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0060541~respiratory system development,GO:0061041~regulation of wound healing,GO:0061061~muscle structure development,GO:0065009~regulation of molecular function,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0080134~regulation of response to stress,GO:0090303~positive regulation of wound healing,GO:0097659~nucleic acid-templated transcription,GO:0098732~macromolecule deacylation,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903034~regulation of response to wounding,GO:1903036~positive regulation of response to wounding,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903522~regulation of blood circulation,GO:2000026~regulation of multicellular organismal development,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,		GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
1645_at	KiSS-1 metastasis-suppressor(KISS1)	Homo sapiens	breast cancer   ,hypertension,Hypogonadism|Kallmann Syndrome,Hypogonadism|Puberty, Precocious,Menarch|Natural Menopause|Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious,precocious puberty,Puberty, Precocious,Tobacco Use Disorder,	CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,METABOLIC,REPRODUCTION,UNKNOWN,	GO:0000003~reproduction,GO:0000165~MAPK cascade,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002790~peptide secretion,GO:0002791~regulation of peptide secretion,GO:0002793~positive regulation of peptide secretion,GO:0003008~system process,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007010~cytoskeleton organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009893~positive regulation of metabolic process,GO:0009914~hormone transport,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010817~regulation of hormone levels,GO:0015833~peptide transport,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0022414~reproductive process,GO:0022602~ovulation cycle process,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023061~signal release,GO:0030003~cellular cation homeostasis,GO:0030072~peptide hormone secretion,GO:0030252~growth hormone secretion,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032274~gonadotropin secretion,GO:0032275~luteinizing hormone secretion,GO:0032276~regulation of gonadotropin secretion,GO:0032278~positive regulation of gonadotropin secretion,GO:0032504~multicellular organism reproduction,GO:0032940~secretion by cell,GO:0033684~regulation of luteinizing hormone secretion,GO:0033686~positive regulation of luteinizing hormone secretion,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042592~homeostatic process,GO:0042698~ovulation cycle,GO:0042886~amide transport,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0044057~regulation of system process,GO:0044060~regulation of endocrine process,GO:0044702~single organism reproductive process,GO:0045937~positive regulation of phosphate metabolic process,GO:0046879~hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,GO:0046903~secretion,GO:0048511~rhythmic process,GO:0048584~positive regulation of response to stimulus,GO:0048609~multicellular organismal reproductive process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050804~modulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050886~endocrine process,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0055065~metal ion homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060112~generation of ovulation cycle rhythm,GO:0060123~regulation of growth hormone secretion,GO:0060124~positive regulation of growth hormone secretion,GO:0060986~endocrine hormone secretion,GO:0071705~nitrogen compound transport,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072507~divalent inorganic cation homeostasis,GO:0090087~regulation of peptide transport,GO:0090276~regulation of peptide hormone secretion,GO:0090277~positive regulation of peptide hormone secretion,GO:0098771~inorganic ion homeostasis,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1903530~regulation of secretion by cell,GO:1903532~positive regulation of secretion by cell,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016324~apical plasma membrane,GO:0036477~somatodendritic compartment,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0044297~cell body,GO:0044421~extracellular region part,GO:0045177~apical part of cell,GO:0097458~neuron part,GO:0098590~plasma membrane region,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0031773~kisspeptin receptor binding,GO:0071855~neuropeptide receptor binding,		614842~Hypogonadotropic hypogonadism 13 with or without anosmia,
1786_at	MER proto-oncogene, tyrosine kinase(MERTK)	Homo sapiens	atherosclerosis,Chronic renal failure|Kidney Failure, Chronic,lupus erythematosus,Lupus Erythematosus, Systemic|Systemic lupus erythematosus,Multiple Sclerosis,Retinal Diseases,Retinitis Pigmentosa,Tobacco Use Disorder,	CARDIOVASCULAR,CHEMDEPENDENCY,IMMUNE,RENAL,VISION,	GO:0000003~reproduction,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001654~eye development,GO:0001775~cell activation,GO:0001779~natural killer cell differentiation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002682~regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0003006~developmental process involved in reproduction,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007423~sensory organ development,GO:0007548~sex differentiation,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008219~cell death,GO:0009611~response to wounding,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018193~peptidyl-amino acid modification,GO:0018212~peptidyl-tyrosine modification,GO:0019953~sexual reproduction,GO:0022414~reproductive process,GO:0022610~biological adhesion,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030100~regulation of endocytosis,GO:0030101~natural killer cell activation,GO:0030168~platelet activation,GO:0030540~female genitalia development,GO:0031589~cell-substrate adhesion,GO:0032504~multicellular organism reproduction,GO:0032940~secretion by cell,GO:0032989~cellular component morphogenesis,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0040011~locomotion,GO:0042060~wound healing,GO:0042981~regulation of apoptotic process,GO:0043010~camera-type eye development,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043277~apoptotic cell clearance,GO:0043491~protein kinase B signaling,GO:0044702~single organism reproductive process,GO:0044703~multi-organism reproductive process,GO:0045321~leukocyte activation,GO:0045807~positive regulation of endocytosis,GO:0046649~lymphocyte activation,GO:0046660~female sex differentiation,GO:0046903~secretion,GO:0048232~male gamete generation,GO:0048468~cell development,GO:0048534~hematopoietic or lymphoid organ development,GO:0048608~reproductive structure development,GO:0048609~multicellular organismal reproductive process,GO:0048806~genitalia development,GO:0048870~cell motility,GO:0050764~regulation of phagocytosis,GO:0050766~positive regulation of phagocytosis,GO:0050817~coagulation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050878~regulation of body fluid levels,GO:0050900~leukocyte migration,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051674~localization of cell,GO:0060041~retina development in camera-type eye,GO:0060068~vagina development,GO:0060548~negative regulation of cell death,GO:0060627~regulation of vesicle-mediated transport,GO:0061458~reproductive system development,GO:0071887~leukocyte apoptotic process,GO:0098602~single organism cell adhesion,GO:2000106~regulation of leukocyte apoptotic process,GO:2000107~negative regulation of leukocyte apoptotic process,	GO:0001750~photoreceptor outer segment,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,GO:0005929~cilium,GO:0016028~rhabdomere,GO:0031226~intrinsic component of plasma membrane,GO:0031513~nonmotile primary cilium,GO:0044421~extracellular region part,GO:0072372~primary cilium,GO:0097458~neuron part,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0017076~purine nucleotide binding,GO:0019199~transmembrane receptor protein kinase activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0038023~signaling receptor activity,GO:0060089~molecular transducer activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:0099600~transmembrane receptor activity,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		613862~Retinitis pigmentosa 38,
38128_at	N-acetyltransferase 8B (putative, gene/pseudogene)(NAT8B)	Homo sapiens			GO:0001702~gastrulation with mouth forming second,GO:0006464~cellular protein modification process,GO:0006473~protein acetylation,GO:0006475~internal protein amino acid acetylation,GO:0006518~peptide metabolic process,GO:0006915~apoptotic process,GO:0007369~gastrulation,GO:0008219~cell death,GO:0009790~embryo development,GO:0009893~positive regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0018003~peptidyl-lysine N6-acetylation,GO:0018193~peptidyl-amino acid modification,GO:0018205~peptidyl-lysine modification,GO:0018393~internal peptidyl-lysine acetylation,GO:0018394~peptidyl-lysine acetylation,GO:0036211~protein modification process,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043543~protein acylation,GO:0043603~cellular amide metabolic process,GO:0048598~embryonic morphogenesis,GO:0050435~beta-amyloid metabolic process,GO:0060548~negative regulation of cell death,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0044432~endoplasmic reticulum part,	GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0008080~N-acetyltransferase activity,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,		
40058_s_at	PDZ and LIM domain 5(PDLIM5)	Homo sapiens	Bipolar Disorder,Cholesterol,Cholesterol, LDL,Chronic renal failure|Kidney Failure, Chronic,Depression,Parietal Lobe,prostate cancer,Prostatic Neoplasms,Schizophrenia,schizophrenia; bipolar disorder,	AGING,CANCER,METABOLIC,PSYCH,RENAL,	GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0003008~system process,GO:0003012~muscle system process,GO:0003298~physiological muscle hypertrophy,GO:0003300~cardiac muscle hypertrophy,GO:0003301~physiological cardiac muscle hypertrophy,GO:0007155~cell adhesion,GO:0007399~nervous system development,GO:0007507~heart development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0014706~striated muscle tissue development,GO:0014896~muscle hypertrophy,GO:0014897~striated muscle hypertrophy,GO:0016049~cell growth,GO:0016358~dendrite development,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035051~cardiocyte differentiation,GO:0035265~organ growth,GO:0040007~growth,GO:0042692~muscle cell differentiation,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0045595~regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0048468~cell development,GO:0048588~developmental cell growth,GO:0048589~developmental growth,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048738~cardiac muscle tissue development,GO:0048812~neuron projection morphogenesis,GO:0048813~dendrite morphogenesis,GO:0048814~regulation of dendrite morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050803~regulation of synapse structure or activity,GO:0050807~regulation of synapse organization,GO:0050808~synapse organization,GO:0051128~regulation of cellular component organization,GO:0051146~striated muscle cell differentiation,GO:0051960~regulation of nervous system development,GO:0051963~regulation of synapse assembly,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055006~cardiac cell development,GO:0055007~cardiac muscle cell differentiation,GO:0055013~cardiac muscle cell development,GO:0055017~cardiac muscle tissue growth,GO:0060284~regulation of cell development,GO:0060419~heart growth,GO:0060537~muscle tissue development,GO:0060996~dendritic spine development,GO:0060998~regulation of dendritic spine development,GO:0061001~regulation of dendritic spine morphogenesis,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0061061~muscle structure development,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0098609~cell-cell adhesion,GO:2000026~regulation of multicellular organismal development,	GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0043005~neuron projection,GO:0044456~synapse part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0060076~excitatory synapse,GO:0070161~anchoring junction,GO:0097060~synaptic membrane,GO:0097458~neuron part,GO:0098590~plasma membrane region,GO:0098794~postsynapse,GO:0099572~postsynaptic specialization,	GO:0003779~actin binding,GO:0005080~protein kinase C binding,GO:0008092~cytoskeletal protein binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0042805~actinin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0047485~protein N-terminus binding,GO:0050839~cell adhesion molecule binding,GO:0098631~protein binding involved in cell adhesion,GO:0098632~protein binding involved in cell-cell adhesion,GO:0098641~cadherin binding involved in cell-cell adhesion,		
33922_at	PR/SET domain 2(PRDM2)	Homo sapiens	Alzheimer's disease   ,Body Mass Index,Bone Mineral Density,Breast Cancer,Breath Tests,Cholesterol, HDL,Colorectal Cancer,Echocardiography,epithelial ovarian cancer ,Fibrinogen,Fractures, Bone|Osteoporosis|Osteoporosis, Postmenopausal,Heart Rate,Lung Cancer,Marijuana Abuse|Psychoses, Substance-Induced,overall effect,Parkinson Disease,Respiratory Function Tests,	CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,METABOLIC,NEUROLOGICAL,OTHER,	GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006464~cellular protein modification process,GO:0006479~protein methylation,GO:0007568~aging,GO:0008213~protein alkylation,GO:0008340~determination of adult lifespan,GO:0010259~multicellular organism aging,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0016070~RNA metabolic process,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0018022~peptidyl-lysine methylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018205~peptidyl-lysine modification,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0032259~methylation,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034968~histone lysine methylation,GO:0036211~protein modification process,GO:0043414~macromolecule methylation,GO:0043933~macromolecular complex subunit organization,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0097659~nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,		GO:0001071~nucleic acid binding transcription factor activity,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008168~methyltransferase activity,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016741~transferase activity, transferring one-carbon groups,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
35069_at	PRAME family member 1(PRAMEF1)	Homo sapiens			GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0060548~negative regulation of cell death,GO:0097659~nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,				
33371_s_at	RAB31, member RAS oncogene family(RAB31)	Homo sapiens	Cell Adhesion Molecules,Hemoglobin A, Glycosylated,Tobacco Use Disorder,	CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,	GO:0006887~exocytosis,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007009~plasma membrane organization,GO:0007264~small GTPase mediated signal transduction,GO:0008104~protein localization,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0010256~endomembrane system organization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0031623~receptor internalization,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032940~secretion by cell,GO:0033036~macromolecule localization,GO:0034613~cellular protein localization,GO:0035556~intracellular signal transduction,GO:0043001~Golgi to plasma membrane protein transport,GO:0043112~receptor metabolic process,GO:0043434~response to peptide hormone,GO:0044802~single-organism membrane organization,GO:0045055~regulated exocytosis,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0051641~cellular localization,GO:0061024~membrane organization,GO:0070727~cellular macromolecule localization,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071375~cellular response to peptide hormone stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071495~cellular response to endogenous stimulus,GO:0072657~protein localization to membrane,GO:0072659~protein localization to plasma membrane,GO:0090002~establishment of protein localization to plasma membrane,GO:0090150~establishment of protein localization to membrane,GO:0090382~phagosome maturation,GO:1901652~response to peptide,GO:1901653~cellular response to peptide,GO:1901698~response to nitrogen compound,GO:1901699~cellular response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1902580~single-organism cellular localization,GO:1990778~protein localization to cell periphery,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030670~phagocytic vesicle membrane,GO:0031984~organelle subcompartment,GO:0031988~membrane-bounded vesicle,GO:0032588~trans-Golgi network membrane,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0045335~phagocytic vesicle,GO:0098791~Golgi subcompartment,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0019001~guanyl nucleotide binding,GO:0019003~GDP binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa04144:Endocytosis,	
967_g_at, 966_at	RAD54-like (S. cerevisiae)(RAD54L)	Homo sapiens	benzene haematotoxicity,Bladder Cancer,brain cancer,Brain Neoplasms|Glioma,Breast Cancer,chronic obstructive pulmonary disease,Hodgkin Disease|Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoproliferative Disorders|Waldenstrom Macroglobulinemia,Lung Cancer,lung cancer ,Lymphoma, Non-Hodgkin|Lymphoma, Non-Hodgkin's,Multiple Sclerosis,pancreatic cancer,Pancreatic Neoplasms,	CANCER,IMMUNE,OTHER,PHARMACOGENOMIC,	GO:0000003~reproduction,GO:0000280~nuclear division,GO:0000724~double-strand break repair via homologous recombination,GO:0000725~recombinational repair,GO:0000733~DNA strand renaturation,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007126~meiotic nuclear division,GO:0007568~aging,GO:0008340~determination of adult lifespan,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0010212~response to ionizing radiation,GO:0010259~multicellular organism aging,GO:0022402~cell cycle process,GO:0022414~reproductive process,GO:0033554~cellular response to stress,GO:0042493~response to drug,GO:0044702~single organism reproductive process,GO:0048285~organelle fission,GO:0051276~chromosome organization,GO:0051321~meiotic cell cycle,GO:1903046~meiotic cell cycle process,	GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0036310~annealing helicase activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:0097617~annealing activity,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa03440:Homologous recombination,	114480~Breast cancer, invasive ductal,605027~Lymphoma, non-Hodgkin, somatic,Adenocarcinoma, colonic, somatic~Adenocarcinoma, colonic, somatic,
33080_s_at	RAP1 GTPase activating protein(RAP1GAP)	Homo sapiens	Leukemia, Lymphocytic, Chronic, B-Cell,plasma levels of liver enzymes,Socioeconomic Factors,	CANCER,METABOLIC,OTHER,	GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009966~regulation of signal transduction,GO:0010033~response to organic substance,GO:0010646~regulation of cell communication,GO:0010721~negative regulation of cell development,GO:0022008~neurogenesis,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030033~microvillus assembly,GO:0030182~neuron differentiation,GO:0030878~thyroid gland development,GO:0031344~regulation of cell projection organization,GO:0031345~negative regulation of cell projection organization,GO:0032528~microvillus organization,GO:0032530~regulation of microvillus organization,GO:0032534~regulation of microvillus assembly,GO:0035270~endocrine system development,GO:0035556~intracellular signal transduction,GO:0042127~regulation of cell proliferation,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0048468~cell development,GO:0048699~generation of neurons,GO:0048732~gland development,GO:0050673~epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050790~regulation of catalytic activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051093~negative regulation of developmental process,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051128~regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051241~negative regulation of multicellular organismal process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051960~regulation of nervous system development,GO:0051961~negative regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060491~regulation of cell projection assembly,GO:0065009~regulation of molecular function,GO:0070848~response to growth factor,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071363~cellular response to growth factor stimulus,GO:0071495~cellular response to endogenous stimulus,GO:1902531~regulation of intracellular signal transduction,GO:1903697~negative regulation of microvillus assembly,GO:1904424~regulation of GTP binding,GO:1904425~negative regulation of GTP binding,GO:1904441~regulation of thyroid gland epithelial cell proliferation,GO:1904442~negative regulation of thyroid gland epithelial cell proliferation,GO:1990789~thyroid gland epithelial cell proliferation,GO:1990790~response to glial cell derived neurotrophic factor,GO:1990792~cellular response to glial cell derived neurotrophic factor,GO:2000026~regulation of multicellular organismal development,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030424~axon,GO:0030425~dendrite,GO:0036477~somatodendritic compartment,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0044297~cell body,GO:0044431~Golgi apparatus part,GO:0097458~neuron part,	GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0017016~Ras GTPase binding,GO:0017111~nucleoside-triphosphatase activity,GO:0019899~enzyme binding,GO:0030234~enzyme regulator activity,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0098772~molecular function regulator,	hsa04015:Rap1 signaling pathway,	
606_at	Rho family GTPase 2(RND2)	Homo sapiens			GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001558~regulation of cell growth,GO:0007264~small GTPase mediated signal transduction,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0008361~regulation of cell size,GO:0010720~positive regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010770~positive regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0010976~positive regulation of neuron projection development,GO:0016049~cell growth,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022604~regulation of cell morphogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030307~positive regulation of cell growth,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035556~intracellular signal transduction,GO:0040007~growth,GO:0040008~regulation of growth,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045927~positive regulation of growth,GO:0048468~cell development,GO:0048588~developmental cell growth,GO:0048589~developmental growth,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048668~collateral sprouting,GO:0048670~regulation of collateral sprouting,GO:0048672~positive regulation of collateral sprouting,GO:0048699~generation of neurons,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050772~positive regulation of axonogenesis,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060560~developmental growth involved in morphogenesis,GO:0061387~regulation of extent of cell growth,GO:0061564~axon development,GO:0090066~regulation of anatomical structure size,GO:2000026~regulation of multicellular organismal development,	GO:0001669~acrosomal vesicle,GO:0002080~acrosomal membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005773~vacuole,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0030659~cytoplasmic vesicle membrane,GO:0030667~secretory granule membrane,GO:0031988~membrane-bounded vesicle,GO:0044433~cytoplasmic vesicle part,GO:0097223~sperm part,GO:0099503~secretory vesicle,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0019001~guanyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0047485~protein N-terminus binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		
39908_at	TATA-box binding protein associated factor 6 like(TAF6L)	Homo sapiens			GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0006473~protein acetylation,GO:0006475~internal protein amino acid acetylation,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0016070~RNA metabolic process,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018205~peptidyl-lysine modification,GO:0018393~internal peptidyl-lysine acetylation,GO:0018394~peptidyl-lysine acetylation,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0036211~protein modification process,GO:0043543~protein acylation,GO:0043933~macromolecular complex subunit organization,GO:0043966~histone H3 acetylation,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0065009~regulation of molecular function,GO:0097659~nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0000118~histone deacetylase complex,GO:0000123~histone acetyltransferase complex,GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0030914~STAGA complex,GO:0031248~protein acetyltransferase complex,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044451~nucleoplasm part,GO:0070062~extracellular exosome,GO:0070461~SAGA-type complex,GO:1902493~acetyltransferase complex,GO:1903561~extracellular vesicle,	GO:0000988~transcription factor activity, protein binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0034212~peptide N-acetyltransferase activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0061733~peptide-lysine-N-acetyltransferase activity,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,	hsa03022:Basal transcription factors,hsa05168:Herpes simplex infection,	
1372_at	TNF alpha induced protein 6(TNFAIP6)	Homo sapiens	Body Height,Hypercholesterolemia|LDLC levels,Nasal Polyps|Recurrence|Rhinitis|Sinusitis,Osteoarthritis,ovarian cancer,	CANCER,DEVELOPMENTAL,IMMUNE,METABOLIC,	GO:0000003~reproduction,GO:0006928~movement of cell or subcellular component,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0007276~gamete generation,GO:0007292~female gamete generation,GO:0009605~response to external stimulus,GO:0016477~cell migration,GO:0019953~sexual reproduction,GO:0022414~reproductive process,GO:0022610~biological adhesion,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030728~ovulation,GO:0031347~regulation of defense response,GO:0031348~negative regulation of defense response,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032504~multicellular organism reproduction,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0044702~single organism reproductive process,GO:0044703~multi-organism reproductive process,GO:0048585~negative regulation of response to stimulus,GO:0048609~multicellular organismal reproductive process,GO:0048870~cell motility,GO:0050727~regulation of inflammatory response,GO:0050728~negative regulation of inflammatory response,GO:0051270~regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0051674~localization of cell,GO:0080134~regulation of response to stress,GO:2000145~regulation of cell motility,GO:2000147~positive regulation of cell motility,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0005539~glycosaminoglycan binding,GO:0005540~hyaluronic acid binding,GO:0097367~carbohydrate derivative binding,		
1331_s_at	TNF receptor superfamily member 25(TNFRSF25)	Homo sapiens	benzene haematotoxicity,diabetes, type 1,multiple myeloma,null,	CANCER,IMMUNE,NORMALVARIATION,PHARMACOGENOMIC,	GO:0000165~MAPK cascade,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002237~response to molecule of bacterial origin,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006915~apoptotic process,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0008219~cell death,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019221~cytokine-mediated signaling pathway,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0033993~response to lipid,GO:0034097~response to cytokine,GO:0034612~response to tumor necrosis factor,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043207~response to external biotic stimulus,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0045937~positive regulation of phosphate metabolic process,GO:0048584~positive regulation of response to stimulus,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051707~response to other organism,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071345~cellular response to cytokine stimulus,GO:0071356~cellular response to tumor necrosis factor,GO:0097190~apoptotic signaling pathway,GO:1901700~response to oxygen-containing compound,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0031226~intrinsic component of plasma membrane,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005035~death receptor activity,GO:0038023~signaling receptor activity,GO:0060089~molecular transducer activity,GO:0099600~transmembrane receptor activity,	hsa04060:Cytokine-cytokine receptor interaction,	
32680_at	TRAF2 and NCK interacting kinase(TNIK)	Homo sapiens	Brain imaging in schizophrenia (interaction),Cell Adhesion Molecules,Cholesterol, HDL,Coronary Disease,Hemoglobins,Schizophrenia,Tobacco Use Disorder,	CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,METABOLIC,PSYCH,	GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0007009~plasma membrane organization,GO:0007010~cytoskeleton organization,GO:0007166~cell surface receptor signaling pathway,GO:0007254~JNK cascade,GO:0007256~activation of JNKK activity,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0008104~protein localization,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010256~endomembrane system organization,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0016055~Wnt signaling pathway,GO:0016310~phosphorylation,GO:0016358~dendrite development,GO:0019220~regulation of phosphate metabolic process,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022604~regulation of cell morphogenesis,GO:0022607~cellular component assembly,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030033~microvillus assembly,GO:0030036~actin cytoskeleton organization,GO:0030182~neuron differentiation,GO:0031098~stress-activated protein kinase signaling cascade,GO:0031175~neuron projection development,GO:0031325~positive regulation of cellular metabolic process,GO:0031344~regulation of cell projection organization,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031532~actin cytoskeleton reorganization,GO:0032147~activation of protein kinase activity,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032528~microvillus organization,GO:0032872~regulation of stress-activated MAPK cascade,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0032989~cellular component morphogenesis,GO:0033036~macromolecule localization,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0034613~cellular protein localization,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043506~regulation of JUN kinase activity,GO:0043549~regulation of kinase activity,GO:0044085~cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0044802~single-organism membrane organization,GO:0045595~regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045937~positive regulation of phosphate metabolic process,GO:0046328~regulation of JNK cascade,GO:0046330~positive regulation of JNK cascade,GO:0046777~protein autophosphorylation,GO:0048468~cell development,GO:0048584~positive regulation of response to stimulus,GO:0048666~neuron development,GO:0048699~generation of neurons,GO:0048814~regulation of dendrite morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050790~regulation of catalytic activity,GO:0051128~regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051403~stress-activated MAPK cascade,GO:0051641~cellular localization,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0061024~membrane organization,GO:0065009~regulation of molecular function,GO:0070302~regulation of stress-activated protein kinase signaling cascade,GO:0070304~positive regulation of stress-activated protein kinase signaling cascade,GO:0070727~cellular macromolecule localization,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0072657~protein localization to membrane,GO:0072659~protein localization to plasma membrane,GO:0080134~regulation of response to stress,GO:0080135~regulation of cellular response to stress,GO:0198738~cell-cell signaling by wnt,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902580~single-organism cellular localization,GO:1902589~single-organism organelle organization,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1990778~protein localization to cell periphery,GO:2000026~regulation of multicellular organismal development,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005768~endosome,GO:0005773~vacuole,GO:0016324~apical plasma membrane,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,GO:0098590~plasma membrane region,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004871~signal transducer activity,GO:0005057~receptor signaling protein activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,		
35213_at	WW domain binding protein 4(WBP4)	Homo sapiens			GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010467~gene expression,GO:0016070~RNA metabolic process,GO:0016071~mRNA metabolic process,GO:0045292~mRNA cis splicing, via spliceosome,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0044451~nucleoplasm part,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070064~proline-rich region binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
40089_at	Williams-Beuren syndrome chromosome region 22(WBSCR22)	Homo sapiens			GO:0000154~rRNA modification,GO:0001510~RNA methylation,GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0009451~RNA modification,GO:0009452~7-methylguanosine RNA capping,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0016070~RNA metabolic process,GO:0016072~rRNA metabolic process,GO:0016569~covalent chromatin modification,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0031167~rRNA methylation,GO:0032259~methylation,GO:0032774~RNA biosynthetic process,GO:0034470~ncRNA processing,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034660~ncRNA metabolic process,GO:0036260~RNA capping,GO:0036265~RNA (guanine-N7)-methylation,GO:0042254~ribosome biogenesis,GO:0043414~macromolecule methylation,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0070475~rRNA base methylation,GO:0070476~rRNA (guanine-N7)-methylation,GO:0097659~nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008173~RNA methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0016741~transferase activity, transferring one-carbon groups,GO:0044822~poly(A) RNA binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
33684_at	Wnt family member 2B(WNT2B)	Homo sapiens	allergic rhinitis,Bipolar Disorder,Colorectal Cancer,Head and Neck Neoplasms|Neoplasm Recurrence, Local|Neoplasms, Second Primary,Type 2 Diabetes| edema | rosiglitazone,	CANCER,IMMUNE,PHARMACOGENOMIC,PSYCH,	GO:0000003~reproduction,GO:0001501~skeletal system development,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001759~organ induction,GO:0001763~morphogenesis of a branching structure,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0002009~morphogenesis of an epithelium,GO:0002062~chondrocyte differentiation,GO:0002088~lens development in camera-type eye,GO:0002520~immune system development,GO:0003002~regionalization,GO:0003006~developmental process involved in reproduction,GO:0003156~regulation of organ formation,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007389~pattern specification process,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007423~sensory organ development,GO:0007548~sex differentiation,GO:0008283~cell proliferation,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009267~cellular response to starvation,GO:0009605~response to external stimulus,GO:0009790~embryo development,GO:0009887~organ morphogenesis,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009991~response to extracellular stimulus,GO:0010092~specification of organ identity,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0016055~Wnt signaling pathway,GO:0021871~forebrain regionalization,GO:0022008~neurogenesis,GO:0022414~reproductive process,GO:0022603~regulation of anatomical structure morphogenesis,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030097~hemopoiesis,GO:0030111~regulation of Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030900~forebrain development,GO:0031128~developmental induction,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0033554~cellular response to stress,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040019~positive regulation of embryonic development,GO:0042594~response to starvation,GO:0043010~camera-type eye development,GO:0044702~single organism reproductive process,GO:0045137~development of primary sexual characteristics,GO:0045165~cell fate commitment,GO:0045995~regulation of embryonic development,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048534~hematopoietic or lymphoid organ development,GO:0048584~positive regulation of response to stimulus,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048608~reproductive structure development,GO:0048645~organ formation,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048699~generation of neurons,GO:0048729~tissue morphogenesis,GO:0048754~branching morphogenesis of an epithelial tube,GO:0051094~positive regulation of developmental process,GO:0051216~cartilage development,GO:0051240~positive regulation of multicellular organismal process,GO:0060070~canonical Wnt signaling pathway,GO:0060322~head development,GO:0060425~lung morphogenesis,GO:0060429~epithelium development,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060492~lung induction,GO:0060541~respiratory system development,GO:0060562~epithelial tube morphogenesis,GO:0060638~mesenchymal-epithelial cell signaling,GO:0060675~ureteric bud morphogenesis,GO:0060688~regulation of morphogenesis of a branching structure,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0060993~kidney morphogenesis,GO:0061046~regulation of branching involved in lung morphogenesis,GO:0061047~positive regulation of branching involved in lung morphogenesis,GO:0061072~iris morphogenesis,GO:0061138~morphogenesis of a branching epithelium,GO:0061213~positive regulation of mesonephros development,GO:0061217~regulation of mesonephros development,GO:0061303~cornea development in camera-type eye,GO:0061326~renal tubule development,GO:0061333~renal tubule morphogenesis,GO:0061448~connective tissue development,GO:0061458~reproductive system development,GO:0071425~hematopoietic stem cell proliferation,GO:0071496~cellular response to external stimulus,GO:0072001~renal system development,GO:0072006~nephron development,GO:0072009~nephron epithelium development,GO:0072028~nephron morphogenesis,GO:0072073~kidney epithelium development,GO:0072078~nephron tubule morphogenesis,GO:0072080~nephron tubule development,GO:0072088~nephron epithelium morphogenesis,GO:0072089~stem cell proliferation,GO:0072163~mesonephric epithelium development,GO:0072164~mesonephric tubule development,GO:0072171~mesonephric tubule morphogenesis,GO:0090183~regulation of kidney development,GO:0090184~positive regulation of kidney development,GO:0090189~regulation of branching involved in ureteric bud morphogenesis,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090596~sensory organ morphogenesis,GO:0198738~cell-cell signaling by wnt,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:2000026~regulation of multicellular organismal development,GO:2000027~regulation of organ morphogenesis,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0005109~frizzled binding,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	
2090_i_at	Wnt family member 6(WNT6)	Homo sapiens	cleft lip with cleft palate cleft lip without cleft palate cleft palate,Cleft Lip|Cleft Palate,	DEVELOPMENTAL,	GO:0001101~response to acid chemical,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001763~morphogenesis of a branching structure,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0001838~embryonic epithelial tube formation,GO:0002009~morphogenesis of an epithelium,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007389~pattern specification process,GO:0007399~nervous system development,GO:0007423~sensory organ development,GO:0009790~embryo development,GO:0009798~axis specification,GO:0009887~organ morphogenesis,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0016070~RNA metabolic process,GO:0016331~morphogenesis of embryonic epithelium,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0030182~neuron differentiation,GO:0031214~biomineral tissue development,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032526~response to retinoic acid,GO:0032774~RNA biosynthetic process,GO:0033993~response to lipid,GO:0034505~tooth mineralization,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035148~tube formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042476~odontogenesis,GO:0042481~regulation of odontogenesis,GO:0042482~positive regulation of odontogenesis,GO:0043010~camera-type eye development,GO:0045165~cell fate commitment,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0048598~embryonic morphogenesis,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048699~generation of neurons,GO:0048729~tissue morphogenesis,GO:0048754~branching morphogenesis of an epithelial tube,GO:0051094~positive regulation of developmental process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0060684~epithelial-mesenchymal cell signaling,GO:0060993~kidney morphogenesis,GO:0061138~morphogenesis of a branching epithelium,GO:0061303~cornea development in camera-type eye,GO:0061326~renal tubule development,GO:0061333~renal tubule morphogenesis,GO:0070167~regulation of biomineral tissue development,GO:0070169~positive regulation of biomineral tissue development,GO:0070170~regulation of tooth mineralization,GO:0070172~positive regulation of tooth mineralization,GO:0070887~cellular response to chemical stimulus,GO:0071229~cellular response to acid chemical,GO:0071300~cellular response to retinoic acid,GO:0071310~cellular response to organic substance,GO:0071396~cellular response to lipid,GO:0072001~renal system development,GO:0072006~nephron development,GO:0072009~nephron epithelium development,GO:0072028~nephron morphogenesis,GO:0072073~kidney epithelium development,GO:0072078~nephron tubule morphogenesis,GO:0072079~nephron tubule formation,GO:0072080~nephron tubule development,GO:0072088~nephron epithelium morphogenesis,GO:0072163~mesonephric epithelium development,GO:0072164~mesonephric tubule development,GO:0072171~mesonephric tubule morphogenesis,GO:0072175~epithelial tube formation,GO:0097659~nucleic acid-templated transcription,GO:0198738~cell-cell signaling by wnt,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:2000026~regulation of multicellular organismal development,GO:2000027~regulation of organ morphogenesis,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0009986~cell surface,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0031012~extracellular matrix,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044431~Golgi apparatus part,GO:0044432~endoplasmic reticulum part,GO:0044433~cytoplasmic vesicle part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0005109~frizzled binding,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	
37953_s_at	acid sensing ion channel subunit 1(ASIC1)	Homo sapiens	Diseases in Twins,Multiple Sclerosis,	IMMUNE,UNKNOWN,	GO:0001505~regulation of neurotransmitter levels,GO:0003008~system process,GO:0006461~protein complex assembly,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006816~calcium ion transport,GO:0006836~neurotransmitter transport,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007613~memory,GO:0008306~associative learning,GO:0009268~response to pH,GO:0009628~response to abiotic stimulus,GO:0010447~response to acidic pH,GO:0010646~regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0015672~monovalent inorganic cation transport,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0023057~negative regulation of signaling,GO:0023061~signal release,GO:0030001~metal ion transport,GO:0032940~secretion by cell,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044708~single-organism behavior,GO:0046903~secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0046929~negative regulation of neurotransmitter secretion,GO:0050804~modulation of synaptic transmission,GO:0050805~negative regulation of synaptic transmission,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050909~sensory perception of taste,GO:0050915~sensory perception of sour taste,GO:0051046~regulation of secretion,GO:0051048~negative regulation of secretion,GO:0051049~regulation of transport,GO:0051051~negative regulation of transport,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051588~regulation of neurotransmitter transport,GO:0051589~negative regulation of neurotransmitter transport,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0055085~transmembrane transport,GO:0060341~regulation of cellular localization,GO:0065003~macromolecular complex assembly,GO:0070206~protein trimerization,GO:0070207~protein homotrimerization,GO:0070271~protein complex biogenesis,GO:0070588~calcium ion transmembrane transport,GO:0070838~divalent metal ion transport,GO:0071214~cellular response to abiotic stimulus,GO:0071467~cellular response to pH,GO:0071822~protein complex subunit organization,GO:0072511~divalent inorganic cation transport,GO:0098655~cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098662~inorganic cation transmembrane transport,GO:0098916~anterograde trans-synaptic signaling,GO:0099531~presynaptic process involved in chemical synaptic transmission,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:0099643~signal release from synapse,GO:1903530~regulation of secretion by cell,GO:1903531~negative regulation of secretion by cell,	GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0031226~intrinsic component of plasma membrane,GO:0045202~synapse,	GO:0004872~receptor activity,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0008324~cation transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015280~ligand-gated sodium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate-specific channel activity,GO:0022839~ion gated channel activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0044736~acid-sensing ion channel activity,GO:0046873~metal ion transmembrane transporter activity,GO:0060089~molecular transducer activity,GO:0099600~transmembrane receptor activity,	hsa04750:Inflammatory mediator regulation of TRP channels,	
40317_at	acid sensing ion channel subunit 2(ASIC2)	Homo sapiens	Alcoholism,autism,Body Mass Index,Body Weight,C-Reactive Protein,Coronary Artery Disease,F8 protein, human,Gout,Hypothyroidism,Leukocyte Count,Multiple Sclerosis,Narcolepsy,Stroke,Tobacco Use Disorder,	CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,IMMUNE,METABOLIC,NEUROLOGICAL,PSYCH,	GO:0001976~neurological system process involved in regulation of systemic arterial blood pressure,GO:0003008~system process,GO:0003013~circulatory system process,GO:0003018~vascular process in circulatory system,GO:0003025~regulation of systemic arterial blood pressure by baroreceptor feedback,GO:0003026~regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,GO:0003073~regulation of systemic arterial blood pressure,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006915~apoptotic process,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007399~nervous system development,GO:0007416~synapse assembly,GO:0007417~central nervous system development,GO:0007422~peripheral nervous system development,GO:0007599~hemostasis,GO:0007600~sensory perception,GO:0007602~phototransduction,GO:0007605~sensory perception of sound,GO:0007606~sensory perception of chemical stimulus,GO:0008015~blood circulation,GO:0008104~protein localization,GO:0008217~regulation of blood pressure,GO:0008219~cell death,GO:0009268~response to pH,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009581~detection of external stimulus,GO:0009582~detection of abiotic stimulus,GO:0009583~detection of light stimulus,GO:0009605~response to external stimulus,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0010447~response to acidic pH,GO:0010468~regulation of gene expression,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0015672~monovalent inorganic cation transport,GO:0019229~regulation of vasoconstriction,GO:0022607~cellular component assembly,GO:0030001~metal ion transport,GO:0030193~regulation of blood coagulation,GO:0032101~regulation of response to external stimulus,GO:0033036~macromolecule localization,GO:0034220~ion transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0035150~regulation of tube size,GO:0035418~protein localization to synapse,GO:0035725~sodium ion transmembrane transport,GO:0042060~wound healing,GO:0042391~regulation of membrane potential,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043269~regulation of ion transport,GO:0044057~regulation of system process,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044089~positive regulation of cellular component biogenesis,GO:0050803~regulation of synapse structure or activity,GO:0050807~regulation of synapse organization,GO:0050808~synapse organization,GO:0050817~coagulation,GO:0050818~regulation of coagulation,GO:0050877~neurological system process,GO:0050878~regulation of body fluid levels,GO:0050880~regulation of blood vessel size,GO:0050906~detection of stimulus involved in sensory perception,GO:0050909~sensory perception of taste,GO:0050915~sensory perception of sour taste,GO:0050954~sensory perception of mechanical stimulus,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0050982~detection of mechanical stimulus,GO:0051049~regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051606~detection of stimulus,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0051963~regulation of synapse assembly,GO:0051965~positive regulation of synapse assembly,GO:0055085~transmembrane transport,GO:0060548~negative regulation of cell death,GO:0061041~regulation of wound healing,GO:0080134~regulation of response to stress,GO:0090066~regulation of anatomical structure size,GO:0098655~cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098662~inorganic cation transmembrane transport,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:1900046~regulation of hemostasis,GO:1903034~regulation of response to wounding,GO:1903522~regulation of blood circulation,GO:2000026~regulation of multicellular organismal development,	GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,GO:0031226~intrinsic component of plasma membrane,GO:0036477~somatodendritic compartment,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0044297~cell body,GO:0044309~neuron spine,GO:0044456~synapse part,GO:0045202~synapse,GO:0097458~neuron part,GO:0098794~postsynapse,	GO:0004872~receptor activity,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0008324~cation transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015280~ligand-gated sodium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate-specific channel activity,GO:0022839~ion gated channel activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0044736~acid-sensing ion channel activity,GO:0046873~metal ion transmembrane transporter activity,GO:0060089~molecular transducer activity,GO:0099600~transmembrane receptor activity,	hsa04742:Taste transduction,hsa04750:Inflammatory mediator regulation of TRP channels,	
34606_s_at	activating transcription factor 7(ATF7)	Homo sapiens	Body Height,height,	DEVELOPMENTAL,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0097659~nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005654~nucleoplasm,GO:0034399~nuclear periphery,	GO:0000975~regulatory region DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001067~regulatory region nucleic acid binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0051019~mitogen-activated protein kinase binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,GO:1990837~sequence-specific double-stranded DNA binding,		
39511_at	afadin, adherens junction formation factor(AFDN)	Homo sapiens	Fibrinogen,Tobacco Use Disorder,	CHEMDEPENDENCY,HEMATOLOGICAL,	GO:0001885~endothelial cell development,GO:0002064~epithelial cell development,GO:0002065~columnar/cuboidal epithelial cell differentiation,GO:0003158~endothelium development,GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0009887~organ morphogenesis,GO:0010001~glial cell differentiation,GO:0014013~regulation of gliogenesis,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021987~cerebral cortex development,GO:0022008~neurogenesis,GO:0022610~biological adhesion,GO:0030855~epithelial cell differentiation,GO:0030900~forebrain development,GO:0032880~regulation of protein localization,GO:0034330~cell junction organization,GO:0034331~cell junction maintenance,GO:0034332~adherens junction organization,GO:0034334~adherens junction maintenance,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0043954~cellular component maintenance,GO:0044093~positive regulation of molecular function,GO:0045216~cell-cell junction organization,GO:0045446~endothelial cell differentiation,GO:0045595~regulation of cell differentiation,GO:0048468~cell development,GO:0048699~generation of neurons,GO:0048854~brain morphogenesis,GO:0048872~homeostasis of number of cells,GO:0050767~regulation of neurogenesis,GO:0050790~regulation of catalytic activity,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051960~regulation of nervous system development,GO:0060019~radial glial cell differentiation,GO:0060284~regulation of cell development,GO:0060322~head development,GO:0060429~epithelium development,GO:0060563~neuroepithelial cell differentiation,GO:0061028~establishment of endothelial barrier,GO:0061351~neural precursor cell proliferation,GO:0065009~regulation of molecular function,GO:0070445~regulation of oligodendrocyte progenitor proliferation,GO:0090557~establishment of endothelial intestinal barrier,GO:0098609~cell-cell adhesion,GO:2000026~regulation of multicellular organismal development,GO:2000177~regulation of neural precursor cell proliferation,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0030054~cell junction,GO:0045177~apical part of cell,GO:0070161~anchoring junction,	GO:0008022~protein C-terminus binding,GO:0017016~Ras GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,GO:0051020~GTPase binding,GO:0098631~protein binding involved in cell adhesion,GO:0098632~protein binding involved in cell-cell adhesion,GO:0098641~cadherin binding involved in cell-cell adhesion,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,	
37983_at	angiotensin II receptor type 1(AGTR1)	Homo sapiens	Acromegaly,Acute Coronary Syndrome|,aging,Albuminuria|Cardiovascular Diseases|Diabetes Mellitus, Type 2|Hypertension|Kidney Diseases,Albuminuria|Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1|Diabetic Nephropathies|Diabetic Nephropathy,Albuminuria|Diabetes Mellitus, Type 1|Diabetic Nephropathies|,Albuminuria|Hypertension,Altitude Sickness|Chromosome Deletion|Pulmonary Edema,Altitude Sickness|Chronic Disease,Altitude Sickness|Pulmonary Edema,Alzheimer's disease   ,Amyotrophic Lateral Sclerosis|,Angina Pectoris|Myocardial Infarction|Obesity|Recurrence,Angina, Unstable|Myocardial Infarction|Syndrome|Unstable angina,anthropometric and metabolic traits, relative to cardiovascular risk,Aortic Aneurysm, Abdominal,Aortic Aneurysm, Abdominal|,Aortic Aneurysm, Abdominal|Hypertension,aortic stiffness,Apoplexy|Brain Ischemia|Hypertension|Stroke,Apoplexy|Myocardial ischemia|Stroke,Apoplexy|Stroke,arterial disease,arterial stiffness,atherosclerosis,atherosclerosis, coronary,atherosclerosis, coronary endothelial function hypercholesterolemia lipids,atherosclerosis, coronary; hypertension,atherosclerosis, generalized blood pressure, arterial cardiovascular disease,Atherosclerosis|Myocardial Infarction,Atrial Fibrillation,autonomic nervous system function,blood pressure, arterial,blood pressure, arterial; atherosclerosis,blood pressure; aldosterone; glomerular filtration rate; renal plasma flow,Body Weight|Hypertension|Obesity,Brain Ischemia,Brain Ischemia|Hypertension|Osteoporosis|Stroke,Breast Cancer,cardiac death; cardiac morbidity,Cardiac Output, Low,Cardiomyopathies|Heart Defects, Congenital,Cardiomyopathy, Hypertrophic,Cardiomyopathy, Hypertrophic, Familial,Cardiomyopathy, Hypertrophic, Familial|Hypertrophy, Left Ventricular,Cardiomyopathy, Hypertrophic|Hypertrophic Cardiomyopathy|Hypertrophy, Left Ventricular|Left Ventricular Hypertrophy,cardiovascular,cardiovascular disease,Cardiovascular Diseases,Cardiovascular Diseases|,Cardiovascular Diseases|Carotid Artery Diseases|Cerebrovascular Disorders|Hypertension,Cardiovascular Diseases|Coronary Artery Disease,Cardiovascular Diseases|Hypertension,carotid artery stenosis ,carotid intima-media thickness,Cerebral Arterial Diseases|Constriction, Pathologic|Diabetes mellitus type II|Diabetes Mellitus, Type 2,Cerebral Hemorrhage|Cerebral Hemorrhages|Cerebrovascular Disorders|Hypertension,cerebral infarct,Cerebral Infarction,Cerebral Palsy,cerebral white matter lesions,Cerebrovascular Disorders,cholesterol; triglycerides; hypertension; blood pressure, arterial; potassium; urea,cholesterol; triglycerides; hypertension; glucose tolerance,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes|Obstetric Labor, Premature|Pre-Eclampsia|Premature Birth,Chromosome Deletion,Chronic Glomerulonephritis,chronic obstructive pulmonary disease/COPD,Chronic Periodontitis|,Chronic renal failure|Death, Sudden, Cardiac|Kidney Failure, Chronic|Long QT Syndrome|Sudden Cardiac Death,Chronic renal failure|Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1|Diabetic Nephropathies|Diabetic Nephropathy|Kidney Failure, Chronic,Chronic renal failure|Glomerulonephritis, IGA|IGA Glomerulonephritides|Kidney Failure, Chronic,Chronic renal failure|Hypertension|Kidney Failure, Chronic|Lupus Erythematosus, Systemic|Lupus Nephritis|Nephritis SLE|Systemic lupus erythematosus,Chronic renal failure|Kidney Failure, Chronic,Chronic renal failure|Kidney Failure, Chronic|Nephritis, Interstitial,Chronic renal failure|Kidney Failure, Chronic|Uremia|Vesico-Ureteral Reflux|Vesicoureteral reflux,Cicatrization|Kidney Diseases|Recurrence|Urinary tract infection|Urinary Tract Infections|Vesico-Ureteral Reflux|Vesicoureteral reflux,Connective Tissue Diseases|Hypertension, Pulmonary,Convalescence|Coronary Stenosis|Mucocutaneous Lymph Node Syndrome|Myocardial ischemia,Coronary Artery Disease,Coronary Artery Disease|,Coronary Artery Disease|Hypercholesterolemia,Coronary Artery Disease|Myocardial Infarction,Coronary Artery Disease|Myocardial ischemia,coronary artery thrombosis,coronary artery vasoconstriction.,coronary atherosclerosis.,Coronary Disease,Coronary Disease|Coronary heart disease,Coronary Disease|Coronary heart disease|Hyperlipidemias|Hyperlipoproteinemia Type I,Coronary Disease|Hyperlipoproteinemia Type II,Coronary Heart Disease,Coronary Restenosis|Diabetes mellitus|Myocardial ischemia|Recurrence,Coronary Stenosis|Recurrence,cough,cysclosporine toxicity,Dawson's inclusion body encephalitis|Subacute Sclerosing Panencephalitis,deep venous thrombosis,Dementia, Vascular,Depression,Diabetes mellitus type II|Diabetes Mellitus, Type 2|Diabetic Nephropathies|Diabetic Nephropathy,Diabetes mellitus type II|Diabetes Mellitus, Type 2|Diabetic Nephropathies|Diabetic Nephropathy|Diabetic Neuropathies|Disease Susceptibility,Diabetes mellitus type II|Diabetes Mellitus, Type 2|Hypertension,Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Diabetic Retinopathy,Diabetes Mellitus, Type 1|Diabetic Nephropathies,Diabetes Mellitus, Type 1|Hypoglycemia,Diabetes Mellitus, Type 2,Diabetes Mellitus|Diabetic Angiopathies|Hypertension,Diabetes Mellitus|Hypertension,diabetes, type 1 ,diabetes, type 2,diabetes, type 2; hypertension,diabetic nephropathy,Ductus Arteriosus, Patent|Patent ductus arteriosus,Dyslipidemias|Metabolic Syndrome X|Obesity|Renal hypertension,Edema|Nephrotic Syndrome,elite atheletes,esophageal varices,Essential Hypertension,Fatty Liver|Liver Cirrhosis,Fetal Death|Hyperhomocysteinemia|Pregnancy Complications, Hematologic|Thrombophilia,Fetal Membranes, Premature Rupture|Premature Birth,Fibromuscular Dysplasia|Hypertension|Renal Artery Obstruction,Fibrosis|Glomerulonephritis, IGA|Hepatitis C, Chronic|IGA Glomerulonephritides,Focal segmental glomsclerosis|Glomerulosclerosis, Focal Segmental|Hypertension|Kidney Diseases,Gastrointestinal Diseases|Gastrointestinal Hemorrhage|Peptic Ulcer|Peptic Ulcer Hemorrhage,glaucoma; glaucoma, primary open-angle,glomerulonephritis,Glomerulonephritis, IGA,Glomerulonephritis, IGA|IGA Glomerulonephritides,Glomerulonephritis, IGA|IGA Glomerulonephritides|Proteinuria,Glomerulonephritis, IGA|IGA Glomerulonephritides|Recurrence,graft-versus-host disease,Heart Failure,Heart Failure, Diastolic,Heart Failure|Hypertension,heart muscle disease, alcoholic,Heart Rate,Hemolytic-Uremic Syndrome,Henoch-Schoenlein Purpura|Kidney Diseases|Nephrotic Syndrome|Proteinuria|Purpura, Schoenlein-Henoch,hepatitis B liver disease, chronic and cirrhosis,high-altitude tolerance,Hypercholesterolemia|LDLC levels,Hypercholesterolemia|Myocardial Infarction,hypertension,hypertension and ESRD,hypertension, gestational,hypertension, pregnancy induced,hypertension, pregnancy induced preeclampsia,Hypertension, Renal,Hypertension, Renal|Hypertrophy, Left Ventricular|Retinal Diseases,Hypertension/complications*,hypertension; left ventricular hypertrophy,Hypertension|Hypertrophy, Left Ventricular,Hypertension|Hypertrophy, Left Ventricular|Left Ventricular Hypertrophy,Hypertension|Hypertrophy, Left Ventricular|Ventricular Remodeling,Hypertension|Insulin Resistance,Hypertension|Kidney Diseases,Hypertension|Kidney Failure, Chronic,Hypertension|Metabolic Syndrome X,Hypertension|Myocardial Infarction,Hypertension|Myocardial Ischemia,Hypertension|Stroke,Hypertrophy, Left Ventricular|Left Ventricular Hypertrophy,Hypertrophy, Left Ventricular|Left Ventricular Hypertrophy|Ventricular Remodeling,Idiopathic Dilated Cardiomyopathy,IgA nephropathy,increased vascular reactivity,Infant, Premature, Diseases,Insulin Resistance,intima-media thickness,kidney disease,Kidney Diseases,Kidney Failure,kidney failure, acute,Kidney Failure, Acute|Postoperative Complications,kidney failure, chronic,Kidney Failure, Chronic|Vesico-Ureteral Reflux,Kidney Function Post-Kidney Transplant,kidney transplant,left ventricular hypertrophy,left ventricular mass myocardial infarct,Lupus Nephritis|Nephritis SLE,Meningococcal Infections,metabolic syndrome,Metabolic Syndrome X,Migraine Disorders,Mitral valve prolapse syndromes,myocardial infarct,myocardial infarct stroke,myocardial infarct; atherosclerosis, coronary,myocardial infarct; cardiovascular disease,myocardial infarct; cholesterol, HDL; triglycerides; atherosclerosis, coronary; macular degeneration; colorectal cancer,Myocardial Infarction,Myocardial Infarction|Stroke,Myocardial Infarction|Ventricular Dysfunction, Left|Ventricular Remodeling,nephropathy in other diseases,nephropathy, diabetic,nephropathy, diabetic; blood pressure, arterial; proteinuria,normal variation,null,Obesity|Vascular Diseases,otosclerosis,PAI-1 levels tissue plasminogen activator,periodontitis,peritoneal transport,pharmacogenetic studies,plasma HDL cholesterol (HDL-C) levels,plasminogen activator inhibitor-1,polycystic kidney disease,Polycystic Kidney Diseases,posttransplantation erythrocytosis,Pre-Eclampsia,precocious adrenarche,preeclampsia,pregnancy loss, recurrent,prostate cancer,Recurrence|Venous Thromboembolism,renal allograft function,Renal Insufficiency,restenosis,Rheumatic Heart Disease,Sarcoidosis,Sarcoidosis, Pulmonary,several psychiatric disorders,Stroke,sudden cardiac arrest risk,suicide,Syncope, Vasovagal,t-PA and PAI-1 levels,Tuberculosis, Pulmonary,Type 2 diabetes,Type 2 Diabetes| edema | rosiglitazone,type 2 diabetic nephropathy,vesicoureteral reflux,Wall Thickness of the Radial and carotid Arteries,	AGING,CANCER,CARDIOVASCULAR,DEVELOPMENTAL,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0001558~regulation of cell growth,GO:0001655~urogenital system development,GO:0001822~kidney development,GO:0001990~regulation of systemic arterial blood pressure by hormone,GO:0002016~regulation of blood volume by renin-angiotensin,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0002034~regulation of blood vessel size by renin-angiotensin,GO:0003008~system process,GO:0003013~circulatory system process,GO:0003014~renal system process,GO:0003018~vascular process in circulatory system,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003072~renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,GO:0003073~regulation of systemic arterial blood pressure,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0006629~lipid metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0007588~excretion,GO:0008015~blood circulation,GO:0008202~steroid metabolic process,GO:0008217~regulation of blood pressure,GO:0009605~response to external stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone,GO:0009893~positive regulation of metabolic process,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010742~macrophage derived foam cell differentiation,GO:0010743~regulation of macrophage derived foam cell differentiation,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010872~regulation of cholesterol esterification,GO:0010873~positive regulation of cholesterol esterification,GO:0016477~cell migration,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0019229~regulation of vasoconstriction,GO:0019722~calcium-mediated signaling,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0030003~cellular cation homeostasis,GO:0030258~lipid modification,GO:0031325~positive regulation of cellular metabolic process,GO:0031347~regulation of defense response,GO:0031349~positive regulation of defense response,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032429~regulation of phospholipase A2 activity,GO:0032430~positive regulation of phospholipase A2 activity,GO:0032844~regulation of homeostatic process,GO:0032870~cellular response to hormone stimulus,GO:0033860~regulation of NAD(P)H oxidase activity,GO:0033864~positive regulation of NAD(P)H oxidase activity,GO:0034367~macromolecular complex remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0034433~steroid esterification,GO:0034434~sterol esterification,GO:0034435~cholesterol esterification,GO:0035150~regulation of tube size,GO:0035556~intracellular signal transduction,GO:0035813~regulation of renal sodium excretion,GO:0038166~angiotensin-activated signaling pathway,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040011~locomotion,GO:0042127~regulation of cell proliferation,GO:0042312~regulation of vasodilation,GO:0042330~taxis,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043434~response to peptide hormone,GO:0043933~macromolecular complex subunit organization,GO:0044057~regulation of system process,GO:0044062~regulation of excretion,GO:0044093~positive regulation of molecular function,GO:0044255~cellular lipid metabolic process,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045834~positive regulation of lipid metabolic process,GO:0045940~positive regulation of steroid metabolic process,GO:0046903~secretion,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050790~regulation of catalytic activity,GO:0050801~ion homeostasis,GO:0050880~regulation of blood vessel size,GO:0050886~endocrine process,GO:0051046~regulation of secretion,GO:0051049~regulation of transport,GO:0051128~regulation of cellular component organization,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051341~regulation of oxidoreductase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051353~positive regulation of oxidoreductase activity,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0051674~localization of cell,GO:0055065~metal ion homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0060326~cell chemotaxis,GO:0065009~regulation of molecular function,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071375~cellular response to peptide hormone stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071495~cellular response to endogenous stimulus,GO:0071825~protein-lipid complex subunit organization,GO:0071827~plasma lipoprotein particle organization,GO:0072001~renal system development,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072507~divalent inorganic cation homeostasis,GO:0072593~reactive oxygen species metabolic process,GO:0080134~regulation of response to stress,GO:0086097~phospholipase C-activating angiotensin-activated signaling pathway,GO:0090066~regulation of anatomical structure size,GO:0090077~foam cell differentiation,GO:0097006~regulation of plasma lipoprotein particle levels,GO:0098771~inorganic ion homeostasis,GO:0098801~regulation of renal system process,GO:1901652~response to peptide,GO:1901653~cellular response to peptide,GO:1901698~response to nitrogen compound,GO:1901699~cellular response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1903522~regulation of blood circulation,GO:1904385~cellular response to angiotensin,GO:1990776~response to angiotensin,GO:2000021~regulation of ion homeostasis,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005887~integral component of plasma membrane,GO:0031226~intrinsic component of plasma membrane,	GO:0001595~angiotensin receptor activity,GO:0001596~angiotensin type I receptor activity,GO:0001653~peptide receptor activity,GO:0001664~G-protein coupled receptor binding,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004945~angiotensin type II receptor activity,GO:0005102~receptor binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0031711~bradykinin receptor binding,GO:0038023~signaling receptor activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0060089~molecular transducer activity,GO:0099600~transmembrane receptor activity,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04614:Renin-angiotensin system,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa05200:Pathways in cancer,	145500~Hypertension, essential,267430~Renal tubular dysgenesis,
37954_at	annexin A8(ANXA8)	Homo sapiens			GO:0006508~proteolysis,GO:0007032~endosome organization,GO:0007033~vacuole organization,GO:0007034~vacuolar transport,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0009611~response to wounding,GO:0009892~negative regulation of metabolic process,GO:0010256~endomembrane system organization,GO:0010466~negative regulation of peptidase activity,GO:0010517~regulation of phospholipase activity,GO:0010519~negative regulation of phospholipase activity,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010951~negative regulation of endopeptidase activity,GO:0016197~endosomal transport,GO:0030162~regulation of proteolysis,GO:0031324~negative regulation of cellular metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032429~regulation of phospholipase A2 activity,GO:0042060~wound healing,GO:0043086~negative regulation of catalytic activity,GO:0044092~negative regulation of molecular function,GO:0045861~negative regulation of proteolysis,GO:0050790~regulation of catalytic activity,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051246~regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051346~negative regulation of hydrolase activity,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0060191~regulation of lipase activity,GO:0060192~negative regulation of lipase activity,GO:0065009~regulation of molecular function,GO:1900003~regulation of serine-type endopeptidase activity,GO:1900004~negative regulation of serine-type endopeptidase activity,GO:1900138~negative regulation of phospholipase A2 activity,GO:1902571~regulation of serine-type peptidase activity,GO:1902572~negative regulation of serine-type peptidase activity,	GO:0005768~endosome,GO:0005770~late endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0031902~late endosome membrane,GO:0044437~vacuolar part,GO:0044440~endosomal part,	GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008092~cytoskeletal protein binding,GO:0008289~lipid binding,GO:0032403~protein complex binding,GO:0035091~phosphatidylinositol binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043169~cation binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,GO:1901981~phosphatidylinositol phosphate binding,GO:1902936~phosphatidylinositol bisphosphate binding,		
34636_at	arachidonate 15-lipoxygenase(ALOX15)	Homo sapiens	Alzheimer's disease   ,Asthma|Bronchial Hyperreactivity,Asthma|Drug Hypersensitivity,atherosclerosis,atherosclerosis, coronary,Atherosclerosis|Carotid Artery Diseases,Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma,Bladder Cancer,Bone Density,Bone Mineral Density,Brain Ischemia|Myocardial Infarction|Stroke,Carotid Artery Diseases,chronic obstructive pulmonary disease,Coronary Artery Disease,Coronary Artery Disease|Kidney Neoplasms,Endometriosis|Infertility, Female,Inflammation|Myocardial Infarction|Thrombosis,Lung Cancer,lung cancer ,Meningeal Neoplasms|meningioma,Type 2 Diabetes| edema | rosiglitazone,	CANCER,CARDIOVASCULAR,IMMUNE,METABOLIC,NEUROLOGICAL,OTHER,PHARMACOGENOMIC,REPRODUCTION,UNKNOWN,	GO:0000165~MAPK cascade,GO:0001503~ossification,GO:0001676~long-chain fatty acid metabolic process,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002250~adaptive immune response,GO:0002682~regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002819~regulation of adaptive immune response,GO:0002820~negative regulation of adaptive immune response,GO:0006082~organic acid metabolic process,GO:0006461~protein complex assembly,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006650~glycerophospholipid metabolic process,GO:0006690~icosanoid metabolic process,GO:0006691~leukotriene metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006911~phagocytosis, engulfment,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008154~actin polymerization or depolymerization,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0009611~response to wounding,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010324~membrane invagination,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010638~positive regulation of organelle organization,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010810~regulation of cell-substrate adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0016053~organic acid biosynthetic process,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0019220~regulation of phosphate metabolic process,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0019637~organophosphate metabolic process,GO:0019752~carboxylic acid metabolic process,GO:0022407~regulation of cell-cell adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022607~cellular component assembly,GO:0022610~biological adhesion,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0030282~bone mineralization,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0031214~biomineral tissue development,GO:0031325~positive regulation of cellular metabolic process,GO:0031334~positive regulation of protein complex assembly,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031589~cell-substrate adhesion,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032271~regulation of protein polymerization,GO:0032273~positive regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032787~monocarboxylic acid metabolic process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0033554~cellular response to stress,GO:0033559~unsaturated fatty acid metabolic process,GO:0034097~response to cytokine,GO:0034113~heterotypic cell-cell adhesion,GO:0034114~regulation of heterotypic cell-cell adhesion,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0034622~cellular macromolecular complex assembly,GO:0034976~response to endoplasmic reticulum stress,GO:0035358~regulation of peroxisome proliferator activated receptor signaling pathway,GO:0035556~intracellular signal transduction,GO:0035962~response to interleukin-13,GO:0035963~cellular response to interleukin-13,GO:0036211~protein modification process,GO:0042060~wound healing,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042759~long-chain fatty acid biosynthetic process,GO:0043254~regulation of protein complex assembly,GO:0043277~apoptotic cell clearance,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043436~oxoacid metabolic process,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044089~positive regulation of cellular component biogenesis,GO:0044255~cellular lipid metabolic process,GO:0044283~small molecule biosynthetic process,GO:0045017~glycerolipid biosynthetic process,GO:0045785~positive regulation of cell adhesion,GO:0045937~positive regulation of phosphate metabolic process,GO:0046337~phosphatidylethanolamine metabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0050764~regulation of phagocytosis,GO:0050776~regulation of immune response,GO:0050777~negative regulation of immune response,GO:0051049~regulation of transport,GO:0051121~hepoxilin metabolic process,GO:0051122~hepoxilin biosynthetic process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051258~protein polymerization,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051592~response to calcium ion,GO:0055114~oxidation-reduction process,GO:0060099~regulation of phagocytosis, engulfment,GO:0060627~regulation of vesicle-mediated transport,GO:0061024~membrane organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070371~ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070887~cellular response to chemical stimulus,GO:0071241~cellular response to inorganic substance,GO:0071248~cellular response to metal ion,GO:0071277~cellular response to calcium ion,GO:0071310~cellular response to organic substance,GO:0071345~cellular response to cytokine stimulus,GO:0071822~protein complex subunit organization,GO:0072330~monocarboxylic acid biosynthetic process,GO:0090066~regulation of anatomical structure size,GO:0090407~organophosphate biosynthetic process,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:1901074~regulation of engulfment of apoptotic cell,GO:1901568~fatty acid derivative metabolic process,GO:1901570~fatty acid derivative biosynthetic process,GO:1901615~organic hydroxy compound metabolic process,GO:1901617~organic hydroxy compound biosynthetic process,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902589~single-organism organelle organization,GO:1905153~regulation of membrane invagination,GO:2000425~regulation of apoptotic cell clearance,GO:2001300~lipoxin metabolic process,GO:2001301~lipoxin biosynthetic process,GO:2001302~lipoxin A4 metabolic process,GO:2001303~lipoxin A4 biosynthetic process,	GO:0005811~lipid particle,GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0019897~extrinsic component of plasma membrane,GO:0019898~extrinsic component of membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0098552~side of membrane,GO:0098562~cytoplasmic side of membrane,	GO:0004052~arachidonate 12-lipoxygenase activity,GO:0005506~iron ion binding,GO:0005543~phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008289~lipid binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016801~hydrolase activity, acting on ether bonds,GO:0016803~ether hydrolase activity,GO:0016853~isomerase activity,GO:0035091~phosphatidylinositol binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0047977~hepoxilin-epoxide hydrolase activity,GO:0050473~arachidonate 15-lipoxygenase activity,GO:0051120~hepoxilin A3 synthase activity,GO:0051213~dioxygenase activity,GO:0097260~eoxin A4 synthase activity,GO:1901981~phosphatidylinositol phosphate binding,GO:1902936~phosphatidylinositol bisphosphate binding,	hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa01100:Metabolic pathways,hsa04726:Serotonergic synapse,	
35648_at	autism susceptibility candidate 2(AUTS2)	Homo sapiens	ADHD | attention-deficit hyperactivity disorder,Adiponectin,Autistic Disorder,Bipolar Disorder,Blood Pressure,Celiac Disease|,Cholesterol,Coronary Disease,Heart Rate,Hip,Psychiatric Disorders,several psychiatric disorders,Tobacco Use Disorder,Type 2 Diabetes| edema | rosiglitazone,	CARDIOVASCULAR,CHEMDEPENDENCY,IMMUNE,METABOLIC,PHARMACOGENOMIC,PSYCH,	GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0006473~protein acetylation,GO:0006475~internal protein amino acid acetylation,GO:0006479~protein methylation,GO:0007610~behavior,GO:0008213~protein alkylation,GO:0009605~response to external stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010638~positive regulation of organelle organization,GO:0016070~RNA metabolic process,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0016573~histone acetylation,GO:0018022~peptidyl-lysine methylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018205~peptidyl-lysine modification,GO:0018393~internal peptidyl-lysine acetylation,GO:0018394~peptidyl-lysine acetylation,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0031056~regulation of histone modification,GO:0031058~positive regulation of histone modification,GO:0031060~regulation of histone methylation,GO:0031062~positive regulation of histone methylation,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032259~methylation,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032774~RNA biosynthetic process,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034968~histone lysine methylation,GO:0035065~regulation of histone acetylation,GO:0035066~positive regulation of histone acetylation,GO:0036211~protein modification process,GO:0043414~macromolecule methylation,GO:0043543~protein acylation,GO:0043933~macromolecular complex subunit organization,GO:0043967~histone H4 acetylation,GO:0043984~histone H4-K16 acetylation,GO:0044708~single-organism behavior,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051568~histone H3-K4 methylation,GO:0051569~regulation of histone H3-K4 methylation,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0060004~reflex,GO:0060013~righting reflex,GO:0071625~vocalization behavior,GO:0090239~regulation of histone H4 acetylation,GO:0090240~positive regulation of histone H4 acetylation,GO:0097659~nucleic acid-templated transcription,GO:0098582~innate vocalization behavior,GO:1901983~regulation of protein acetylation,GO:1901985~positive regulation of protein acetylation,GO:1902275~regulation of chromatin organization,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1905269~positive regulation of chromatin organization,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000618~regulation of histone H4-K16 acetylation,GO:2000620~positive regulation of histone H4-K16 acetylation,GO:2000756~regulation of peptidyl-lysine acetylation,GO:2000758~positive regulation of peptidyl-lysine acetylation,GO:2001141~regulation of RNA biosynthetic process,GO:2001252~positive regulation of chromosome organization,		GO:0003682~chromatin binding,GO:0044877~macromolecular complex binding,		615834~Mental retardation, autosomal dominant 26,
33963_at	azurocidin 1(AZU1)	Homo sapiens	Blood Pressure,HIV,	CARDIOVASCULAR,INFECTION,	GO:0001774~microglial cell activation,GO:0001775~cell activation,GO:0001816~cytokine production,GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0001906~cell killing,GO:0001909~leukocyte mediated cytotoxicity,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002252~immune effector process,GO:0002274~myeloid leukocyte activation,GO:0002443~leukocyte mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002446~neutrophil mediated immunity,GO:0003008~system process,GO:0003013~circulatory system process,GO:0003018~vascular process in circulatory system,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006508~proteolysis,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007399~nervous system development,GO:0008015~blood circulation,GO:0008219~cell death,GO:0008347~glial cell migration,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010799~regulation of peptidyl-threonine phosphorylation,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016032~viral process,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0016485~protein processing,GO:0018107~peptidyl-threonine phosphorylation,GO:0018193~peptidyl-amino acid modification,GO:0018210~peptidyl-threonine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019722~calcium-mediated signaling,GO:0019730~antimicrobial humoral response,GO:0019932~second-messenger-mediated signaling,GO:0022008~neurogenesis,GO:0022610~biological adhesion,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0030595~leukocyte chemotaxis,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031640~killing of cells of other organism,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032602~chemokine production,GO:0032603~fractalkine production,GO:0032611~interleukin-1 beta production,GO:0032612~interleukin-1 production,GO:0032640~tumor necrosis factor production,GO:0032642~regulation of chemokine production,GO:0032644~regulation of fractalkine production,GO:0032651~regulation of interleukin-1 beta production,GO:0032652~regulation of interleukin-1 production,GO:0032680~regulation of tumor necrosis factor production,GO:0032722~positive regulation of chemokine production,GO:0032724~positive regulation of fractalkine production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033674~positive regulation of kinase activity,GO:0035556~intracellular signal transduction,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0035821~modification of morphology or physiology of other organism,GO:0036211~protein modification process,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042033~chemokine biosynthetic process,GO:0042035~regulation of cytokine biosynthetic process,GO:0042063~gliogenesis,GO:0042089~cytokine biosynthetic process,GO:0042107~cytokine metabolic process,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042116~macrophage activation,GO:0042117~monocyte activation,GO:0042222~interleukin-1 biosynthetic process,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042330~taxis,GO:0042533~tumor necrosis factor biosynthetic process,GO:0042534~regulation of tumor necrosis factor biosynthetic process,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0042742~defense response to bacterium,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043114~regulation of vascular permeability,GO:0043207~response to external biotic stimulus,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0044364~disruption of cells of other organism,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0045073~regulation of chemokine biosynthetic process,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045123~cellular extravasation,GO:0045321~leukocyte activation,GO:0045342~MHC class II biosynthetic process,GO:0045346~regulation of MHC class II biosynthetic process,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045360~regulation of interleukin-1 biosynthetic process,GO:0045362~positive regulation of interleukin-1 biosynthetic process,GO:0045785~positive regulation of cell adhesion,GO:0045807~positive regulation of endocytosis,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045937~positive regulation of phosphate metabolic process,GO:0048246~macrophage chemotaxis,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0050720~interleukin-1 beta biosynthetic process,GO:0050722~regulation of interleukin-1 beta biosynthetic process,GO:0050725~positive regulation of interleukin-1 beta biosynthetic process,GO:0050751~fractalkine biosynthetic process,GO:0050752~regulation of fractalkine biosynthetic process,GO:0050754~positive regulation of fractalkine biosynthetic process,GO:0050755~chemokine metabolic process,GO:0050756~fractalkine metabolic process,GO:0050764~regulation of phagocytosis,GO:0050766~positive regulation of phagocytosis,GO:0050790~regulation of catalytic activity,GO:0050829~defense response to Gram-negative bacterium,GO:0050900~leukocyte migration,GO:0050918~positive chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050921~positive regulation of chemotaxis,GO:0050926~regulation of positive chemotaxis,GO:0050927~positive regulation of positive chemotaxis,GO:0050930~induction of positive chemotaxis,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051604~protein maturation,GO:0051607~defense response to virus,GO:0051674~localization of cell,GO:0051702~interaction with symbiont,GO:0051707~response to other organism,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051852~disruption by host of symbiont cells,GO:0051873~killing by host of symbiont cells,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0060326~cell chemotaxis,GO:0060548~negative regulation of cell death,GO:0060627~regulation of vesicle-mediated transport,GO:0065009~regulation of molecular function,GO:0070528~protein kinase C signaling,GO:0070887~cellular response to chemical stimulus,GO:0070942~neutrophil mediated cytotoxicity,GO:0070943~neutrophil mediated killing of symbiont cell,GO:0070944~neutrophil mediated killing of bacterium,GO:0071706~tumor necrosis factor superfamily cytokine production,GO:0097529~myeloid leukocyte migration,GO:0098542~defense response to other organism,GO:1903555~regulation of tumor necrosis factor superfamily cytokine production,GO:1903557~positive regulation of tumor necrosis factor superfamily cytokine production,	GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005766~primary lysosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0019898~extrinsic component of membrane,GO:0030141~secretory granule,GO:0030659~cytoplasmic vesicle membrane,GO:0030667~secretory granule membrane,GO:0031988~membrane-bounded vesicle,GO:0035577~azurophil granule membrane,GO:0042582~azurophil granule,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044437~vacuolar part,GO:0070062~extracellular exosome,GO:0098852~lytic vacuole membrane,GO:0099503~secretory vesicle,GO:1903561~extracellular vesicle,	GO:0001948~glycoprotein binding,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0015643~toxic substance binding,GO:0017171~serine hydrolase activity,GO:0043394~proteoglycan binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0097367~carbohydrate derivative binding,GO:1901681~sulfur compound binding,		
40790_at	basic helix-loop-helix family member e40(BHLHE40)	Homo sapiens	Bipolar Disorder,Depression,Lupus Erythematosus, Systemic,Sleep Disorders,Type 2 Diabetes| edema | rosiglitazone,	IMMUNE,OTHER,PHARMACOGENOMIC,PSYCH,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009605~response to external stimulus,GO:0009628~response to abiotic stimulus,GO:0009648~photoperiodism,GO:0009649~entrainment of circadian clock,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0032922~circadian regulation of gene expression,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0044092~negative regulation of molecular function,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0048511~rhythmic process,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0065009~regulation of molecular function,GO:0097659~nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005730~nucleolus,GO:0005794~Golgi apparatus,	GO:0000975~regulatory region DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0000988~transcription factor activity, protein binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001067~regulatory region nucleic acid binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0033613~activating transcription factor binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043425~bHLH transcription factor binding,GO:0043426~MRF binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,	hsa04710:Circadian rhythm,	
38201_at	branched chain amino acid transaminase 1(BCAT1)	Homo sapiens	Acquired Immunodeficiency Syndrome|Disease Progression,Insulin,Insulin Resistance,normal variation,Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious|Thrombophilia|Tobacco Use Disorder,Stroke,Tobacco Use Disorder,Type 2 Diabetes| edema | rosiglitazone,	CHEMDEPENDENCY,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,PHARMACOGENOMIC,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006082~organic acid metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006531~aspartate metabolic process,GO:0006532~aspartate biosynthetic process,GO:0006551~leucine metabolic process,GO:0006573~valine metabolic process,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0008652~cellular amino acid biosynthetic process,GO:0009066~aspartate family amino acid metabolic process,GO:0009067~aspartate family amino acid biosynthetic process,GO:0009081~branched-chain amino acid metabolic process,GO:0009082~branched-chain amino acid biosynthetic process,GO:0009083~branched-chain amino acid catabolic process,GO:0009098~leucine biosynthetic process,GO:0009099~valine biosynthetic process,GO:0016053~organic acid biosynthetic process,GO:0016054~organic acid catabolic process,GO:0019752~carboxylic acid metabolic process,GO:0022402~cell cycle process,GO:0043436~oxoacid metabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0043650~dicarboxylic acid biosynthetic process,GO:0044248~cellular catabolic process,GO:0044282~small molecule catabolic process,GO:0044283~small molecule biosynthetic process,GO:0044712~single-organism catabolic process,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044843~cell cycle G1/S phase transition,GO:0046394~carboxylic acid biosynthetic process,GO:1901565~organonitrogen compound catabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:1901605~alpha-amino acid metabolic process,GO:1901607~alpha-amino acid biosynthetic process,GO:1903047~mitotic cell cycle process,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004084~branched-chain-amino-acid transaminase activity,GO:0008483~transaminase activity,GO:0016769~transferase activity, transferring nitrogenous groups,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0048037~cofactor binding,GO:0052654~L-leucine transaminase activity,GO:0052655~L-valine transaminase activity,GO:0052656~L-isoleucine transaminase activity,	hsa00280:Valine, leucine and isoleucine degradation,hsa00290:Valine, leucine and isoleucine biosynthesis,hsa00770:Pantothenate and CoA biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01210:2-Oxocarboxylic acid metabolism,hsa01230:Biosynthesis of amino acids,	Hyperleucinemia-isoleucinemia or hypervalinemia~Hyperleucinemia-isoleucinemia or hypervalinemia,
39094_at	bromodomain containing 4(BRD4)	Homo sapiens			GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001932~regulation of protein phosphorylation,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006354~DNA-templated transcription, elongation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006952~defense response,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007346~regulation of mitotic cell cycle,GO:0009605~response to external stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010948~negative regulation of cell cycle process,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016310~phosphorylation,GO:0016569~covalent chromatin modification,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0022402~cell cycle process,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031347~regulation of defense response,GO:0031399~regulation of protein modification process,GO:0031570~DNA integrity checkpoint,GO:0032101~regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032774~RNA biosynthetic process,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0033554~cellular response to stress,GO:0034243~regulation of transcription elongation from RNA polymerase II promoter,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042325~regulation of phosphorylation,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043933~macromolecular complex subunit organization,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044839~cell cycle G2/M phase transition,GO:0044843~cell cycle G1/S phase transition,GO:0045786~negative regulation of cell cycle,GO:0045787~positive regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0050727~regulation of inflammatory response,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0080134~regulation of response to stress,GO:0080135~regulation of cellular response to stress,GO:0090068~positive regulation of cell cycle process,GO:0097659~nucleic acid-templated transcription,GO:1901407~regulation of phosphorylation of RNA polymerase II C-terminal domain,GO:1901976~regulation of cell cycle checkpoint,GO:1901977~negative regulation of cell cycle checkpoint,GO:1901987~regulation of cell cycle phase transition,GO:1901989~positive regulation of cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901992~positive regulation of mitotic cell cycle phase transition,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1902751~positive regulation of cell cycle G2/M phase transition,GO:1903047~mitotic cell cycle process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:2000001~regulation of DNA damage checkpoint,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001020~regulation of response to DNA damage stimulus,GO:2001021~negative regulation of response to DNA damage stimulus,GO:2001141~regulation of RNA biosynthetic process,	GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0000993~RNA polymerase II core binding,GO:0001098~basal transcription machinery binding,GO:0001099~basal RNA polymerase II transcription machinery binding,GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0019899~enzyme binding,GO:0032403~protein complex binding,GO:0042393~histone binding,GO:0043175~RNA polymerase core enzyme binding,GO:0044877~macromolecular complex binding,GO:0070063~RNA polymerase binding,GO:0070577~lysine-acetylated histone binding,		
37172_at	carboxypeptidase B2(CPB2)	Homo sapiens	Abortion, Habitual,Aneurysm, Ruptured|Subarachnoid Hemorrhage,angina,Apoplexy|Diabetes mellitus|Hypertension|Myocardial Infarction|Stroke,Behcet Syndrome|Thrombosis,Blood Pressure,Brain Ischemia,Carcinoma, Squamous Cell|Inflammation|Mouth Neoplasms|Thrombosis,Carcinoma, Squamous Cell|Mouth Neoplasms|Squamous cell carcinoma,Cardiovascular Diseases|,cerebral infarct, atherothrombotic,Coronary Artery Disease|Death, Sudden, Cardiac,Coronary Disease,Hemorrhage|Hemorrhagic Disorders,Hypercholesterolemia|Myocardial Infarction|Recurrence,kidney failure, chronic,metabolic syndrome,Myocardial Infarction,null,ovarian cancer  ,Placenta Diseases,preeclampsia,pregnancy loss,Stroke,thrombin-activatable fibrinolysis inhibitor levels,thromboembolism, venous,thrombosis, deep vein,Tobacco Use Disorder,Type 2 Diabetes| edema | rosiglitazone,vein thrombosis, splanchnic,Venous Thrombosis,	CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,IMMUNE,METABOLIC,PHARMACOGENOMIC,RENAL,REPRODUCTION,UNKNOWN,	GO:0001678~cellular glucose homeostasis,GO:0001889~liver development,GO:0003330~regulation of extracellular matrix constituent secretion,GO:0003331~positive regulation of extracellular matrix constituent secretion,GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0009605~response to external stimulus,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009743~response to carbohydrate,GO:0009746~response to hexose,GO:0009749~response to glucose,GO:0009887~organ morphogenesis,GO:0009892~negative regulation of metabolic process,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010755~regulation of plasminogen activation,GO:0010757~negative regulation of plasminogen activation,GO:0010955~negative regulation of protein processing,GO:0016485~protein processing,GO:0019725~cellular homeostasis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022612~gland morphogenesis,GO:0030162~regulation of proteolysis,GO:0030193~regulation of blood coagulation,GO:0030194~positive regulation of blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0030198~extracellular matrix organization,GO:0031099~regeneration,GO:0031100~organ regeneration,GO:0031324~negative regulation of cellular metabolic process,GO:0031638~zymogen activation,GO:0031639~plasminogen activation,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032940~secretion by cell,GO:0033500~carbohydrate homeostasis,GO:0034284~response to monosaccharide,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0042730~fibrinolysis,GO:0043062~extracellular structure organization,GO:0045861~negative regulation of proteolysis,GO:0046903~secretion,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048732~gland development,GO:0048878~chemical homeostasis,GO:0050673~epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050817~coagulation,GO:0050818~regulation of coagulation,GO:0050819~negative regulation of coagulation,GO:0050820~positive regulation of coagulation,GO:0050878~regulation of body fluid levels,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051093~negative regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051604~protein maturation,GO:0051917~regulation of fibrinolysis,GO:0051918~negative regulation of fibrinolysis,GO:0055082~cellular chemical homeostasis,GO:0061008~hepaticobiliary system development,GO:0061041~regulation of wound healing,GO:0061045~negative regulation of wound healing,GO:0070278~extracellular matrix constituent secretion,GO:0070613~regulation of protein processing,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071322~cellular response to carbohydrate stimulus,GO:0071326~cellular response to monosaccharide stimulus,GO:0071331~cellular response to hexose stimulus,GO:0071333~cellular response to glucose stimulus,GO:0072574~hepatocyte proliferation,GO:0072575~epithelial cell proliferation involved in liver morphogenesis,GO:0072576~liver morphogenesis,GO:0080134~regulation of response to stress,GO:0090303~positive regulation of wound healing,GO:0097421~liver regeneration,GO:1900046~regulation of hemostasis,GO:1900047~negative regulation of hemostasis,GO:1900048~positive regulation of hemostasis,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1903034~regulation of response to wounding,GO:1903035~negative regulation of response to wounding,GO:1903036~positive regulation of response to wounding,GO:1903053~regulation of extracellular matrix organization,GO:1903055~positive regulation of extracellular matrix organization,GO:1903317~regulation of protein maturation,GO:1903318~negative regulation of protein maturation,GO:1903530~regulation of secretion by cell,GO:1903532~positive regulation of secretion by cell,GO:2000026~regulation of multicellular organismal development,GO:2000027~regulation of organ morphogenesis,GO:2000345~regulation of hepatocyte proliferation,GO:2000346~negative regulation of hepatocyte proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,	hsa04610:Complement and coagulation cascades,hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,	
32469_at	carcinoembryonic antigen related cell adhesion molecule 3(CEACAM3)	Homo sapiens	Tobacco Use Disorder,	CHEMDEPENDENCY,					
33530_at	carcinoembryonic antigen related cell adhesion molecule 8(CEACAM8)	Homo sapiens			GO:0006928~movement of cell or subcellular component,GO:0006955~immune response,GO:0016477~cell migration,GO:0040011~locomotion,GO:0048870~cell motility,GO:0050900~leukocyte migration,GO:0051674~localization of cell,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,			
679_at, 37105_at	cathepsin G(CTSG)	Homo sapiens	Alzheimer's Disease,cardiovascular disease; cerebrovascular disease,HIV,kidney failure, chronic,longevity,metabolic syndrome,sepsis,Type 2 Diabetes| edema | rosiglitazone,	AGING,CARDIOVASCULAR,INFECTION,METABOLIC,NEUROLOGICAL,PHARMACOGENOMIC,RENAL,	GO:0001906~cell killing,GO:0001909~leukocyte mediated cytotoxicity,GO:0001990~regulation of systemic arterial blood pressure by hormone,GO:0001991~regulation of systemic arterial blood pressure by circulatory renin-angiotensin,GO:0002002~regulation of angiotensin levels in blood,GO:0002003~angiotensin maturation,GO:0002237~response to molecule of bacterial origin,GO:0002252~immune effector process,GO:0002443~leukocyte mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002446~neutrophil mediated immunity,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0003008~system process,GO:0003013~circulatory system process,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003073~regulation of systemic arterial blood pressure,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006508~proteolysis,GO:0006518~peptide metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006952~defense response,GO:0006955~immune response,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010817~regulation of hormone levels,GO:0016310~phosphorylation,GO:0016485~protein processing,GO:0016486~peptide hormone processing,GO:0022411~cellular component disassembly,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0031640~killing of cells of other organism,GO:0032496~response to lipopolysaccharide,GO:0033993~response to lipid,GO:0035821~modification of morphology or physiology of other organism,GO:0036211~protein modification process,GO:0040007~growth,GO:0040008~regulation of growth,GO:0042445~hormone metabolic process,GO:0042742~defense response to bacterium,GO:0043062~extracellular structure organization,GO:0043207~response to external biotic stimulus,GO:0043603~cellular amide metabolic process,GO:0043900~regulation of multi-organism process,GO:0043901~negative regulation of multi-organism process,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0044110~growth involved in symbiotic interaction,GO:0044116~growth of symbiont involved in interaction with host,GO:0044117~growth of symbiont in host,GO:0044126~regulation of growth of symbiont in host,GO:0044130~negative regulation of growth of symbiont in host,GO:0044144~modulation of growth of symbiont involved in interaction with host,GO:0044146~negative regulation of growth of symbiont involved in interaction with host,GO:0044364~disruption of cells of other organism,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0045926~negative regulation of growth,GO:0048584~positive regulation of response to stimulus,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050830~defense response to Gram-positive bacterium,GO:0050832~defense response to fungus,GO:0050886~endocrine process,GO:0051246~regulation of protein metabolic process,GO:0051604~protein maturation,GO:0051702~interaction with symbiont,GO:0051707~response to other organism,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051852~disruption by host of symbiont cells,GO:0051873~killing by host of symbiont cells,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0060177~regulation of angiotensin metabolic process,GO:0070942~neutrophil mediated cytotoxicity,GO:0070943~neutrophil mediated killing of symbiont cell,GO:0070944~neutrophil mediated killing of bacterium,GO:0070946~neutrophil mediated killing of gram-positive bacterium,GO:0098542~defense response to other organism,GO:1901700~response to oxygen-containing compound,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:0099503~secretory vesicle,GO:1903561~extracellular vesicle,	GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0097367~carbohydrate derivative binding,GO:1901681~sulfur compound binding,	hsa04080:Neuroactive ligand-receptor interaction,hsa04142:Lysosome,hsa04614:Renin-angiotensin system,hsa05146:Amoebiasis,hsa05322:Systemic lupus erythematosus,	
37061_at	chitinase 1(CHIT1)	Homo sapiens	Asthma,bacterial infection,candidiasis,Coronary Artery Disease,filiariasis,Gram-Negative Bacterial Infections|Gram-Positive Bacterial Infections|Leukemia, Myeloid, Acute|Sepsis|Systemic infection,Hypersensitivity|Tuberculosis,hypertension,longevity,null,Type 2 Diabetes| edema | rosiglitazone,	AGING,CANCER,CARDIOVASCULAR,IMMUNE,INFECTION,PHARMACOGENOMIC,	GO:0000272~polysaccharide catabolic process,GO:0005975~carbohydrate metabolic process,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006026~aminoglycan catabolic process,GO:0006030~chitin metabolic process,GO:0006032~chitin catabolic process,GO:0006040~amino sugar metabolic process,GO:0006955~immune response,GO:0009057~macromolecule catabolic process,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0016052~carbohydrate catabolic process,GO:0043207~response to external biotic stimulus,GO:0046348~amino sugar catabolic process,GO:0051707~response to other organism,GO:1901071~glucosamine-containing compound metabolic process,GO:1901072~glucosamine-containing compound catabolic process,GO:1901135~carbohydrate derivative metabolic process,GO:1901136~carbohydrate derivative catabolic process,GO:1901565~organonitrogen compound catabolic process,	GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005773~vacuole,GO:0044421~extracellular region part,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004568~chitinase activity,GO:0008061~chitin binding,GO:0008843~endochitinase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0097367~carbohydrate derivative binding,	hsa00520:Amino sugar and nucleotide sugar metabolism,	614122~Chitotriosidase deficiency,
38482_at	claudin 7(CLDN7)	Homo sapiens			GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0022607~cellular component assembly,GO:0022610~biological adhesion,GO:0030155~regulation of cell adhesion,GO:0031333~negative regulation of protein complex assembly,GO:0032459~regulation of protein oligomerization,GO:0032460~negative regulation of protein oligomerization,GO:0032462~regulation of protein homooligomerization,GO:0032463~negative regulation of protein homooligomerization,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043254~regulation of protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0048870~cell motility,GO:0051128~regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051270~regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0051674~localization of cell,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0071822~protein complex subunit organization,GO:0098609~cell-cell adhesion,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,GO:2000145~regulation of cell motility,GO:2000147~positive regulation of cell motility,	GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016323~basolateral plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0030054~cell junction,GO:0043296~apical junction complex,GO:0070160~occluding junction,GO:0098590~plasma membrane region,	GO:0005198~structural molecule activity,GO:0042802~identical protein binding,GO:0050839~cell adhesion molecule binding,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05160:Hepatitis C,	
35169_at	collagen type XVI alpha 1 chain(COL16A1)	Homo sapiens	Type 2 Diabetes| edema | rosiglitazone,	PHARMACOGENOMIC,	GO:0000003~reproduction,GO:0001101~response to acid chemical,GO:0001952~regulation of cell-matrix adhesion,GO:0001954~positive regulation of cell-matrix adhesion,GO:0006461~protein complex assembly,GO:0007044~cell-substrate junction assembly,GO:0007045~cell-substrate adherens junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007565~female pregnancy,GO:0009719~response to endogenous stimulus,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0010810~regulation of cell-substrate adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0022414~reproductive process,GO:0022607~cellular component assembly,GO:0022610~biological adhesion,GO:0030155~regulation of cell adhesion,GO:0030198~extracellular matrix organization,GO:0031589~cell-substrate adhesion,GO:0033622~integrin activation,GO:0033627~cell adhesion mediated by integrin,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0034332~adherens junction organization,GO:0034333~adherens junction assembly,GO:0043062~extracellular structure organization,GO:0043200~response to amino acid,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044089~positive regulation of cellular component biogenesis,GO:0044703~multi-organism reproductive process,GO:0044706~multi-multicellular organism process,GO:0045216~cell-cell junction organization,GO:0045785~positive regulation of cell adhesion,GO:0048041~focal adhesion assembly,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051893~regulation of focal adhesion assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070887~cellular response to chemical stimulus,GO:0071229~cellular response to acid chemical,GO:0071230~cellular response to amino acid stimulus,GO:0071310~cellular response to organic substance,GO:0071417~cellular response to organonitrogen compound,GO:0071495~cellular response to endogenous stimulus,GO:0071822~protein complex subunit organization,GO:0090109~regulation of cell-substrate junction assembly,GO:1901698~response to nitrogen compound,GO:1901699~cellular response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1901888~regulation of cell junction assembly,GO:1901890~positive regulation of cell junction assembly,GO:1903391~regulation of adherens junction organization,GO:1903393~positive regulation of adherens junction organization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005593~FACIT collagen trimer,GO:0005597~collagen type XVI trimer,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0044432~endoplasmic reticulum part,	GO:0005102~receptor binding,GO:0005178~integrin binding,GO:0032403~protein complex binding,GO:0044877~macromolecular complex binding,GO:0050839~cell adhesion molecule binding,		
32250_at	complement factor H(CFH)	Homo sapiens	age-related macular degeneration,age-related maculopathy,Alzheimer's Disease,Alzheimer's disease   ,Angiomatosis|Choroidal Neovascularization|Macular Degeneration,Arthritis, Rheumatoid|,Ataxia Telangiectasia,atherosclerosis,atherosclerosis, coronary,atherosclerosis, coronary myocardial infarct,Atherosclerosis|Carotid Artery Diseases,Atherosclerosis|Hypertension|Macular Degeneration|Prostatic Neoplasms,Atherosclerosis|Inflammation|Macular Degeneration,atypical hemolytic uremic syndrome,Bladder Cancer,Blind Vision|Blindness|Choroidal Neovascularization|Macular Degeneration,blood pressure, arterial hypertension,Cardiovascular Diseases|Hyperlipoproteinemia Type II,Cardiovascular Diseases|Inflammation|Macular Degeneration,Cardiovascular Diseases|Kidney Failure, Chronic,Chlamydia Infections|Macular Degeneration,Chlamydophila Infections|Macular Degeneration,Choroid Diseases|Macular Degeneration|Peripheral Vascular Diseases,Choroid Diseases|Macular Degeneration|Peripheral Vascular Diseases|Retinal Neovascularization,Choroid Diseases|Peripheral Vascular Diseases,choroidal neovascularization,choroidal neovascularization geographic atrophy macular degeneration,Choroidal Neovascularization|Geographic Atrophy,Choroidal Neovascularization|Macular Degeneration,Choroidal Neovascularization|Macular Degeneration|Retinal Drusen,Choroidal Neovascularization|Retinal Drusen|Wet Macular Degeneration,Choroiditis|Macular Degeneration,chronic obstructive pulmonary disease,Chronic renal failure|Haemolytic-uraemic syndrome|Hemolytic-Uremic Syndrome|Kidney Failure, Chronic,Coronary Artery Disease,Coronary Disease,Coronary Disease|Coronary heart disease,Coronary Disease|Coronary heart disease|Myocardial Infarction,Coronary Disease|Hyperlipoproteinemia Type II,Dengue Hemorrhagic Fever,Diabetes Mellitus, Type 2|Inflammatory Bowel Diseases|Macular Degeneration|Prostatic Neoplasms,diabetes, type 1,Diabetic Nephropathies|Diabetic Nephropathy,Diseases in Twins|Macular Degeneration|Retinal Drusen,Furunculosis|Staphylococcal Infections,Geographic Atrophy|Macular Degeneration,Geographic Atrophy|Macular Degeneration|Retinal Drusen,glomerular filtration rate macular degeneration,glomerulonephritis,Glomerulonephritis, IGA,Haemolytic uraemic syndrome,Haemolytic-uraemic syndrome|Hemolytic-Uremic Syndrome,Haemolytic-uraemic syndrome|Hemolytic-Uremic Syndrome|Recurrence,heart disease, ischemic,hemolytic uremic syndrome,hypertension,Lung Cancer,lung cancer ,Lymphoma, Non-Hodgkin,macular degeneration,macular degeneration, age-related,macular degeneration; soft drusen,Macular Degeneration|Nephritis, Hereditary|Retinal Degeneration|Retinal Drusen,Meningococcal Infections,myocardial infarct,myocardial infarct; thromboembolism, venous; C-reactive protein; stroke, ischemic,Myocardial Infarction,null,Parkinson's Disease,patent ductus arteriosus,Pre-Eclampsia,Pseudoxanthoma Elasticum,Retinal Diseases,retinal venular dilatation,Retinopathy of Prematurity,Systemic inflam response synd|Systemic Inflammatory Response Syndrome,Type 2 Diabetes| edema | rosiglitazone,	CANCER,CARDIOVASCULAR,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,OTHER,PHARMACOGENOMIC,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002526~acute inflammatory response,GO:0002673~regulation of acute inflammatory response,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002697~regulation of immune effector process,GO:0002920~regulation of humoral immune response,GO:0006508~proteolysis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006959~humoral immune response,GO:0009605~response to external stimulus,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0016485~protein processing,GO:0030162~regulation of proteolysis,GO:0030449~regulation of complement activation,GO:0031347~regulation of defense response,GO:0032101~regulation of response to external stimulus,GO:0045087~innate immune response,GO:0048584~positive regulation of response to stimulus,GO:0050727~regulation of inflammatory response,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0051246~regulation of protein metabolic process,GO:0051604~protein maturation,GO:0070613~regulation of protein processing,GO:0072376~protein activation cascade,GO:0080134~regulation of response to stress,GO:1903317~regulation of protein maturation,GO:2000257~regulation of protein activation cascade,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,	GO:0001948~glycoprotein binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0043394~proteoglycan binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0097367~carbohydrate derivative binding,GO:1901681~sulfur compound binding,	hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,	126700~Basal laminar drusen,235400~Hemolytic uremic syndrome, atypical, susceptibility to, 1,609814~Complement factor H deficiency,610698~Macular degeneration, age-related, 4,
36317_at	coronin 2A(CORO2A)	Homo sapiens	Iron,Vitiligo,	IMMUNE,METABOLIC,	GO:0007010~cytoskeleton organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0035556~intracellular signal transduction,GO:1902589~single-organism organelle organization,	GO:0015629~actin cytoskeleton,GO:0017053~transcriptional repressor complex,	GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0032403~protein complex binding,GO:0044877~macromolecular complex binding,GO:0051015~actin filament binding,		
1983_at	cyclin D2(CCND2)	Homo sapiens	Breast Cancer,breast cancer   ,Carcinoma, Hepatocellular|Hepatitis B|LCC - Liver cell carcinoma|Liver neoplasms,Chronic renal failure|Kidney Failure, Chronic,diabetes, type 2,Leukemia, Lymphoid,major depressive disorder,Narcolepsy,ovarian cancer,ovarian cancer  ,	CANCER,METABOLIC,NEUROLOGICAL,PSYCH,RENAL,	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009893~positive regulation of metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0033674~positive regulation of kinase activity,GO:0036211~protein modification process,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044843~cell cycle G1/S phase transition,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045931~positive regulation of mitotic cell cycle,GO:0045937~positive regulation of phosphate metabolic process,GO:0050790~regulation of catalytic activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051301~cell division,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0060548~negative regulation of cell death,GO:0065009~regulation of molecular function,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0090068~positive regulation of cell cycle process,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1901987~regulation of cell cycle phase transition,GO:1901989~positive regulation of cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901992~positive regulation of mitotic cell cycle phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902808~positive regulation of cell cycle G1/S phase transition,GO:1903047~mitotic cell cycle process,GO:1904029~regulation of cyclin-dependent protein kinase activity,GO:1904031~positive regulation of cyclin-dependent protein kinase activity,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000785~chromatin,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044427~chromosomal part,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0097129~cyclin D2-CDK4 complex,GO:1902554~serine/threonine protein kinase complex,GO:1902911~protein kinase complex,	GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04510:Focal adhesion,hsa04630:Jak-STAT signaling pathway,hsa04917:Prolactin signaling pathway,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,	615938~Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3,
38229_at	cytochrome P450 family 3 subfamily A member 5(CYP3A5)	Homo sapiens	1'-hydroxymidazolam; midazolam level,9-Hydroxyrisperidone and Risperidone,ABT-773 plasma levels,Acute Coronary Syndrome,Acute Coronary Syndrome|Cardiovascular Diseases|Thrombosis,Acute Coronary Syndrome|Recurrence,aflatoxin-albumin,aging,Amlodipine,anticoagulant complications,Atherosclerosis|Hypertension|Macular Degeneration|Prostatic Neoplasms,Bladder Cancer,blood pressure, arterial,blood tacrolimus concentrations ,BMI- Edema rosiglitazone or pioglitazone,Body Weight,Body Weight|Gastrointestinal Stromal Tumors,Body Weight|HIV Infections,Breast Cancer,breast cancer   ,breast cancer; tamoxifen, prophylactic effect of,Breast Neoplasms|Neoplasms, Germ Cell and Embryonal|Ovarian Neoplasms,Cadaver,Cancer,Carcinoma, Non-Small-Cell Lung|Diarrhea|Exanthema|Head and Neck Neoplasms|Lung Neoplasms|Neoplasms, Squamous Cell|Ovarian Neoplasms,Carcinoma, Renal Cell|Gilbert Disease|Hyperbilirubinemia|Kidney Neoplasms|Renal Cell Carcinoma,Carcinoma, Renal Cell|Kidney Neoplasms|Renal Cell Carcinoma,Carcinoma, Squamous Cell|Head and Neck Neoplasms,Cardiovascular Diseases|Myocardial Infarction|Stroke,cholesterol, HDL; cholesterol, LDL; leukemia; 9-hydroxyrisperidone; risperidone,cholesterol; cholesterol, HDL; triglycerides; diabetes, type 2; ulcerative colitis; cholesterol, LDL; liver disease;,cholesterol; cholesterol, LDL,Chronic renal failure|Kidney Failure, Chronic,citalopram,clopidogrel,Clozapine,Colorectal Cancer,Colorectal Neoplasms|Neutropenia,Coronary Artery Disease,cyclophosphamide phamacokinetics,cyclosporine,cyclosporine A,cyclosporine pharmacokinetics,CYP3A activity,CYP3A5 levels,Delayed Graft Function|Diabetes mellitus,Delta9-tetrahydrocannabinol,Diabetes Mellitus|Postoperative Complications,DNA damage,docetaxel elimination,dose of nevirapine or efavirenz,Drug-Induced Liver Injury|Hepatitis, Toxic,drug-related genes ,Efavirenz ,efavirenz pharmacokinetics,endoxifen,epilepsy,epithelial ovarian cancer ,esophageal adenocarcinoma,Esophageal Cancer,Genitourinary Neoplasms|Urogenital Neoplasms,graft-versus-host disease,Hepatitis B, Chronic,HIV,HIV infection,HIV Infections,HIV Infections|[X]Human immunodeficiency virus disease,Hypercholesterolemia,hypercholesterolemia; drug hypersensitivity,Hypercholesterolemia|LDLC levels,Hyperlipidemias,hypertension,irinotecan pharmacokinetics,Kidney Diseases,kidney failure, chronic,kidney transplant,kidney transplant complications,kidney transplant; cyclospoine pharmacokinetics; heart transplant,leukemia,leukemia, lymphoid; leukemia, myeloid,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Leukemia, Myelogenous, Chronic, BCR-ABL Positive|Neovascularization, Pathologic,Leukemia, Myeloid,Leukemia, Myeloid, Acute,Leukemia, Myeloid, Chronic-Phase,Leukemia, Pre-B-Cell|Neurotoxicity Syndromes|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,Leukopenia|Neutropenia,liver transplant; prostate cancer; premature ovarian failure; lupus nephritis,lopinavir accumulation,Lung Cancer,lung cancer ,lung cancer; breast cancer; liver cancer; oral cancer; prostate cancer; thyroid cancer; cervical cancer,lung cancer; breast cancer; liver cancer; oral cancer; thyroid cancer; cervical cancer,lung transplant complications,Lymphoma, T-Cell, Cutaneous|Lymphoma, T-Cell, Peripheral|Skin Neoplasms,Malaria,midazolam,midazolam clearance,midazolam pharmacokinetics,Multiple Chemical Sensitivity,muscle damage,myeloid leukemia,Myocardial Infarction,Myocardial Infarction|Stroke,Neoplasms,nephropathy,neutropenia,Nevirapine,nifedipine disposition,normal variation,null,ovarian cancer,paclitaxel pharmacokinetics,paediatric renal allograft,Perioperative genomic profiles ,pharmacogenetic diversity ,pharmacogenetic variation,pharmacogenetics of cyclosporine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,premature ovarian failure; lupus nephritis,prostate cancer,prostate cancer; liver function,prostatic hyperplasia,puberty onset,Pulmonary Disease, Chronic Obstructive,Renal Insufficiency,renal transplant,repaglinide pharmacokinetics,Schizophrenia,sibutramine,tacrolimus,tacrolimus and cyclosporine,tacrolimus phamacokinetics,tacrolimus pharmacokinetics; cyclosporine pharmacokinetics,tacrolimus pharmacokinetics; sirolimus pharmacokinetics,tardive dyskinesia,testicular cancer,treatment resistance to typical neuroleptics,Type 2 Diabetes| edema | rosiglitazone,Urologic Neoplasms,Venous Thromboembolism,voriconazole,	AGING,CANCER,CARDIOVASCULAR,DEVELOPMENTAL,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,	GO:0002933~lipid hydroxylation,GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,GO:0009410~response to xenobiotic stimulus,GO:0009820~alkaloid metabolic process,GO:0009822~alkaloid catabolic process,GO:0017144~drug metabolic process,GO:0030258~lipid modification,GO:0042737~drug catabolic process,GO:0044248~cellular catabolic process,GO:0044255~cellular lipid metabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0055114~oxidation-reduction process,GO:0070887~cellular response to chemical stimulus,GO:0070988~demethylation,GO:0070989~oxidative demethylation,GO:0071466~cellular response to xenobiotic stimulus,GO:1901565~organonitrogen compound catabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0044432~endoplasmic reticulum part,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0070330~aromatase activity,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,	hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,	145500~Hypertension, salt-sensitive essential, susceptibility to,
1391_s_at	cytochrome P450 family 4 subfamily A member 11(CYP4A11)	Homo sapiens	Apoplexy|Stroke,blood pressure, arterial hypertension,Brain Ischemia|Hypertension|Stroke,Cerebral Infarction,Coronary Artery Disease|,drug-related genes ,hearing loss,hypertension,hypertension; left ventricular function,Hypertension|Nephrosclerosis,plasma HDL cholesterol (HDL-C) levels,	CARDIOVASCULAR,METABOLIC,OTHER,PHARMACOGENOMIC,	GO:0001676~long-chain fatty acid metabolic process,GO:0001977~renal system process involved in regulation of blood volume,GO:0003008~system process,GO:0003013~circulatory system process,GO:0003014~renal system process,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003073~regulation of systemic arterial blood pressure,GO:0003091~renal water homeostasis,GO:0003095~pressure natriuresis,GO:0006082~organic acid metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006690~icosanoid metabolic process,GO:0006691~leukotriene metabolic process,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006869~lipid transport,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0010876~lipid localization,GO:0015711~organic anion transport,GO:0015718~monocarboxylic acid transport,GO:0015908~fatty acid transport,GO:0016042~lipid catabolic process,GO:0016054~organic acid catabolic process,GO:0019369~arachidonic acid metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0019752~carboxylic acid metabolic process,GO:0030104~water homeostasis,GO:0032303~regulation of icosanoid secretion,GO:0032305~positive regulation of icosanoid secretion,GO:0032309~icosanoid secretion,GO:0032368~regulation of lipid transport,GO:0032370~positive regulation of lipid transport,GO:0032787~monocarboxylic acid metabolic process,GO:0033036~macromolecule localization,GO:0033559~unsaturated fatty acid metabolic process,GO:0036101~leukotriene B4 catabolic process,GO:0036102~leukotriene B4 metabolic process,GO:0042592~homeostatic process,GO:0043269~regulation of ion transport,GO:0043270~positive regulation of ion transport,GO:0043436~oxoacid metabolic process,GO:0044070~regulation of anion transport,GO:0044248~cellular catabolic process,GO:0044255~cellular lipid metabolic process,GO:0044282~small molecule catabolic process,GO:0044712~single-organism catabolic process,GO:0046903~secretion,GO:0046942~carboxylic acid transport,GO:0048871~multicellular organismal homeostasis,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050878~regulation of body fluid levels,GO:0050891~multicellular organismal water homeostasis,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0055065~metal ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055078~sodium ion homeostasis,GO:0055080~cation homeostasis,GO:0055114~oxidation-reduction process,GO:0071715~icosanoid transport,GO:0097267~omega-hydroxylase P450 pathway,GO:0098771~inorganic ion homeostasis,GO:1901523~icosanoid catabolic process,GO:1901568~fatty acid derivative metabolic process,GO:1901569~fatty acid derivative catabolic process,GO:1901615~organic hydroxy compound metabolic process,GO:1901616~organic hydroxy compound catabolic process,GO:1903793~positive regulation of anion transport,GO:2000191~regulation of fatty acid transport,GO:2000193~positive regulation of fatty acid transport,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016324~apical plasma membrane,GO:0031988~membrane-bounded vesicle,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044432~endoplasmic reticulum part,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,GO:0098590~plasma membrane region,GO:1903561~extracellular vesicle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008391~arachidonic acid monooxygenase activity,GO:0008392~arachidonic acid epoxygenase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0016713~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,GO:0018685~alkane 1-monooxygenase activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0050051~leukotriene-B4 20-monooxygenase activity,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
31793_at, 31506_s_at	defensin alpha 1(DEFA1)	Homo sapiens	Sepsis|Systemic infection,	INFECTION,	GO:0001906~cell killing,GO:0002227~innate immune response in mucosa,GO:0002251~organ or tissue specific immune response,GO:0002252~immune effector process,GO:0002385~mucosal immune response,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone,GO:0009755~hormone-mediated signaling pathway,GO:0010033~response to organic substance,GO:0014070~response to organic cyclic compound,GO:0016032~viral process,GO:0019730~antimicrobial humoral response,GO:0019731~antibacterial humoral response,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030522~intracellular receptor signaling pathway,GO:0031640~killing of cells of other organism,GO:0032870~cellular response to hormone stimulus,GO:0033993~response to lipid,GO:0035821~modification of morphology or physiology of other organism,GO:0040011~locomotion,GO:0042330~taxis,GO:0042742~defense response to bacterium,GO:0043207~response to external biotic stimulus,GO:0043401~steroid hormone mediated signaling pathway,GO:0044364~disruption of cells of other organism,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0045087~innate immune response,GO:0048545~response to steroid hormone,GO:0050830~defense response to Gram-positive bacterium,GO:0050832~defense response to fungus,GO:0051607~defense response to virus,GO:0051707~response to other organism,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071383~cellular response to steroid hormone stimulus,GO:0071396~cellular response to lipid,GO:0071407~cellular response to organic cyclic compound,GO:0071495~cellular response to endogenous stimulus,GO:0098542~defense response to other organism,	GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005766~primary lysosome,GO:0005773~vacuole,GO:0005775~vacuolar lumen,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0034774~secretory granule lumen,GO:0035578~azurophil granule lumen,GO:0042582~azurophil granule,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0044437~vacuolar part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0070062~extracellular exosome,GO:0099503~secretory vesicle,GO:1903561~extracellular vesicle,			
34546_at	defensin alpha 4(DEFA4)	Homo sapiens	Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma,Dermatitis, Atopic|,HIV,HIV Infections,Meningeal Neoplasms|meningioma,meningococcal disease,	CANCER,IMMUNE,INFECTION,	GO:0001906~cell killing,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0019730~antimicrobial humoral response,GO:0019731~antibacterial humoral response,GO:0031640~killing of cells of other organism,GO:0035821~modification of morphology or physiology of other organism,GO:0042742~defense response to bacterium,GO:0043207~response to external biotic stimulus,GO:0044364~disruption of cells of other organism,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0050832~defense response to fungus,GO:0051707~response to other organism,GO:0098542~defense response to other organism,	GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005766~primary lysosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031988~membrane-bounded vesicle,GO:0042582~azurophil granule,GO:0044421~extracellular region part,GO:0044431~Golgi apparatus part,GO:0099503~secretory vesicle,			
34623_at	defensin alpha 5(DEFA5)	Homo sapiens	Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes|Obstetric Labor, Premature|Pre-Eclampsia|Premature Birth,Dermatitis, Atopic|,HIV Infections,inflammatory bowel disease ,Meningeal Neoplasms|meningioma,	CANCER,IMMUNE,INFECTION,REPRODUCTION,	GO:0001906~cell killing,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0019730~antimicrobial humoral response,GO:0019731~antibacterial humoral response,GO:0031640~killing of cells of other organism,GO:0035821~modification of morphology or physiology of other organism,GO:0042742~defense response to bacterium,GO:0043207~response to external biotic stimulus,GO:0044364~disruption of cells of other organism,GO:0045087~innate immune response,GO:0050832~defense response to fungus,GO:0051707~response to other organism,GO:0098542~defense response to other organism,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030133~transport vesicle,GO:0030141~secretory granule,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0034774~secretory granule lumen,GO:0044421~extracellular region part,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0099503~secretory vesicle,			
40186_at	dual specificity phosphatase 9(DUSP9)	Homo sapiens	Type 2 diabetes,	METABOLIC,	GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0000188~inactivation of MAPK activity,GO:0001932~regulation of protein phosphorylation,GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006470~protein dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0007254~JNK cascade,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023057~negative regulation of signaling,GO:0031098~stress-activated protein kinase signaling cascade,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032147~activation of protein kinase activity,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0033674~positive regulation of kinase activity,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043408~regulation of MAPK cascade,GO:0043409~negative regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045936~negative regulation of phosphate metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0050790~regulation of catalytic activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051403~stress-activated MAPK cascade,GO:0065009~regulation of molecular function,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1902531~regulation of intracellular signal transduction,GO:1902532~negative regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,	GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0033549~MAP kinase phosphatase activity,GO:0042578~phosphoric ester hydrolase activity,	hsa04010:MAPK signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,	
34972_s_at	dynein axonemal heavy chain 17(DNAH17)	Homo sapiens	Celiac Disease|,	IMMUNE,	GO:0001539~cilium or flagellum-dependent cell motility,GO:0006928~movement of cell or subcellular component,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0040011~locomotion,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0060285~cilium-dependent cell motility,	GO:0005858~axonemal dynein complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0030286~dynein complex,GO:0044441~ciliary part,GO:0044447~axoneme part,GO:0097014~ciliary plasm,GO:0099512~supramolecular fiber,GO:0099513~polymeric cytoskeletal fiber,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa05016:Huntington's disease,	
37096_at	elastase, neutrophil expressed(ELANE)	Homo sapiens	Blood Pressure,congenital neutropenia,Coronary Disease|Coronary heart disease|Myocardial Infarction,Hepatopulmonary Syndrome|Liver Cirrhosis,Lung Cancer,lung cancer ,neutropenia,	CANCER,CARDIOVASCULAR,HEMATOLOGICAL,UNKNOWN,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPK cascade,GO:0001816~cytokine production,GO:0001817~regulation of cytokine production,GO:0001818~negative regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0001878~response to yeast,GO:0001906~cell killing,GO:0001909~leukocyte mediated cytotoxicity,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002237~response to molecule of bacterial origin,GO:0002252~immune effector process,GO:0002437~inflammatory response to antigenic stimulus,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0002443~leukocyte mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002446~neutrophil mediated immunity,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002526~acute inflammatory response,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002685~regulation of leukocyte migration,GO:0002687~positive regulation of leukocyte migration,GO:0002691~regulation of cellular extravasation,GO:0002693~positive regulation of cellular extravasation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006508~proteolysis,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0009628~response to abiotic stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0016070~RNA metabolic process,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019725~cellular homeostasis,GO:0022407~regulation of cell-cell adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022411~cellular component disassembly,GO:0022610~biological adhesion,GO:0022617~extracellular matrix disassembly,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030003~cellular cation homeostasis,GO:0030155~regulation of cell adhesion,GO:0030163~protein catabolic process,GO:0030198~extracellular matrix organization,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031347~regulation of defense response,GO:0031348~negative regulation of defense response,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031640~killing of cells of other organism,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032496~response to lipopolysaccharide,GO:0032602~chemokine production,GO:0032637~interleukin-8 production,GO:0032642~regulation of chemokine production,GO:0032677~regulation of interleukin-8 production,GO:0032682~negative regulation of chemokine production,GO:0032717~negative regulation of interleukin-8 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032774~RNA biosynthetic process,GO:0033002~muscle cell proliferation,GO:0033674~positive regulation of kinase activity,GO:0033993~response to lipid,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035556~intracellular signal transduction,GO:0035821~modification of morphology or physiology of other organism,GO:0036211~protein modification process,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042033~chemokine biosynthetic process,GO:0042035~regulation of cytokine biosynthetic process,GO:0042036~negative regulation of cytokine biosynthetic process,GO:0042089~cytokine biosynthetic process,GO:0042107~cytokine metabolic process,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0042228~interleukin-8 biosynthetic process,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042330~taxis,GO:0042592~homeostatic process,GO:0042742~defense response to bacterium,GO:0043062~extracellular structure organization,GO:0043085~positive regulation of catalytic activity,GO:0043207~response to external biotic stimulus,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043549~regulation of kinase activity,GO:0043900~regulation of multi-organism process,GO:0043901~negative regulation of multi-organism process,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0044093~positive regulation of molecular function,GO:0044110~growth involved in symbiotic interaction,GO:0044116~growth of symbiont involved in interaction with host,GO:0044117~growth of symbiont in host,GO:0044126~regulation of growth of symbiont in host,GO:0044130~negative regulation of growth of symbiont in host,GO:0044144~modulation of growth of symbiont involved in interaction with host,GO:0044146~negative regulation of growth of symbiont involved in interaction with host,GO:0044364~disruption of cells of other organism,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0045073~regulation of chemokine biosynthetic process,GO:0045079~negative regulation of chemokine biosynthetic process,GO:0045123~cellular extravasation,GO:0045414~regulation of interleukin-8 biosynthetic process,GO:0045415~negative regulation of interleukin-8 biosynthetic process,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0045785~positive regulation of cell adhesion,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045926~negative regulation of growth,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048659~smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050727~regulation of inflammatory response,GO:0050728~negative regulation of inflammatory response,GO:0050755~chemokine metabolic process,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050790~regulation of catalytic activity,GO:0050801~ion homeostasis,GO:0050832~defense response to fungus,GO:0050900~leukocyte migration,GO:0050901~leukocyte tethering or rolling,GO:0050920~regulation of chemotaxis,GO:0050922~negative regulation of chemotaxis,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051270~regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051674~localization of cell,GO:0051702~interaction with symbiont,GO:0051707~response to other organism,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051852~disruption by host of symbiont cells,GO:0051873~killing by host of symbiont cells,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0055065~metal ion homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0061756~leukocyte adhesion to vascular endothelial cell,GO:0065009~regulation of molecular function,GO:0070942~neutrophil mediated cytotoxicity,GO:0070943~neutrophil mediated killing of symbiont cell,GO:0070947~neutrophil mediated killing of fungus,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072507~divalent inorganic cation homeostasis,GO:0080134~regulation of response to stress,GO:0097659~nucleic acid-templated transcription,GO:0098542~defense response to other organism,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:0098771~inorganic ion homeostasis,GO:1901700~response to oxygen-containing compound,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903236~regulation of leukocyte tethering or rolling,GO:1903238~positive regulation of leukocyte tethering or rolling,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1904994~regulation of leukocyte adhesion to vascular endothelial cell,GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000145~regulation of cell motility,GO:2000147~positive regulation of cell motility,GO:2001141~regulation of RNA biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0017053~transcriptional repressor complex,GO:0030141~secretory granule,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:0099503~secretory vesicle,GO:1903561~extracellular vesicle,	GO:0000988~transcription factor activity, protein binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0002020~protease binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0019899~enzyme binding,GO:0019955~cytokine binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0097367~carbohydrate derivative binding,GO:1901681~sulfur compound binding,	hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,	162800~Neutropenia, cyclic,202700~Neutropenia, severe congenital 1, autosomal dominant,
31621_s_at	elastin(ELN)	Homo sapiens	abdominal aortic aneurysm,Acquired Immunodeficiency Syndrome|Disease Progression,Alzheimer's disease   ,atherosclerosis,brain aneurysm,brain hemorrhage,carotid artery distensibility,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes|Obstetric Labor, Premature|Pre-Eclampsia|Premature Birth,Choroidal Neovascularization|Macular Degeneration|Peripheral Vascular Diseases,congenital ductus arteriosus aneurysm,Emphysema|Pulmonary Disease, Chronic Obstructive,Hepatopulmonary Syndrome|Liver Cirrhosis,hypertension,kidney failure, chronic,macular degeneration,metabolic syndrome,null,pseudoexfoliation syndrome and glaucoma,Stroke,subarachnoid hemorrhage,supravalvular aortic stenosis,Type 2 Diabetes| edema | rosiglitazone,Williams Syndrome,	CARDIOVASCULAR,INFECTION,METABOLIC,NEUROLOGICAL,OTHER,PHARMACOGENOMIC,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0003008~system process,GO:0003013~circulatory system process,GO:0006461~protein complex assembly,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007585~respiratory gaseous exchange,GO:0008015~blood circulation,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008154~actin polymerization or depolymerization,GO:0008283~cell proliferation,GO:0009887~organ morphogenesis,GO:0014706~striated muscle tissue development,GO:0022411~cellular component disassembly,GO:0022607~cellular component assembly,GO:0022617~extracellular matrix disassembly,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030038~contractile actin filament bundle assembly,GO:0030198~extracellular matrix organization,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0031032~actomyosin structure organization,GO:0032271~regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0034622~cellular macromolecular complex assembly,GO:0043062~extracellular structure organization,GO:0043149~stress fiber assembly,GO:0043254~regulation of protein complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0051017~actin filament bundle assembly,GO:0051128~regulation of cellular component organization,GO:0051258~protein polymerization,GO:0051493~regulation of cytoskeleton organization,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0061061~muscle structure development,GO:0061572~actin filament bundle organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0071822~protein complex subunit organization,GO:0090066~regulation of anatomical structure size,GO:1902589~single-organism organelle organization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005739~mitochondrion,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix component,GO:0044421~extracellular region part,GO:0071953~elastic fiber,	GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0050840~extracellular matrix binding,	hsa04974:Protein digestion and absorption,	123700~Cutis laxa, AD,185500~Supravalvar aortic stenosis,
34249_at	epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)(EPM2A)	Homo sapiens	Lafora Disease,	UNKNOWN,	GO:0000271~polysaccharide biosynthetic process,GO:0003008~system process,GO:0005975~carbohydrate metabolic process,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0006464~cellular protein modification process,GO:0006470~protein dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006914~autophagy,GO:0007399~nervous system development,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0009250~glucan biosynthetic process,GO:0009966~regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010506~regulation of autophagy,GO:0010508~positive regulation of autophagy,GO:0010646~regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016051~carbohydrate biosynthetic process,GO:0016236~macroautophagy,GO:0016239~positive regulation of macroautophagy,GO:0016241~regulation of macroautophagy,GO:0016311~dephosphorylation,GO:0023051~regulation of signaling,GO:0023057~negative regulation of signaling,GO:0031929~TOR signaling,GO:0032006~regulation of TOR signaling,GO:0032007~negative regulation of TOR signaling,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0044042~glucan metabolic process,GO:0044262~cellular carbohydrate metabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0044708~single-organism behavior,GO:0044723~single-organism carbohydrate metabolic process,GO:0046958~nonassociative learning,GO:0046959~habituation,GO:0048585~negative regulation of response to stimulus,GO:0050877~neurological system process,GO:0050890~cognition,GO:0055114~oxidation-reduction process,GO:1902531~regulation of intracellular signal transduction,GO:1902532~negative regulation of intracellular signal transduction,	GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005844~polysome,GO:0030529~intracellular ribonucleoprotein complex,GO:1990904~ribonucleoprotein complex,	GO:0001871~pattern binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0019203~carbohydrate phosphatase activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0042578~phosphoric ester hydrolase activity,GO:2001070~starch binding,		254780~Epilepsy, progressive myoclonic 2A (Lafora),
1901_s_at	erb-b2 receptor tyrosine kinase 2(ERBB2)	Homo sapiens	advanced uterine cervical carcinoma,Bladder Cancer,body mass; lipoproteins; blood pressure; CrossLaps, urinary; osteocalcin,Brain Neoplasms|Glioma,Breast Cancer,breast cancer   ,breast cancer colorectal cancer stomach cancer,breast cancer recurrence,Breast Neoplasms,Breast Neoplasms|Cell Transformation, Neoplastic|Heart Diseases|Mammary Neoplasms|Neoplasms, Experimental,Breast Neoplasms|Fibroadenoma|Mammary Neoplasms,Breast Neoplasms|Mammary Neoplasms,Carcinoma, Squamous Cell|Mouth Neoplasms|Neoplasm Metastasis|Squamous cell carcinoma,cervical cancer,chronic obstructive pulmonary disease,Chronic renal failure|Kidney Failure, Chronic,Cleft Lip|Cleft Palate|Tooth Abnormalities,Colorectal Cancer,cutaneous squamous cell carcinoma,endometrial cancer,Endometrial Neoplasms,Endometrial Neoplasms|Obesity,epithelial ovarian cancer ,esophageal adenocarcinoma,Esophageal Neoplasms|Head and Neck Neoplasms|Laryngeal Neoplasms|Mouth Neoplasms|Pharyngeal Neoplasms,gastric cancer,Lung Cancer,lung cancer ,Neoplasm Metastasis|Thyroid Neoplasms,non-inflammatory breast carcinomas,null,oral cavity cancer,ovarian cancer,ovarian cancer  ,overall effect,Pancreatic Neoplasms,pharmacogenetic studies,prostate cancer,stomach cancer,	CANCER,DEVELOPMENTAL,METABOLIC,OTHER,PHARMACOGENOMIC,RENAL,UNKNOWN,	GO:0000165~MAPK cascade,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001558~regulation of cell growth,GO:0001775~cell activation,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001944~vasculature development,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002682~regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006356~regulation of transcription from RNA polymerase I promoter,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006360~transcription from RNA polymerase I promoter,GO:0006383~transcription from RNA polymerase III promoter,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006518~peptide metabolic process,GO:0006605~protein targeting,GO:0006612~protein targeting to membrane,GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006886~intracellular protein transport,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007272~ensheathment of neurons,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007422~peripheral nervous system development,GO:0007507~heart development,GO:0007528~neuromuscular junction development,GO:0008045~motor neuron axon guidance,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008366~axon ensheathment,GO:0009605~response to external stimulus,GO:0009611~response to wounding,GO:0009719~response to endogenous stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0015031~protein transport,GO:0016049~cell growth,GO:0016070~RNA metabolic process,GO:0016310~phosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018212~peptidyl-tyrosine modification,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019637~organophosphate metabolic process,GO:0022008~neurogenesis,GO:0022407~regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022610~biological adhesion,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030030~cell projection organization,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030217~T cell differentiation,GO:0030258~lipid modification,GO:0030307~positive regulation of cell growth,GO:0031175~neuron projection development,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032774~RNA biosynthetic process,GO:0032880~regulation of protein localization,GO:0032886~regulation of microtubule-based process,GO:0032943~mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033036~macromolecule localization,GO:0033077~T cell differentiation in thymus,GO:0033079~immature T cell proliferation,GO:0033080~immature T cell proliferation in thymus,GO:0033081~regulation of T cell differentiation in thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033084~regulation of immature T cell proliferation in thymus,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033157~regulation of intracellular protein transport,GO:0033674~positive regulation of kinase activity,GO:0034248~regulation of cellular amide metabolic process,GO:0034250~positive regulation of cellular amide metabolic process,GO:0034613~cellular protein localization,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0038127~ERBB signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0042060~wound healing,GO:0042063~gliogenesis,GO:0042098~T cell proliferation,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042330~taxis,GO:0042552~myelination,GO:0043043~peptide biosynthetic process,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043547~positive regulation of GTPase activity,GO:0043549~regulation of kinase activity,GO:0043603~cellular amide metabolic process,GO:0043604~amide biosynthetic process,GO:0044093~positive regulation of molecular function,GO:0044255~cellular lipid metabolic process,GO:0044802~single-organism membrane organization,GO:0045184~establishment of protein localization,GO:0045321~leukocyte activation,GO:0045580~regulation of T cell differentiation,GO:0045581~negative regulation of T cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045620~negative regulation of lymphocyte differentiation,GO:0045727~positive regulation of translation,GO:0045765~regulation of angiogenesis,GO:0045785~positive regulation of cell adhesion,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045927~positive regulation of growth,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0046486~glycerolipid metabolic process,GO:0046488~phosphatidylinositol metabolic process,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046777~protein autophosphorylation,GO:0046834~lipid phosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0046907~intracellular transport,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048017~inositol lipid-mediated signaling,GO:0048468~cell development,GO:0048534~hematopoietic or lymphoid organ development,GO:0048584~positive regulation of response to stimulus,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048709~oligodendrocyte differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050670~regulation of lymphocyte proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050673~epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050790~regulation of catalytic activity,GO:0050808~synapse organization,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051093~negative regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051241~negative regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051270~regulation of cellular component movement,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051347~positive regulation of transferase activity,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0060341~regulation of cellular localization,GO:0061024~membrane organization,GO:0061564~axon development,GO:0065009~regulation of molecular function,GO:0070201~regulation of establishment of protein localization,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070486~leukocyte aggregation,GO:0070489~T cell aggregation,GO:0070661~leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,GO:0070727~cellular macromolecule localization,GO:0070848~response to growth factor,GO:0070849~response to epidermal growth factor,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071363~cellular response to growth factor stimulus,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071495~cellular response to endogenous stimulus,GO:0071593~lymphocyte aggregation,GO:0071594~thymocyte aggregation,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0072657~protein localization to membrane,GO:0090150~establishment of protein localization to membrane,GO:0090313~regulation of protein targeting to membrane,GO:0090314~positive regulation of protein targeting to membrane,GO:0090316~positive regulation of intracellular protein transport,GO:0097485~neuron projection guidance,GO:0097659~nucleic acid-templated transcription,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:1901342~regulation of vasculature development,GO:1901566~organonitrogen compound biosynthetic process,GO:1902105~regulation of leukocyte differentiation,GO:1902106~negative regulation of leukocyte differentiation,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902580~single-organism cellular localization,GO:1902582~single-organism intracellular transport,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903533~regulation of protein targeting,GO:1903706~regulation of hemopoiesis,GO:1903707~negative regulation of hemopoiesis,GO:1903827~regulation of cellular protein localization,GO:1903829~positive regulation of cellular protein localization,GO:1904951~positive regulation of establishment of protein localization,GO:2000026~regulation of multicellular organismal development,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000145~regulation of cell motility,GO:2000398~regulation of thymocyte aggregation,GO:2000399~negative regulation of thymocyte aggregation,GO:2001141~regulation of RNA biosynthetic process,	GO:0005768~endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0010008~endosome membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0043209~myelin sheath,GO:0043235~receptor complex,GO:0044437~vacuolar part,GO:0044440~endosomal part,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0098590~plasma membrane region,	GO:0000166~nucleotide binding,GO:0001042~RNA polymerase I core binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005057~receptor signaling protein activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0017076~purine nucleotide binding,GO:0019199~transmembrane receptor protein kinase activity,GO:0019838~growth factor binding,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035004~phosphatidylinositol 3-kinase activity,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0038023~signaling receptor activity,GO:0042802~identical protein binding,GO:0043125~ErbB-3 class receptor binding,GO:0043175~RNA polymerase core enzyme binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0052813~phosphatidylinositol bisphosphate kinase activity,GO:0060089~molecular transducer activity,GO:0070063~RNA polymerase binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:0098772~molecular function regulator,GO:0099600~transmembrane receptor activity,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05219:Bladder cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	137800~Glioblastoma, somatic,211980~Adenocarcinoma of lung, somatic,613659~Gastric cancer, somatic,Ovarian cancer, somatic,~Ovarian cancer, somatic,,
36234_at	eukaryotic translation initiation factor 4A1(EIF4A1)	Homo sapiens			GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0006518~peptide metabolic process,GO:0009057~macromolecule catabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016071~mRNA metabolic process,GO:0019439~aromatic compound catabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0034248~regulation of cellular amide metabolic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034655~nucleobase-containing compound catabolic process,GO:0043043~peptide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043604~amide biosynthetic process,GO:0044248~cellular catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0046700~heterocycle catabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051246~regulation of protein metabolic process,GO:1901361~organic cyclic compound catabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0031012~extracellular matrix,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0000339~RNA cap binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008135~translation factor activity, RNA binding,GO:0008186~RNA-dependent ATPase activity,GO:0016462~pyrophosphatase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0042623~ATPase activity, coupled,GO:0044822~poly(A) RNA binding,GO:0070035~purine NTP-dependent helicase activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa03013:RNA transport,	
1855_at	fibroblast growth factor 3(FGF3)	Homo sapiens	Bone Mineral Density,protein quantitative trait loci,	METABOLIC,OTHER,	GO:0000165~MAPK cascade,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006661~phosphatidylinositol biosynthetic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007267~cell-cell signaling,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0009719~response to endogenous stimulus,GO:0009966~regulation of signal transduction,GO:0010033~response to organic substance,GO:0010646~regulation of cell communication,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014706~striated muscle tissue development,GO:0016202~regulation of striated muscle tissue development,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018193~peptidyl-amino acid modification,GO:0018212~peptidyl-tyrosine modification,GO:0019637~organophosphate metabolic process,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0030258~lipid modification,GO:0035556~intracellular signal transduction,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036211~protein modification process,GO:0042127~regulation of cell proliferation,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0044255~cellular lipid metabolic process,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045017~glycerolipid biosynthetic process,GO:0045843~negative regulation of striated muscle tissue development,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046488~phosphatidylinositol metabolic process,GO:0046834~lipid phosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048017~inositol lipid-mediated signaling,GO:0048634~regulation of muscle organ development,GO:0048635~negative regulation of muscle organ development,GO:0048738~cardiac muscle tissue development,GO:0050790~regulation of catalytic activity,GO:0051093~negative regulation of developmental process,GO:0051241~negative regulation of multicellular organismal process,GO:0051301~cell division,GO:0051302~regulation of cell division,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051781~positive regulation of cell division,GO:0055024~regulation of cardiac muscle tissue development,GO:0055026~negative regulation of cardiac muscle tissue development,GO:0060537~muscle tissue development,GO:0061061~muscle structure development,GO:0065009~regulation of molecular function,GO:0070848~response to growth factor,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071363~cellular response to growth factor stimulus,GO:0071495~cellular response to endogenous stimulus,GO:0071774~response to fibroblast growth factor,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0090407~organophosphate biosynthetic process,GO:1901861~regulation of muscle tissue development,GO:1901862~negative regulation of muscle tissue development,GO:1902531~regulation of intracellular signal transduction,GO:2000026~regulation of multicellular organismal development,	GO:0005576~extracellular region,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005104~fibroblast growth factor receptor binding,GO:0008083~growth factor activity,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0035004~phosphatidylinositol 3-kinase activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0052742~phosphatidylinositol kinase activity,GO:0052813~phosphatidylinositol bisphosphate kinase activity,GO:0070851~growth factor receptor binding,GO:0098772~molecular function regulator,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05218:Melanoma,	610706~Deafness, congenital with inner ear agenesis, microtia, and microdontia,
35367_at	galectin 3(LGALS3)	Homo sapiens	Body Weight,Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1|Diabetic Nephropathies|Diabetic Nephropathy,longevity,thyroid cancer,Type 2 Diabetes| edema | rosiglitazone,	AGING,CANCER,IMMUNE,METABOLIC,PHARMACOGENOMIC,	GO:0001771~immunological synapse formation,GO:0001775~cell activation,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002263~cell activation involved in immune response,GO:0002285~lymphocyte activation involved in immune response,GO:0002286~T cell activation involved in immune response,GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:0002366~leukocyte activation involved in immune response,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002548~monocyte chemotaxis,GO:0002682~regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002685~regulation of leukocyte migration,GO:0002687~positive regulation of leukocyte migration,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002698~negative regulation of immune effector process,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signaling pathway,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006897~endocytosis,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0008037~cell recognition,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008380~RNA splicing,GO:0009605~response to external stimulus,GO:0009966~regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0009988~cell-cell recognition,GO:0010467~gene expression,GO:0010646~regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0010959~regulation of metal ion transport,GO:0012501~programmed cell death,GO:0016070~RNA metabolic process,GO:0016071~mRNA metabolic process,GO:0016192~vesicle-mediated transport,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0022407~regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0022610~biological adhesion,GO:0023051~regulation of signaling,GO:0023057~negative regulation of signaling,GO:0030001~metal ion transport,GO:0030097~hemopoiesis,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0030595~leukocyte chemotaxis,GO:0030855~epithelial cell differentiation,GO:0032943~mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042330~taxis,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043269~regulation of ion transport,GO:0043270~positive regulation of ion transport,GO:0045087~innate immune response,GO:0045321~leukocyte activation,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045806~negative regulation of endocytosis,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048534~hematopoietic or lymphoid organ development,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048870~cell motility,GO:0050670~regulation of lymphocyte proliferation,GO:0050776~regulation of immune response,GO:0050777~negative regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0050854~regulation of antigen receptor-mediated signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050858~negative regulation of antigen receptor-mediated signaling pathway,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050900~leukocyte migration,GO:0050918~positive chemotaxis,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051051~negative regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051270~regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0051674~localization of cell,GO:0051924~regulation of calcium ion transport,GO:0051928~positive regulation of calcium ion transport,GO:0060326~cell chemotaxis,GO:0060429~epithelium development,GO:0060548~negative regulation of cell death,GO:0060627~regulation of vesicle-mediated transport,GO:0070227~lymphocyte apoptotic process,GO:0070228~regulation of lymphocyte apoptotic process,GO:0070232~regulation of T cell apoptotic process,GO:0070486~leukocyte aggregation,GO:0070489~T cell aggregation,GO:0070509~calcium ion import,GO:0070661~leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070838~divalent metal ion transport,GO:0070887~cellular response to chemical stimulus,GO:0071593~lymphocyte aggregation,GO:0071621~granulocyte chemotaxis,GO:0071674~mononuclear cell migration,GO:0071675~regulation of mononuclear cell migration,GO:0071677~positive regulation of mononuclear cell migration,GO:0071887~leukocyte apoptotic process,GO:0072511~divalent inorganic cation transport,GO:0072677~eosinophil migration,GO:0090279~regulation of calcium ion import,GO:0090280~positive regulation of calcium ion import,GO:0097028~dendritic cell differentiation,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097529~myeloid leukocyte migration,GO:0097530~granulocyte migration,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902105~regulation of leukocyte differentiation,GO:1902107~positive regulation of leukocyte differentiation,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903706~regulation of hemopoiesis,GO:1903708~positive regulation of hemopoiesis,GO:1990266~neutrophil migration,GO:2000026~regulation of multicellular organismal development,GO:2000106~regulation of leukocyte apoptotic process,GO:2000145~regulation of cell motility,GO:2000147~positive regulation of cell motility,GO:2000520~regulation of immunological synapse formation,GO:2000521~negative regulation of immunological synapse formation,GO:2001188~regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:2001189~negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:2001198~regulation of dendritic cell differentiation,GO:2001200~positive regulation of dendritic cell differentiation,GO:2001233~regulation of apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001236~regulation of extrinsic apoptotic signaling pathway,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005681~spliceosomal complex,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0019866~organelle inner membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044429~mitochondrial part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0019863~IgE binding,GO:0019865~immunoglobulin binding,GO:0030246~carbohydrate binding,GO:0032403~protein complex binding,GO:0042056~chemoattractant activity,GO:0043236~laminin binding,GO:0044822~poly(A) RNA binding,GO:0044877~macromolecular complex binding,GO:0050840~extracellular matrix binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
32279_at	glutamate decarboxylase 2(GAD2)	Homo sapiens	alcohol,alcohol consumption,Alcoholism,Alzheimer's disease   ,anxiety disorder; depressive disorder, major; neuroticism,Atherosclerosis|Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1|Diabetic Angiopathies,autism,Body Fat Distribution,body mass glucose tolerance glycemia obesity, localized,Body Mass Index,Body Weight,Body Weights and Measures,Bulimia,Cholesterol,Cleft Lip|Cleft Palate,Coronary Artery Disease,Depression,Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1,diabetes, type 1,Hyperandrogenism|Obesity|Puberty, Precocious,Hypercholesterolemia|LDLC levels,Obesity,obesity; birth weight,Schizophrenia,several psychiatric disorders,Tobacco Use Disorder,Type 2 Diabetes| edema | rosiglitazone,Waist Circumference,Weight Gain,	CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,IMMUNE,METABOLIC,NEUROLOGICAL,PHARMACOGENOMIC,PSYCH,UNKNOWN,	GO:0001505~regulation of neurotransmitter levels,GO:0006082~organic acid metabolic process,GO:0006105~succinate metabolic process,GO:0006536~glutamate metabolic process,GO:0006538~glutamate catabolic process,GO:0006540~glutamate decarboxylation to succinate,GO:0006836~neurotransmitter transport,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0009064~glutamine family amino acid metabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0016054~organic acid catabolic process,GO:0019752~carboxylic acid metabolic process,GO:0023061~signal release,GO:0032940~secretion by cell,GO:0042133~neurotransmitter metabolic process,GO:0042136~neurotransmitter biosynthetic process,GO:0042493~response to drug,GO:0043436~oxoacid metabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0043649~dicarboxylic acid catabolic process,GO:0044248~cellular catabolic process,GO:0044282~small molecule catabolic process,GO:0044712~single-organism catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0046903~secretion,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0098916~anterograde trans-synaptic signaling,GO:0099531~presynaptic process involved in chemical synaptic transmission,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:0099643~signal release from synapse,GO:1901565~organonitrogen compound catabolic process,GO:1901605~alpha-amino acid metabolic process,GO:1901606~alpha-amino acid catabolic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0008021~synaptic vesicle,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0030133~transport vesicle,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030424~axon,GO:0030658~transport vesicle membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin-coated vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031225~anchored component of membrane,GO:0031988~membrane-bounded vesicle,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0044456~synapse part,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0060077~inhibitory synapse,GO:0060198~clathrin-sculpted vesicle,GO:0061200~clathrin-sculpted gamma-aminobutyric acid transport vesicle,GO:0061202~clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,GO:0070382~exocytic vesicle,GO:0097060~synaptic membrane,GO:0097458~neuron part,GO:0098590~plasma membrane region,GO:0098793~presynapse,GO:0099501~exocytic vesicle membrane,GO:0099503~secretory vesicle,	GO:0004351~glutamate decarboxylase activity,GO:0016595~glutamate binding,GO:0016830~carbon-carbon lyase activity,GO:0016831~carboxy-lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0031406~carboxylic acid binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0048037~cofactor binding,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00410:beta-Alanine metabolism,hsa00430:Taurine and hypotaurine metabolism,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,hsa04727:GABAergic synapse,hsa04940:Type I diabetes mellitus,	
38236_at	glutamate ionotropic receptor NMDA type subunit 2A(GRIN2A)	Homo sapiens	ADHD | attention-deficit hyperactivity disorder,alcohol consumption,Alcoholism,Amyotrophic Lateral Sclerosis,autism,Bipolar Disorder,Breath Tests,Bulimia,Eosinophils,hepatitis B,HIV-1,Huntington's disease,Myocardial Infarction,Narcolepsy,Psychiatric Disorders,Schizophrenia,schizophrenia; d-serine,several psychiatric disorders,smoking,smoking cessation,Tobacco Use Disorder,Tunica Media,Weight Gain,	CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,INFECTION,METABOLIC,NEUROLOGICAL,OTHER,PSYCH,	GO:0000165~MAPK cascade,GO:0001964~startle response,GO:0001975~response to amphetamine,GO:0003008~system process,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006584~catecholamine metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006915~apoptotic process,GO:0007166~cell surface receptor signaling pathway,GO:0007215~glutamate receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007399~nervous system development,GO:0007600~sensory perception,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007613~memory,GO:0007632~visual behavior,GO:0008104~protein localization,GO:0008219~cell death,GO:0008306~associative learning,GO:0008542~visual learning,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009605~response to external stimulus,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009712~catechol-containing compound metabolic process,GO:0009719~response to endogenous stimulus,GO:0009892~negative regulation of metabolic process,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0014075~response to amine,GO:0016310~phosphorylation,GO:0018958~phenol-containing compound metabolic process,GO:0019233~sensory perception of pain,GO:0022008~neurogenesis,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030001~metal ion transport,GO:0030163~protein catabolic process,GO:0030431~sleep,GO:0031644~regulation of neurological system process,GO:0033036~macromolecule localization,GO:0033058~directional locomotion,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0040011~locomotion,GO:0042176~regulation of protein catabolic process,GO:0042177~negative regulation of protein catabolic process,GO:0042391~regulation of membrane potential,GO:0042417~dopamine metabolic process,GO:0042428~serotonin metabolic process,GO:0042430~indole-containing compound metabolic process,GO:0042493~response to drug,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0044708~single-organism behavior,GO:0045471~response to ethanol,GO:0048167~regulation of synaptic plasticity,GO:0050790~regulation of catalytic activity,GO:0050803~regulation of synapse structure or activity,GO:0050804~modulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050905~neuromuscular process,GO:0051246~regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051930~regulation of sensory perception of pain,GO:0051931~regulation of sensory perception,GO:0055085~transmembrane transport,GO:0060078~regulation of postsynaptic membrane potential,GO:0060079~excitatory postsynaptic potential,GO:0060291~long-term synaptic potentiation,GO:0065009~regulation of molecular function,GO:0070588~calcium ion transmembrane transport,GO:0070838~divalent metal ion transport,GO:0072511~divalent inorganic cation transport,GO:0097305~response to alcohol,GO:0098655~cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098662~inorganic cation transmembrane transport,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:0099565~chemical synaptic transmission, postsynaptic,GO:1900271~regulation of long-term synaptic potentiation,GO:1900273~positive regulation of long-term synaptic potentiation,GO:1901160~primary amino compound metabolic process,GO:1901615~organic hydroxy compound metabolic process,GO:1901698~response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,	GO:0005783~endoplasmic reticulum,GO:0005887~integral component of plasma membrane,GO:0008021~synaptic vesicle,GO:0008328~ionotropic glutamate receptor complex,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0017146~NMDA selective glutamate receptor complex,GO:0030054~cell junction,GO:0030133~transport vesicle,GO:0031226~intrinsic component of plasma membrane,GO:0031988~membrane-bounded vesicle,GO:0034702~ion channel complex,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,GO:0043235~receptor complex,GO:0044456~synapse part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0060076~excitatory synapse,GO:0070382~exocytic vesicle,GO:0097060~synaptic membrane,GO:0097458~neuron part,GO:0098590~plasma membrane region,GO:0098793~presynapse,GO:0098794~postsynapse,GO:0098802~plasma membrane receptor complex,GO:0098878~neurotransmitter receptor complex,GO:0099503~secretory vesicle,GO:0099572~postsynaptic specialization,GO:1902495~transmembrane transporter complex,GO:1990351~transporter complex,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004970~ionotropic glutamate receptor activity,GO:0004972~NMDA glutamate receptor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005231~excitatory extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0008066~glutamate receptor activity,GO:0008270~zinc ion binding,GO:0008324~cation transmembrane transporter activity,GO:0015085~calcium ion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022824~transmitter-gated ion channel activity,GO:0022834~ligand-gated channel activity,GO:0022835~transmitter-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate-specific channel activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030594~neurotransmitter receptor activity,GO:0038023~signaling receptor activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046914~transition metal ion binding,GO:0060089~molecular transducer activity,GO:0072509~divalent inorganic cation transmembrane transporter activity,GO:0098772~molecular function regulator,GO:0099600~transmembrane receptor activity,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04724:Glutamatergic synapse,hsa04728:Dopaminergic synapse,hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05033:Nicotine addiction,hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,	245570~Epilepsy, focal, with speech disorder and with or without mental retardation,
36479_at	growth arrest specific 8(GAS8)	Homo sapiens	Heart Failure,	CARDIOVASCULAR,	GO:0001539~cilium or flagellum-dependent cell motility,GO:0003341~cilium movement,GO:0006928~movement of cell or subcellular component,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030317~sperm motility,GO:0033036~macromolecule localization,GO:0034613~cellular protein localization,GO:0040011~locomotion,GO:0042127~regulation of cell proliferation,GO:0043393~regulation of protein binding,GO:0048870~cell motility,GO:0051098~regulation of binding,GO:0051641~cellular localization,GO:0051674~localization of cell,GO:0060285~cilium-dependent cell motility,GO:0060294~cilium movement involved in cell motility,GO:0065009~regulation of molecular function,GO:0070727~cellular macromolecule localization,GO:1904526~regulation of microtubule binding,	GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0031514~motile cilium,GO:0036064~ciliary basal body,GO:0044441~ciliary part,GO:0097014~ciliary plasm,GO:0099512~supramolecular fiber,GO:0099513~polymeric cytoskeletal fiber,	GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,		
1890_at	growth differentiation factor 15(GDF15)	Homo sapiens	Alzheimer's disease   ,Bladder Cancer,chronic obstructive pulmonary disease,Colorectal Cancer,Hypertension|Hypertrophy, Left Ventricular|Ventricular Remodeling,longevity,Lung Cancer,lung cancer ,prostate cancer,Type 2 Diabetes| edema | rosiglitazone,	AGING,CANCER,CARDIOVASCULAR,NEUROLOGICAL,OTHER,PHARMACOGENOMIC,	GO:0000768~syncytium formation by plasma membrane fusion,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006949~syncytium formation,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007520~myoblast fusion,GO:0008219~cell death,GO:0009719~response to endogenous stimulus,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010830~regulation of myotube differentiation,GO:0010831~positive regulation of myotube differentiation,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0014902~myotube differentiation,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0022603~regulation of anatomical structure morphogenesis,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042692~muscle cell differentiation,GO:0042981~regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043408~regulation of MAPK cascade,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045937~positive regulation of phosphate metabolic process,GO:0048468~cell development,GO:0048584~positive regulation of response to stimulus,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051146~striated muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0060142~regulation of syncytium formation by plasma membrane fusion,GO:0060143~positive regulation of syncytium formation by plasma membrane fusion,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060393~regulation of pathway-restricted SMAD protein phosphorylation,GO:0060395~SMAD protein signal transduction,GO:0061061~muscle structure development,GO:0070848~response to growth factor,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071363~cellular response to growth factor stimulus,GO:0071495~cellular response to endogenous stimulus,GO:0071559~response to transforming growth factor beta,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090092~regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090100~positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:1901739~regulation of myoblast fusion,GO:1901741~positive regulation of myoblast fusion,GO:1902531~regulation of intracellular signal transduction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0005160~transforming growth factor beta receptor binding,GO:0008083~growth factor activity,		
31525_s_at	hemoglobin subunit alpha 1(HBA1)	Homo sapiens	Albuminuria|Alpha Thalassemia|alpha-Thalassemia|Anemia, Sickle Cell|Sickle cell anemia,Alpha Thalassemia|alpha-Thalassemia,Alpha Thalassemia|alpha-Thalassemia|Anemia, Hypochromic,Alpha Thalassemia|alpha-Thalassemia|Fetal Diseases,alpha-Thalassemia,alpha-Thalassemia|Anemia, Hypochromic,alpha-Thalassemia|Anemia, Sickle Cell|Glucosephosphate Dehydrogenase Deficiency|Hemolysis|Stroke,alpha-Thalassemia|Anemia|Glucosephosphate Dehydrogenase Deficiency|Malaria, Falciparum|Sickle Cell Trait,alpha-Thalassemia|Anemia|Malaria,alpha-Thalassemia|beta-Thalassemia,alpha-Thalassemia|Glucosephosphate Dehydrogenase Deficiency|Malaria, Falciparum|Sickle Cell Trait,beta-thalassemia,Dyslipidemias|Thalassemia,haptoglobin,hemoglobin disorders,hemoglobin H disease,hypertension,Malaria, Falciparum,malaria, plasmodium falciparum,microcytic hypochromic anemia,microcytosis,pregnancy loss,rheumatoid arthritis,thalasemia, alpha,Thalassemia,thalassemia, alpha,	CARDIOVASCULAR,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,OTHER,REPRODUCTION,UNKNOWN,	GO:0000302~response to reactive oxygen species,GO:0006461~protein complex assembly,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006979~response to oxidative stress,GO:0008219~cell death,GO:0009636~response to toxic substance,GO:0010035~response to inorganic substance,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0015669~gas transport,GO:0015671~oxygen transport,GO:0015701~bicarbonate transport,GO:0015711~organic anion transport,GO:0016192~vesicle-mediated transport,GO:0022607~cellular component assembly,GO:0042542~response to hydrogen peroxide,GO:0042743~hydrogen peroxide metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044248~cellular catabolic process,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0071822~protein complex subunit organization,GO:0072593~reactive oxygen species metabolic process,GO:0098754~detoxification,GO:0098869~cellular oxidant detoxification,GO:1901700~response to oxygen-containing compound,GO:1990748~cellular detoxification,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0022626~cytosolic ribosome,GO:0022627~cytosolic small ribosomal subunit,GO:0030139~endocytic vesicle,GO:0030529~intracellular ribonucleoprotein complex,GO:0031838~haptoglobin-hemoglobin complex,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044391~ribosomal subunit,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044445~cytosolic part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,GO:1990904~ribonucleoprotein complex,	GO:0004601~peroxidase activity,GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0016209~antioxidant activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0031720~haptoglobin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,	hsa05143:African trypanosomiasis,hsa05144:Malaria,	140700~Heinz body anemias, alpha-,604131~Thalassemias, alpha-,613978~Hemoglobin H disease, nondeletional,Erythremias, alpha-~Erythremias, alpha-,Methemoglobinemias, alpha-~Methemoglobinemias, alpha-,
31687_f_at	hemoglobin subunit beta(HBB)	Homo sapiens	Albuminuria|Alpha Thalassemia|alpha-Thalassemia|Anemia, Sickle Cell|Sickle cell anemia,Alpha Thalassemia|alpha-Thalassemia|Anemia, Sickle Cell|Sickle cell anemia,Alpha Thalassemia|alpha-Thalassemia|Anemia|Malaria, Cerebral|Malaria, Falciparum,Alpha Thalassemia|alpha-Thalassemia|beta Thalassemia|beta-Thalassemia,Alpha Thalassemia|alpha-Thalassemia|beta Thalassemia|beta-Thalassemia|Disease Progression,Alpha Thalassemia|alpha-Thalassemia|Hydrops Fetalis,alpha-Thalassemia|Anemia, Hypochromic,alpha-Thalassemia|Anemia, Sickle Cell|Cholelithiasis,alpha-Thalassemia|Anemia, Sickle Cell|Glucosephosphate Dehydrogenase Deficiency|Hemolysis|Stroke,alpha-Thalassemia|Anemia|beta-Thalassemia|HIV Infections|Pregnancy Complications, Hematologic|Pregnancy Complications, Infectious,alpha-Thalassemia|Anemia|Glucosephosphate Dehydrogenase Deficiency|Malaria, Falciparum|Sickle Cell Trait,alpha-Thalassemia|beta-Thalassemia,anemia,anemia in pregnancy,Anemia, Iron-Deficiency|beta Thalassemia|beta-Thalassemia|Iron deficiency anaemia,Anemia, Sickle Cell,Anemia, Sickle Cell|beta Thalassemia|beta-Thalassemia|Sickle cell anemia,Anemia, Sickle Cell|beta-Thalassemia|Hemoglobinopathies,Anemia, Sickle Cell|Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1|Sickle cell anemia,Anemia, Sickle Cell|Glucosephosphate Dehydrogenase Deficiency|Sickle cell anemia,Anemia, Sickle Cell|Heterozygous haemoglobin S|Malaria|Sickle cell anemia|Sickle Cell Trait,Anemia, Sickle Cell|Inflammation|Sickle cell anemia,Anemia, Sickle Cell|Pain,Anemia, Sickle Cell|Sickle cell anemia,Anemia, Sickle Cell|Sickle cell anemia|Trachoma,Anemia|Anemia, Sickle Cell|Hemoglobin C Disease|Hemoglobin SC Disease|Heterozygous haemoglobin S|Malaria, Falciparum|Parasitemia|Sickle cell anemia|Sickle Cell Trait,Anemia|Malaria|Parasitemia,atherosclerosis, coronary,beta thalassemia,beta Thalassemia|beta-Thalassemia,beta Thalassemia|beta-Thalassemia|Fetal Diseases,beta Thalassemia|beta-Thalassemia|Hemochromatosis,beta Thalassemia|beta-Thalassemia|Hemoglobin SC Disease|Heterozygous haemoglobin S|Sickle Cell Trait,beta Thalassemia|beta-Thalassemia|Heterozygous haemoglobin S|Sickle Cell Trait,beta Thalassemia|beta-Thalassemia|Myocardial ischemia,beta-thalassemia,blood and blood forming organ disorders,Buruli ulcer,Cholelithiasis,Coronary Disease|Coronary heart disease,Dyslipidemias|Thalassemia,F-cell distribution,Fetal Diseases|Hemoglobinopathies,Fetal Hemoglobin,fetal hemoglobin levels,Hb F,Hearing Loss, Sensorineural|Hemoglobin SC Disease|Sensorineural Hearing Loss,hemoglobin disorders,Hemoglobinopathies,Hemoglobinopathies|Thalassemia,Heterozygous haemoglobin S|Malaria|Sickle Cell Trait,hypertension,iron levels,Malaria,Malaria infection,Malaria, Falciparum,Malaria, Falciparum|Parasitemia|Sickle Cell Trait,null,Perioperative genomic profiles ,sickle cell,sickle cell anemia,sickle cell anemia; G6PD deficiency,sickle cell disease,Thalassemia,thalassemia, beta,thalassemia; thalassemia, beta,transfusion-dependent Hb H disease,Type 2 Diabetes| edema | rosiglitazone,	CARDIOVASCULAR,HEMATOLOGICAL,INFECTION,METABOLIC,NORMALVARIATION,OTHER,PHARMACOGENOMIC,UNKNOWN,	GO:0000302~response to reactive oxygen species,GO:0001775~cell activation,GO:0003008~system process,GO:0003013~circulatory system process,GO:0003014~renal system process,GO:0003018~vascular process in circulatory system,GO:0006461~protein complex assembly,GO:0006809~nitric oxide biosynthetic process,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006979~response to oxidative stress,GO:0007155~cell adhesion,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0008219~cell death,GO:0009611~response to wounding,GO:0009636~response to toxic substance,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0010035~response to inorganic substance,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0015669~gas transport,GO:0015671~oxygen transport,GO:0015701~bicarbonate transport,GO:0015711~organic anion transport,GO:0016192~vesicle-mediated transport,GO:0016337~single organismal cell-cell adhesion,GO:0022607~cellular component assembly,GO:0022610~biological adhesion,GO:0030168~platelet activation,GO:0030185~nitric oxide transport,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0034109~homotypic cell-cell adhesion,GO:0035150~regulation of tube size,GO:0042060~wound healing,GO:0042542~response to hydrogen peroxide,GO:0042743~hydrogen peroxide metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044248~cellular catabolic process,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0046209~nitric oxide metabolic process,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0050880~regulation of blood vessel size,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070293~renal absorption,GO:0070527~platelet aggregation,GO:0071705~nitrogen compound transport,GO:0071822~protein complex subunit organization,GO:0072593~reactive oxygen species metabolic process,GO:0090066~regulation of anatomical structure size,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:0098754~detoxification,GO:0098869~cellular oxidant detoxification,GO:1901700~response to oxygen-containing compound,GO:1903409~reactive oxygen species biosynthetic process,GO:1903426~regulation of reactive oxygen species biosynthetic process,GO:1903428~positive regulation of reactive oxygen species biosynthetic process,GO:1904407~positive regulation of nitric oxide metabolic process,GO:1990748~cellular detoxification,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001057~reactive nitrogen species metabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030139~endocytic vesicle,GO:0031838~haptoglobin-hemoglobin complex,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044445~cytosolic part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,	GO:0004601~peroxidase activity,GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0016209~antioxidant activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0030492~hemoglobin binding,GO:0031720~haptoglobin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,	hsa05143:African trypanosomiasis,hsa05144:Malaria,	140700~Heinz body anemias, beta-,141749~Delta-beta thalassemia,141749~Hereditary persistence of fetal hemoglobin,603902~Thalassemia-beta, dominant inclusion-body,603903~Sickle cell anemia,611162~Malaria, resistance to,613985~Thalassemias, beta-,Erythremias, beta-~Erythremias, beta-,Methemoglobinemias, beta-~Methemoglobinemias, beta-,
33516_at	hemoglobin subunit delta(HBD)	Homo sapiens	Beta thalassemia/hemoglobin E disease,Echocardiography,	CARDIOVASCULAR,HEMATOLOGICAL,	GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0009611~response to wounding,GO:0015669~gas transport,GO:0015671~oxygen transport,GO:0042060~wound healing,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0044421~extracellular region part,GO:0044445~cytosolic part,GO:0072562~blood microparticle,	GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		Thalassemia due to Hb Lepore~Thalassemia due to Hb Lepore,Thalassemia, delta-~Thalassemia, delta-,
40735_at	histidine ammonia-lyase(HAL)	Homo sapiens	Carcinoma, Basal Cell|Carcinoma, Squamous Cell|Neoplasms, Radiation-Induced|Skin Neoplasms|Sunburn,Schizophrenia,	CANCER,PSYCH,	GO:0006082~organic acid metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006536~glutamate metabolic process,GO:0006547~histidine metabolic process,GO:0006548~histidine catabolic process,GO:0009063~cellular amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0015942~formate metabolic process,GO:0016054~organic acid catabolic process,GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019557~histidine catabolic process to glutamate and formate,GO:0019752~carboxylic acid metabolic process,GO:0032787~monocarboxylic acid metabolic process,GO:0043436~oxoacid metabolic process,GO:0043603~cellular amide metabolic process,GO:0043606~formamide metabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0044248~cellular catabolic process,GO:0044282~small molecule catabolic process,GO:0044712~single-organism catabolic process,GO:0046395~carboxylic acid catabolic process,GO:1901565~organonitrogen compound catabolic process,GO:1901605~alpha-amino acid metabolic process,	GO:0005829~cytosol,	GO:0004397~histidine ammonia-lyase activity,GO:0016840~carbon-nitrogen lyase activity,GO:0016841~ammonia-lyase activity,	hsa00340:Histidine metabolism,hsa01100:Metabolic pathways,	235800~Histidinemia,
31512_at	immunoglobulin kappa constant(IGKC)	Homo sapiens	Dermatomyositis|Polymyositis,Helicobacter Infections|Purpura, Thrombocytopenic, Idiopathic,Sarcoidosis,Sjogren's syndrome,	IMMUNE,INFECTION,	GO:0001775~cell activation,GO:0001894~tissue homeostasis,GO:0001895~retina homeostasis,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002433~immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signaling pathway,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006508~proteolysis,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006909~phagocytosis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006952~defense response,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0006959~humoral immune response,GO:0007166~cell surface receptor signaling pathway,GO:0008037~cell recognition,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0010324~membrane invagination,GO:0016064~immunoglobulin mediated immune response,GO:0016192~vesicle-mediated transport,GO:0019724~B cell mediated immunity,GO:0038093~Fc receptor signaling pathway,GO:0038094~Fc-gamma receptor signaling pathway,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042113~B cell activation,GO:0042592~homeostatic process,GO:0042742~defense response to bacterium,GO:0043207~response to external biotic stimulus,GO:0045087~innate immune response,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0048584~positive regulation of response to stimulus,GO:0048871~multicellular organismal homeostasis,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050871~positive regulation of B cell activation,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051707~response to other organism,GO:0060249~anatomical structure homeostasis,GO:0061024~membrane organization,GO:0072376~protein activation cascade,GO:0098542~defense response to other organism,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0019814~immunoglobulin complex,GO:0031988~membrane-bounded vesicle,GO:0042571~immunoglobulin complex, circulating,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:0098552~side of membrane,GO:1903561~extracellular vesicle,	GO:0003823~antigen binding,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0034987~immunoglobulin receptor binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,		614102~Kappa light chain deficiency,
34618_at	indian hedgehog(IHH)	Homo sapiens	Body Height,Bone Mineral Density,Chronic renal failure|Kidney Failure, Chronic,Crohn Disease|Crohn's disease|Growth Disorders,Degenerative arthropathy |Osteoarthritis,height,Hirschsprung's disease,	DEVELOPMENTAL,IMMUNE,METABOLIC,NORMALVARIATION,OTHER,RENAL,	GO:0000003~reproduction,GO:0001501~skeletal system development,GO:0001775~cell activation,GO:0001947~heart looping,GO:0002009~morphogenesis of an epithelium,GO:0002062~chondrocyte differentiation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002682~regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0003007~heart morphogenesis,GO:0003143~embryonic heart tube morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007267~cell-cell signaling,GO:0007368~determination of left/right symmetry,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0007565~female pregnancy,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009790~embryo development,GO:0009799~specification of symmetry,GO:0009855~determination of bilateral symmetry,GO:0009887~organ morphogenesis,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0014070~response to organic cyclic compound,GO:0016070~RNA metabolic process,GO:0016337~single organismal cell-cell adhesion,GO:0016485~protein processing,GO:0016539~intein-mediated protein splicing,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0022407~regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022414~reproductive process,GO:0022610~biological adhesion,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023057~negative regulation of signaling,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030217~T cell differentiation,GO:0030326~embryonic limb morphogenesis,GO:0030908~protein splicing,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032330~regulation of chondrocyte differentiation,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0032504~multicellular organism reproduction,GO:0032774~RNA biosynthetic process,GO:0032943~mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0033077~T cell differentiation in thymus,GO:0033079~immature T cell proliferation,GO:0033080~immature T cell proliferation in thymus,GO:0033081~regulation of T cell differentiation in thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033084~regulation of immature T cell proliferation in thymus,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0033993~response to lipid,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035050~embryonic heart tube development,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042098~T cell proliferation,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0044702~single organism reproductive process,GO:0044703~multi-organism reproductive process,GO:0044706~multi-multicellular organism process,GO:0045321~leukocyte activation,GO:0045580~regulation of T cell differentiation,GO:0045581~negative regulation of T cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045620~negative regulation of lymphocyte differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045785~positive regulation of cell adhesion,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046631~alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046634~regulation of alpha-beta T cell activation,GO:0046635~positive regulation of alpha-beta T cell activation,GO:0046636~negative regulation of alpha-beta T cell activation,GO:0046637~regulation of alpha-beta T cell differentiation,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0048534~hematopoietic or lymphoid organ development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048598~embryonic morphogenesis,GO:0048609~multicellular organismal reproductive process,GO:0048729~tissue morphogenesis,GO:0048736~appendage development,GO:0050670~regulation of lymphocyte proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050673~epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050870~positive regulation of T cell activation,GO:0051093~negative regulation of developmental process,GO:0051094~positive regulation of developmental process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051604~protein maturation,GO:0060135~maternal process involved in female pregnancy,GO:0060173~limb development,GO:0060429~epithelium development,GO:0060548~negative regulation of cell death,GO:0060562~epithelial tube morphogenesis,GO:0061035~regulation of cartilage development,GO:0061036~positive regulation of cartilage development,GO:0061053~somite development,GO:0061371~determination of heart left/right asymmetry,GO:0061448~connective tissue development,GO:0070486~leukocyte aggregation,GO:0070489~T cell aggregation,GO:0070661~leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,GO:0071593~lymphocyte aggregation,GO:0071594~thymocyte aggregation,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0097659~nucleic acid-templated transcription,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:1901700~response to oxygen-containing compound,GO:1902105~regulation of leukocyte differentiation,GO:1902106~negative regulation of leukocyte differentiation,GO:1902107~positive regulation of leukocyte differentiation,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903706~regulation of hemopoiesis,GO:1903707~negative regulation of hemopoiesis,GO:1903708~positive regulation of hemopoiesis,GO:2000026~regulation of multicellular organismal development,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000398~regulation of thymocyte aggregation,GO:2000399~negative regulation of thymocyte aggregation,GO:2000400~positive regulation of thymocyte aggregation,GO:2001141~regulation of RNA biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0005102~receptor binding,GO:0005113~patched binding,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,	hsa04340:Hedgehog signaling pathway,	112500~Brachydactyly, type A1,607778~Acrocapitofemoral dysplasia,
35915_at	inhibin beta C subunit(INHBC)	Homo sapiens	Chronic Lymphocytic Leukemia|Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoma|Syndrome,Disease Models, Animal|Neoplasms, Germ Cell and Embryonal|Testicular Neoplasms,epithelial ovarian cancer ,macular degeneration,Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious|Thrombophilia|Tobacco Use Disorder,	CANCER,METABOLIC,VISION,	GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0008219~cell death,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0031325~positive regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043408~regulation of MAPK cascade,GO:0045937~positive regulation of phosphate metabolic process,GO:0048468~cell development,GO:0048584~positive regulation of response to stimulus,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060393~regulation of pathway-restricted SMAD protein phosphorylation,GO:0060395~SMAD protein signal transduction,GO:0090092~regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090100~positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:1902531~regulation of intracellular signal transduction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0005160~transforming growth factor beta receptor binding,GO:0005179~hormone activity,GO:0008083~growth factor activity,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,	
38674_at	kelch like family member 9(KLHL9)	Homo sapiens	melanoma|Nevus|Skin Neoplasms,	CANCER,	GO:0000278~mitotic cell cycle,GO:0000280~nuclear division,GO:0000910~cytokinesis,GO:0006464~cellular protein modification process,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0016567~protein ubiquitination,GO:0022402~cell cycle process,GO:0032446~protein modification by small protein conjugation,GO:0036211~protein modification process,GO:0048285~organelle fission,GO:0051301~cell division,GO:0070647~protein modification by small protein conjugation or removal,GO:1903047~mitotic cell cycle process,	GO:0000151~ubiquitin ligase complex,GO:0030496~midbody,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0019787~ubiquitin-like protein transferase activity,	hsa04120:Ubiquitin mediated proteolysis,	
34012_at	keratin, type I cuticular Ha4(LOC100653049)	Homo sapiens			GO:0008544~epidermis development,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005882~intermediate filament,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0045111~intermediate filament cytoskeleton,GO:0070062~extracellular exosome,GO:0099512~supramolecular fiber,GO:0099513~polymeric cytoskeletal fiber,GO:1903561~extracellular vesicle,	GO:0005198~structural molecule activity,		
36436_at	leukocyte cell derived chemotaxin 2(LECT2)	Homo sapiens	Celiac Disease|,Magnesium,	IMMUNE,METABOLIC,	GO:0001501~skeletal system development,GO:0006935~chemotaxis,GO:0009605~response to external stimulus,GO:0040011~locomotion,GO:0042330~taxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0042802~identical protein binding,		
32073_at	lysine demethylase 4A(KDM4A)	Homo sapiens	hypertension,	CARDIOVASCULAR,	GO:0003008~system process,GO:0003012~muscle system process,GO:0003299~muscle hypertrophy in response to stress,GO:0003300~cardiac muscle hypertrophy,GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006464~cellular protein modification process,GO:0006479~protein methylation,GO:0006482~protein demethylation,GO:0006914~autophagy,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0008213~protein alkylation,GO:0008214~protein dealkylation,GO:0008219~cell death,GO:0009605~response to external stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009991~response to extracellular stimulus,GO:0010001~glial cell differentiation,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010506~regulation of autophagy,GO:0010507~negative regulation of autophagy,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010639~negative regulation of organelle organization,GO:0010720~positive regulation of cell development,GO:0010721~negative regulation of cell development,GO:0010941~regulation of cell death,GO:0014013~regulation of gliogenesis,GO:0014014~negative regulation of gliogenesis,GO:0014887~cardiac muscle adaptation,GO:0014888~striated muscle adaptation,GO:0014896~muscle hypertrophy,GO:0014897~striated muscle hypertrophy,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0016577~histone demethylation,GO:0018022~peptidyl-lysine methylation,GO:0018023~peptidyl-lysine trimethylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018205~peptidyl-lysine modification,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0022008~neurogenesis,GO:0030182~neuron differentiation,GO:0031056~regulation of histone modification,GO:0031057~negative regulation of histone modification,GO:0031060~regulation of histone methylation,GO:0031061~negative regulation of histone methylation,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031667~response to nutrient levels,GO:0032259~methylation,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032774~RNA biosynthetic process,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034968~histone lysine methylation,GO:0036124~histone H3-K9 trimethylation,GO:0036211~protein modification process,GO:0042063~gliogenesis,GO:0043414~macromolecule methylation,GO:0043500~muscle adaptation,GO:0043933~macromolecular complex subunit organization,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045685~regulation of glial cell differentiation,GO:0045686~negative regulation of glial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0048468~cell development,GO:0048699~generation of neurons,GO:0048708~astrocyte differentiation,GO:0048710~regulation of astrocyte differentiation,GO:0048712~negative regulation of astrocyte differentiation,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0051093~negative regulation of developmental process,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051567~histone H3-K9 methylation,GO:0051570~regulation of histone H3-K9 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0051960~regulation of nervous system development,GO:0051961~negative regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0055114~oxidation-reduction process,GO:0060284~regulation of cell development,GO:0060548~negative regulation of cell death,GO:0061647~histone H3-K9 modification,GO:0070076~histone lysine demethylation,GO:0070544~histone H3-K36 demethylation,GO:0070988~demethylation,GO:0097659~nucleic acid-templated transcription,GO:1900112~regulation of histone H3-K9 trimethylation,GO:1900113~negative regulation of histone H3-K9 trimethylation,GO:1902275~regulation of chromatin organization,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1905268~negative regulation of chromatin organization,GO:2000026~regulation of multicellular organismal development,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,GO:2001251~negative regulation of chromosome organization,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0000792~heterochromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005721~pericentric heterochromatin,GO:0005730~nucleolus,GO:0044427~chromosomal part,GO:0098687~chromosomal region,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0008270~zinc ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0032451~demethylase activity,GO:0032452~histone demethylase activity,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051213~dioxygenase activity,GO:0051864~histone demethylase activity (H3-K36 specific),GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
37408_at	mannose receptor C type 2(MRC2)	Homo sapiens	head and neck cancer,	CANCER,	GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0006897~endocytosis,GO:0016192~vesicle-mediated transport,GO:0030574~collagen catabolic process,GO:0032963~collagen metabolic process,GO:0044236~multicellular organism metabolic process,GO:0044243~multicellular organism catabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0044712~single-organism catabolic process,	GO:0005887~integral component of plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031226~intrinsic component of plasma membrane,GO:0070161~anchoring junction,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005518~collagen binding,GO:0030246~carbohydrate binding,GO:0032403~protein complex binding,GO:0038023~signaling receptor activity,GO:0044877~macromolecular complex binding,GO:0060089~molecular transducer activity,GO:0099600~transmembrane receptor activity,	hsa04145:Phagosome,hsa05152:Tuberculosis,	
38945_at	metal regulatory transcription factor 1(MTF1)	Homo sapiens	ALS/amyotrophic lateral sclerosis,autism,Carcinoma, Papillary|DNA Damage|Neoplasms, Radiation-Induced|thyroid neoplasm|Thyroid Neoplasms,Hypothyroidism,	CANCER,METABOLIC,NEUROLOGICAL,PSYCH,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006979~response to oxidative stress,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046686~response to cadmium ion,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0097659~nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005654~nucleoplasm,	GO:0000975~regulatory region DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000988~transcription factor activity, protein binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001067~regulatory region nucleic acid binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0019899~enzyme binding,GO:0035035~histone acetyltransferase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,GO:1990837~sequence-specific double-stranded DNA binding,		
41280_r_at	mitogen-activated protein kinase 8 interacting protein 1(MAPK8IP1)	Homo sapiens	Alzheimer's Disease,	NEUROLOGICAL,	GO:0000165~MAPK cascade,GO:0001932~regulation of protein phosphorylation,GO:0001933~negative regulation of protein phosphorylation,GO:0006355~regulation of transcription, DNA-templated,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006915~apoptotic process,GO:0007254~JNK cascade,GO:0007258~JUN phosphorylation,GO:0008219~cell death,GO:0009892~negative regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016070~RNA metabolic process,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023057~negative regulation of signaling,GO:0031098~stress-activated protein kinase signaling cascade,GO:0031324~negative regulation of cellular metabolic process,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032774~RNA biosynthetic process,GO:0032872~regulation of stress-activated MAPK cascade,GO:0032873~negative regulation of stress-activated MAPK cascade,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043408~regulation of MAPK cascade,GO:0043409~negative regulation of MAPK cascade,GO:0043506~regulation of JUN kinase activity,GO:0043508~negative regulation of JUN kinase activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045936~negative regulation of phosphate metabolic process,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0050790~regulation of catalytic activity,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051403~stress-activated MAPK cascade,GO:0060548~negative regulation of cell death,GO:0065009~regulation of molecular function,GO:0070302~regulation of stress-activated protein kinase signaling cascade,GO:0070303~negative regulation of stress-activated protein kinase signaling cascade,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:0080134~regulation of response to stress,GO:0080135~regulation of cellular response to stress,GO:0097190~apoptotic signaling pathway,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097659~nucleic acid-templated transcription,GO:1902531~regulation of intracellular signal transduction,GO:1902532~negative regulation of intracellular signal transduction,GO:1903506~regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,GO:2001233~regulation of apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001242~regulation of intrinsic apoptotic signaling pathway,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0033267~axon part,GO:0036477~somatodendritic compartment,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0043005~neuron projection,GO:0044292~dendrite terminus,GO:0044294~dendritic growth cone,GO:0044295~axonal growth cone,GO:0044297~cell body,GO:0044302~dentate gyrus mossy fiber,GO:0044429~mitochondrial part,GO:0044432~endoplasmic reticulum part,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0097458~neuron part,	GO:0004857~enzyme inhibitor activity,GO:0004860~protein kinase inhibitor activity,GO:0005078~MAP-kinase scaffold activity,GO:0005198~structural molecule activity,GO:0008092~cytoskeletal protein binding,GO:0008432~JUN kinase binding,GO:0016301~kinase activity,GO:0019207~kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019887~protein kinase regulator activity,GO:0019894~kinesin binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030234~enzyme regulator activity,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0032947~protein complex scaffold,GO:0035591~signaling adaptor activity,GO:0042802~identical protein binding,GO:0060090~binding, bridging,GO:0098772~molecular function regulator,	hsa04010:MAPK signaling pathway,	125853~Diabetes mellitus, noninsulin-dependent,
33284_at	myeloperoxidase(MPO)	Homo sapiens	Adenocarcinoma|Pancreatic Neoplasms,Aggressive Periodontitis|Chronic Periodontitis|Periodontitis, Juvenile,Aging/ Telomere Length,agranulocytosis,Alzheimer's Disease,Alzheimer's disease   ,anti-neutrophil cytoplasmic antibodies kidney failure, chronic polyangiitis Wegener's granulomatosis,Asthma,Asthma|Hypersensitivity, Immediate,atherosclerosis,Atherosclerosis|Carotid Artery Diseases|Diabetes Mellitus, Type 2|,Atherosclerosis|Diabetes Complications|Diabetes mellitus type II|Diabetes Mellitus, Type 2|Myocardial Infarction,bacterial infection,Behcet Syndrome,benzene toxicity,Biliary Tract Neoplasms|Inflammation,Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma,Bladder Cancer,bone marrow transplantation,Brain Ischemia|Stroke,Brain Neoplasms|Occupational Diseases,Breast Cancer,breast cancer   ,breast cancer survival,Carcinoma, Hepatocellular|Liver Cirrhosis, Alcoholic|Liver Neoplasms,Carcinoma, Squamous Cell|Esophageal Neoplasms|Precancerous Conditions,Carcinoma, Squamous Cell|Mouth Neoplasms|Oropharyngeal Neoplasms,Carcinoma|Urinary Bladder Neoplasms,cardiac death cardiovascular disease oxidative stress,cardiovascular disease,Cardiovascular Diseases|,cerebral infarct,cervical cancer,Charcot-Marie-Tooth disease,chronic benzene poisoning,chronic obstructive pulmonary disease,Chronic renal failure|Kidney Failure, Chronic,cirrhosis,cognitive decline,cognitive function,cognitive trait,Colorectal Cancer,Coronary Artery Disease,Coronary Disease|Inflammation,coronary vasculopathy,cutaneous reactions to sulfonamides,DNA adducts,DNA Damage|,Duodenal Ulcer,Endometriosis,Esophageal Cancer,Esophageal Neoplasms|Head and Neck Neoplasms|Laryngeal Neoplasms|Mouth Neoplasms|Pharyngeal Neoplasms,Esophageal Neoplasms|Head and Neck Neoplasms|Laryngeal neoplasm|Laryngeal Neoplasms|Mouth Neoplasms|Oesophageal neoplasm|Pharyngeal Neoplasms,Eye Diseases|Hypersensitivity|Respiratory Tract Diseases,gastric atrophy gastric disease,gastric disease,Gastritis|Helicobacter Infections|Peptic Ulcer|Stomach Diseases|Stomach Neoplasms,Gastritis|Helicobacter Infections|Stomach Neoplasms,genetic polymorphism,Giant Cell Arteritis|Ischemia|Polymyalgia Rheumatica,Glomerulonephritis, IGA,Graft vs Host Disease|Hematologic Neoplasms|Neoplasm Recurrence, Local,H. pylori infection,Helicobacter pylori infection; gastritis, Helicobacter pylori-induced,hepatitis C,hyperkeratosis,impaired left ventricular function,Kidney Diseases|Lupus Erythematosus, Systemic|Systemic lupus erythematosus,kidney failure, chronic,kidney graft function,LDL oxidation,Leiomyoma|Uterine Neoplasms,leukemia,leukemia, acute myeloid,leukemia, childhood acute lymphoblastic,liver cancer,liver disease,Lung Cancer,lung cancer ,lung cancer risk,lung cancer; asthma; emphysema; bronchitis; pneumonia; hay fever,lung cancer; homocysteine,Lung Neoplasms|Neoplasm of lung (disorder)|Occupational Diseases,lung squamous cell carcinoma,lymphoma lymphoma, non-Hodgkin,lymphoma, malignant,Lymphoma, Non-Hodgkin,Lymphoma, Non-Hodgkin|Lymphoma, Non-Hodgkin's,Meningeal Neoplasms|meningioma,metabolism of toluene di-isocyanate,Micronuclei, Chromosome-Defective,Mouth Neoplasms|Substance-Related Disorders,MPO -463 A allele,Multiple Myeloma|Pneumonia|Sepsis,Multiple Sclerosis,myeloperoxidase activity,Myocardial Infarction,Narcolepsy,Neoplasms,non-Hodgkin lymphoma,null,Osteosarcoma,ovarian cancer,oxidative injury,periodontal disease,plasma HDL-C levels,Precursor Cell Lymphoblastic Leukemia-Lymphoma,preeclampsia,prostate cancer,radiotoxicity,reduced risk of lung cancer,renal graft function,Respiratory Tract Diseases,stomach cancer,Type 2 Diabetes| edema | rosiglitazone,vascular disease,vasculitis, antineutrophil cytoplasmic; antibodies-associated small vessel,Vitiligo,	AGING,CANCER,CARDIOVASCULAR,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0000302~response to reactive oxygen species,GO:0000303~response to superoxide,GO:0000305~response to oxygen radical,GO:0001878~response to yeast,GO:0002148~hypochlorous acid metabolic process,GO:0002149~hypochlorous acid biosynthetic process,GO:0002237~response to molecule of bacterial origin,GO:0002252~immune effector process,GO:0002679~respiratory burst involved in defense response,GO:0006082~organic acid metabolic process,GO:0006801~superoxide metabolic process,GO:0006915~apoptotic process,GO:0006952~defense response,GO:0006979~response to oxidative stress,GO:0007568~aging,GO:0008219~cell death,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0009628~response to abiotic stimulus,GO:0009636~response to toxic substance,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0019430~removal of superoxide radicals,GO:0031667~response to nutrient levels,GO:0032094~response to food,GO:0032496~response to lipopolysaccharide,GO:0033554~cellular response to stress,GO:0033993~response to lipid,GO:0034367~macromolecular complex remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0040007~growth,GO:0040008~regulation of growth,GO:0042742~defense response to bacterium,GO:0042743~hydrogen peroxide metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043207~response to external biotic stimulus,GO:0043436~oxoacid metabolic process,GO:0043900~regulation of multi-organism process,GO:0043901~negative regulation of multi-organism process,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0043933~macromolecular complex subunit organization,GO:0044110~growth involved in symbiotic interaction,GO:0044116~growth of symbiont involved in interaction with host,GO:0044117~growth of symbiont in host,GO:0044126~regulation of growth of symbiont in host,GO:0044130~negative regulation of growth of symbiont in host,GO:0044144~modulation of growth of symbiont involved in interaction with host,GO:0044146~negative regulation of growth of symbiont involved in interaction with host,GO:0044248~cellular catabolic process,GO:0044283~small molecule biosynthetic process,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0045730~respiratory burst,GO:0045926~negative regulation of growth,GO:0050832~defense response to fungus,GO:0051707~response to other organism,GO:0055114~oxidation-reduction process,GO:0060548~negative regulation of cell death,GO:0070887~cellular response to chemical stimulus,GO:0071450~cellular response to oxygen radical,GO:0071451~cellular response to superoxide,GO:0071825~protein-lipid complex subunit organization,GO:0071827~plasma lipoprotein particle organization,GO:0072593~reactive oxygen species metabolic process,GO:0097006~regulation of plasma lipoprotein particle levels,GO:0098542~defense response to other organism,GO:0098754~detoxification,GO:0098869~cellular oxidant detoxification,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1990267~response to transition metal nanoparticle,GO:1990268~response to gold nanoparticle,GO:1990748~cellular detoxification,	GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0005766~primary lysosome,GO:0005773~vacuole,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031988~membrane-bounded vesicle,GO:0042582~azurophil granule,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:0099503~secretory vesicle,GO:1903561~extracellular vesicle,	GO:0003682~chromatin binding,GO:0004601~peroxidase activity,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0016209~antioxidant activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901363~heterocyclic compound binding,GO:1901681~sulfur compound binding,	hsa04145:Phagosome,hsa05202:Transcriptional misregulation in cancer,	104300~Alzheimer disease, susceptibility to,254600~Myeloperoxidase deficiency,Lung cancer, protection against, in smokers~Lung cancer, protection against, in smokers,
37711_at	myocyte enhancer factor 2C(MEF2C)	Homo sapiens	Blood Pressure,Body Height,Body Weights and Measures,Bone Density,Bone Mineral Density,Bone mineral density (hip),breast cancer   ,Cardiomegaly,Cardiovascular Diseases,Diabetes Mellitus, Type 2,Erythrocytes,Fibrinogen,Fractures, Bone,Hemoglobins,Lupus Erythematosus, Systemic,Mental Retardation|Syndrome,plasma HDL cholesterol (HDL-C) levels,Platelet Count,Pulse,tonometry,Type 2 Diabetes| edema | rosiglitazone,	CANCER,CARDIOVASCULAR,DEVELOPMENTAL,HEMATOLOGICAL,IMMUNE,METABOLIC,OTHER,PHARMACOGENOMIC,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPK cascade,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001101~response to acid chemical,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001505~regulation of neurotransmitter levels,GO:0001568~blood vessel development,GO:0001649~osteoblast differentiation,GO:0001655~urogenital system development,GO:0001662~behavioral fear response,GO:0001678~cellular glucose homeostasis,GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0001775~cell activation,GO:0001776~leukocyte homeostasis,GO:0001782~B cell homeostasis,GO:0001822~kidney development,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001944~vasculature development,GO:0001947~heart looping,GO:0001958~endochondral ossification,GO:0001974~blood vessel remodeling,GO:0002009~morphogenesis of an epithelium,GO:0002062~chondrocyte differentiation,GO:0002209~behavioral defense response,GO:0002237~response to molecule of bacterial origin,GO:0002250~adaptive immune response,GO:0002253~activation of immune response,GO:0002260~lymphocyte homeostasis,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002467~germinal center formation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0002634~regulation of germinal center formation,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signaling pathway,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002819~regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002931~response to ischemia,GO:0003002~regionalization,GO:0003007~heart morphogenesis,GO:0003008~system process,GO:0003012~muscle system process,GO:0003128~heart field specification,GO:0003138~primary heart field specification,GO:0003139~secondary heart field specification,GO:0003143~embryonic heart tube morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003170~heart valve development,GO:0003172~sinoatrial valve development,GO:0003179~heart valve morphogenesis,GO:0003185~sinoatrial valve morphogenesis,GO:0003205~cardiac chamber development,GO:0003206~cardiac chamber morphogenesis,GO:0003207~cardiac chamber formation,GO:0003208~cardiac ventricle morphogenesis,GO:0003211~cardiac ventricle formation,GO:0003231~cardiac ventricle development,GO:0003299~muscle hypertrophy in response to stress,GO:0003300~cardiac muscle hypertrophy,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006811~ion transport,GO:0006836~neurotransmitter transport,GO:0006915~apoptotic process,GO:0006925~inflammatory cell apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007010~cytoskeleton organization,GO:0007166~cell surface receptor signaling pathway,GO:0007215~glutamate receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007368~determination of left/right symmetry,GO:0007389~pattern specification process,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007521~muscle cell fate determination,GO:0007584~response to nutrient,GO:0007610~behavior,GO:0007611~learning or memory,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone,GO:0009743~response to carbohydrate,GO:0009746~response to hexose,GO:0009749~response to glucose,GO:0009790~embryo development,GO:0009792~embryo development ending in birth or egg hatching,GO:0009799~specification of symmetry,GO:0009855~determination of bilateral symmetry,GO:0009887~organ morphogenesis,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010092~specification of organ identity,GO:0010243~response to organonitrogen compound,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010469~regulation of receptor activity,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010692~regulation of alkaline phosphatase activity,GO:0010694~positive regulation of alkaline phosphatase activity,GO:0010720~positive regulation of cell development,GO:0010921~regulation of phosphatase activity,GO:0010922~positive regulation of phosphatase activity,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010975~regulation of neuron projection development,GO:0012501~programmed cell death,GO:0014033~neural crest cell differentiation,GO:0014070~response to organic cyclic compound,GO:0014706~striated muscle tissue development,GO:0014855~striated muscle cell proliferation,GO:0014887~cardiac muscle adaptation,GO:0014888~striated muscle adaptation,GO:0014896~muscle hypertrophy,GO:0014897~striated muscle hypertrophy,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0014902~myotube differentiation,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016202~regulation of striated muscle tissue development,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0016358~dendrite development,GO:0016477~cell migration,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019725~cellular homeostasis,GO:0021537~telencephalon development,GO:0021542~dentate gyrus development,GO:0021543~pallium development,GO:0021761~limbic system development,GO:0021766~hippocampus development,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022607~cellular component assembly,GO:0022898~regulation of transmembrane transporter activity,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030182~neuron differentiation,GO:0030220~platelet formation,GO:0030224~monocyte differentiation,GO:0030278~regulation of ossification,GO:0030279~negative regulation of ossification,GO:0030282~bone mineralization,GO:0030318~melanocyte differentiation,GO:0030500~regulation of bone mineralization,GO:0030501~positive regulation of bone mineralization,GO:0030855~epithelial cell differentiation,GO:0030888~regulation of B cell proliferation,GO:0030890~positive regulation of B cell proliferation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0031214~biomineral tissue development,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031344~regulation of cell projection organization,GO:0031347~regulation of defense response,GO:0031349~positive regulation of defense response,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031667~response to nutrient levels,GO:0032092~positive regulation of protein binding,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032409~regulation of transporter activity,GO:0032412~regulation of ion transmembrane transporter activity,GO:0032496~response to lipopolysaccharide,GO:0032526~response to retinoic acid,GO:0032774~RNA biosynthetic process,GO:0032835~glomerulus development,GO:0032870~cellular response to hormone stimulus,GO:0032940~secretion by cell,GO:0032943~mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0032989~cellular component morphogenesis,GO:0033002~muscle cell proliferation,GO:0033028~myeloid cell apoptotic process,GO:0033032~regulation of myeloid cell apoptotic process,GO:0033034~positive regulation of myeloid cell apoptotic process,GO:0033043~regulation of organelle organization,GO:0033197~response to vitamin E,GO:0033273~response to vitamin,GO:0033500~carbohydrate homeostasis,GO:0033554~cellular response to stress,GO:0033555~multicellular organismal response to stress,GO:0033674~positive regulation of kinase activity,GO:0033993~response to lipid,GO:0034220~ion transmembrane transport,GO:0034284~response to monosaccharide,GO:0034405~response to fluid shear stress,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034762~regulation of transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0035050~embryonic heart tube development,GO:0035051~cardiocyte differentiation,GO:0035239~tube morphogenesis,GO:0035265~organ growth,GO:0035295~tube development,GO:0035303~regulation of dephosphorylation,GO:0035306~positive regulation of dephosphorylation,GO:0035556~intracellular signal transduction,GO:0035690~cellular response to drug,GO:0035850~epithelial cell differentiation involved in kidney development,GO:0035914~skeletal muscle cell differentiation,GO:0035983~response to trichostatin A,GO:0035984~cellular response to trichostatin A,GO:0036075~replacement ossification,GO:0036211~protein modification process,GO:0036344~platelet morphogenesis,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040011~locomotion,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0042596~fear response,GO:0042692~muscle cell differentiation,GO:0042693~muscle cell fate commitment,GO:0042981~regulation of apoptotic process,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043207~response to external biotic stimulus,GO:0043269~regulation of ion transport,GO:0043393~regulation of protein binding,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043473~pigmentation,GO:0043496~regulation of protein homodimerization activity,GO:0043500~muscle adaptation,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0043549~regulation of kinase activity,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044708~single-organism behavior,GO:0044764~multi-organism cellular process,GO:0045165~cell fate commitment,GO:0045321~leukocyte activation,GO:0045445~myoblast differentiation,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045652~regulation of megakaryocyte differentiation,GO:0045661~regulation of myoblast differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045844~positive regulation of striated muscle tissue development,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045927~positive regulation of growth,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046620~regulation of organ growth,GO:0046622~positive regulation of organ growth,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046677~response to antibiotic,GO:0046903~secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0048066~developmental pigmentation,GO:0048167~regulation of synaptic plasticity,GO:0048468~cell development,GO:0048520~positive regulation of behavior,GO:0048534~hematopoietic or lymphoid organ development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048584~positive regulation of response to stimulus,GO:0048589~developmental growth,GO:0048598~embryonic morphogenesis,GO:0048634~regulation of muscle organ development,GO:0048636~positive regulation of muscle organ development,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048641~regulation of skeletal muscle tissue development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048645~organ formation,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048729~tissue morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0048762~mesenchymal cell differentiation,GO:0048771~tissue remodeling,GO:0048870~cell motility,GO:0048872~homeostasis of number of cells,GO:0048878~chemical homeostasis,GO:0050670~regulation of lymphocyte proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050673~epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050790~regulation of catalytic activity,GO:0050795~regulation of behavior,GO:0050803~regulation of synapse structure or activity,GO:0050804~modulation of synaptic transmission,GO:0050807~regulation of synapse organization,GO:0050808~synapse organization,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050871~positive regulation of B cell activation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050931~pigment cell differentiation,GO:0051046~regulation of secretion,GO:0051049~regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051128~regulation of cellular component organization,GO:0051145~smooth muscle cell differentiation,GO:0051146~striated muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051216~cartilage development,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051347~positive regulation of transferase activity,GO:0051402~neuron apoptotic process,GO:0051493~regulation of cytoskeleton organization,GO:0051588~regulation of neurotransmitter transport,GO:0051592~response to calcium ion,GO:0051641~cellular localization,GO:0051674~localization of cell,GO:0051707~response to other organism,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0051963~regulation of synapse assembly,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0055007~cardiac muscle cell differentiation,GO:0055012~ventricular cardiac muscle cell differentiation,GO:0055017~cardiac muscle tissue growth,GO:0055021~regulation of cardiac muscle tissue growth,GO:0055023~positive regulation of cardiac muscle tissue growth,GO:0055024~regulation of cardiac muscle tissue development,GO:0055025~positive regulation of cardiac muscle tissue development,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0060021~palate development,GO:0060025~regulation of synaptic activity,GO:0060038~cardiac muscle cell proliferation,GO:0060043~regulation of cardiac muscle cell proliferation,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060078~regulation of postsynaptic membrane potential,GO:0060079~excitatory postsynaptic potential,GO:0060284~regulation of cell development,GO:0060290~transdifferentiation,GO:0060297~regulation of sarcomere organization,GO:0060322~head development,GO:0060341~regulation of cellular localization,GO:0060348~bone development,GO:0060349~bone morphogenesis,GO:0060350~endochondral bone morphogenesis,GO:0060419~heart growth,GO:0060420~regulation of heart growth,GO:0060421~positive regulation of heart growth,GO:0060429~epithelium development,GO:0060485~mesenchyme development,GO:0060536~cartilage morphogenesis,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060548~negative regulation of cell death,GO:0060562~epithelial tube morphogenesis,GO:0060914~heart formation,GO:0060998~regulation of dendritic spine development,GO:0061005~cell differentiation involved in kidney development,GO:0061061~muscle structure development,GO:0061326~renal tubule development,GO:0061333~renal tubule morphogenesis,GO:0061371~determination of heart left/right asymmetry,GO:0061448~connective tissue development,GO:0065009~regulation of molecular function,GO:0070167~regulation of biomineral tissue development,GO:0070169~positive regulation of biomineral tissue development,GO:0070661~leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070665~positive regulation of leukocyte proliferation,GO:0070848~response to growth factor,GO:0070887~cellular response to chemical stimulus,GO:0070925~organelle assembly,GO:0070997~neuron death,GO:0071107~response to parathyroid hormone,GO:0071216~cellular response to biotic stimulus,GO:0071219~cellular response to molecule of bacterial origin,GO:0071222~cellular response to lipopolysaccharide,GO:0071229~cellular response to acid chemical,GO:0071236~cellular response to antibiotic,GO:0071241~cellular response to inorganic substance,GO:0071248~cellular response to metal ion,GO:0071277~cellular response to calcium ion,GO:0071300~cellular response to retinoic acid,GO:0071310~cellular response to organic substance,GO:0071322~cellular response to carbohydrate stimulus,GO:0071326~cellular response to monosaccharide stimulus,GO:0071331~cellular response to hexose stimulus,GO:0071333~cellular response to glucose stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071396~cellular response to lipid,GO:0071407~cellular response to organic cyclic compound,GO:0071417~cellular response to organonitrogen compound,GO:0071495~cellular response to endogenous stimulus,GO:0071498~cellular response to fluid shear stress,GO:0071559~response to transforming growth factor beta,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071838~cell proliferation in bone marrow,GO:0071863~regulation of cell proliferation in bone marrow,GO:0071864~positive regulation of cell proliferation in bone marrow,GO:0071887~leukocyte apoptotic process,GO:0071888~macrophage apoptotic process,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0072001~renal system development,GO:0072006~nephron development,GO:0072009~nephron epithelium development,GO:0072073~kidney epithelium development,GO:0072080~nephron tubule development,GO:0072102~glomerulus morphogenesis,GO:0072160~nephron tubule epithelial cell differentiation,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0080134~regulation of response to stress,GO:0090073~positive regulation of protein homodimerization activity,GO:0097659~nucleic acid-templated transcription,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:0099565~chemical synaptic transmission, postsynaptic,GO:0099601~regulation of neurotransmitter receptor activity,GO:1900449~regulation of glutamate receptor signaling pathway,GO:1901214~regulation of neuron death,GO:1901215~negative regulation of neuron death,GO:1901698~response to nitrogen compound,GO:1901699~cellular response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1901861~regulation of muscle tissue development,GO:1901863~positive regulation of muscle tissue development,GO:1902115~regulation of organelle assembly,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902589~single-organism organelle organization,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903365~regulation of fear response,GO:1903367~positive regulation of fear response,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903530~regulation of secretion by cell,GO:1903706~regulation of hemopoiesis,GO:1904888~cranial skeletal system development,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1905207~regulation of cardiocyte differentiation,GO:1905209~positive regulation of cardiocyte differentiation,GO:2000026~regulation of multicellular organismal development,GO:2000106~regulation of leukocyte apoptotic process,GO:2000108~positive regulation of leukocyte apoptotic process,GO:2000109~regulation of macrophage apoptotic process,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000310~regulation of N-methyl-D-aspartate selective glutamate receptor activity,GO:2000311~regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,GO:2000725~regulation of cardiac muscle cell differentiation,GO:2000727~positive regulation of cardiac muscle cell differentiation,GO:2000822~regulation of behavioral fear response,GO:2000987~positive regulation of behavioral fear response,GO:2001013~epithelial cell proliferation involved in renal tubule morphogenesis,GO:2001014~regulation of skeletal muscle cell differentiation,GO:2001016~positive regulation of skeletal muscle cell differentiation,GO:2001141~regulation of RNA biosynthetic process,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0044451~nucleoplasm part,GO:0044456~synapse part,GO:0045202~synapse,GO:0098794~postsynapse,	GO:0000975~regulatory region DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001067~regulatory region nucleic acid binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001159~core promoter proximal region DNA binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0033613~activating transcription factor binding,GO:0035198~miRNA binding,GO:0035326~enhancer binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044877~macromolecular complex binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0071837~HMG box domain binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,GO:1990837~sequence-specific double-stranded DNA binding,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05202:Transcriptional misregulation in cancer,	613443~Chromosome 5q14.3 deletion syndrome,613443~Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations,
35038_at	myosin binding protein C, cardiac(MYBPC3)	Homo sapiens	Cardiomegaly|Cardiomyopathy, Dilated|,Cardiomyopathies,Cardiomyopathies|,cardiomyopathy,Cardiomyopathy, Dilated,Cardiomyopathy, Dilated|DCM - Dilated cardiomyopathy,Cardiomyopathy, Hypertrophic,Cardiomyopathy, Hypertrophic, Familial|Hypertrophy, Left Ventricular|Ventricular Dysfunction, Left,Cardiomyopathy, Hypertrophic|,Cardiomyopathy, Hypertrophic|Death, Sudden, Cardiac|Hypertrophic Cardiomyopathy|Sudden Cardiac Death,Cardiomyopathy, Hypertrophic|Hypertrophic Cardiomyopathy,Cardiomyopathy, Hypertrophic|Hypertrophy, Left Ventricular|Tachycardia, Ventricular,familial hypertrophic cardiomyopathy.,hypertrophic cardiomyopathy,Hypertrophy, Left Ventricular|Left Ventricular Hypertrophy,Idiopathic Dilated Cardiomyopathy,left ventricular wall thickness,null,Tobacco Use Disorder,Type 2 Diabetes| edema | rosiglitazone,	CARDIOVASCULAR,CHEMDEPENDENCY,PHARMACOGENOMIC,UNKNOWN,	GO:0003007~heart morphogenesis,GO:0003008~system process,GO:0003012~muscle system process,GO:0003013~circulatory system process,GO:0003015~heart process,GO:0003205~cardiac chamber development,GO:0003206~cardiac chamber morphogenesis,GO:0003208~cardiac ventricle morphogenesis,GO:0003229~ventricular cardiac muscle tissue development,GO:0003231~cardiac ventricle development,GO:0006928~movement of cell or subcellular component,GO:0006936~muscle contraction,GO:0006937~regulation of muscle contraction,GO:0006941~striated muscle contraction,GO:0006942~regulation of striated muscle contraction,GO:0007155~cell adhesion,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008015~blood circulation,GO:0009887~organ morphogenesis,GO:0014706~striated muscle tissue development,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030048~actin filament-based movement,GO:0030049~muscle filament sliding,GO:0032386~regulation of intracellular transport,GO:0032781~positive regulation of ATPase activity,GO:0032970~regulation of actin filament-based process,GO:0032971~regulation of muscle filament sliding,GO:0033275~actin-myosin filament sliding,GO:0043085~positive regulation of catalytic activity,GO:0043462~regulation of ATPase activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0046907~intracellular transport,GO:0048644~muscle organ morphogenesis,GO:0048729~tissue morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0050790~regulation of catalytic activity,GO:0051049~regulation of transport,GO:0051270~regulation of cellular component movement,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060047~heart contraction,GO:0060048~cardiac muscle contraction,GO:0060341~regulation of cellular localization,GO:0060415~muscle tissue morphogenesis,GO:0060537~muscle tissue development,GO:0061061~muscle structure development,GO:0065009~regulation of molecular function,GO:0070252~actin-mediated cell contraction,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0090257~regulation of muscle system process,GO:1903115~regulation of actin filament-based movement,	GO:0005829~cytosol,GO:0005859~muscle myosin complex,GO:0005863~striated muscle myosin thick filament,GO:0014705~C zone,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0031672~A band,GO:0032982~myosin filament,GO:0036379~myofilament,GO:0043292~contractile fiber,GO:0044449~contractile fiber part,	GO:0001671~ATPase activator activity,GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0008047~enzyme activator activity,GO:0008092~cytoskeletal protein binding,GO:0008307~structural constituent of muscle,GO:0017022~myosin binding,GO:0030234~enzyme regulator activity,GO:0031432~titin binding,GO:0032036~myosin heavy chain binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0060590~ATPase regulator activity,GO:0098772~molecular function regulator,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	115197~Cardiomyopathy, hypertrophic, 4,615396~Cardiomyopathy, dilated, 1MM,615396~Left ventricular noncompaction 10,
37968_at	natural cytotoxicity triggering receptor 3(NCR3)	Homo sapiens	Abortion, Spontaneous,Behcet Syndrome,Body Weight,Diabetes Mellitus, Type 1|,Lupus Erythematosus, Systemic,Malaria,malaria, plasmodium falciparum,Obesity,Respiratory Function Tests,Retinal Detachment|Vitreoretinopathy, Proliferative,Type 2 Diabetes| edema | rosiglitazone,weight ,	CARDIOVASCULAR,IMMUNE,INFECTION,METABOLIC,PHARMACOGENOMIC,REPRODUCTION,VISION,	GO:0001906~cell killing,GO:0001909~leukocyte mediated cytotoxicity,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001913~T cell mediated cytotoxicity,GO:0001914~regulation of T cell mediated cytotoxicity,GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002228~natural killer cell mediated immunity,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002347~response to tumor cell,GO:0002418~immune response to tumor cell,GO:0002420~natural killer cell mediated cytotoxicity directed against tumor cell target,GO:0002423~natural killer cell mediated immune response to tumor cell,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002456~T cell mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002682~regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002703~regulation of leukocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002709~regulation of T cell mediated immunity,GO:0002711~positive regulation of T cell mediated immunity,GO:0002715~regulation of natural killer cell mediated immunity,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0002819~regulation of adaptive immune response,GO:0002821~positive regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002824~positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002831~regulation of response to biotic stimulus,GO:0002833~positive regulation of response to biotic stimulus,GO:0002834~regulation of response to tumor cell,GO:0002836~positive regulation of response to tumor cell,GO:0002837~regulation of immune response to tumor cell,GO:0002839~positive regulation of immune response to tumor cell,GO:0002855~regulation of natural killer cell mediated immune response to tumor cell,GO:0002857~positive regulation of natural killer cell mediated immune response to tumor cell,GO:0002858~regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,GO:0002860~positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0009607~response to biotic stimulus,GO:0022610~biological adhesion,GO:0031341~regulation of cell killing,GO:0031343~positive regulation of cell killing,GO:0031347~regulation of defense response,GO:0031349~positive regulation of defense response,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042269~regulation of natural killer cell mediated cytotoxicity,GO:0042271~susceptibility to natural killer cell mediated cytotoxicity,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0048584~positive regulation of response to stimulus,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0060370~susceptibility to T cell mediated cytotoxicity,GO:0080134~regulation of response to stress,GO:0098609~cell-cell adhesion,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,	GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0030054~cell junction,GO:0031226~intrinsic component of plasma membrane,GO:0070161~anchoring junction,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,GO:0050839~cell adhesion molecule binding,GO:0060089~molecular transducer activity,	hsa04650:Natural killer cell mediated cytotoxicity,	609148~Malaria, mild, susceptibility to,
34233_i_at	natural killer cell triggering receptor(NKTR)	Homo sapiens			GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0006464~cellular protein modification process,GO:0018193~peptidyl-amino acid modification,GO:0018208~peptidyl-proline modification,GO:0036211~protein modification process,		GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0008144~drug binding,GO:0016018~cyclosporin A binding,GO:0016853~isomerase activity,GO:0016859~cis-trans isomerase activity,GO:0033218~amide binding,GO:0042277~peptide binding,		
1112_g_at	neural cell adhesion molecule 1(NCAM1)	Homo sapiens	affective disorder,alcohol,Alcoholism,Alcoholism|Substance-Related Disorders,Alzheimer Disease,Bipolar Disorder,bipolar disorder schizophrenia,Blood Vessels,Creatinine,Myocardial Infarction,Natriuretic Peptide, Brain,nicotine dependence,Schizophrenia,several psychiatric disorders,Tobacco Use Disorder,Type 2 Diabetes| edema | rosiglitazone,	CARDIOVASCULAR,CHEMDEPENDENCY,METABOLIC,NEUROLOGICAL,PHARMACOGENOMIC,PSYCH,	GO:0000165~MAPK cascade,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0009605~response to external stimulus,GO:0010033~response to organic substance,GO:0010646~regulation of cell communication,GO:0016032~viral process,GO:0016310~phosphorylation,GO:0019058~viral life cycle,GO:0019221~cytokine-mediated signaling pathway,GO:0022008~neurogenesis,GO:0022610~biological adhesion,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030260~entry into host cell,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0034097~response to cytokine,GO:0034341~response to interferon-gamma,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0040011~locomotion,GO:0042330~taxis,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044409~entry into host,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0045087~innate immune response,GO:0046718~viral entry into host cell,GO:0048167~regulation of synaptic plasticity,GO:0048468~cell development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050790~regulation of catalytic activity,GO:0050803~regulation of synapse structure or activity,GO:0050804~modulation of synaptic transmission,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051701~interaction with host,GO:0051806~entry into cell of other organism involved in symbiotic interaction,GO:0051828~entry into other organism involved in symbiotic interaction,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0061564~axon development,GO:0065009~regulation of molecular function,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071345~cellular response to cytokine stimulus,GO:0071346~cellular response to interferon-gamma,GO:0097485~neuron projection guidance,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0031225~anchored component of membrane,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0044431~Golgi apparatus part,GO:0070062~extracellular exosome,GO:0098552~side of membrane,GO:1903561~extracellular vesicle,	GO:0001618~virus receptor activity,GO:0004872~receptor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0060089~molecular transducer activity,GO:0098772~molecular function regulator,	hsa04514:Cell adhesion molecules (CAMs),hsa05020:Prion diseases,	
32717_at	neuralized E3 ubiquitin protein ligase 1(NEURL1)	Homo sapiens	Alzheimer's disease   ,Platelet Aggregation,	HEMATOLOGICAL,NEUROLOGICAL,	GO:0000003~reproduction,GO:0000226~microtubule cytoskeleton organization,GO:0000902~cell morphogenesis,GO:0001101~response to acid chemical,GO:0001578~microtubule bundle formation,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0003006~developmental process involved in reproduction,GO:0006417~regulation of translation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006513~protein monoubiquitination,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007176~regulation of epidermal growth factor-activated receptor activity,GO:0007219~Notch signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007288~sperm axoneme assembly,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007589~body fluid secretion,GO:0007595~lactation,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008593~regulation of Notch signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010469~regulation of receptor activity,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010720~positive regulation of cell development,GO:0010927~cellular component assembly involved in morphogenesis,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010975~regulation of neuron projection development,GO:0010976~positive regulation of neuron projection development,GO:0012501~programmed cell death,GO:0014706~striated muscle tissue development,GO:0016310~phosphorylation,GO:0016358~dendrite development,GO:0016567~protein ubiquitination,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018193~peptidyl-amino acid modification,GO:0018212~peptidyl-tyrosine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019953~sexual reproduction,GO:0021700~developmental maturation,GO:0022008~neurogenesis,GO:0022412~cellular process involved in reproduction in multicellular organism,GO:0022414~reproductive process,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023057~negative regulation of signaling,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030182~neuron differentiation,GO:0030317~sperm motility,GO:0030879~mammary gland development,GO:0031175~neuron projection development,GO:0031325~positive regulation of cellular metabolic process,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032446~protein modification by small protein conjugation,GO:0032504~multicellular organism reproduction,GO:0032941~secretion by tissue,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033674~positive regulation of kinase activity,GO:0034248~regulation of cellular amide metabolic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0035082~axoneme assembly,GO:0036211~protein modification process,GO:0038127~ERBB signaling pathway,GO:0040011~locomotion,GO:0042058~regulation of epidermal growth factor receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042384~cilium assembly,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043200~response to amino acid,GO:0043549~regulation of kinase activity,GO:0043603~cellular amide metabolic process,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044089~positive regulation of cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0044702~single organism reproductive process,GO:0044703~multi-organism reproductive process,GO:0044782~cilium organization,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045746~negative regulation of Notch signaling pathway,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045937~positive regulation of phosphate metabolic process,GO:0046847~filopodium assembly,GO:0046903~secretion,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048232~male gamete generation,GO:0048468~cell development,GO:0048515~spermatid differentiation,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048609~multicellular organismal reproductive process,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048666~neuron development,GO:0048699~generation of neurons,GO:0048732~gland development,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050790~regulation of catalytic activity,GO:0050803~regulation of synapse structure or activity,GO:0050804~modulation of synaptic transmission,GO:0050807~regulation of synapse organization,GO:0050808~synapse organization,GO:0050878~regulation of body fluid levels,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051489~regulation of filopodium assembly,GO:0051491~positive regulation of filopodium assembly,GO:0051674~localization of cell,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0060074~synapse maturation,GO:0060271~cilium morphogenesis,GO:0060284~regulation of cell development,GO:0060322~head development,GO:0060491~regulation of cell projection assembly,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060996~dendritic spine development,GO:0060998~regulation of dendritic spine development,GO:0060999~positive regulation of dendritic spine development,GO:0061061~muscle structure development,GO:0061097~regulation of protein tyrosine kinase activity,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0065009~regulation of molecular function,GO:0070647~protein modification by small protein conjugation or removal,GO:0070887~cellular response to chemical stimulus,GO:0070925~organelle assembly,GO:0071229~cellular response to acid chemical,GO:0071230~cellular response to amino acid stimulus,GO:0071310~cellular response to organic substance,GO:0071417~cellular response to organonitrogen compound,GO:0071495~cellular response to endogenous stimulus,GO:0090128~regulation of synapse maturation,GO:0090129~positive regulation of synapse maturation,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:1900006~positive regulation of dendrite development,GO:1901184~regulation of ERBB signaling pathway,GO:1901186~positive regulation of ERBB signaling pathway,GO:1901698~response to nitrogen compound,GO:1901699~cellular response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1902589~single-organism organelle organization,GO:2000026~regulation of multicellular organismal development,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000273~positive regulation of receptor activity,	GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0036477~somatodendritic compartment,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0044297~cell body,GO:0044309~neuron spine,GO:0044456~synapse part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0060076~excitatory synapse,GO:0097060~synaptic membrane,GO:0097440~apical dendrite,GO:0097458~neuron part,GO:0098590~plasma membrane region,GO:0098794~postsynapse,GO:0099572~postsynaptic specialization,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019787~ubiquitin-like protein transferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0045182~translation regulator activity,GO:0045183~translation factor activity, non-nucleic acid binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0061630~ubiquitin protein ligase activity,GO:0061659~ubiquitin-like protein ligase activity,		
35090_g_at, 35091_at	neuregulin 2(NRG2)	Homo sapiens	Body Weight,glaucoma, primary open-angle,Schizophrenia,several psychiatric disorders,Stroke,Waist-Hip Ratio,	METABOLIC,NEUROLOGICAL,PSYCH,VISION,	GO:0000165~MAPK cascade,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006928~movement of cell or subcellular component,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009966~regulation of signal transduction,GO:0010646~regulation of cell communication,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018193~peptidyl-amino acid modification,GO:0018212~peptidyl-tyrosine modification,GO:0019637~organophosphate metabolic process,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0030258~lipid modification,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0038127~ERBB signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0044255~cellular lipid metabolic process,GO:0046486~glycerolipid metabolic process,GO:0046488~phosphatidylinositol metabolic process,GO:0046834~lipid phosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048017~inositol lipid-mediated signaling,GO:0050790~regulation of catalytic activity,GO:0051270~regulation of cellular component movement,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0065009~regulation of molecular function,GO:1902531~regulation of intracellular signal transduction,GO:2000145~regulation of cell motility,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0008083~growth factor activity,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0035004~phosphatidylinositol 3-kinase activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0052813~phosphatidylinositol bisphosphate kinase activity,GO:0098772~molecular function regulator,	hsa04012:ErbB signaling pathway,	
936_s_at	neuron specific gene family member 1(NSG1)	Homo sapiens			GO:0001881~receptor recycling,GO:0001919~regulation of receptor recycling,GO:0001921~positive regulation of receptor recycling,GO:0006461~protein complex assembly,GO:0007034~vacuolar transport,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,GO:0009893~positive regulation of metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0016197~endosomal transport,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0031325~positive regulation of cellular metabolic process,GO:0034622~cellular macromolecular complex assembly,GO:0043112~receptor metabolic process,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0048268~clathrin coat assembly,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0071822~protein complex subunit organization,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0016328~lateral plasma membrane,GO:0044431~Golgi apparatus part,GO:0044456~synapse part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0097060~synaptic membrane,GO:0098590~plasma membrane region,GO:0098794~postsynapse,	GO:0005102~receptor binding,GO:0030276~clathrin binding,GO:0032051~clathrin light chain binding,		
38604_at	neuropeptide Y(NPY)	Homo sapiens	alcohol,alcohol abuse,alcohol consumption,alcohol dependence,alcohol withdrawal,Alcoholism,Alcoholism|Cocaine-Related Disorders|Substance Withdrawal Syndrome,Amphetamine-Related Disorders,Apoplexy|Brain Ischemia|Stroke,Arteriosclerosis|Coronary Disease|Coronary heart disease,atherosclerosis,atherosclerosis, coronary,atherosclerosis, coronary; diabetes, type 1; nephropathy in other diseases,autism,birth weight and serum triglyceride concentration,Birth Weight|Body Weight,blood pressure, arterial cortisol glucose heart rate insulin leptin,body mass,Body Mass Index,body mass leptin obesity, localized,Body Weight,Bone Density,Bone Mineral Density,Brain Ischemia|Stroke,Bulimia,C-Reactive Protein,Cardiovascular Diseases|,Cardiovascular Diseases|Overweight|Thinness,Celiac Disease|,Cholesterol,cholesterol, HDL; triglycerides; coronary heart disease; cholesterol, LDL; cholesterol, total,cholesterol; cholesterol, HDL; lipoprotein, LDL; triglycerides; hypertension,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes|Obstetric Labor, Premature|Pre-Eclampsia|Premature Birth,Chronic renal failure|Hypertrophy, Left Ventricular|Kidney Failure, Chronic|Left Ventricular Hypertrophy,Chronic renal failure|Kidney Failure, Chronic,Depression,Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1|Diabetic Nephropathies|Diabetic Nephropathy,Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Diabetic Retinopathy,diabetes, type 2,diabetes, type 2 ghrelin insulin,diabetes, type 2; glucose tolerance,diurnal sympathoadrenal balance and pituitary hormone secretion,Edema rosiglitazone or pioglitazone,esophageal adenocarcinoma,glucose tolerance; insulin; vascular disease,Hypercholesterolemia,Hypercholesterolemia|Hyperlipidemias,Hypercholesterolemia|LDLC levels,hypertension,Insulin Resistance,lipids; blood pressure; atherosclerosis, carotid,Lymphoma, Non-Hodgkin,macular degeneration,Marijuana Abuse|Psychoses, Substance-Induced,metabolic syndrome,null,Obesity,Obesity, Morbid,Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious|Thrombophilia|Tobacco Use Disorder,Obesity|Weight Loss,Pain, Postoperative|Radius Fractures|Reflex Sympathetic Dystrophy,physical activity,progression of carotid atherosclerosis blood pressure and serum lipids,retinopathy, diabetic,Schizophrenia,schizophrenia; panic disorder; unipolar disorder,seizures, febrile,several psychiatric disorders,Stroke,Type 2 diabetes,Type 2 Diabetes| edema | rosiglitazone,	CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,IMMUNE,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0001878~response to yeast,GO:0003008~system process,GO:0003013~circulatory system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006928~movement of cell or subcellular component,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007586~digestion,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0008343~adult feeding behavior,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0009991~response to extracellular stimulus,GO:0019730~antimicrobial humoral response,GO:0019731~antibacterial humoral response,GO:0019732~antifungal humoral response,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021987~cerebral cortex development,GO:0022008~neurogenesis,GO:0030001~metal ion transport,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030534~adult behavior,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0031667~response to nutrient levels,GO:0032094~response to food,GO:0032095~regulation of response to food,GO:0032097~positive regulation of response to food,GO:0032098~regulation of appetite,GO:0032100~positive regulation of appetite,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032104~regulation of response to extracellular stimulus,GO:0032106~positive regulation of response to extracellular stimulus,GO:0032107~regulation of response to nutrient levels,GO:0032109~positive regulation of response to nutrient levels,GO:0042742~defense response to bacterium,GO:0043207~response to external biotic stimulus,GO:0044708~single-organism behavior,GO:0045087~innate immune response,GO:0048468~cell development,GO:0048584~positive regulation of response to stimulus,GO:0048666~neuron development,GO:0048699~generation of neurons,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0050832~defense response to fungus,GO:0051707~response to other organism,GO:0060322~head development,GO:0070838~divalent metal ion transport,GO:0072511~divalent inorganic cation transport,GO:0098542~defense response to other organism,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0044421~extracellular region part,	GO:0001664~G-protein coupled receptor binding,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005102~receptor binding,GO:0005179~hormone activity,GO:0005184~neuropeptide hormone activity,GO:0005246~calcium channel regulator activity,GO:0016247~channel regulator activity,GO:0038023~signaling receptor activity,GO:0060089~molecular transducer activity,GO:0098772~molecular function regulator,GO:0099600~transmembrane receptor activity,	hsa04024:cAMP signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa05034:Alcoholism,	
1355_g_at	neurotrophic receptor tyrosine kinase 2(NTRK2)	Homo sapiens	ADHD | attention-deficit hyperactivity disorder,alcohol abuse alcoholism,alcohol consumption,Alzheimer's Disease,Alzheimer's disease   ,anorexia nervosa; bulimia,autism,Bipolar Disorder,Body Height,Body Weight,Bone Mineral Density,Bulimia,C-Reactive Protein,Cholesterol, LDL,Depression,depressive disorder, major; bipolar disorder; dysthymic disorder,Echocardiography,Epilepsies, Partial,Glomerular Filtration Rate,Hip,nicotine dependence,null,obsessive-compulsive disorder,post-traumatic stress disorder suicide,response to antidepressants,Schizophrenia,several psychiatric disorders,smoking,Tobacco Use Disorder,Type 2 Diabetes| edema | rosiglitazone,Waist Circumference,Weight Gain,	CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,METABOLIC,NEUROLOGICAL,PHARMACOGENOMIC,PSYCH,RENAL,UNKNOWN,	GO:0000165~MAPK cascade,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001101~response to acid chemical,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001654~eye development,GO:0001754~eye photoreceptor cell differentiation,GO:0001764~neuron migration,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001944~vasculature development,GO:0003008~system process,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006835~dicarboxylic acid transport,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007416~synapse assembly,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007422~peripheral nervous system development,GO:0007423~sensory organ development,GO:0007528~neuromuscular junction development,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007623~circadian rhythm,GO:0007631~feeding behavior,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009887~organ morphogenesis,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010720~positive regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010770~positive regulation of cell morphogenesis involved in differentiation,GO:0010941~regulation of cell death,GO:0010975~regulation of neuron projection development,GO:0010976~positive regulation of neuron projection development,GO:0012501~programmed cell death,GO:0014047~glutamate secretion,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0015711~organic anion transport,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0018105~peptidyl-serine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018193~peptidyl-amino acid modification,GO:0018209~peptidyl-serine modification,GO:0018212~peptidyl-tyrosine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019722~calcium-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021987~cerebral cortex development,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022604~regulation of cell morphogenesis,GO:0022607~cellular component assembly,GO:0023014~signal transduction by protein phosphorylation,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0031325~positive regulation of cellular metabolic process,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032940~secretion by cell,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0036211~protein modification process,GO:0038179~neurotrophin signaling pathway,GO:0040011~locomotion,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042461~photoreceptor cell development,GO:0042462~eye photoreceptor cell development,GO:0042490~mechanoreceptor differentiation,GO:0042981~regulation of apoptotic process,GO:0043010~camera-type eye development,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043087~regulation of GTPase activity,GO:0043200~response to amino acid,GO:0043276~anoikis,GO:0043408~regulation of MAPK cascade,GO:0043410~positive regulation of MAPK cascade,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044089~positive regulation of cellular component biogenesis,GO:0044708~single-organism behavior,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045937~positive regulation of phosphate metabolic process,GO:0046530~photoreceptor cell differentiation,GO:0046548~retinal rod cell development,GO:0046777~protein autophosphorylation,GO:0046903~secretion,GO:0046942~carboxylic acid transport,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048017~inositol lipid-mediated signaling,GO:0048167~regulation of synaptic plasticity,GO:0048468~cell development,GO:0048511~rhythmic process,GO:0048514~blood vessel morphogenesis,GO:0048584~positive regulation of response to stimulus,GO:0048592~eye morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048709~oligodendrocyte differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0048934~peripheral nervous system neuron differentiation,GO:0048935~peripheral nervous system neuron development,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050772~positive regulation of axonogenesis,GO:0050790~regulation of catalytic activity,GO:0050803~regulation of synapse structure or activity,GO:0050804~modulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050807~regulation of synapse organization,GO:0050808~synapse organization,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051094~positive regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051402~neuron apoptotic process,GO:0051674~localization of cell,GO:0051896~regulation of protein kinase B signaling,GO:0051960~regulation of nervous system development,GO:0051962~positive regulation of nervous system development,GO:0051963~regulation of synapse assembly,GO:0051965~positive regulation of synapse assembly,GO:0060041~retina development in camera-type eye,GO:0060284~regulation of cell development,GO:0060291~long-term synaptic potentiation,GO:0060322~head development,GO:0060548~negative regulation of cell death,GO:0061564~axon development,GO:0065009~regulation of molecular function,GO:0070848~response to growth factor,GO:0070887~cellular response to chemical stimulus,GO:0070997~neuron death,GO:0071229~cellular response to acid chemical,GO:0071230~cellular response to amino acid stimulus,GO:0071310~cellular response to organic substance,GO:0071363~cellular response to growth factor stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071495~cellular response to endogenous stimulus,GO:0072358~cardiovascular system development,GO:0072359~circulatory system development,GO:0090596~sensory organ morphogenesis,GO:0098916~anterograde trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099537~trans-synaptic signaling,GO:1901214~regulation of neuron death,GO:1901215~negative regulation of neuron death,GO:1901698~response to nitrogen compound,GO:1901699~cellular response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:2000026~regulation of multicellular organismal development,GO:2000209~regulation of anoikis,GO:2000811~negative regulation of anoikis,	GO:0005768~endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0030424~axon,GO:0031226~intrinsic component of plasma membrane,GO:0033267~axon part,GO:0043005~neuron projection,GO:0043195~terminal bouton,GO:0043235~receptor complex,GO:0043679~axon terminus,GO:0044306~neuron projection terminus,GO:0044437~vacuolar part,GO:0044440~endosomal part,GO:0044456~synapse part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0060076~excitatory synapse,GO:0097060~synaptic membrane,GO:0097458~neuron part,GO:0098590~plasma membrane region,GO:0098793~presynapse,GO:0098794~postsynapse,GO:0099572~postsynaptic specialization,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005030~neurotrophin receptor activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0017076~purine nucleotide binding,GO:0019199~transmembrane receptor protein kinase activity,GO:0019838~growth factor binding,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0038023~signaling receptor activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043121~neurotrophin binding,GO:0046983~protein dimerization activity,GO:0048403~brain-derived neurotrophic factor binding,GO:0060089~molecular transducer activity,GO:0060175~brain-derived neurotrophic factor-activated receptor activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:0099600~transmembrane receptor activity,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa04010:MAPK signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05034:Alcoholism,	613886~Obesity, hyperphagia, and developmental delay,
1419_g_at	nitric oxide synthase 2(NOS2)	Homo sapiens	achalasia,Adenocarcinoma|Barrett Esophagus|Esophageal Neoplasms|Esophagitis, Peptic,Adenocarcinoma|Helicobacter Infections|Stomach Neoplasms,Aging/ Telomere Length,Albuminuria|Inflammation|Kidney Diseases,alcohol,alcohol abuse; smoking behavior,Alzheimer's disease   ,Alzheimer's disease; dementia,Arthritis,Arthritis, Psoriatic|Psoriasis|Psoriatic arthropathy,Arthritis, Rheumatoid,Arthritis, Rheumatoid|,Arthritis, Rheumatoid|Myocardial Ischemia,Asthma,asthma atopy,asthma; atopy,Asthma|Bronchial Hyperreactivity,Asthma|Bronchial Hyperreactivity|Hypersensitivity, Immediate,Asthma|Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,atherosclerosis, coronary,Atopy,autism,Behcet's disease,beta-thalassemia,Birth Weight|Leukemia|Leukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma,Bladder Cancer,brain hemorrhage,Brain Infarction,Brain Ischemia|Hypertension|Osteoporosis|Stroke,Brain Ischemia|Inflammation|Stroke,Brain Ischemia|Stroke,Brain Neoplasms|Occupational Diseases,Breast Cancer,Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Brucellosis,Cerebral Palsy|,cervical cancer,cervical intraepithelial neoplasia grade 3,Chagas Disease,Chlamydia Infections|Inflammation|Trachoma,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes,Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes|Obstetric Labor, Premature|Pre-Eclampsia|Premature Birth,chronic obstructive pulmonary disease,Chronic renal failure|Kidney Failure, Chronic,Chronic ulcerative colitis|Colitis, Ulcerative|Crohn Disease|Crohn's disease|Inflammatory bowel disease, NOS|Inflammatory Bowel Diseases,cirrhosis,Cluster Headache,cognitive trait,Colorectal Cancer,Coronary Artery Disease,Coronary Artery Disease|Inflammation,Coronary Disease|Coronary heart disease,Crohn's disease ulcerative colitis,Cystic Fibrosis,dementia,diabetes, type 1,diabetes, type 2,diabetes, type 2; liver disease,diabetic neuropathy,Diabetic Retinopathy,epithelial ovarian cancer ,Erythema Nodosum|Sarcoidosis,Esophageal Achalasia|,esophageal adenocarcinoma,Essential Hypertension,giant cell arteritis,glaucoma,Graft vs Host Disease|Hematologic Neoplasms|Neoplasm Recurrence, Local,Guillain-Barre syndrome,H. pylori infection stomach cancer,Heart Failure|Myocardial ischemia,Heart Rate,Helicobacter Infections|Inflammation|Precancerous Conditions|Stomach Neoplasms,hepatitis C, chronic,Hepatopulmonary Syndrome|Liver Cirrhosis,HIV,hypertension,hypertension sclerosis, systemic,increased nitric oxide production and protection from malaria,Infection,Inflammation|Venous Thromboembolism,Kawasaki disease,Leukemia, Lymphocytic, Chronic, B-Cell,Leukocyte Count,Lung Cancer,lung cancer ,lupus erythematosus,lymphoma lymphoma, non-Hodgkin,Lymphoma, Non-Hodgkin,macular degeneration,Maduromycosis,Malaria,Malaria infection,Malaria susceptibility,Malaria, Cerebral|Malaria, Falciparum,Malaria, Cerebral|Malaria, Falciparum|Parasitemia,Malaria, Falciparum,malaria, plasmodium falciparum,melanoma,Meningeal Neoplasms|meningioma,migraine,Migraine Disorders,Multiple Sclerosis,Multiple Sclerosis, Relapsing-Remitting,nephropathy, diabetic,nephropathy, diabetic; retinopathy, diabetic; neuropathy, diabetic; microalbuminuria, diabetic,non-Hodgkin lymphoma,normal variation,null,Osteomyelitis,Otitis Media|Recurrence,oxidative stress ,Parkinson's Disease,patent ductus arteriosus,Pneumococcal Infections,Postoperative Complications,Pre-Eclampsia,preterm delivery,priapism,prostate cancer,prostatic hyperplasia,Psoriasis,Psychiatric Disorders,purpura, Henoch-Schonlein,Recurrence|Venous Thromboembolism,respiratory syncytial virus bronchiolitis,retinopathy, diabetic,retinopathy, diabetic; nephropathy in other diseases,rheumatoid arthritis,several psychiatric disorders,silicosis tuberculosis,Spinal Dysraphism,stomach cancer,Stomach Neoplasms,suicide,systemic lupus erythematosus,Trypanosoma cruzi infection,Tuberculosis,Tuberculosis, Pulmonary,Type 2 diabetes,Type 2 Diabetes (Retinopathy),Type 2 Diabetes| edema | rosiglitazone,	AGING,CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0001666~response to hypoxia,GO:0001816~cytokine production,GO:0001817~regulation of cytokine production,GO:0001906~cell killing,GO:0001909~leukocyte mediated cytotoxicity,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0002227~innate immune response in mucosa,GO:0002237~response to molecule of bacterial origin,GO:0002251~organ or tissue specific immune response,GO:0002385~mucosal immune response,GO:0002790~peptide secretion,GO:0002791~regulation of peptide secretion,GO:0003008~system process,GO:0003013~circulatory system process,GO:0003018~vascular process in circulatory system,GO:0006082~organic acid metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006140~regulation of nucleotide metabolic process,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006182~cGMP biosynthetic process,GO:0006464~cellular protein modification process,GO:0006520~cellular amino acid metabolic process,GO:0006525~arginine metabolic process,GO:0006527~arginine catabolic process,GO:0006753~nucleoside phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006801~superoxide metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006869~lipid transport,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007263~nitric oxide mediated signal transduction,GO:0007267~cell-cell signaling,GO:0007623~circadian rhythm,GO:0008015~blood circulation,GO:0008104~protein localization,GO:0008217~regulation of blood pressure,GO:0009057~macromolecule catabolic process,GO:0009063~cellular amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0009117~nucleotide metabolic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009187~cyclic nucleotide metabolic process,GO:0009190~cyclic nucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0009306~protein secretion,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0009628~response to abiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0009914~hormone transport,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010817~regulation of hormone levels,GO:0010876~lipid localization,GO:0015031~protein transport,GO:0015711~organic anion transport,GO:0015718~monocarboxylic acid transport,GO:0015732~prostaglandin transport,GO:0015833~peptide transport,GO:0015908~fatty acid transport,GO:0016054~organic acid catabolic process,GO:0017014~protein nitrosylation,GO:0018119~peptidyl-cysteine S-nitrosylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018198~peptidyl-cysteine modification,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019637~organophosphate metabolic process,GO:0019693~ribose phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0019752~carboxylic acid metabolic process,GO:0019932~second-messenger-mediated signaling,GO:0023051~regulation of signaling,GO:0023061~signal release,GO:0030072~peptide hormone secretion,GO:0030163~protein catabolic process,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030801~positive regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030804~positive regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030810~positive regulation of nucleotide biosynthetic process,GO:0030823~regulation of cGMP metabolic process,GO:0030825~positive regulation of cGMP metabolic process,GO:0030826~regulation of cGMP biosynthetic process,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0031282~regulation of guanylate cyclase activity,GO:0031284~positive regulation of guanylate cyclase activity,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031341~regulation of cell killing,GO:0031343~positive regulation of cell killing,GO:0031347~regulation of defense response,GO:0031640~killing of cells of other organism,GO:0032101~regulation of response to external stimulus,GO:0032309~icosanoid secretion,GO:0032310~prostaglandin secretion,GO:0032496~response to lipopolysaccharide,GO:0032635~interleukin-6 production,GO:0032637~interleukin-8 production,GO:0032880~regulation of protein localization,GO:0032940~secretion by cell,GO:0033036~macromolecule localization,GO:0033993~response to lipid,GO:0034097~response to cytokine,GO:0034341~response to interferon-gamma,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035150~regulation of tube size,GO:0035556~intracellular signal transduction,GO:0035690~cellular response to drug,GO:0035821~modification of morphology or physiology of other organism,GO:0036211~protein modification process,GO:0036293~response to decreased oxygen levels,GO:0042127~regulation of cell proliferation,GO:0042176~regulation of protein catabolic process,GO:0042177~negative regulation of protein catabolic process,GO:0042311~vasodilation,GO:0042312~regulation of vasodilation,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042742~defense response to bacterium,GO:0042886~amide transport,GO:0043085~positive regulation of catalytic activity,GO:0043207~response to external biotic stimulus,GO:0043436~oxoacid metabolic process,GO:0043457~regulation of cellular respiration,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043900~regulation of multi-organism process,GO:0043902~positive regulation of multi-organism process,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0044248~cellular catabolic process,GO:0044282~small molecule catabolic process,GO:0044364~disruption of cells of other organism,GO:0044712~single-organism catabolic process,GO:0045087~innate immune response,GO:0045184~establishment of protein localization,GO:0045454~cell redox homeostasis,GO:0045776~negative regulation of blood pressure,GO:0045909~positive regulation of vasodilation,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045981~positive regulation of nucleotide metabolic process,GO:0046068~cGMP metabolic process,GO:0046209~nitric oxide metabolic process,GO:0046390~ribose phosphate biosynthetic process,GO:0046395~carboxylic acid catabolic process,GO:0046879~hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046903~secretion,GO:0046942~carboxylic acid transport,GO:0048511~rhythmic process,GO:0050663~cytokine secretion,GO:0050708~regulation of protein secretion,GO:0050727~regulation of inflammatory response,GO:0050790~regulation of catalytic activity,GO:0050796~regulation of insulin secretion,GO:0050829~defense response to Gram-negative bacterium,GO:0050880~regulation of blood vessel size,GO:0051046~regulation of secretion,GO:0051049~regulation of transport,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051223~regulation of protein transport,GO:0051240~positive regulation of multicellular organismal process,GO:0051246~regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051339~regulation of lyase activity,GO:0051349~positive regulation of lyase activity,GO:0051707~response to other organism,GO:0051709~regulation of killing of cells of other organism,GO:0051712~positive regulation of killing of cells of other organism,GO:0052652~cyclic purine nucleotide metabolic process,GO:0055086~nucleobase-containing small molecule metabolic process,GO:0055114~oxidation-reduction process,GO:0065009~regulation of molecular function,GO:0070201~regulation of establishment of protein localization,GO:0070482~response to oxygen levels,GO:0070887~cellular response to chemical stimulus,GO:0071216~cellular response to biotic stimulus,GO:0071219~cellular response to molecule of bacterial origin,GO:0071222~cellular response to lipopolysaccharide,GO:0071310~cellular response to organic substance,GO:0071345~cellular response to cytokine stimulus,GO:0071346~cellular response to interferon-gamma,GO:0071396~cellular response to lipid,GO:0071705~nitrogen compound transport,GO:0071715~icosanoid transport,GO:0072521~purine-containing compound metabolic process,GO:0072522~purine-containing compound biosynthetic process,GO:0072593~reactive oxygen species metabolic process,GO:0072604~interleukin-6 secretion,GO:0072606~interleukin-8 secretion,GO:0080134~regulation of response to stress,GO:0090066~regulation of anatomical structure size,GO:0090087~regulation of peptide transport,GO:0090276~regulation of peptide hormone secretion,GO:0090407~organophosphate biosynthetic process,GO:0098542~defense response to other organism,GO:1900015~regulation of cytokine production involved in inflammatory response,GO:1900371~regulation of purine nucleotide biosynthetic process,GO:1900373~positive regulation of purine nucleotide biosynthetic process,GO:1900542~regulation of purine nucleotide metabolic process,GO:1900544~positive regulation of purine nucleotide metabolic process,GO:1901135~carbohydrate derivative metabolic process,GO:1901137~carbohydrate derivative biosynthetic process,GO:1901293~nucleoside phosphate biosynthetic process,GO:1901565~organonitrogen compound catabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:1901605~alpha-amino acid metabolic process,GO:1901606~alpha-amino acid catabolic process,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1903409~reactive oxygen species biosynthetic process,GO:1903522~regulation of blood circulation,GO:1903524~positive regulation of blood circulation,GO:1903530~regulation of secretion by cell,GO:2001057~reactive nitrogen species metabolic process,	GO:0005777~peroxisome,GO:0005829~cytosol,GO:0005938~cell cortex,GO:0030863~cortical cytoskeleton,GO:0042579~microbody,GO:0044448~cell cortex part,GO:0048471~perinuclear region of cytoplasm,GO:0099568~cytoplasmic region,	GO:0000166~nucleotide binding,GO:0004497~monooxygenase activity,GO:0004517~nitric-oxide synthase activity,GO:0005102~receptor binding,GO:0005516~calmodulin binding,GO:0010181~FMN binding,GO:0016597~amino acid binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0031406~carboxylic acid binding,GO:0032553~ribonucleotide binding,GO:0034617~tetrahydrobiopterin binding,GO:0034618~arginine binding,GO:0036094~small molecule binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046983~protein dimerization activity,GO:0048037~cofactor binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,GO:0050662~coenzyme binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa00220:Arginine biosynthesis,hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04146:Peroxisome,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	145500~Hypertension, susceptibility to,611162~Malaria, resistance to,
34720_at	nuclear factor I B(NFIB)	Homo sapiens	Body Weight,Lipoproteins,macular degeneration,Sodium,Stroke,Type 2 Diabetes| edema | rosiglitazone,	METABOLIC,NEUROLOGICAL,PHARMACOGENOMIC,VISION,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001501~skeletal system development,GO:0002062~chondrocyte differentiation,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007431~salivary gland development,GO:0007435~salivary gland morphogenesis,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009605~response to external stimulus,GO:0009887~organ morphogenesis,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0010001~glial cell differentiation,GO:0010463~mesenchymal cell proliferation,GO:0010464~regulation of mesenchymal cell proliferation,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0021537~telencephalon development,GO:0021730~trigeminal sensory nucleus development,GO:0021740~principal sensory nucleus of trigeminal nerve development,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021955~central nervous system neuron axonogenesis,GO:0021960~anterior commissure morphogenesis,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022612~gland morphogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030855~epithelial cell differentiation,GO:0030900~forebrain development,GO:0030902~hindbrain development,GO:0031175~neuron projection development,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035148~tube formation,GO:0035239~tube morphogenesis,GO:0035272~exocrine system development,GO:0035295~tube development,GO:0040011~locomotion,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042330~taxis,GO:0043392~negative regulation of DNA binding,GO:0044092~negative regulation of molecular function,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048468~cell development,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0048732~gland development,GO:0048812~neuron projection morphogenesis,GO:0048857~neural nucleus development,GO:0048858~cell projection morphogenesis,GO:0050673~epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051093~negative regulation of developmental process,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051101~regulation of DNA binding,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051241~negative regulation of multicellular organismal process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060322~head development,GO:0060425~lung morphogenesis,GO:0060428~lung epithelium development,GO:0060429~epithelium development,GO:0060479~lung cell differentiation,GO:0060486~Clara cell differentiation,GO:0060487~lung epithelial cell differentiation,GO:0060502~epithelial cell proliferation involved in lung morphogenesis,GO:0060509~Type I pneumocyte differentiation,GO:0060510~Type II pneumocyte differentiation,GO:0060541~respiratory system development,GO:0060605~tube lumen cavitation,GO:0060662~salivary gland cavitation,GO:0060689~cell differentiation involved in salivary gland development,GO:0060916~mesenchymal cell proliferation involved in lung development,GO:0061140~lung secretory cell differentiation,GO:0061141~lung ciliated cell differentiation,GO:0061448~connective tissue development,GO:0061564~axon development,GO:0061614~pri-miRNA transcription from RNA polymerase II promoter,GO:0065009~regulation of molecular function,GO:0071679~commissural neuron axon guidance,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0097485~neuron projection guidance,GO:0097659~nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902893~regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:2000026~regulation of multicellular organismal development,GO:2000027~regulation of organ morphogenesis,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000790~regulation of mesenchymal cell proliferation involved in lung development,GO:2000791~negative regulation of mesenchymal cell proliferation involved in lung development,GO:2000794~regulation of epithelial cell proliferation involved in lung morphogenesis,GO:2000795~negative regulation of epithelial cell proliferation involved in lung morphogenesis,GO:2001141~regulation of RNA biosynthetic process,	GO:0005730~nucleolus,GO:0030424~axon,GO:0043005~neuron projection,GO:0044300~cerebellar mossy fiber,GO:0097458~neuron part,	GO:0000975~regulatory region DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000988~transcription factor activity, protein binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001067~regulatory region nucleic acid binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0001159~core promoter proximal region DNA binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,GO:1990837~sequence-specific double-stranded DNA binding,		
40271_at	nucleoporin 93(NUP93)	Homo sapiens	Body Mass Index,Body Weight,HDL cholesterol,	METABOLIC,	GO:0000278~mitotic cell cycle,GO:0000302~response to reactive oxygen species,GO:0001655~urogenital system development,GO:0001667~ameboidal-type cell migration,GO:0001822~kidney development,GO:0002064~epithelial cell development,GO:0006403~RNA localization,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0006461~protein complex assembly,GO:0006464~cellular protein modification process,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006928~movement of cell or subcellular component,GO:0006979~response to oxidative stress,GO:0006997~nucleus organization,GO:0006998~nuclear envelope organization,GO:0006999~nuclear pore organization,GO:0007049~cell cycle,GO:0007077~mitotic nuclear envelope disassembly,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007184~SMAD protein import into nucleus,GO:0008104~protein localization,GO:0008219~cell death,GO:0009892~negative regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010035~response to inorganic substance,GO:0010256~endomembrane system organization,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010631~epithelial cell migration,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010827~regulation of glucose transport,GO:0010941~regulation of cell death,GO:0015031~protein transport,GO:0015931~nucleobase-containing compound transport,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016458~gene silencing,GO:0016477~cell migration,GO:0016925~protein sumoylation,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0017038~protein import,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018205~peptidyl-lysine modification,GO:0019058~viral life cycle,GO:0019080~viral gene expression,GO:0019083~viral transcription,GO:0019438~aromatic compound biosynthetic process,GO:0022402~cell cycle process,GO:0022411~cellular component disassembly,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030397~membrane disassembly,GO:0030855~epithelial cell differentiation,GO:0031047~gene silencing by RNA,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032446~protein modification by small protein conjugation,GO:0032774~RNA biosynthetic process,GO:0032835~glomerulus development,GO:0032880~regulation of protein localization,GO:0033036~macromolecule localization,GO:0033157~regulation of intracellular protein transport,GO:0033365~protein localization to organelle,GO:0033554~cellular response to stress,GO:0034504~protein localization to nucleus,GO:0034599~cellular response to oxidative stress,GO:0034613~cellular protein localization,GO:0034614~cellular response to reactive oxygen species,GO:0034622~cellular macromolecular complex assembly,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035850~epithelial cell differentiation involved in kidney development,GO:0036211~protein modification process,GO:0036473~cell death in response to oxidative stress,GO:0036474~cell death in response to hydrogen peroxide,GO:0040011~locomotion,GO:0042306~regulation of protein import into nucleus,GO:0042307~positive regulation of protein import into nucleus,GO:0042542~response to hydrogen peroxide,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044033~multi-organism metabolic process,GO:0044085~cellular component biogenesis,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044744~protein targeting to nucleus,GO:0044764~multi-organism cellular process,GO:0044766~multi-organism transport,GO:0044802~single-organism membrane organization,GO:0045184~establishment of protein localization,GO:0046794~transport of virus,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0046907~intracellular transport,GO:0046931~pore complex assembly,GO:0048468~cell development,GO:0048584~positive regulation of response to stimulus,GO:0048585~negative regulation of response to stimulus,GO:0048870~cell motility,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051031~tRNA transport,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051081~nuclear envelope disassembly,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051236~establishment of RNA localization,GO:0051292~nuclear pore complex assembly,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0051674~localization of cell,GO:0060341~regulation of cellular localization,GO:0060390~regulation of SMAD protein import into nucleus,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0060395~SMAD protein signal transduction,GO:0060429~epithelium development,GO:0060548~negative regulation of cell death,GO:0061005~cell differentiation involved in kidney development,GO:0061024~membrane organization,GO:0061318~renal filtration cell differentiation,GO:0065003~macromolecular complex assembly,GO:0070201~regulation of establishment of protein localization,GO:0070271~protein complex biogenesis,GO:0070301~cellular response to hydrogen peroxide,GO:0070647~protein modification by small protein conjugation or removal,GO:0070727~cellular macromolecule localization,GO:0070887~cellular response to chemical stimulus,GO:0071166~ribonucleoprotein complex localization,GO:0071426~ribonucleoprotein complex export from nucleus,GO:0071427~mRNA-containing ribonucleoprotein complex export from nucleus,GO:0071431~tRNA-containing ribonucleoprotein complex export from nucleus,GO:0071705~nitrogen compound transport,GO:0071822~protein complex subunit organization,GO:0072001~renal system development,GO:0072006~nephron development,GO:0072009~nephron epithelium development,GO:0072010~glomerular epithelium development,GO:0072015~glomerular visceral epithelial cell development,GO:0072073~kidney epithelium development,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0072310~glomerular epithelial cell development,GO:0072311~glomerular epithelial cell differentiation,GO:0072594~establishment of protein localization to organelle,GO:0075733~intracellular transport of virus,GO:0080134~regulation of response to stress,GO:0080135~regulation of cellular response to stress,GO:0090092~regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090100~positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090130~tissue migration,GO:0090132~epithelium migration,GO:0090316~positive regulation of intracellular protein transport,GO:0090521~glomerular visceral epithelial cell migration,GO:1900034~regulation of cellular response to heat,GO:1900180~regulation of protein localization to nucleus,GO:1900182~positive regulation of protein localization to nucleus,GO:1900407~regulation of cellular response to oxidative stress,GO:1900408~negative regulation of cellular response to oxidative stress,GO:1901031~regulation of response to reactive oxygen species,GO:1901032~negative regulation of response to reactive oxygen species,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1902579~multi-organism localization,GO:1902580~single-organism cellular localization,GO:1902581~multi-organism cellular localization,GO:1902582~single-organism intracellular transport,GO:1902583~multi-organism intracellular transport,GO:1902593~single-organism nuclear import,GO:1902882~regulation of response to oxidative stress,GO:1902883~negative regulation of response to oxidative stress,GO:1903047~mitotic cell cycle process,GO:1903201~regulation of oxidative stress-induced cell death,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:1903205~regulation of hydrogen peroxide-induced cell death,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,GO:1903533~regulation of protein targeting,GO:1903827~regulation of cellular protein localization,GO:1903829~positive regulation of cellular protein localization,GO:1904589~regulation of protein import,GO:1904591~positive regulation of protein import,GO:1904951~positive regulation of establishment of protein localization,	GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0034399~nuclear periphery,	GO:0005198~structural molecule activity,GO:0017056~structural constituent of nuclear pore,	hsa03013:RNA transport,	
32418_at	phosphodiesterase 1C(PDE1C)	Homo sapiens	Apolipoproteins B,Arteries,Celiac Disease|,Erythrocytes,Glucose,Lipoproteins, VLDL,smoking,Tobacco Use Disorder,Triglycerides,Tunica Media,	CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,IMMUNE,METABOLIC,	GO:0003008~system process,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,	GO:0005829~cytosol,GO:0005929~cilium,	GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004117~calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,GO:0005516~calmodulin binding,GO:0008081~phosphoric diester hydrolase activity,GO:0042578~phosphoric ester hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,	hsa00230:Purine metabolism,hsa04020:Calcium signaling pathway,hsa04740:Olfactory transduction,hsa04924:Renin secretion,hsa05032:Morphine addiction,	
35373_at	phosphoinositide-3-kinase regulatory subunit 1(PIK3R1)	Homo sapiens	alcohol,Alzheimer's Disease,Arteries,BMI- Edema rosiglitazone or pioglitazone,Body Mass Index,Body Weight,Cholesterol,Colonic Neoplasms,diabetes, type 2,diabetes, type 2; hypertension,HIV,Hypercholesterolemia|LDLC levels,Insulin Resistance|Obesity,Insulin Resistance|Polycystic Ovary Syndrome,kidney failure, chronic,longevity,Neoplasms,Pancreatic Neoplasms,periodontitis,plasma HDL cholesterol (HDL-C) levels,polycystic ovary syndrome,prostate cancer,Tobacco Use Disorder,Tunica Media,Type 2 Diabetes| edema | rosiglitazone,	AGING,CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,PHARMACOGENOMIC,RENAL,REPRODUCTION,	GO:0001678~cellular glucose homeostasis,GO:0001775~cell activation,GO:0001816~cytokine production,GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002433~immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0002682~regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002757~immune response-activating signal transduction,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002764~immune response-regulating signaling pathway,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006661~phosphatidylinositol biosynthetic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006955~immune response,GO:0006974~cellular response to DNA damage stimulus,GO:0006986~response to unfolded protein,GO:0007009~plasma membrane organization,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008104~protein localization,GO:0008219~cell death,GO:0008286~insulin receptor signaling pathway,GO:0008380~RNA splicing,GO:0008610~lipid biosynthetic process,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008643~carbohydrate transport,GO:0008645~hexose transport,GO:0008654~phospholipid biosynthetic process,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone,GO:0009891~positive regulation of biosynthetic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010243~response to organonitrogen compound,GO:0010256~endomembrane system organization,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010810~regulation of cell-substrate adhesion,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010827~regulation of glucose transport,GO:0010828~positive regulation of glucose transport,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0015031~protein transport,GO:0015749~monosaccharide transport,GO:0015758~glucose transport,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0017038~protein import,GO:0018130~heterocycle biosynthetic process,GO:0019216~regulation of lipid metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019637~organophosphate metabolic process,GO:0019725~cellular homeostasis,GO:0022407~regulation of cell-cell adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022607~cellular component assembly,GO:0022610~biological adhesion,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030099~myeloid cell differentiation,GO:0030155~regulation of cell adhesion,GO:0030168~platelet activation,GO:0030183~B cell differentiation,GO:0030258~lipid modification,GO:0030316~osteoclast differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031294~lymphocyte costimulation,GO:0031295~T cell costimulation,GO:0031325~positive regulation of cellular metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031589~cell-substrate adhesion,GO:0031647~regulation of protein stability,GO:0032231~regulation of actin filament bundle assembly,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032640~tumor necrosis factor production,GO:0032680~regulation of tumor necrosis factor production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032774~RNA biosynthetic process,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032880~regulation of protein localization,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033036~macromolecule localization,GO:0033043~regulation of organelle organization,GO:0033120~positive regulation of RNA splicing,GO:0033157~regulation of intracellular protein transport,GO:0033365~protein localization to organelle,GO:0033500~carbohydrate homeostasis,GO:0033554~cellular response to stress,GO:0034504~protein localization to nucleus,GO:0034613~cellular protein localization,GO:0034620~cellular response to unfolded protein,GO:0034644~cellular response to UV,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034976~response to endoplasmic reticulum stress,GO:0035556~intracellular signal transduction,GO:0035966~response to topologically incorrect protein,GO:0035967~cellular response to topologically incorrect protein,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036211~protein modification process,GO:0038093~Fc receptor signaling pathway,GO:0038094~Fc-gamma receptor signaling pathway,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038127~ERBB signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042060~wound healing,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042306~regulation of protein import into nucleus,GO:0042307~positive regulation of protein import into nucleus,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0042981~regulation of apoptotic process,GO:0042990~regulation of transcription factor import into nucleus,GO:0042991~transcription factor import into nucleus,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043434~response to peptide hormone,GO:0043484~regulation of RNA splicing,GO:0043549~regulation of kinase activity,GO:0043550~regulation of lipid kinase activity,GO:0043551~regulation of phosphatidylinositol 3-kinase activity,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044255~cellular lipid metabolic process,GO:0044381~glucose import in response to insulin stimulus,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044744~protein targeting to nucleus,GO:0044764~multi-organism cellular process,GO:0044802~single-organism membrane organization,GO:0045017~glycerolipid biosynthetic process,GO:0045184~establishment of protein localization,GO:0045321~leukocyte activation,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045785~positive regulation of cell adhesion,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046323~glucose import,GO:0046324~regulation of glucose import,GO:0046326~positive regulation of glucose import,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046488~phosphatidylinositol metabolic process,GO:0046649~lymphocyte activation,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0046834~lipid phosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0046907~intracellular transport,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048017~inositol lipid-mediated signaling,GO:0048534~hematopoietic or lymphoid organ development,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050776~regulation of immune response,GO:0050778~positive regulation of immune response,GO:0050790~regulation of catalytic activity,GO:0050817~coagulation,GO:0050821~protein stabilization,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050870~positive regulation of T cell activation,GO:0050878~regulation of body fluid levels,GO:0050900~leukocyte migration,GO:0051017~actin filament bundle assembly,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051093~negative regulation of developmental process,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051270~regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0051338~regulation of transferase activity,GO:0051492~regulation of stress fiber assembly,GO:0051493~regulation of cytoskeleton organization,GO:0051531~NFAT protein import into nucleus,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0051674~localization of cell,GO:0055082~cellular chemical homeostasis,GO:0060341~regulation of cellular localization,GO:0060396~growth hormone receptor signaling pathway,GO:0060416~response to growth hormone,GO:0060548~negative regulation of cell death,GO:0061024~membrane organization,GO:0061572~actin filament bundle organization,GO:0065009~regulation of molecular function,GO:0070201~regulation of establishment of protein localization,GO:0070486~leukocyte aggregation,GO:0070489~T cell aggregation,GO:0070727~cellular macromolecule localization,GO:0070887~cellular response to chemical stimulus,GO:0071214~cellular response to abiotic stimulus,GO:0071310~cellular response to organic substance,GO:0071375~cellular response to peptide hormone stimulus,GO:0071378~cellular response to growth hormone stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071478~cellular response to radiation,GO:0071482~cellular response to light stimulus,GO:0071495~cellular response to endogenous stimulus,GO:0071593~lymphocyte aggregation,GO:0071706~tumor necrosis factor superfamily cytokine production,GO:0072594~establishment of protein localization to organelle,GO:0072657~protein localization to membrane,GO:0072659~protein localization to plasma membrane,GO:0080134~regulation of response to stress,GO:0080135~regulation of cellular response to stress,GO:0090002~establishment of protein localization to plasma membrane,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090150~establishment of protein localization to membrane,GO:0090316~positive regulation of intracellular protein transport,GO:0090407~organophosphate biosynthetic process,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097659~nucleic acid-templated transcription,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:1900076~regulation of cellular response to insulin stimulus,GO:1900078~positive regulation of cellular response to insulin stimulus,GO:1900101~regulation of endoplasmic reticulum unfolded protein response,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1900180~regulation of protein localization to nucleus,GO:1900182~positive regulation of protein localization to nucleus,GO:1901652~response to peptide,GO:1901653~cellular response to peptide,GO:1901698~response to nitrogen compound,GO:1901699~cellular response to nitrogen compound,GO:1901700~response to oxygen-containing compound,GO:1901701~cellular response to oxygen-containing compound,GO:1902105~regulation of leukocyte differentiation,GO:1902106~negative regulation of leukocyte differentiation,GO:1902531~regulation of intracellular signal transduction,GO:1902580~single-organism cellular localization,GO:1902582~single-organism intracellular transport,GO:1902589~single-organism organelle organization,GO:1902593~single-organism nuclear import,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903076~regulation of protein localization to plasma membrane,GO:1903078~positive regulation of protein localization to plasma membrane,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903533~regulation of protein targeting,GO:1903555~regulation of tumor necrosis factor superfamily cytokine production,GO:1903557~positive regulation of tumor necrosis factor superfamily cytokine production,GO:1903706~regulation of hemopoiesis,GO:1903707~negative regulation of hemopoiesis,GO:1903725~regulation of phospholipid metabolic process,GO:1903729~regulation of plasma membrane organization,GO:1903827~regulation of cellular protein localization,GO:1903829~positive regulation of cellular protein localization,GO:1904375~regulation of protein localization to cell periphery,GO:1904377~positive regulation of protein localization to cell periphery,GO:1904589~regulation of protein import,GO:1904591~positive regulation of protein import,GO:1904951~positive regulation of establishment of protein localization,GO:1990778~protein localization to cell periphery,GO:2000026~regulation of multicellular organismal development,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000145~regulation of cell motility,GO:2000147~positive regulation of cell motility,GO:2001141~regulation of RNA biosynthetic process,GO:2001273~regulation of glucose import in response to insulin stimulus,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005783~endoplasmic reticulum,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0044432~endoplasmic reticulum part,GO:0048471~perinuclear region of cytoplasm,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0097038~perinuclear endoplasmic reticulum,GO:0097651~phosphatidylinositol 3-kinase complex, class I,GO:1990578~perinuclear endoplasmic reticulum membrane,	GO:0004871~signal transducer activity,GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005102~receptor binding,GO:0005126~cytokine receptor binding,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005165~neurotrophin receptor binding,GO:0005167~neurotrophin TRK receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0017046~peptide hormone binding,GO:0019207~kinase regulator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030234~enzyme regulator activity,GO:0030674~protein binding, bridging,GO:0030971~receptor tyrosine kinase binding,GO:0032403~protein complex binding,GO:0033218~amide binding,GO:0035004~phosphatidylinositol 3-kinase activity,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0035591~signaling adaptor activity,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0043125~ErbB-3 class receptor binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,GO:0044877~macromolecular complex binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0052742~phosphatidylinositol kinase activity,GO:0052813~phosphatidylinositol bisphosphate kinase activity,GO:0060090~binding, bridging,GO:0098772~molecular function regulator,GO:1990782~protein tyrosine kinase binding,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	269880~SHORT syndrome,615214~Agammaglobulinemia 7, autosomal recessive,616005~Immunodeficiency 36,
40959_at	pleckstrin homology and RhoGEF domain containing G3(PLEKHG3)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0009966~regulation of signal transduction,GO:0010646~regulation of cell communication,GO:0023051~regulation of signaling,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0046578~regulation of Ras protein signal transduction,GO:0050790~regulation of catalytic activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0065009~regulation of molecular function,GO:1902531~regulation of intracellular signal transduction,		GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0098772~molecular function regulator,		
35956_s_at	pregnancy specific beta-1-glycoprotein 4(PSG4)	Homo sapiens			GO:0000003~reproduction,GO:0007565~female pregnancy,GO:0022414~reproductive process,GO:0044703~multi-organism reproductive process,GO:0044706~multi-multicellular organism process,	GO:0005576~extracellular region,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,			
38948_at	protein phosphatase 1 regulatory subunit 3D(PPP1R3D)	Homo sapiens			GO:0000271~polysaccharide biosynthetic process,GO:0005975~carbohydrate metabolic process,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005981~regulation of glycogen catabolic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006109~regulation of carbohydrate metabolic process,GO:0006112~energy reserve metabolic process,GO:0006464~cellular protein modification process,GO:0006470~protein dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0009250~glucan biosynthetic process,GO:0009894~regulation of catabolic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010906~regulation of glucose metabolic process,GO:0010962~regulation of glucan biosynthetic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016051~carbohydrate biosynthetic process,GO:0016052~carbohydrate catabolic process,GO:0016311~dephosphorylation,GO:0019318~hexose metabolic process,GO:0031329~regulation of cellular catabolic process,GO:0032881~regulation of polysaccharide metabolic process,GO:0032885~regulation of polysaccharide biosynthetic process,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0036211~protein modification process,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043470~regulation of carbohydrate catabolic process,GO:0043471~regulation of cellular carbohydrate catabolic process,GO:0044042~glucan metabolic process,GO:0044248~cellular catabolic process,GO:0044262~cellular carbohydrate metabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0044723~single-organism carbohydrate metabolic process,GO:0055114~oxidation-reduction process,GO:0070873~regulation of glycogen metabolic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,	GO:0042587~glycogen granule,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0019899~enzyme binding,GO:0042578~phosphoric ester hydrolase activity,	hsa04910:Insulin signaling pathway,hsa04931:Insulin resistance,	
38646_s_at	regenerating family member 1 alpha(REG1A)	Homo sapiens	Calcinosis|Pancreatitis,diabetes, type 1,diabetes, type 2,Tobacco Use Disorder,	CHEMDEPENDENCY,IMMUNE,UNKNOWN,	GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0042127~regulation of cell proliferation,	GO:0005576~extracellular region,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005102~receptor binding,GO:0008083~growth factor activity,GO:0030246~carbohydrate binding,		
36766_at	ribonuclease A family member 2(RNASE2)	Homo sapiens	Dermatitis, Atopic,normmal variation,tropical pulmonary eosinophilia,	IMMUNE,NORMALVARIATION,UNKNOWN,	GO:0006401~RNA catabolic process,GO:0006605~protein targeting,GO:0006626~protein targeting to mitochondrion,GO:0006839~mitochondrial transport,GO:0006886~intracellular protein transport,GO:0006935~chemotaxis,GO:0007005~mitochondrion organization,GO:0008104~protein localization,GO:0009057~macromolecule catabolic process,GO:0009605~response to external stimulus,GO:0010638~positive regulation of organelle organization,GO:0010821~regulation of mitochondrion organization,GO:0010822~positive regulation of mitochondrion organization,GO:0015031~protein transport,GO:0016070~RNA metabolic process,GO:0019439~aromatic compound catabolic process,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032880~regulation of protein localization,GO:0033036~macromolecule localization,GO:0033043~regulation of organelle organization,GO:0033157~regulation of intracellular protein transport,GO:0033365~protein localization to organelle,GO:0034613~cellular protein localization,GO:0034655~nucleobase-containing compound catabolic process,GO:0040011~locomotion,GO:0042330~taxis,GO:0044248~cellular catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0045184~establishment of protein localization,GO:0046700~heterocycle catabolic process,GO:0046907~intracellular transport,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0060341~regulation of cellular localization,GO:0070201~regulation of establishment of protein localization,GO:0070585~protein localization to mitochondrion,GO:0070727~cellular macromolecule localization,GO:0072594~establishment of protein localization to organelle,GO:0072655~establishment of protein localization to mitochondrion,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:0090316~positive regulation of intracellular protein transport,GO:0090501~RNA phosphodiester bond hydrolysis,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,GO:1901361~organic cyclic compound catabolic process,GO:1903214~regulation of protein targeting to mitochondrion,GO:1903533~regulation of protein targeting,GO:1903747~regulation of establishment of protein localization to mitochondrion,GO:1903749~positive regulation of establishment of protein localization to mitochondrion,GO:1903827~regulation of cellular protein localization,GO:1903829~positive regulation of cellular protein localization,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:1904951~positive regulation of establishment of protein localization,	GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005773~vacuole,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0003676~nucleic acid binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0004522~ribonuclease A activity,GO:0004540~ribonuclease activity,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0016894~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
33979_at	ribonuclease A family member 3(RNASE3)	Homo sapiens	allergic rhinitis,Asthma,Carcinoma, Squamous Cell|Embolism|Eosinophilia|Mouth Neoplasms|Neoplasm Invasiveness|Neoplasm Recurrence, Local|Squamous cell carcinoma,Dermatitis, Atopic,schistosomiasis,tropical pulmonary eosinophilia,	CANCER,IMMUNE,INFECTION,UNKNOWN,	GO:0002227~innate immune response in mucosa,GO:0002251~organ or tissue specific immune response,GO:0002385~mucosal immune response,GO:0006401~RNA catabolic process,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0009057~macromolecule catabolic process,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009617~response to bacterium,GO:0016070~RNA metabolic process,GO:0019439~aromatic compound catabolic process,GO:0019730~antimicrobial humoral response,GO:0019731~antibacterial humoral response,GO:0034655~nucleobase-containing compound catabolic process,GO:0042742~defense response to bacterium,GO:0043207~response to external biotic stimulus,GO:0044248~cellular catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0045087~innate immune response,GO:0046700~heterocycle catabolic process,GO:0050830~defense response to Gram-positive bacterium,GO:0051707~response to other organism,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:0090501~RNA phosphodiester bond hydrolysis,GO:0098542~defense response to other organism,GO:1901361~organic cyclic compound catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0003676~nucleic acid binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004540~ribonuclease activity,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,	hsa05310:Asthma,	
32413_at	ribosomal protein S14(RPS14)	Homo sapiens	Acquired Immunodeficiency Syndrome|Disease Progression,Diamond-Blackfan anemia,	HEMATOLOGICAL,INFECTION,	GO:0000028~ribosomal small subunit assembly,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0002262~myeloid cell homeostasis,GO:0002520~immune system development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006364~rRNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006518~peptide metabolic process,GO:0006605~protein targeting,GO:0006612~protein targeting to membrane,GO:0006613~cotranslational protein targeting to membrane,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0009057~macromolecule catabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0015031~protein transport,GO:0016032~viral process,GO:0016070~RNA metabolic process,GO:0016071~mRNA metabolic process,GO:0016072~rRNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019058~viral life cycle,GO:0019080~viral gene expression,GO:0019083~viral transcription,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019439~aromatic compound catabolic process,GO:0022607~cellular component assembly,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030490~maturation of SSU-rRNA,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032774~RNA biosynthetic process,GO:0033036~macromolecule localization,GO:0033365~protein localization to organelle,GO:0034101~erythrocyte homeostasis,GO:0034248~regulation of cellular amide metabolic process,GO:0034470~ncRNA processing,GO:0034613~cellular protein localization,GO:0034622~cellular macromolecular complex assembly,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034655~nucleobase-containing compound catabolic process,GO:0034660~ncRNA metabolic process,GO:0042254~ribosome biogenesis,GO:0042255~ribosome assembly,GO:0042274~ribosomal small subunit biogenesis,GO:0042592~homeostatic process,GO:0043043~peptide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043604~amide biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0044033~multi-organism metabolic process,GO:0044085~cellular component biogenesis,GO:0044248~cellular catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0044802~single-organism membrane organization,GO:0045047~protein targeting to ER,GO:0045184~establishment of protein localization,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0046700~heterocycle catabolic process,GO:0046907~intracellular transport,GO:0048534~hematopoietic or lymphoid organ development,GO:0048872~homeostasis of number of cells,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0061024~membrane organization,GO:0065003~macromolecular complex assembly,GO:0070727~cellular macromolecule localization,GO:0070925~organelle assembly,GO:0070972~protein localization to endoplasmic reticulum,GO:0071826~ribonucleoprotein complex subunit organization,GO:0072594~establishment of protein localization to organelle,GO:0072599~establishment of protein localization to endoplasmic reticulum,GO:0072657~protein localization to membrane,GO:0090150~establishment of protein localization to membrane,GO:0097659~nucleic acid-templated transcription,GO:1901361~organic cyclic compound catabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:1902580~single-organism cellular localization,GO:1902582~single-organism intracellular transport,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0022627~cytosolic small ribosomal subunit,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044391~ribosomal subunit,GO:0044421~extracellular region part,GO:0044445~cytosolic part,GO:0070062~extracellular exosome,GO:0070161~anchoring junction,GO:1903561~extracellular vesicle,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:0048027~mRNA 5'-UTR binding,GO:0070181~small ribosomal subunit rRNA binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,	hsa03010:Ribosome,	153550~Macrocytic anemia, refractory, due to 5q deletion, somatic,
39187_at	runt related transcription factor 2(RUNX2)	Homo sapiens	Alzheimer's disease   ,Bone Density,Bone Diseases|Osteoporosis,Bone Mineral Density,Bone Size,Cleft Lip|Cleft Palate,Cleft Lip|Cleft Palate|,Cleidocranial Dysplasia,Diabetes Mellitus, Type 2,Fibrinogen,height,Hip,Insulin,null,Occipital Lobe,Ossification of Posterior Longitudinal Ligament|Ossification, Heterotopic,Osteoporosis,Osteoporosis, Postmenopausal,Schizophrenia,Tobacco Use Disorder,	AGING,CHEMDEPENDENCY,DEVELOPMENTAL,HEMATOLOGICAL,METABOLIC,NEUROLOGICAL,PSYCH,UNKNOWN,	GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001775~cell activation,GO:0001958~endochondral ossification,GO:0002051~osteoblast fate commitment,GO:0002062~chondrocyte differentiation,GO:0002063~chondrocyte development,GO:0002076~osteoblast development,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009790~embryo development,GO:0009792~embryo development ending in birth or egg hatching,GO:0009887~organ morphogenesis,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0016070~RNA metabolic process,GO:0016337~single organismal cell-cell adhesion,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0021700~developmental maturation,GO:0022008~neurogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022610~biological adhesion,GO:0023051~regulation of signaling,GO:0023057~negative regulation of signaling,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030182~neuron differentiation,GO:0030217~T cell differentiation,GO:0030278~regulation of ossification,GO:0030326~embryonic limb morphogenesis,GO:0030509~BMP signaling pathway,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032330~regulation of chondrocyte differentiation,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0036075~replacement ossification,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042476~odontogenesis,GO:0042481~regulation of odontogenesis,GO:0042487~regulation of odontogenesis of dentin-containing tooth,GO:0043009~chordate embryonic development,GO:0045165~cell fate commitment,GO:0045321~leukocyte activation,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046649~lymphocyte activation,GO:0048468~cell development,GO:0048469~cell maturation,GO:0048534~hematopoietic or lymphoid organ development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048585~negative regulation of response to stimulus,GO:0048598~embryonic morphogenesis,GO:0048699~generation of neurons,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048736~appendage development,GO:0048863~stem cell differentiation,GO:0051094~positive regulation of developmental process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051240~positive regulation of multicellular organismal process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060173~limb development,GO:0060348~bone development,GO:0060349~bone morphogenesis,GO:0060350~endochondral bone morphogenesis,GO:0061035~regulation of cartilage development,GO:0061036~positive regulation of cartilage development,GO:0061448~connective tissue development,GO:0070486~leukocyte aggregation,GO:0070489~T cell aggregation,GO:0070848~response to growth factor,GO:0070887~cellular response to chemical stimulus,GO:0071310~cellular response to organic substance,GO:0071363~cellular response to growth factor stimulus,GO:0071495~cellular response to endogenous stimulus,GO:0071593~lymphocyte aggregation,GO:0071772~response to BMP,GO:0071773~cellular response to BMP stimulus,GO:0090287~regulation of cellular response to growth factor stimulus,GO:0097659~nucleic acid-templated transcription,GO:0098602~single organism cell adhesion,GO:0098609~cell-cell adhesion,GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902680~positive regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1904888~cranial skeletal system development,GO:2000026~regulation of multicellular organismal development,GO:2000027~regulation of organ morphogenesis,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,	GO:0000166~nucleotide binding,GO:0000975~regulatory region DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001067~regulatory region nucleic acid binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0017076~purine nucleotide binding,GO:0019904~protein domain specific binding,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044877~macromolecular complex binding,GO:0070491~repressing transcription factor binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,GO:1990837~sequence-specific double-stranded DNA binding,	hsa05202:Transcriptional misregulation in cancer,	119600~Cleidocranial dysplasia,119600~Cleidocranial dysplasia, forme fruste, dental anomalies only,119600~Cleidocranial dysplasia, forme fruste, with brachydactyly,156510~Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly,
36328_at	sex hormone binding globulin(SHBG)	Homo sapiens	Abortion, Habitual|Infertility, Female,aging,attention deficit disorder conduct disorder oppositional defiant disorder,autism,Bladder Cancer,bone density dihydrotestosterone estradiol sex hormone binding globulin testosterone,Bone Mineral Density,Breast Cancer,breast cancer   ,breast cancer|prostate cancer,chronic obstructive pulmonary disease,Chronic renal failure|Kidney Failure, Chronic,Coronary Artery Disease,diabetes, type 2,endometrial cancer,Endometrial Neoplasms,epithelial ovarian cancer ,estradiol; sex hormone binding globulin,Hepatopulmonary Syndrome|Liver Cirrhosis,hormone disturbance,human spermatogenic defect,Hyperandrogenism|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Puberty, Precocious,infertility,infertility, male,Insulin Resistance|Polycystic Ovary Syndrome,Lung Cancer,lung cancer ,Lymphoma, Non-Hodgkin,mamographic density,Menarche,normal variation,Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious|Thrombophilia|Tobacco Use Disorder,Oligospermia,Osteoporosis, Postmenopausal,ovarian cancer,Ovarian Failure, Premature|POF - Premature ovarian failure,overall effect,polycystic ovarian syndrome; hyperinsulinemia,POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome,polycystic ovary syndrome,prostate cancer,protein quantitative trait loci,several psychiatric disorders,sex homone-binding globulin,sex hormones,sex steroid hormone blood levels,sex steroid hormone-binding globulin,Stomach Neoplasms,systemic lupus erythematosus ,Testosterone,testosterone; androgen; phytoestrogen,	AGING,CANCER,CARDIOVASCULAR,IMMUNE,METABOLIC,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,		GO:0005576~extracellular region,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005496~steroid binding,GO:0005497~androgen binding,GO:0008289~lipid binding,GO:0042562~hormone binding,GO:0097159~organic cyclic compound binding,		
37097_at	solute carrier family 17 member 1(SLC17A1)	Homo sapiens	Alzheimer's disease   ,Blood Cells,Erythrocyte Indices,Gout,Iron,Iron-Regulatory Proteins,null,Peripheral Vascular Diseases,Schizophrenia,serum markers of iron status,serum uric acid,Transferrin,Uric Acid,	CARDIOVASCULAR,HEMATOLOGICAL,METABOLIC,NEUROLOGICAL,PSYCH,RENAL,UNKNOWN,	GO:0006082~organic acid metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006817~phosphate ion transport,GO:0006820~anion transport,GO:0015672~monovalent inorganic cation transport,GO:0015698~inorganic anion transport,GO:0030001~metal ion transport,GO:0034220~ion transmembrane transport,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0044341~sodium-dependent phosphate transport,GO:0046415~urate metabolic process,GO:0055085~transmembrane transport,GO:0098655~cation transmembrane transport,GO:0098656~anion transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098661~inorganic anion transmembrane transport,GO:0098662~inorganic cation transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0031226~intrinsic component of plasma membrane,	GO:0005436~sodium:phosphate symporter activity,GO:0008324~cation transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015296~anion:cation symporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,GO:0022804~active transmembrane transporter activity,GO:0022853~active ion transmembrane transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,		
34436_at	solute carrier family 17 member 3(SLC17A3)	Homo sapiens	Abortion, Spontaneous,atherogenic uric acid concentrations,Gout,Gout|Hyperuricemia,mean corpuscular hemoglobin,Schizophrenia,serum urate,Tobacco Use Disorder,Uric Acid,	CHEMDEPENDENCY,HEMATOLOGICAL,METABOLIC,PSYCH,RENAL,REPRODUCTION,	GO:0006082~organic acid metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006817~phosphate ion transport,GO:0006820~anion transport,GO:0006855~drug transmembrane transport,GO:0015672~monovalent inorganic cation transport,GO:0015698~inorganic anion transport,GO:0015711~organic anion transport,GO:0015712~hexose phosphate transport,GO:0015747~urate transport,GO:0015748~organophosphate ester transport,GO:0015760~glucose-6-phosphate transport,GO:0015849~organic acid transport,GO:0015893~drug transport,GO:0030001~metal ion transport,GO:0034220~ion transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042493~response to drug,GO:0043269~regulation of ion transport,GO:0044070~regulation of anion transport,GO:0044341~sodium-dependent phosphate transport,GO:0046415~urate metabolic process,GO:0051049~regulation of transport,GO:0055085~transmembrane transport,GO:0098655~cation transmembrane transport,GO:0098656~anion transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098661~inorganic anion transmembrane transport,GO:0098662~inorganic cation transmembrane transport,GO:1901264~carbohydrate derivative transport,GO:1901998~toxin transport,GO:1903825~organic acid transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0005903~brush border,GO:0016324~apical plasma membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0044432~endoplasmic reticulum part,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0098590~plasma membrane region,GO:0098862~cluster of actin-based cell projections,	GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005253~anion channel activity,GO:0005342~organic acid transmembrane transporter activity,GO:0005436~sodium:phosphate symporter activity,GO:0008308~voltage-gated anion channel activity,GO:0008324~cation transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0008514~organic anion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0015143~urate transmembrane transporter activity,GO:0015238~drug transmembrane transporter activity,GO:0015267~channel activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015296~anion:cation symporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,GO:0015562~efflux transmembrane transporter activity,GO:0019534~toxin transporter activity,GO:0022803~passive transmembrane transporter activity,GO:0022804~active transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate-specific channel activity,GO:0022853~active ion transmembrane transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,GO:0090484~drug transporter activity,GO:1901702~salt transmembrane transporter activity,		612671~Gout susceptibility 4,612671~Uric acid concentration, serum, QTL4,
32084_at	solute carrier family 22 member 5(SLC22A5)	Homo sapiens	Asthma,Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Cardiomyopathies,Cholangitis, Sclerosing,Cholangitis, Sclerosing|Crohn Disease|Liver Cirrhosis, Biliary,Chronic renal failure|Kidney Failure, Chronic,Chronic ulcerative colitis|Colitis, Ulcerative|Crohn Disease|Crohn's disease|Inflammatory bowel disease, NOS|Inflammatory Bowel Diseases,Colitis, Ulcerative|Crohn Disease,Colitis, Ulcerative|Crohn Disease|,Colorectal Cancer,Crohn Disease,Crohn Disease|,Crohn Disease|Crohn's disease,Crohn Disease|Crohn's disease|Growth Disorders,Crohn's disease,Crohn's disease inflammatory bowel disease ulcerative colitis,Crohn's disease ulcerative colitis,Crohn's disease; ulcerative colitis,Crohn's disease; ulcerative colitis; inflammatory bowel disease,diabetes, type 1,Disorder of muscle, unspec|Lipidoses|Lipoidosis|Multiple Acyl Coenzyme A Dehydrogenase Deficiency|Muscular Diseases,drug-related genes ,Fibrinogen,Hypertension|Pre-Eclampsia|Pregnancy Complications,inflammatory bowel disease ,Inflammatory Bowel Diseases,left ventricular hypertrophy,normal variation,null,perianal disease,Psoriasis,psoriasis; arthritis, psoriatic; arthritis, inflammatory,rheumatoid arthritis,Tobacco Use Disorder,Tuberculosis,Type 2 Diabetes| edema | rosiglitazone,ulcerative colitis,	CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NORMALVARIATION,OTHER,PHARMACOGENOMIC,RENAL,UNKNOWN,	GO:0001894~tissue homeostasis,GO:0003008~system process,GO:0006577~amino-acid betaine metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006855~drug transmembrane transport,GO:0007586~digestion,GO:0009372~quorum sensing,GO:0009437~carnitine metabolic process,GO:0010669~epithelial structure maintenance,GO:0015672~monovalent inorganic cation transport,GO:0015695~organic cation transport,GO:0015697~quaternary ammonium group transport,GO:0015838~amino-acid betaine transport,GO:0015879~carnitine transport,GO:0015893~drug transport,GO:0022600~digestive system process,GO:0030001~metal ion transport,GO:0030277~maintenance of gastrointestinal epithelium,GO:0032844~regulation of homeostatic process,GO:0032846~positive regulation of homeostatic process,GO:0034220~ion transmembrane transport,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0044057~regulation of system process,GO:0044058~regulation of digestive system process,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0048871~multicellular organismal homeostasis,GO:0048872~homeostasis of number of cells,GO:0048874~homeostasis of number of cells in a free-living population,GO:0051240~positive regulation of multicellular organismal process,GO:0051701~interaction with host,GO:0052097~interspecies quorum sensing,GO:0052106~quorum sensing involved in interaction with host,GO:0055085~transmembrane transport,GO:0060249~anatomical structure homeostasis,GO:0060456~positive regulation of digestive system process,GO:0060729~intestinal epithelial structure maintenance,GO:0060730~regulation of intestinal epithelial structure maintenance,GO:0060731~positive regulation of intestinal epithelial structure maintenance,GO:0070715~sodium-dependent organic cation transport,GO:0071705~nitrogen compound transport,GO:0098655~cation transmembrane transport,GO:1902603~carnitine transmembrane transport,	GO:0005576~extracellular region,GO:0005887~integral component of plasma membrane,GO:0005903~brush border,GO:0016324~apical plasma membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,GO:0098590~plasma membrane region,GO:0098862~cluster of actin-based cell projections,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008324~cation transmembrane transporter activity,GO:0015101~organic cation transmembrane transporter activity,GO:0015199~amino-acid betaine transmembrane transporter activity,GO:0015226~carnitine transmembrane transporter activity,GO:0015238~drug transmembrane transporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015293~symporter activity,GO:0015297~antiporter activity,GO:0015298~solute:cation antiporter activity,GO:0015491~cation:cation antiporter activity,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0017076~purine nucleotide binding,GO:0019904~protein domain specific binding,GO:0022804~active transmembrane transporter activity,GO:0030165~PDZ domain binding,GO:0030554~adenyl nucleotide binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0072349~modified amino acid transmembrane transporter activity,GO:0090484~drug transporter activity,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:0099516~ion antiporter activity,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,	hsa05231:Choline metabolism in cancer,	212140~Carnitine deficiency, systemic primary,
35121_at	solute carrier family 6 member 6(SLC6A6)	Homo sapiens	Alcoholism,Basophils,Glucose,Hyperparathyroidism, Secondary,Psychomotor Performance,	CHEMDEPENDENCY,IMMUNE,METABOLIC,NEUROLOGICAL,	GO:0003333~amino acid transmembrane transport,GO:0006082~organic acid metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015711~organic anion transport,GO:0015734~taurine transport,GO:0015849~organic acid transport,GO:0019752~carboxylic acid metabolic process,GO:0043436~oxoacid metabolic process,GO:0046942~carboxylic acid transport,GO:0055085~transmembrane transport,GO:0071705~nitrogen compound transport,GO:0072348~sulfur compound transport,GO:1903825~organic acid transmembrane transport,GO:1905039~carboxylic acid transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0031226~intrinsic component of plasma membrane,	GO:0005326~neurotransmitter transporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0005342~organic acid transmembrane transporter activity,GO:0005343~organic acid:sodium symporter activity,GO:0005368~taurine transmembrane transporter activity,GO:0005369~taurine:sodium symporter activity,GO:0008324~cation transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015370~solute:sodium symporter activity,GO:0022804~active transmembrane transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,GO:0046943~carboxylic acid transmembrane transporter activity,GO:1901682~sulfur compound transmembrane transporter activity,		
35439_at	splicing factor 1(SF1)	Homo sapiens	Gout,	METABOLIC,	GO:0000003~reproduction,GO:0000245~spliceosomal complex assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000389~mRNA 3'-splice site recognition,GO:0000398~mRNA splicing, via spliceosome,GO:0003006~developmental process involved in reproduction,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006376~mRNA splice site selection,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006629~lipid metabolic process,GO:0007530~sex determination,GO:0007548~sex differentiation,GO:0008202~steroid metabolic process,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0008610~lipid biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016070~RNA metabolic process,GO:0016071~mRNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0022414~reproductive process,GO:0022607~cellular component assembly,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0030238~male sex determination,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0033002~muscle cell proliferation,GO:0033327~Leydig cell differentiation,GO:0034622~cellular macromolecular complex assembly,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044702~single organism reproductive process,GO:0045137~development of primary sexual characteristics,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0046890~regulation of lipid biosynthetic process,GO:0048608~reproductive structure development,GO:0048659~smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050810~regulation of steroid biosynthetic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0061458~reproductive system development,GO:0065003~macromolecular complex assembly,GO:0071826~ribonucleoprotein complex subunit organization,GO:0097659~nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005840~ribosome,GO:0030529~intracellular ribonucleoprotein complex,GO:1990904~ribonucleoprotein complex,	GO:0000988~transcription factor activity, protein binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0003676~nucleic acid binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0036002~pre-mRNA binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0044822~poly(A) RNA binding,GO:0045131~pre-mRNA branch point binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
38691_s_at	surfactant protein C(SFTPC)	Homo sapiens	asthma respiratory syncytial virus,Asthma|Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,Bronchiolitis, Viral|Respiratory Syncytial Virus Infections,bronchopulmonary dysplasia,bronchopulmonary dysplasia; respiratory distress syndrome, neonatal,fibrosing lung disease,Interstitial lung disease,interstitial pneumonias pulmonary fibrosis,Lung disease,Lung Diseases,null,Pulmonary Disease, Chronic Obstructive|Pulmonary Emphysema,Pulmonary Fibrosis,Resp distress syndrome neonatal|Respiratory Distress Syndrome, Newborn,respiratory syncytial virus bronchiolitis,	CARDIOVASCULAR,IMMUNE,INFECTION,OTHER,UNKNOWN,	GO:0007585~respiratory gaseous exchange,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005768~endosome,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005773~vacuole,GO:0005775~vacuolar lumen,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030139~endocytic vesicle,GO:0030141~secretory granule,GO:0031904~endosome lumen,GO:0031906~late endosome lumen,GO:0031988~membrane-bounded vesicle,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0042599~lamellar body,GO:0044421~extracellular region part,GO:0044432~endoplasmic reticulum part,GO:0044437~vacuolar part,GO:0044440~endosomal part,GO:0045334~clathrin-coated endocytic vesicle,GO:0097486~multivesicular body lumen,GO:0099503~secretory vesicle,	GO:0042802~identical protein binding,		610913~Surfactant metabolism dysfunction, pulmonary, 2,
38508_s_at	tenascin XA (pseudogene)(TNXA)	Homo sapiens	smoking behavior,	CHEMDEPENDENCY,	GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0043062~extracellular structure organization,GO:0043933~macromolecular complex subunit organization,GO:0071822~protein complex subunit organization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,			
39198_s_at	trafficking protein particle complex 12(TRAPPC12)	Homo sapiens	Tobacco Use Disorder,	CHEMDEPENDENCY,	GO:0000070~mitotic sister chromatid segregation,GO:0000075~cell cycle checkpoint,GO:0000278~mitotic cell cycle,GO:0000280~nuclear division,GO:0000819~sister chromatid segregation,GO:0006461~protein complex assembly,GO:0006508~proteolysis,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007088~regulation of mitotic nuclear division,GO:0007091~metaphase/anaphase transition of mitotic cell cycle,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0007346~regulation of mitotic cell cycle,GO:0010564~regulation of cell cycle process,GO:0010638~positive regulation of organelle organization,GO:0010639~negative regulation of organelle organization,GO:0010948~negative regulation of cell cycle process,GO:0010965~regulation of mitotic sister chromatid separation,GO:0016192~vesicle-mediated transport,GO:0022402~cell cycle process,GO:0022607~cellular component assembly,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0031577~spindle checkpoint,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0033045~regulation of sister chromatid segregation,GO:0033046~negative regulation of sister chromatid segregation,GO:0033047~regulation of mitotic sister chromatid segregation,GO:0033048~negative regulation of mitotic sister chromatid segregation,GO:0034508~centromere complex assembly,GO:0034622~cellular macromolecular complex assembly,GO:0043254~regulation of protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044784~metaphase/anaphase transition of cell cycle,GO:0045786~negative regulation of cell cycle,GO:0045787~positive regulation of cell cycle,GO:0045839~negative regulation of mitotic nuclear division,GO:0045840~positive regulation of mitotic nuclear division,GO:0045841~negative regulation of mitotic metaphase/anaphase transition,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0045930~negative regulation of mitotic cell cycle,GO:0045931~positive regulation of mitotic cell cycle,GO:0048285~organelle fission,GO:0050000~chromosome localization,GO:0051128~regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051276~chromosome organization,GO:0051303~establishment of chromosome localization,GO:0051304~chromosome separation,GO:0051306~mitotic sister chromatid separation,GO:0051310~metaphase plate congression,GO:0051640~organelle localization,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0051656~establishment of organelle localization,GO:0051726~regulation of cell cycle,GO:0051783~regulation of nuclear division,GO:0051784~negative regulation of nuclear division,GO:0051785~positive regulation of nuclear division,GO:0051983~regulation of chromosome segregation,GO:0051984~positive regulation of chromosome segregation,GO:0051985~negative regulation of chromosome segregation,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0070271~protein complex biogenesis,GO:0070925~organelle assembly,GO:0071173~spindle assembly checkpoint,GO:0071174~mitotic spindle checkpoint,GO:0071822~protein complex subunit organization,GO:0071824~protein-DNA complex subunit organization,GO:0090068~positive regulation of cell cycle process,GO:0090230~regulation of centromere complex assembly,GO:0090231~regulation of spindle checkpoint,GO:0090233~negative regulation of spindle checkpoint,GO:0090234~regulation of kinetochore assembly,GO:0090266~regulation of mitotic cell cycle spindle assembly checkpoint,GO:0098813~nuclear chromosome segregation,GO:1901970~positive regulation of mitotic sister chromatid separation,GO:1901976~regulation of cell cycle checkpoint,GO:1901977~negative regulation of cell cycle checkpoint,GO:1901987~regulation of cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901989~positive regulation of cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1901992~positive regulation of mitotic cell cycle phase transition,GO:1902099~regulation of metaphase/anaphase transition of cell cycle,GO:1902100~negative regulation of metaphase/anaphase transition of cell cycle,GO:1902101~positive regulation of metaphase/anaphase transition of cell cycle,GO:1902115~regulation of organelle assembly,GO:1902426~negative regulation of mitotic spindle assembly checkpoint,GO:1902589~single-organism organelle organization,GO:1903047~mitotic cell cycle process,GO:1903504~regulation of mitotic spindle checkpoint,GO:2000816~negative regulation of mitotic sister chromatid separation,GO:2001251~negative regulation of chromosome organization,GO:2001252~positive regulation of chromosome organization,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0044427~chromosomal part,GO:0098687~chromosomal region,	GO:0004175~endopeptidase activity,GO:0008233~peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,		
41489_at	transducin like enhancer of split 1(TLE1)	Homo sapiens	Colorectal Cancer,Tobacco Use Disorder,	CANCER,CHEMDEPENDENCY,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0007166~cell surface receptor signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007267~cell-cell signaling,GO:0008219~cell death,GO:0009887~organ morphogenesis,GO:0009890~negative regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010646~regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016055~Wnt signaling pathway,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0023057~negative regulation of signaling,GO:0030111~regulation of Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0031324~negative regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0035556~intracellular signal transduction,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043276~anoikis,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0048585~negative regulation of response to stimulus,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0071822~protein complex subunit organization,GO:0097659~nucleic acid-templated transcription,GO:0198738~cell-cell signaling by wnt,GO:1902531~regulation of intracellular signal transduction,GO:1902532~negative regulation of intracellular signal transduction,GO:1902679~negative regulation of RNA biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1904837~beta-catenin-TCF complex assembly,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000209~regulation of anoikis,GO:2000811~negative regulation of anoikis,GO:2001141~regulation of RNA biosynthetic process,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,	GO:0000988~transcription factor activity, protein binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,		
38816_at	transforming acidic coiled-coil containing protein 2(TACC2)	Homo sapiens	Alzheimer's disease   ,Breast Cancer,Tobacco Use Disorder,	CANCER,CHEMDEPENDENCY,NEUROLOGICAL,	GO:0000226~microtubule cytoskeleton organization,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021987~cerebral cortex development,GO:0030900~forebrain development,GO:0060322~head development,GO:1902589~single-organism organelle organization,	GO:0005730~nucleolus,GO:0005815~microtubule organizing center,GO:0015630~microtubule cytoskeleton,	GO:0005102~receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0051427~hormone receptor binding,		
37898_r_at	trefoil factor 3(TFF3)	Homo sapiens	Bladder Cancer,chronic obstructive pulmonary disease,Lung Cancer,lung cancer ,	CANCER,OTHER,	GO:0005975~carbohydrate metabolic process,GO:0006109~regulation of carbohydrate metabolic process,GO:0006952~defense response,GO:0007586~digestion,GO:0009611~response to wounding,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010906~regulation of glucose metabolic process,GO:0042060~wound healing,GO:0044262~cellular carbohydrate metabolic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0070062~extracellular exosome,GO:0099503~secretory vesicle,GO:1903561~extracellular vesicle,			
36713_at	tripartite motif containing 58(TRIM58)	Homo sapiens	Erythrocyte Indices,HIV Infections|[X]Human immunodeficiency virus disease,hypertension,	CARDIOVASCULAR,HEMATOLOGICAL,INFECTION,	GO:0006464~cellular protein modification process,GO:0016567~protein ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0036211~protein modification process,GO:0070647~protein modification by small protein conjugation or removal,		GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,		
34629_at	tumor protein p53 inducible protein 11(TP53I11)	Homo sapiens	Attention Deficit Disorder with Hyperactivity,	PSYCH,	GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,				
1974_s_at	tumor protein p53(TP53)	Homo sapiens	Abortion, Habitual,Abortion, Habitual|Recurrence,Abortion, Spontaneous,activation of the c-K-ras-2 protooncogene,Adenocarcinoma, Clear Cell|Adenocarcinoma, Mucinous|Carcinoma, Endometrioid|Cystadenocarcinoma, Serous|ovarian neoplasm|Ovarian Neoplasms,Adenocarcinoma, Follicular|Adenoma|Carcinoma, Papillary|Thyroid Diseases|thyroid neoplasm|Thyroid Neoplasms,Adenocarcinoma|Aneuploidy|Barrett Esophagus|Esophageal Neoplasms|Oesophageal neoplasm,Adenocarcinoma|Barrett Esophagus|Carcinoma, Squamous Cell|Cell Transformation, Neoplastic|Esophageal Neoplasms|Oesophageal neoplasm|Squamous cell carcinoma,Adenocarcinoma|Carcinoma, Adenosquamous|Pancreatic Neoplasms,Adenocarcinoma|Carcinoma, Non-Small-Cell Lung|Carcinoma, Squamous Cell|Lung Neoplasms,Adenocarcinoma|Carcinoma, Squamous Cell|Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Papillomavirus Infections|Squamous cell carcinoma|Uterine Cervical Neoplasms,Adenocarcinoma|Carcinoma, Squamous Cell|Cervical Neoplasm|Squamous cell carcinoma|Uterine Cervical Neoplasms,Adenocarcinoma|Carcinoma, Squamous Cell|Esophageal Neoplasms,Adenocarcinoma|Carcinoma, Squamous Cell|Esophageal Neoplasms|Oesophageal neoplasm|Squamous cell carcinoma,Adenocarcinoma|Carcinoma, Squamous Cell|Esophageal Neoplasms|Stomach Neoplasms,Adenocarcinoma|Cervical Neoplasm|Papillomavirus Infections|Uterine Cervical Neoplasms,Adenocarcinoma|Cervical Neoplasm|Uterine Cervical Neoplasms,Adenocarcinoma|Chronic ulcerative colitis|Colitis, Ulcerative|Colorectal Neoplasms,Adenocarcinoma|Colorectal Neoplasms,Adenocarcinoma|Colorectal Neoplasms|,Adenocarcinoma|Colorectal Neoplasms|Papillomavirus Infections,Adenocarcinoma|Colorectal Neoplasms|Stomach Neoplasms,Adenocarcinoma|Epstein-Barr Virus Infections|Nasopharyngeal Neoplasms,Adenocarcinoma|Gastritis, Atrophic|Helicobacter Infections|Stomach Neoplasms,Adenocarcinoma|Gastritis|Stomach Neoplasms,Adenocarcinoma|Lung Neoplasms,Adenocarcinoma|Lymphatic Metastasis|Stomach Neoplasms,Adenocarcinoma|Stomach Neoplasms,Adenocarcinoma|Uterine Cervical Neoplasms,Adenoma, Liver Cell|Hepatocellular Adenoma|Liver neoplasms,Adenomatous Polyposis Coli|Colorectal Neoplasms|Microsatellite Instability,Adenoma|Colorectal Neoplasms,Adrenal Cortex Neoplasms|Breast Neoplasms|Li-Fraumeni Syndrome,Adrenal Cortex Neoplasms|Tumors of Adrenal Cortex,adult squamous cell carcinoma,aflatoxin exposure,aggressive behavior of chondrosarcoma,albuminuria among aboriginal Australians,Alcoholism|Carcinoma, Squamous Cell|Esophageal Neoplasms|Oesophageal neoplasm|Squamous cell carcinoma,alpha-particle carcinogenesis,Alzheimer's Disease,Alzheimer's disease   ,Ameloblastoma,anaplastic astrocytoma; glioblastoma multiforme,Anus Neoplasms,areca quid chewing-associated oral squamous cell carcinomas,Arsenic Poisoning|Bladder Neoplasm|Carcinoma, Transitional Cell|Urinary Bladder Neoplasms,Arthritis, Rheumatoid|,Arthritis, Rheumatoid|Rheumatoid Arthritis,arthritis; osteoarthritis,Astrocytoma|Brain Neoplasms,Astrocytoma|Brain Neoplasms|Glioma|oligodendroglioma,Astrocytoma|Brain Neoplasms|Neoplasm Invasiveness,Astrocytoma|Brain Neoplasms|Oligodendroglioma,atherosclerosis,Autoimmune Diseases|Lymphoproliferative Disorders,Azoospermia|Infertility, Male|Oligospermia,Balkan Nephropathy,benzene haematotoxicity,betel-quid chewing,Bladder Cancer,bladder cancer leukemia lung cancer upper aerodigestive tract cancer,Bladder Neoplasm|Breast Neoplasms|Mammary Neoplasms|Urinary Bladder Neoplasms,Bladder Neoplasm|Urinary Bladder Neoplasms,Bone Neoplasms|osteosarcoma,brain cancer,Brain Infarction|Carotid Artery Diseases|Intracranial Thrombosis,Brain Injuries,Brain Neoplasms,Brain Neoplasms|Cerebellar Neoplasms|Ganglioglioma|Glioma|medulloblastoma|Neuroectodermal Tumor, Primitive|Neuroectodermal Tumors, Primitive,Brain Neoplasms|Glioblastoma,Brain Neoplasms|Glioblastoma|Oligodendroglioma,Brain Neoplasms|Glioma,Brain Neoplasms|Glioma|Meningeal Neoplasms|Meningioma,Brain Neoplasms|Glioma|meningioma|Neuroma, Acoustic|Neuromas, Acoustic,Brain Neoplasms|Meningioma|Neurilemmoma,Brain Neoplasms|Oligodendroglioma,brain tumors,Breast Cancer,breast cancer   ,breast cancer by the age of 50 years,breast cancer survival,breast carcinoma,Breast Neoplasms|,Breast Neoplasms|Carcinoma, Basal Cell|Carcinoma, Ductal, Breast,Breast Neoplasms|Carcinoma|,Breast Neoplasms|Cervical Neoplasm|Esophageal Neoplasms|Mammary Neoplasms|Oesophageal neoplasm|Uterine Cervical Neoplasms,Breast Neoplasms|Colorectal Neoplasms|Mammary Neoplasms,Breast Neoplasms|Genetic Diseases, Inborn|Lymphatic Metastasis|Mammary Neoplasms|Neoplasm Invasiveness,Breast Neoplasms|Lung Neoplasms|Mammary Neoplasms|Neoplasm of lung ,Breast Neoplasms|Mammary Neoplasms,Breast Neoplasms|Mammary Neoplasms|ovarian neoplasm|Ovarian Neoplasms,cancer predisposition and susceptibility,Carcinoma, Basal Cell|Carcinoma, Squamous Cell|DNA Damage|Skin Basal Cell Carcinoma|Skin Neoplasms|Squamous cell carcinoma,Carcinoma, Basal Cell|Carcinoma, Squamous Cell|Melanoma|Skin Neoplasms,Carcinoma, Basal Cell|Carcinoma, Squamous Cell|Skin Basal Cell Carcinoma|Skin Neoplasms|Squamous cell carcinoma,Carcinoma, Endometrioid|Endometrial Neoplasms,Carcinoma, Hepatocellular,Carcinoma, Hepatocellular|Cocarcinogenesis|Hepatitis B, Chronic|Liver Neoplasms,Carcinoma, Hepatocellular|Hepatitis B, Chronic|Hepatitis C, Chronic|Liver carcinoma|Liver Cirrhosis|Liver neoplasms,Carcinoma, Hepatocellular|Hepatitis B, Chronic|Liver Neoplasms,Carcinoma, Hepatocellular|Hepatitis B|Hepatitis C|LCC - Liver cell carcinoma|Liver neoplasms,Carcinoma, Hepatocellular|Hepatitis B|Liver Neoplasms,Carcinoma, Hepatocellular|Hepatitis C|LCC - Liver cell carcinoma|Liver Cirrhosis|Liver neoplasms,Carcinoma, Hepatocellular|LCC - Liver cell carcinoma|Liver neoplasms,Carcinoma, Hepatocellular|LCC - Liver cell carcinoma|Liver neoplasms|Neoplasm Recurrence, Local,Carcinoma, Hepatocellular|Liver carcinoma|Liver neoplasms,Carcinoma, Hepatocellular|Liver Neoplasms,Carcinoma, Non-Small-Cell Lung|Lung Neoplasms,Carcinoma, Non-Small-Cell Lung|Lung Neoplasms|Neoplasm of lung ,Carcinoma, Pancreatic Ductal|Pancreatic Neoplasms,Carcinoma, Papillary|DNA Damage|Neoplasms, Radiation-Induced|thyroid neoplasm|Thyroid Neoplasms,Carcinoma, Papillary|Lymphatic Metastasis|Neoplasms, Radiation-Induced|thyroid neoplasm|Thyroid Neoplasms,Carcinoma, Papillary|Thyroid Neoplasms,Carcinoma, Renal Cell|Kidney Neoplasms|Renal Cell Carcinoma,Carcinoma, Squamous Cell|Cell Transformation, Neoplastic|Genomic Instability|Leukoplakia, Oral|Mouth Neoplasms|Precancerous Conditions,Carcinoma, Squamous Cell|Cell Transformation, Neoplastic|Laryngeal neoplasm|Laryngeal Neoplasms|Squamous cell carcinoma,Carcinoma, Squamous Cell|Cervical dysplasia|Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Papillomavirus Infections|Squamous cell carcinoma|Tumor Virus Infections|Uterine Cervical Dysplasia|Uterine Cervical Neoplasms,Carcinoma, Squamous Cell|Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Papillomavirus Infections|Squamous cell carcinoma|Uterine Cervical Neoplasms,Carcinoma, Squamous Cell|Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Squamous cell carcinoma|Uterine Cervical Neoplasms,Carcinoma, Squamous Cell|Cervical Neoplasm|Papillomavirus Infections|Squamous cell carcinoma|Tumor Virus Infections|Uterine Cervical Neoplasms,Carcinoma, Squamous Cell|Cervical Neoplasm|Papillomavirus Infections|Squamous cell carcinoma|Uterine Cervical Neoplasms,Carcinoma, Squamous Cell|Cervical Neoplasm|Squamous cell carcinoma|Uterine Cervical Neoplasms,Carcinoma, Squamous Cell|Condylomata Acuminata|Epidermodysplasia Verruciformis|Squamous cell carcinoma|Tumor Virus Infections|Warts, Genital,Carcinoma, Squamous Cell|Conjunctival Neoplasms|HIV Infections|Squamous cell carcinoma|[X]Human immunodeficiency virus disease,Carcinoma, Squamous Cell|Esophageal Neoplasms,Carcinoma, Squamous Cell|Esophageal Neoplasms|,Carcinoma, Squamous Cell|Esophageal Neoplasms|Lymphatic Metastasis|Oesophageal neoplasm|Squamous cell carcinoma,Carcinoma, Squamous Cell|Esophageal Neoplasms|Oesophageal neoplasm|Papillomavirus Infections|Squamous cell carcinoma,Carcinoma, Squamous Cell|Esophageal Neoplasms|Oesophageal neoplasm|Squamous cell carcinoma,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Mouth Neoplasms|Papillomavirus Infections|Pharyngeal Neoplasms,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Neoplasm Metastasis|Neoplasm Recurrence, Local|Neoplasms, Second Primary|Squamous cell carcinoma,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Neoplasms, Second Primary|Squamous cell carcinoma,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Papillomavirus Infections,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Papillomavirus Infections|Squamous cell carcinoma,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Squamous cell carcinoma,Carcinoma, Squamous Cell|Head and Neck Neoplasms|Tobacco Use Disorder,Carcinoma, Squamous Cell|Hypopharyngeal Neoplasms|Squamous cell carcinoma,Carcinoma, Squamous Cell|Leukoplakia, Oral|Lichen Planus, Oral|Mouth Neoplasms|Precancerous Conditions,Carcinoma, Squamous Cell|Leukoplakia, Oral|Mouth Neoplasms|Oral Submucous Fibrosis,Carcinoma, Squamous Cell|Leukoplakia|Mouth Neoplasms|Squamous cell carcinoma,Carcinoma, Squamous Cell|Lymphatic Metastasis|Mouth Neoplasms,Carcinoma, Squamous Cell|Mouth Neoplasms|Neoplasm Metastasis|Squamous cell carcinoma,Carcinoma, Squamous Cell|Mouth Neoplasms|Neoplasm Recurrence, Local,Carcinoma, Squamous Cell|Mouth Neoplasms|Papillomavirus Infections,Carcinoma, Squamous Cell|Mouth Neoplasms|Papillomavirus Infections|Squamous cell carcinoma|Substance-Related Disorders|Tumor Virus Infections,Carcinoma, Squamous Cell|Mouth Neoplasms|Papillomavirus Infections|Squamous cell carcinoma|Tongue Neoplasms,Carcinoma, Squamous Cell|Mouth Neoplasms|Squamous cell carcinoma,Carcinoma, Squamous Cell|Oropharyngeal Neoplasms|Papillomavirus Infections|Squamous cell carcinoma|Tumor of Oropharynx,Carcinoma, Squamous Cell|Oropharyngeal Neoplasms|Squamous cell carcinoma|Tumor of Oropharynx,Carcinoma, Squamous Cell|Papillomavirus Infections|Penile Neoplasms,Carcinoma, Squamous Cell|Papillomavirus Infections|Skin Neoplasms|Squamous cell carcinoma|Tumor Virus Infections,Carcinoma, Squamous Cell|Penile Neoplasms,Carcinoma, Squamous Cell|Skin Neoplasms,Carcinoma, Squamous Cell|Skin Neoplasms|Squamous cell carcinoma,Carcinoma, Transitional Cell|Urinary Bladder Neoplasms,carcinomas of the thyroid gland,Carcinoma|Carcinoma, Squamous Cell|Nasopharyngeal Neoplasms|Squamous cell carcinoma,Carcinoma|Choroid Plexus Neoplasms|Choroid Plexus Papilloma|Papilloma, Choroid Plexus,Carcinoma|Esophageal Neoplasms|Oesophageal neoplasm|Papillomavirus Infections,Carcinoma|Gastrointestinal Neoplasms,Carcinoma|Lung Neoplasms|Neoplasm of lung ,Carcinoma|Nasopharyngeal Neoplasms,Carcinoma|Neoplasm Invasiveness|Urinary Bladder Neoplasms,Carcinoma|ovarian neoplasm|Ovarian Neoplasms,Carcinoma|Prostatic Neoplasms,cardiovascular disease,Cardiovascular Diseases|Genetic Predisposition to Disease,Cell Transformation, Neoplastic|Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Papillomavirus Infections|Tumor Virus Infections|Uterine Cervical Neoplasms,Cell Transformation, Neoplastic|Epidermodysplasia Verruciformis|Papillomavirus Infections|Skin Neoplasms,Cell Transformation, Neoplastic|Lymphatic Metastasis|Neoplasm Invasiveness|Stomach Neoplasms,Cerebellar Neoplasms|Medulloblastoma,cerebral infarct, atherothrombotic,cervical cancer,cervical cancer ovarian cancer,cervical carcinoma,Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Papillomavirus Infections|Uterine Cervical Neoplasms,Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Uterine Cervical Neoplasms,Cervical Intraepithelial Neoplasia|Papillomavirus Infections,Cervical Intraepithelial Neoplasia|Papillomavirus Infections|Uterine Cervical Neoplasms,Cervical Neoplasm|Mouth Neoplasms|Uterine Cervical Neoplasms,Cervical Neoplasm|Papillomavirus Infections|Precancerous Conditions|Uterine Cervical Neoplasms,Cervical Neoplasm|Papillomavirus Infections|Tumor Virus Infections|Uterine Cervical Neoplasms,Cervical Neoplasm|Papillomavirus Infections|Uterine Cervical Neoplasms,Cervical Neoplasm|Uterine Cervical Neoplasms,Chagas Disease|Esophageal Neoplasms,childhood B-cell non-Hodgkin's lymphoma,Cholecystitis|gallbladder neoplasm|Gallbladder Neoplasms,Choriocarcinoma|Hydatidiform Mole,Chromosomal Instability|Colonic Neoplasms,Chromosome Aberrations|Chromosome abnormality|Chronic Lymphocytic Leukemia|Leukemia, Lymphocytic, Chronic, B-Cell,Chromosome Aberrations|Chromosome abnormality|Neoplasms,Chromosome Aberrations|DNA Damage,Chromosome Aberrations|Intestinal Neoplasms|Lymphoma|Lymphoma, B-Cell, Marginal Zone,Chromosome Aberrations|Keratosis,Chromosome Aberrations|Leukemia, Lymphocytic, Chronic, B-Cell,Chromosome Aberrations|Li-Fraumeni Syndrome,Chromosome Deletion|Leukemia, Lymphocytic, Chronic, B-Cell,Chromosome Deletion|Pancreatic Neoplasms,Chronic B-Cell Leukemias|Leukemia, Lymphocytic, Chronic, B-Cell,Chronic Lymphocytic Leukemia|Leukemia, Lymphocytic, Chronic, B-Cell,chronic obstructive pulmonary disease,chronic obstructive pulmonary disease/COPD,Chronic renal failure|Kidney Failure, Chronic,Chronic ulcerative colitis|Colitis, Ulcerative,clinicopathological features,clinicopathological parameters,Cocarcinogenesis|Esophageal Neoplasms|Oesophageal neoplasm|Papillomavirus Infections|Tumor Virus Infections,Colonic Neoplasms,Colonic Neoplasms|Papillomavirus Infections,Colonic Neoplasms|Rectal Neoplasms,Colonic Neoplasms|Tumor Virus Infections,colorectal adenocarcinomas,colorectal adenomas,Colorectal Cancer,colorectal cancer; esophageal cancer; stomach cancer,colorectal cancers,colorectal carcinoma,Colorectal Neoplasms,Colorectal Neoplasms, Hereditary Nonpolyposis|Microsatellite Instability|Rectal Neoplasms,Colorectal Neoplasms|Liver neoplasms,conversion from colorectal adenoma to early carcinoma,Coronary Artery Disease|Diabetes Mellitus,Coronary Artery Disease|Graft Occlusion, Vascular,Coronary Disease|Coronary heart disease,Craniocerebral Trauma|Hypotension|Injuries, Craniocerebral|Subarachnoid Hemorrhage,Crohn Disease|Crohn's disease,Cystadenocarcinoma, Serous|Ovarian Neoplasms,Cystadenocarcinoma, Serous|ovarian neoplasm|Ovarian Neoplasms,decreased chemosensitivity,Delayed Graft Function|Inflammation,Depression,Dermatomycoses|Postoperative Complications|Precancerous Conditions|Skin Diseases, Bacterial|Skin Diseases, Viral|Skin Neoplasms,Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Type 1,Diabetes Mellitus, Type 1|Diabetic Nephropathies,Diabetes Mellitus, Type 2|Uremia,Disease Susceptibility|Stomach Neoplasms,DNA Damage|Lung Neoplasms,Down Syndrome|Ehlers-Danlos Syndrome,Duodenal Ulcer|Helicobacter Infections|Stomach Neoplasms|Stomach Ulcer,dystonia, primary torsion,endometrial cancer,Endometrial Neoplasms,Endometrial Neoplasms|ovarian neoplasm|Ovarian Neoplasms,Endometriosis,epithelial ovarian cancer ,Epstein-Barr virus,Epstein-Barr Virus Infections|Helicobacter Infections|Stomach Neoplasms,esophageal adenocarcinoma,Esophageal Cancer,esophageal cancer ,Esophageal Neoplasms|Head and Neck Neoplasms|Laryngeal Neoplasms|Mouth Neoplasms|Pharyngeal Neoplasms,Esophageal Neoplasms|Oesophageal neoplasm,fertility,gastric cancer,gastric carcinoma,Gastritis, Atrophic|Helicobacter Infections|Metaplasia|Peptic Ulcer,gastritis, chronic atrophic; stomach cancer,Gastritis|Helicobacter Infections|Stomach Neoplasms,Gastrointestinal Neoplasms,Gastrointestinal Stromal Tumors|Neoplasm Recurrence, Local,Genital Neoplasms, Female,glaucoma,Glaucoma, Open-Angle,Glaucoma, Open-Angle|Low Tension Glaucoma|Ocular Hypertension,Glioblastoma,Glioma,gliomas,Graves disease,Hashimoto Disease|Thyroiditis, Autoimmune,head and neck cancer,head and neck cancer mutagen sensitivity,Head and Neck Neoplasms,Head and Neck Neoplasms|Neoplasms, Squamous Cell,Head and neck squamous cell cancer,head and neck squamous cell carcinoma,healthy oldest-old,Helicobacter Infections|Stomach Neoplasms,hematotoxicity,Hepatitis B, Chronic,hepatitis C virus infection,Hepatitis C virus infection associated with human hepatocellular carcinoma,Hepatitis C, Chronic|Lymphoma, Non-Hodgkin,hepatocellular carcinoma,hepatocellular carcinomas,Herpes Simplex|Herpes Simplex Infections|Postoperative Complications|Roseolovirus Infections,Hodgkin Disease|Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoproliferative Disorders|Waldenstrom Macroglobulinemia,Hodgkin Disease|Neoplasms, Second Primary,HPV infection and cervical disease,human-papillomavirus-negative tumours,increased aggressiveness,increased lung cancer risk,Infertility, Female,Infertility, Female|Recurrence,Inflammation|Rectal Neoplasms,inflammatory bowel disease ,Kaposi's sarcoma,Keloid,keloid disease,Keratosis|Skin Diseases,Large-Cell Lymphomas|Lymphoma, Large B-Cell, Diffuse,Laryngeal neoplasm|Laryngeal Neoplasms,laryngeal squamous cell carcinoma,Leiomyoma|Uterine Neoplasms,leukemia,Leukemia, Lymphocytic, Chronic, B-Cell,Leukemia, Lymphocytic, Chronic|Leukemia, Lymphocytic, Chronic, B-Cell|Lung Neoplasms|Neoplasm of lung ,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Leukemia, Myeloid, Acute,Leukemia, Myeloid, Acute|Recurrence,Leukemia, Myeloid|Myeloid Leukemia,Leukemia, Myeloid|Neoplasms, Second Primary,Leukoplakia|Mouth Neoplasms,Li-Fraumeni and related syndrome,Li-Fraumeni Syndrome,Li-Fraumeni Syndrome|Neoplasm Invasiveness,Li-Fraumeni Syndrome|Neoplasms,liver cancer,longevity,longstanding ulcerative colitis,lung adenocarcinoma,Lung Cancer,lung cancer ,lung cancer; esophageal cancer,Lung Neoplasms|Neoplasm of lung ,Lupus Erythematosus, Systemic|Lupus Nephritis,Lupus Erythematosus, Systemic|Systemic lupus erythematosus,lymphoma,Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse,Lymphoma, B-Cell|Lymphoma, Non-Hodgkin,Lymphoma, Follicular,Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse,Lymphoma, Large B-Cell, Diffuse,Lymphoma, Large B-Cell, Diffuse|Lymphoma, Large-Cell, Diffuse,Lymphoma, Large B-Cell, Diffuse|Lymphoma, Large-Cell, Diffuse|Lymphoma, Non-Hodgkin|Lymphoma, Non-Hodgkin's,lymphomas of mucosa-associated lymphoid tissue.,lymphoproliferative disorders,Lynch syndrome,malignant cystosarcoma phyllodes and soft tissue sarcoma,malignant myeloid disorders,medical history histopathology and environmental exposures,Medulloblastoma|Nijmegen Breakage Syndrome,melanoma,melanoma, sporadic primary,Melanoma|Skin Neoplasms,Meningeal Neoplasms|Meningioma|Neurofibromatosis 2,mental retardation,Metaplasia|Precancerous Conditions,metastases,metastatic progression and poor survival,Microsatellite Instability|Rectal Neoplasms,Microsatellite Instability|Stomach Neoplasms,Mouth Neoplasms,Mouth Neoplasms|Precancerous Conditions,mucosa-associated lymphoid tissue lymphoma,multiple myeloma,Multiple Sclerosis,myelodysplastic syndrome,nasopharyngeal carcinoma.,nasopharyngeal carcinomas,Nasopharyngeal Neoplasms,Neoplasm Recurrence, Local|Prostatic Neoplasms,Neoplasms,Neoplasms, Basal Cell|Skin Neoplasms,Neoplasms, Prostatic|Prostatic Hyperplasia|Prostatic Intraepithelial Neoplasia|Prostatic Neoplasms,Neoplasms|Precancerous Conditions,Nerve Sheath Neoplasms|neurofibroma|[M]Nerve sheath tumor NOS,Neural Tube Defects|Spinal Dysraphism,neuropathy,non-asbestos-associated mesotheliomas.,non-small cell lung cancer,non-small cell lung carcinoma,non-small-cell lung cancer,normal variation,null,Occupational Diseases,oesophageal adenocarcinoma.,oesophageal squamous cell carcinoma,oral cancer,oral lichen planus,oral squamous carcinoma,Osteosarcoma,ovarian cancer,ovarian cancer  ,ovarian cancer peritoneal cancer,ovarian carcinoma,ovarian neoplasm|Ovarian Neoplasms,pancreas adenocarcinomas,pancreatic adenocarcinoma,pancreatic cancer,Pancreatic Neoplasms,pancreatic neoplasm|Pancreatic Neoplasms,Papillomavirus Infections,Papillomavirus Infections|Skin Neoplasms|Sunburn|Tumor Virus Infections,Pemphigus,pharmacogenetic studies,PML,Precursor Cell Lymphoblastic Leukemia-Lymphoma,pregnancy loss,progression of a prostate carcinoma,prostate cancer,prostate carcinoma,psoriasis, psoriatic arthritis, and SAPHO syndrome,psoriatic arthritis,Pterygium,Pulmonary Disease, Chronic Obstructive,radiation, ionizing, sensitivity to,Rectal Neoplasms,restenosis,rhabdomyosarcoma,ring sideroblasts,risk factors and tumor characteristics,sarcoma,Sarcoma, Kaposi,Schizophrenia,schizophrenia | bipolar disorder,Schizophrenia|lung cancer,sensitivity to TZT-1027,skin carcinomas,Skin Neoplasms,Skin Neoplasms|Sunburn,smoking,soft tissue sarcoma,soft tissue sarcomas,squamous cell carcinoma,squamous cell carcinoma of the esophagus,squamous cell carcinoma of the tongue,stomach cancer,stomach cancer; gastric ulcer; duodenal ulcer,Stomach Neoplasms,T-cell acute lymphoblastic leukemia,thryoid nodules|Thyroid Nodule,thyroid tumor progression,Tongue Neoplasms,tumor progression of BCR/ABL negative chronic myeloproliferative disorders,tumor proliferation and other prognostic indicators,tumour progression,tumours of the upper aerodigestive tract,Type 2 Diabetes| edema | rosiglitazone,ulcerative colitis,Uterine Cervical Neoplasms,uterine leiomyomas,vinyl chloride monomer-exposure,Wegener Granulomatosis,xeroderma pigmentosum,	AGING,CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,RENAL,REPRODUCTION,UNKNOWN,VISION,	GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0000733~DNA strand renaturation,GO:0001558~regulation of cell growth,GO:0001666~response to hypoxia,GO:0001836~release of cytochrome c from mitochondria,GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006476~protein deacetylation,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006611~protein export from nucleus,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006839~mitochondrial transport,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0006979~response to oxidative stress,GO:0006983~ER overload response,GO:0006984~ER-nucleus signaling pathway,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0007568~aging,GO:0007569~cell aging,GO:0007610~behavior,GO:0007622~rhythmic behavior,GO:0007623~circadian rhythm,GO:0008104~protein localization,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008637~apoptotic mitochondrial changes,GO:0009057~macromolecule catabolic process,GO:0009267~cellular response to starvation,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009605~response to external stimulus,GO:0009607~response to biotic stimulus,GO:0009628~response to abiotic stimulus,GO:0009648~photoperiodism,GO:0009649~entrainment of circadian clock,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009892~negative regulation of metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009966~regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009991~response to extracellular stimulus,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010259~multicellular organism aging,GO:0010332~response to gamma radiation,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010498~proteasomal protein catabolic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010638~positive regulation of organelle organization,GO:0010646~regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010821~regulation of mitochondrion organization,GO:0010822~positive regulation of mitochondrion organization,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010948~negative regulation of cell cycle process,GO:0012501~programmed cell death,GO:0015031~protein transport,GO:0016032~viral process,GO:0016049~cell growth,GO:0016070~RNA metabolic process,GO:0016310~phosphorylation,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016575~histone deacetylation,GO:0016925~protein sumoylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018130~heterocycle biosynthetic process,GO:0018193~peptidyl-amino acid modification,GO:0018205~peptidyl-lysine modification,GO:0018212~peptidyl-tyrosine modification,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022607~cellular component assembly,GO:0023051~regulation of signaling,GO:0023056~positive regulation of signaling,GO:0030163~protein catabolic process,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031056~regulation of histone modification,GO:0031058~positive regulation of histone modification,GO:0031063~regulation of histone deacetylation,GO:0031065~positive regulation of histone deacetylation,GO:0031324~negative regulation of cellular metabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031334~positive regulation of protein complex assembly,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031497~chromatin assembly,GO:0031570~DNA integrity checkpoint,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032446~protein modification by small protein conjugation,GO:0032459~regulation of protein oligomerization,GO:0032461~positive regulation of protein oligomerization,GO:0032774~RNA biosynthetic process,GO:0032880~regulation of protein localization,GO:0033036~macromolecule localization,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0033157~regulation of intracellular protein transport,GO:0033365~protein localization to organelle,GO:0033554~cellular response to stress,GO:0034349~glial cell apoptotic process,GO:0034599~cellular response to oxidative stress,GO:0034613~cellular protein localization,GO:0034644~cellular response to UV,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034976~response to endoplasmic reticulum stress,GO:0035556~intracellular signal transduction,GO:0035601~protein deacylation,GO:0035690~cellular response to drug,GO:0035794~positive regulation of mitochondrial membrane permeability,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0036211~protein modification process,GO:0036293~response to decreased oxygen levels,GO:0036294~cellular response to decreased oxygen levels,GO:0040007~growth,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042493~response to drug,GO:0042594~response to starvation,GO:0042752~regulation of circadian rhythm,GO:0042770~signal transduction in response to DNA damage,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042772~DNA damage response, signal transduction resulting in transcription,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043254~regulation of protein complex assembly,GO:0043523~regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043618~regulation of transcription from RNA polymerase II promoter in response to stress,GO:0043620~regulation of DNA-templated transcription in response to stress,GO:0043632~modification-dependent macromolecule catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044089~positive regulation of cellular component biogenesis,GO:0044092~negative regulation of molecular function,GO:0044248~cellular catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044419~interspecies interaction between organisms,GO:0044764~multi-organism cellular process,GO:0044770~cell cycle phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044773~mitotic DNA damage checkpoint,GO:0044774~mitotic DNA integrity checkpoint,GO:0044783~G1 DNA damage checkpoint,GO:0044802~single-organism membrane organization,GO:0044819~mitotic G1/S transition checkpoint,GO:0044843~cell cycle G1/S phase transition,GO:0045184~establishment of protein localization,GO:0045786~negative regulation of cell cycle,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045926~negative regulation of growth,GO:0045930~negative regulation of mitotic cell cycle,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046677~response to antibiotic,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0046825~regulation of protein export from nucleus,GO:0046827~positive regulation of protein export from nucleus,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046907~intracellular transport,GO:0048144~fibroblast proliferation,GO:0048145~regulation of fibroblast proliferation,GO:0048147~negative regulation of fibroblast proliferation,GO:0048511~rhythmic process,GO:0048512~circadian behavior,GO:0048584~positive regulation of response to stimulus,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050790~regulation of catalytic activity,GO:0051049~regulation of transport,GO:0051050~positive regulation of transport,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051095~regulation of helicase activity,GO:0051097~negative regulation of helicase activity,GO:0051128~regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051204~protein insertion into mitochondrial membrane,GO:0051205~protein insertion into membrane,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051246~regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051262~protein tetramerization,GO:0051276~chromosome organization,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051346~negative regulation of hydrolase activity,GO:0051348~negative regulation of transferase activity,GO:0051402~neuron apoptotic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051641~cellular localization,GO:0051649~establishment of localization in cell,GO:0051726~regulation of cell cycle,GO:0051972~regulation of telomerase activity,GO:0051974~negative regulation of telomerase activity,GO:0060341~regulation of cellular localization,GO:0060548~negative regulation of cell death,GO:0061024~membrane organization,GO:0065003~macromolecular complex assembly,GO:0065009~regulation of molecular function,GO:0070201~regulation of establishment of protein localization,GO:0070227~lymphocyte apoptotic process,GO:0070228~regulation of lymphocyte apoptotic process,GO:0070230~positive regulation of lymphocyte apoptotic process,GO:0070231~T cell apoptotic process,GO:0070232~regulation of T cell apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,GO:0070242~thymocyte apoptotic process,GO:0070243~regulation of thymocyte apoptotic process,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0070271~protein complex biogenesis,GO:0070482~response to oxygen levels,GO:0070585~protein localization to mitochondrion,GO:0070647~protein modification by small protein conjugation or removal,GO:0070727~cellular macromolecule localization,GO:0070887~cellular response to chemical stimulus,GO:0070997~neuron death,GO:0071103~DNA conformation change,GO:0071156~regulation of cell cycle arrest,GO:0071158~positive regulation of cell cycle arrest,GO:0071214~cellular response to abiotic stimulus,GO:0071216~cellular response to biotic stimulus,GO:0071453~cellular response to oxygen levels,GO:0071456~cellular response to hypoxia,GO:0071478~cellular response to radiation,GO:0071479~cellular response to ionizing radiation,GO:0071482~cellular response to light stimulus,GO:0071496~cellular response to external stimulus,GO:0071822~protein complex subunit organization,GO:0071887~leukocyte apoptotic process,GO:0071897~DNA biosynthetic process,GO:0072331~signal transduction by p53 class mediator,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072395~signal transduction involved in cell cycle checkpoint,GO:0072401~signal transduction involved in DNA integrity checkpoint,GO:0072413~signal transduction involved in mitotic cell cycle checkpoint,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:0072431~signal transduction involved in mitotic G1 DNA damage checkpoint,GO:0072593~reactive oxygen species metabolic process,GO:0072594~establishment of protein localization to organelle,GO:0072655~establishment of protein localization to mitochondrion,GO:0072657~protein localization to membrane,GO:0090068~positive regulation of cell cycle process,GO:0090150~establishment of protein localization to membrane,GO:0090199~regulation of release of cytochrome c from mitochondria,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090311~regulation of protein deacetylation,GO:0090312~positive regulation of protein deacetylation,GO:0090316~positive regulation of intracellular protein transport,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:0090400~stress-induced premature senescence,GO:0090403~oxidative stress-induced premature senescence,GO:0090559~regulation of membrane permeability,GO:0097190~apoptotic signaling pathway,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097194~execution phase of apoptosis,GO:0097252~oligodendrocyte apoptotic process,GO:0097345~mitochondrial outer membrane permeabilization,GO:0097659~nucleic acid-templated transcription,GO:0098732~macromolecule deacylation,GO:1900117~regulation of execution phase of apoptosis,GO:1900119~positive regulation of execution phase of apoptosis,GO:1900739~regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901028~regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901214~regulation of neuron death,GO:1901216~positive regulation of neuron death,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1901987~regulation of cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1902108~regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902110~positive regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902275~regulation of chromatin organization,GO:1902400~intracellular signal transduction involved in G1 DNA damage checkpoint,GO:1902402~signal transduction involved in mitotic DNA damage checkpoint,GO:1902403~signal transduction involved in mitotic DNA integrity checkpoint,GO:1902531~regulation of intracellular signal transduction,GO:1902533~positive regulation of intracellular signal transduction,GO:1902580~single-organism cellular localization,GO:1902589~single-organism organelle organization,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902686~mitochondrial outer membrane permeabilization involved in programmed cell death,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1903047~mitotic cell cycle process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903747~regulation of establishment of protein localization to mitochondrion,GO:1903749~positive regulation of establishment of protein localization to mitochondrion,GO:1903827~regulation of cellular protein localization,GO:1903829~positive regulation of cellular protein localization,GO:1904951~positive regulation of establishment of protein localization,GO:1905269~positive regulation of chromatin organization,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2000106~regulation of leukocyte apoptotic process,GO:2000108~positive regulation of leukocyte apoptotic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000278~regulation of DNA biosynthetic process,GO:2000279~negative regulation of DNA biosynthetic process,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001141~regulation of RNA biosynthetic process,GO:2001233~regulation of apoptotic signaling pathway,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001242~regulation of intrinsic apoptotic signaling pathway,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,GO:2001252~positive regulation of chromosome organization,	GO:0000228~nuclear chromosome,GO:0000428~DNA-directed RNA polymerase complex,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0016604~nuclear body,GO:0016605~PML body,GO:0030880~RNA polymerase complex,GO:0034399~nuclear periphery,GO:0044427~chromosomal part,GO:0044429~mitochondrial part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0044798~nuclear transcription factor complex,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0000975~regulatory region DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001067~regulatory region nucleic acid binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001085~RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0002020~protease binding,GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005102~receptor binding,GO:0005507~copper ion binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030554~adenyl nucleotide binding,GO:0030971~receptor tyrosine kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0032549~ribonucleoside binding,GO:0032550~purine ribonucleoside binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035035~histone acetyltransferase binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0036094~small molecule binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043621~protein self-association,GO:0044212~transcription regulatory region DNA binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,GO:0051721~protein phosphatase 2A binding,GO:0097159~organic cyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:1901265~nucleoside phosphate binding,GO:1901363~heterocyclic compound binding,GO:1990782~protein tyrosine kinase binding,GO:1990837~sequence-specific double-stranded DNA binding,	hsa04010:MAPK signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04310:Wnt signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	114480~Breast cancer,114500~Colorectal cancer,114550~Hepatocellular carcinoma,137800~Glioma susceptibility 1,151623~Li-Fraumeni syndrome,202300~Adrenal cortical carcinoma,259500~Osteosarcoma,260350~Pancreatic cancer,260500~Choroid plexus papilloma,607107~Nasopharyngeal carcinoma,614740~Basal cell carcinoma 7,
36378_at	uroplakin 1A(UPK1A)	Homo sapiens	vesicoureteral reflux,	OTHER,	GO:0006461~protein complex assembly,GO:0007166~cell surface receptor signaling pathway,GO:0022607~cellular component assembly,GO:0030855~epithelial cell differentiation,GO:0043933~macromolecular complex subunit organization,GO:0044085~cellular component biogenesis,GO:0051259~protein oligomerization,GO:0060429~epithelium development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0071822~protein complex subunit organization,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005887~integral component of plasma membrane,GO:0016324~apical plasma membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031988~membrane-bounded vesicle,GO:0043230~extracellular organelle,GO:0044421~extracellular region part,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,GO:0098590~plasma membrane region,GO:1903561~extracellular vesicle,	GO:0030246~carbohydrate binding,GO:0036094~small molecule binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,GO:0048029~monosaccharide binding,		
41113_at	zinc finger protein 500(ZNF500)	Homo sapiens			GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010467~gene expression,GO:0010468~regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0016070~RNA metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0097659~nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2001141~regulation of RNA biosynthetic process,	GO:0005654~nucleoplasm,	GO:0001071~nucleic acid binding transcription factor activity,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0097159~organic cyclic compound binding,GO:1901363~heterocyclic compound binding,		
